i a a p anthroposophic pharmaceutical codex apc second edition 11

ANTHROPOSOPHICPHARMACEUTICAL CODEXAPC

4rd EDITION2017

International Association of Anthroposophic PharmacistsGoetheanumMedical Section4143 DornachSwitzerland

www.iaap.org.ukemail: [email protected]

IAAP International Association of Anthroposophic Pharmacists

ANTHROPOSOPHIC PHARMACEUTICAL CODEX APC 4.0

Introductory Note APC 4th edition, 2017

International Association of Anthroposophic Pharmacists, IAAP

The IAAP is the international umbrella organisation of the national associations of Anthroposophic Pharma- cists.

Its purpose, objective and tasks are, in detail:

• To represent anthroposophic pharmacy in the anthroposophic-medical movement and in public life on an international level: Anthroposophic pharmacy is understood as an extension of conventional pharmacy.

• To establish standards regarding further education and training as well as practice in anthroposophic pharmacy (including but not limited to retail phar-macy).

• To establish quality standards regarding manufactu-ring methods and substances used for anthroposo-phic medicinal products.

• To promote research in anthroposophic pharmacy.• To achieve international recognition by specialised

publications as well as training material for anthroposophic pharmacists.

• To establish a cooperative network between anthroposophic pharmacists to exchange information and best practice throughout the world.

• To initiate / coordinate international activities.

According to these aims the Board is pleased to publish the 4th edition of the Anthroposophic Pharmaceutical Codex (APC). Since this edition will only be presented in an electronic version, it has been possible to add more information, by giving easily accessible links to additional information.

Several manufacturing procedures have been adjusted to the wording and the requirements of the European Pharmacopoeia (Ph.Eur.) 9.2 (including the declaration of ethanol concentration in % V/V), especially because many methods have been adopted by the Ph.Eur. The changes are marked by a line to the side of the text. A new appendix (2.7) has been added to describe the production of some stocks by specific methods. The lists of starting materials used have been updated and widened to include for each substance 1) the manufacturing methods in use, 2) all relevant monographs of the Commission C and 3) the name of the monograph of the pharmacopoeia referred to.

In addition, several new substances, missing in the 3rd edition have been added. Further, the literature

references, which demonstrate that the substance is generally known and used in anthroposophic pharmacy / medicine, have been extended.

The APC is reviewed and updated by an anthropo-sophic pharmaceutical committee reporting to the IAAP board.

The changes in summary:

NEW TEXTS Part IIa: Production methods3.3.33.8.2

Part IV: AppendicesAppendix 2.2Boswellia speciesCampanula rotundifoliaCrataegus laevigata, C. monogyna, dried leavesIllicium verumLedum palustre Ph.fr.Malus domesticaOnonis spinosaOriganum majorana Ph.fr.Passiflora alataPinus sylvestris (essential oil DAB)Polygala senegaPrimula farinosaPrimula veris DAC (dried flowers)Solanum dulcamara Ph.fr.Veratrum album (fresh, underground parts)Veronica officinalis (fresh aerial parts) Viscum album L. 7 new substances

Appendix 2.3Arteria vertebralisCartilago (rabbit)Colon (rabbit)Cor (rabbit)Corpora quadrigemina (pig)Corpus ciliareCortex cerebriCutis (feti) (pig)Disci intervertebrales (pig)Gingiva (pig)Glandula suprarenales (rabbit)Globus oculiHypothalamus (rabbit)Lamina quadrigemina (rabbit)Larynx (rabbit)Lens cristallina (rabbit)Lien (rabbit)Mamma (rabbit)Mandibula (feti) (pig)

• Introductory N

ote

2


Maxilla (feti) (pig)Medulla spinalis (rabbit)Mucosa sinusalis (rabbit)Nervus oculomotorius (pig)Nervus ophtalmicus from the calfNervus opticus (pig)Nervus parasympathicus (rabbit)Ovarium (rabbit)Periodontium (pig)Retina (et chorioidea) (pig)Retina (et chorioidea) (rabbit)Stomachus (rabbit)Thymus (glandula) (rabbit)Truncus cerebri (rabbit)Truncus sympathicus (rabbit)Vaginae synovialis tendinum (pig)Vena cava (rabbit)

Appendix 2.4Calcarea phosphorica (calcium phosphate Ph.Eur.)Calcii lactasHepar sulfurisSulfur ad usum externum

Appendix 2.6Equisetum hyemale-RubellitOnopordon comp. praeparatum (CH)Rubellit comp.Viscum …: 8 new preparations

New appendix 2.7with 15 new preparations

REVISED TEXTS List of abbreviations and SymbolsPart IIa: Production methods"Correlation table ..." changed to "Survey of general methods for the manufacturing of anthroposophic medicinal products and related specific production methods in pharmacopoeias"

All concerned monographs: The test on 2-propanol has been deleted.All concerned monographs: The unit for the ethanol concentration was changed from m/m to V/V.Method 3.6 was changed to be in accordance with HAB 2016.Method 3.8 was changed to be in accordance with Ph.Eur. 9.0.Methods 7.2.3 and 7.2.4: "water for injections" was replaced by "purified water".

• In

trod

ucto

ry N

ote

3

Part IV: AppendicesFor each substance, preparation methods and all monographs have been added. The "references to standards" have been updated. The names of many substances have been changed in accordance with changes to the pharmacopoeias.

Appendix 2.6Quercus robur/petrae e cortice cum Calcio carbonico changed in Quercus e cortice cum Calcio carbonicoFor many compositions the potentising method has been added to the preparation method.

DELETED TEXTS Appendix 2.1:CalciteCalx jurassicaCarnelianDiamondPyrolysitSulfurSulfur selenosumTerra rubraVanadiniteZircon

Appendix 2.2: Acorus calamus (Volatile oil from the underground parts)Adonis vernalis (fresh flowers)Aethusa cynapiumAilanthus altissimaAjuga reptansAlchemilla xanthochloraAmaryllis belladonnaAnagallis arvensis (fresh aerial parts)Anagallis arvensis Ph. fr. (not fresh aerial parts)Angelica archangelica (fermented juice from roots)Armoracea rusticanaArmoracea rusticana Ph.fr.Arundo donax Aspidosperma quebracho-blancoAtropa belladonna Ph.fr. (now Ph.Eur.)Atropa bella-donna DACBallota nigraBambusa arundinacea, Bambusa vulgarisBoswellia species ( Olibanum DAC)Botrychium lunariaCentaurium erythraeaChamaelirium luteumCheiranthus cheiriChondodendron tomentosumCichorium intybus (dried root)Coffea arabica Ph.fr.


4

Colchicum autumnale Ph.fr.Collinsonia canadensis L.Croton tiglium L.Cupressus sempervirensEuphorbia resiniferaFilipendula ulmaria (fresh inflorecence)Fraxinus americanaFucus vesiculosusGalium odoratumGlechoma hederacea Ph.fr.GramineaeHeracleum mantegazzianumHibiscus sabdariffaHippophaë rhamnoides (fresh branches with fruits)Hoya carnosaHumulus lupulusLaurus nobilisLavandula angustifolia HAB (fresh flowers)Lavandula angustifolia Ph.fr. (flowering stems)Leptandra virginicaLevisticum officinale, whole fresh plantLevisticum officinale, fresh flowersLevisticum officinale, fresh leavesLilium lancifolium Ph.fr. (whole fresh flowering plant)Linum usitatissimum (linseed)Lophophora williamsiLycopersicon lycopersicum, fresh ripe fruitsMalus sylvestris (core from fresh fruit)Malus sylvestris (fresh unripe fruit)Malva sylvestris Ph.fr.Medicago sativaMelilotus officinalisMenyanthes trifoliataMomordica balsaminaMonotropa unifloraOcimum basilicum (dried flowering aerial parts)Ornithogalum umbellatumPetroselinum crispum (dried roots)Phyllanthus niruriPicea nigra (dried resin)Piper nigrum (dried fruit)Plantago lanceolata DAB 1999Plantago lanceolata Ph.Eur.Podophyllum peltatumPollenPolygala amaraPolypodium vulgare (fresh underground parts)Primula veris Ph.fr. (dried flowers)Ptelea trifoliateRhamnus purshianaRhododendron ferrugineum L. (Ph.fr. remains)Robinia pseudoacacia (HAB/Ph.fr. remains)Rosa caninaSambucus nigra (dried inflorescence)Sanicula europaea HAB

Saponaria officinalisSarcopoterium spinosumScrophularia nodosaScutellaria laterifoliaSedum acre (HAB remains)Sedum telephiumSenecio vulgarisSerenoa repens HABSmilax species Ph.fr.Solanum dulcamara HABSpigelia anthelmia Ph.fr.Stellaria mediaSyzygium jambosTanacetum vulgareTeucrium marum HABTriticum aestivum (fresh flowers)Urginea maritima var. rubra (HAB remains)Urtica dioica, fresh leavesUrtica dioica: Urticae folium Ph.Eur.Urtica dioica (dried leaves)Vaccinium myrtillus Ph.Eur.Vaccinium vitis-idaeaValeriana officinalis (fresh flowers)Veratrum album Ph.fr. (fresh)Verbascum densiflorum HABVerbascum densiflorum (dried fruit)Vinca minorViola tricolor Ph.fr.Viola tricolor (Violae herba cum flore Ph.Eur.)Viscum album (Fresh plant excluding haustorium (Host tree: Oak))Viscum album (Fresh plant excluding haustorium (Host tree: e.g. Ulmus caprinifolia Gled., Elm))Viscum album HABViscum album (Fresh shoots collected in summer and flowers collected in winter (Host tree: Salix alba))Viscum album (Fresh aerial parts including fruit of Viscum album L. (Host trees: Apple, Birch, Fir, Pine, Lime))Zea mays

Appendix 2.3Asterias rubens BadiagaBlatta orientalisBothropsBufo ranaDuctus deferensElapsFavusFel: Bile from gall bladder from the rabbitGlucogenumJejunumKeratinum EquiLachesis lanceolatus

• Introductory N

ote


5

MoschusNervus trigeminus from the rabbitOssa (Bones from the pig)Ossa longa from the calfPelvis renalis (et Ureter) from the calfPortio vaginalis from the cowSepiaTarantula hispanicaTestes from the rabbitThalamus from the rabbitTruncus encephali (brain stem)Truncus encephali (hypothalamus and other organs)Uterus from the pigVena tibialis

Appendix 2.4Acidum benzoicum Acidum benzoicum e resina Acidum citricum (Citric acid)Acidum formicicumChinini sulfasFerrum gluconicumHydrargyrum stibiato-sulfuratumHydrargyrum sulfuratum nigrumKalium arsenicosum pphStannum silicicumStibium sulfuratum nigrum

Appendix 2.6Hepar sulfuris (now in app. 2.4)Lapis Cancri praeparatusOnopordon comp. praeparatum (D)Quarz cum Ferro sulfuricoViscum Pini cum ArgentoViscum Pini cum Cupro

Members of the APC committee

Gabriele Jones, pharmacist, Germany, member of the Further Education Committee of GAPiD.

Jakob Maier, pharmacist, Switzerland, Board member of VAEPS and member of the Committee on Comple- mentary Medicinal Products of the Swiss Pharmaco- poeia (Ph.Helv.) until April 2017.

Peter Pedersen, pharmacist, Denmark (chairman), former member of the Committee on Manufacturing Methods of the German Homoeopathic Pharmacopoeia (GHP/HAB).

René Schwarz, biology technician, former head of production Weleda Switzerland, Board member of VAEPS.

Responsible person of the IAAP:

Mónica Mennet-von Eiff, pharmacist, Switzerland, President of the Swiss association VAEPS, Board member of the IAAP; member of the Working Group HOM on Homoeopathic Raw Materials and Stocks of the European Pharmacopoeia (Ph. Eur. HOM WP).

The committee appreciates substantial help from Anne Vernet (Weleda, France), Elke Heid (WALA), Wolfram Engel (Weleda, Germany) and Anja Glockmann (ESCAMP, Germany).

The APC is recognised by the following national anthroposophic pharmaceutical associations:

the French Association AFERPA (Association Française d'étude et de recherche sur la pharmacie anthroposophique – French Association for Studies and Research on Anthroposophic Pharmacy);the Brazilian Association Farmantropo (Associação Brasileira de Farmácia Antroposófica – Brazilian An- throposophic Pharmacy Association);the German Association GAPiD (Gesellschaft Anthroposophischer Apotheker in Deutschland – Society of Anthroposophic Pharmacists in Germany);the Austrian Association ÖGAPh (Österreichische Gesellschaft anthroposophischer Pharmazeuten – Austrian Society of Anthroposophic Pharmacists);the Italian Association SOFAI (Società di farmacisti antroposofi in Italia – Society of Anthroposophic Pharmacists in Italy);the pharmacist section of the Swiss association VAEPS (Verband für Anthroposophisch Erweiterte Pharmazie in der Schweiz – Association for Anthroposophically Extended Pharmacy in Switzerland).

Dr. Manfred Kohlhase, President IAAP, 30.06.2017For full details of the IAAP Guidelines, see website www.iaap.org.uk

• In

trod

ucto

ry N

ote


6


• Fo

rew

ord

7

Foreword

Pharmacy extended by the principles of anthroposophy began to be developed at the beginning of the 20th century by Rudolf Steiner (founder of anthroposophy, 1861 – 1925) and Oskar Schmiedel (Austrian chemist, 1887 – 1959), in collaboration with a number of physicians. Their aim was to reinterpret and complement the results of pharmaceutical and medical research with insights gained from anthroposophic research of the human being and nature.The basis of the anthroposophic approach to pharmacy is the “holistic” knowledge of mankind and nature, which recognizes the notion that human beings and the kingdoms of nature are related through a common evolution1.This perception leads to a comprehensive view of substances in their relationship to health, illness and to a specific approach to pharmacy.

Therefore anthroposophic pharmacy uses substances from the mineral, plant and animal kingdoms2,3.

Anthroposophic medicinal products have been on the market world-wide and prescribed by qualified medical practitioners since 1921.

The range of anthroposophic medicinal products is partially determined by the physical characteristics of substances, whereby allopathic, phytotherapeutic and homoeopathic criteria are taken into consideration. Most particularly, anthroposophic medicinal products are characterised by their manufacturing processes involving specific anthroposophic and typical homoeopathic pharmaceutical procedures. The range of anthroposophic medicinal products includes potentised medicinal products, manufactured by using the methods of the official homoeopathic pharmacopoeias, as well as concentrated mineral, herbal or animal substances or preparations and compounded medicinal products. Considering this diversity, anthroposophic medicinal products, cannot be defined under a single substance classification.

1 Jos Verhulst: „Der Erstgeborene“ (The first-born), publisher Verlag Freies Geistesleben, Stuttgart, D 2001.2 Rudolf Steiner/Ita Wegman: „Grundlegendes für eine Erweiterung der Heilkunst nach geisteswissenschaftlichen Erkenntnissen.“ GA 27, publisher Rudolf Steiner Verlag, Dornach, CH, 1992.In English: „Extending Practical Medicine – Fundamental Principles based on the Science of the Spirit“. Rudolf Steiner Press , London, GB, 1996.3 Rudolf Steiner: „Geisteswissenschaft und Medizin“, 20 Vorträge für Ärzte (1920), Rudolf Steiner Verlag, Dornach, CH 1985.In English: „Introducing Anthroposophical Medicine“ (previously published as: Spiritual Science and Medicine). Twenty lectures to doctors. Dornach 21 March – 9 April 1920, GA 312. Anthroposophic Press, Hudson, NY, USA, 1999.

The Anthroposophic Pharmaceutical Codex APC gives an overview of substances and methods used in the manufacture of anthroposophic medicinal products as well as of the related quality parameters.

Legal SituationToday the European Union Directive 2001/83/EEC and amendments contain the main legislation concerning medicinal products. The legal status of anthroposophic medicinal products in the EU is closely related to that of homoeopathic medicinal products (see below).

Preamble of Directive 2001/83/EEC n° (22) refers to anthroposophic medicinal products as follows:“Anthroposophic medicinal products, which are described in an official pharmacopoeia and prepared by a homoeopathic method are to be considered, as regards to registration and marketing authorization, as homeopathic medicinal products.”

From a regulatory point of view anthroposophic medicinal products can be devided into two categories:• anthroposophic medicinal products manufactured

according to a homoeopathic manufacturing method within the meaning of Directive 2001/83/EEC, article 1, 5.: “Any medicinal product prepared from substances called homoeopathic stocks in accordance with a homoeopathic manufacturing procedure described by the European Pharmacopoeia or, in absence thereof, by the pharmacopoeias currently used officially in the Member States. (...)”

• anthroposophic medicinal products other than those manufactured by a homoeopathic manufacturing method.

These are equally important and have never been included in any pharmacopoeia.

The definitions of anthroposophic medicinal products given in the Swiss and German Drug Laws take both categories into account (translations by APC Committee):

Switzerland: Regulation of Swissmedic concerning the simplified Authorisation of Complementary and Herbal Medicinal Products (Verordnung des Schweizerischen Heilmittelinstituts über die vereinfachte Zulassung von Komplementär- und Phytoarzneimitteln) Art. 4,2 f: Anthroposophic medicinal product: Medicinal product, whose active substances are manufactured by a homoeopathic manufacturing procedure, or according to an anthroposophic manufacturing procedure described in the German Homoeopathic Pharmacopoeia or in the British

• Forew

ord

Homoeopathic Pharmacopoeia or according to a special anthroposophic manufacturing procedure and that is formulated and developed according to the anthroposophic knowledge of man, animal, substance and nature and is meant to be used according to these principles.

Germany: Medicinal Products Act (Gesetz über den Verkehr mit Arzneimitteln) Art. 4, (33) An anthroposophic medicinal product is a medicinal product that has been developed according to the anthroposophic knowledge of man and nature and that is manufactured according to a homoeopathic manufacturing procedure described in the European Pharmacopoeia or in absence thereof in a pharmacopoeia officially used in the Member States or according to a special anthroposophic manufacturing procedure and that is meant to be used according to the anthroposophic principles concerning man and nature.

In many EU countries, and also world-wide, medicinal products used for the anthroposophic therapeutics are thus partially integrated in legislation.

In Brazil as well as in Australia the APC has been officially recognised as quality standard and reference for anthroposophic medicinal products (RESOLUÇÃO RDC No – 26, DE 30 DE MARÇO DE 2007; amendments to the Australian Therapeutic Goods Act, 2009).

In summary anthroposophic medicinal products as a whole are step by step gaining legal recognition in the EU as well as world-wide, and among other things this requires comprehensive publication of their pharmaceutical quality.

The publication of the Anthroposophic Pharmaceutical Codex is to provide transparency of anthroposophic pharmaceutical quality for pharmacists and bodies requiring an appreciation of anthroposophic medicinal products and pharmacy. Furthermore it provides a basis for the maintenance of existing and development of new anthroposophic medicinal products.

The relationship of the APC to the European Pharmacopoeia, to other existing official Pharma-copoeias and non official pharmacopoeias

The APC is published by the IAAP, an independent association of professional pharmacists, within the context of official existing pharmacopoeias. It is the intention of the APC to refer where possible to existing pharmacopoeias. In fact anthroposophic medicinal

8

products are often manufactured and controlled according to existing specifications and standards.A part of the reference pharmacopoeias for the APC are published by official Authorities, in particularThe European PharmacopoeiaThe French PharmacopoeiaThe German Homoeopathic Pharmacopoeia (which is a part of the German Pharmacopoeia);The Swiss Pharmacopoiea has implemented two texts concerning anthroposophic pharmacy in the last eight years:• in 2009 (Suppl. 10.1) with the general Ph.Helv.-mo-

nograph “Praeparationes anthroposophicae (Anth-roposophic Preparations)” (Ph.Helv. CH 306); it was the first time that anthroposophic preparations ap-peared as a monograph in an official pharmacopeia. This monograph includes the paragraphs definitions, starting materials, methods of preparation and dosage forms, by analogy with the Ph.Eur.-monograph Homoeopathic preparations Ph.Eur. 1038.

• in September 2013 (Suppl. 11.1) the new Ph.Helv.-chapter “17.7 Manufacturing methods for anthropo-sophic preparations” came into force. This chapter gives an overview on the general manufacturing processes and describes in more detail some manu-facturing methods which are more frequently used in anthroposophic pharmacy and had not been described in an official pharmacopoeia before.

The APC served as important basis to establish both of these Ph.Helv.-texts. Therefore it can be concluded, that the continuing work of the APC supports the establishment of the pharmaceutical quality standards and the regulation of anthroposophic medicinal products in Switzerland.

Further official pharmacopoeias of reference:The Austrian PharmacopoeiaThe British Pharmacopoeia

In particular the European Pharmacopoeia today represents and for the future will represent a reference of paramount importance for the APC.

Therefore in part IV of the APC containing the lists of the various substances used in anthroposophic pharmacy reference is made where possible to the European Pharmacopoeia and other official pharmacopoeias.

Particularly important Ph.Eur. monographs are:Herbal drugs for homoeopathic preparations (2045)Homoeopathic preparations (1038)Methods of preparation of homoeopathic stocks and potentisation (2371)Minimising the risk of transmitting animal spongiform


• Fo

rew

ord

9


encephalopathy agents via human and veterinary medicinal products (50208)Mother tinctures for homoeopathic preparations (2029)Tinctures (chapter in 0765 Extracts)Viral safety (50107)Other pharmacopoeias referred to in the APC are not officially recognised. Nevertheless they provide reliable standards accepted e.g. by regulatory authorities, in particular the British Homoeopathic Pharmacopoeia.

The IAAP understands its task to sustain anthro-posophic pharmaceutical activities at any level (e.g. manufacturing, quality control, regulatory affairs), worldwide, that is, beyond the countries of the European Pharmacopoeia Convention. Therefore during the evolution of the APC other official pharmacopoeias (or reliable private pharmacopoeias) will possibly be referred to, e.g. the Brazilian Pharmacopoeia.

• Table of C

ontent

10


Table of ContentStructure of the Anthroposophic Pharma ceutical Codex, APC ...................................................................................12List of Abbreviations and Symbols ....................................................................................................................................13Glossary ................................................................................................................................................................................14

PART IDefinitions ......................................................................................................................................................... 151. Anthroposophic medicinal product .............................................................................................................................162. Starting materials, general information .......................................................................................................................16

2.1. Minerals, rocks, including natural waters ...........................................................................................................162.4. Starting materials that can be described chemically..........................................................................................162.5. Starting materials that have undergone special treatment ................................................................................162.6. Compositions (for further information see “Glossary”) ...................................................................................16

3. Vehicles and excipients ...................................................................................................................................................184. Active substances .............................................................................................................................................................18

4.1. Starting materials ...................................................................................................................................................184.2. Preparations ............................................................................................................................................................18

PART IIa General monographs of preparations and specific production methods (Pharmaceutical processes) .......... 19Introduction .........................................................................................................................................................................20Survey of general methods for the manufacturing of anthroposophic medicinal products and related specific production methods in pharmacopoeias .........................................................................................................................221. SPECIAL TREATMENTS OF RAW MATERIALS....................................................................................................24

1.1. Vegetabilisation methods (“vegetabilised metals“) ............................................................................................242. METAL PREPARATIONS .............................................................................................................................................25

2.1. Metal mirrors ..........................................................................................................................................................253. TINCTURES, MOTHER TINCTURES, GLYCEROL MACERATES AND VISCOUS EXTRACTS .................26

3.1. Cold treated mother tinctures and liquid preparations thereof .......................................................................263.2. Tinctures and mother tinctures made by macerations with water or ethanol/water ....................................273.3. Glycerol macerates .................................................................................................................................................283.4. Liquid preparations made by maceration with oil .............................................................................................303.5. Mother tinctures made by percolation ................................................................................................................303.6. Buffered aqueous mother tinctures manufactured under exclusion of oxidative influence ..........................313.7. Fermented mother tinctures .................................................................................................................................323.8. Tinctures and mother tinctures made by digestion (Digestio) ........................................................................333.9. Tinctures and mother tinctures made by infusion (Infusum) .........................................................................343.10. Tinctures and mother tinctures made by decoction (Decoction) .................................................................353.11. Viscous extracts with heat treatment .................................................................................................................363.12. Preparations made by distillation (Distillates) .................................................................................................373.13. Mother tinctures obtained by rhythmic application of heat and cold...........................................................38

4. SOLID STARTING MATERIALS OBTAINED BY HEAT .......................................................................................394.1. Toasted preparations – Tosta .................................................................................................................................394.2. Carbons – Carbo .....................................................................................................................................................404.3. Ashes – Cinis ...........................................................................................................................................................40

5. SOLID PREPARATIONS FROM PLANTS (DRYING ONTO A VEHICLE) .......................................................415.1. Solid preparations from fresh plants ...................................................................................................................415.2. Solid preparations from liquids, plant juices or aqueous extracts ...................................................................41

• Ta

ble

of C

onte

nt

11


6. LIQUID DILUTIONS .....................................................................................................................................................427. COMPOSITIONS ...........................................................................................................................................................43

7.1. Compositions made by treating two or more starting materials by one or more pharmaceutical processes .................................................................................................................437.2. Compositions made by treating two or more extracts or mother tinctures of one plant by one or more pharmaceutical processes ............................................................................................437.3. Compositions made by treating one or more starting materials with one or more mother tinctures which undergo one or more pharmaceutical processes together ..........................................................457.4. Compositions made by treating two or more extracts or mother tinctures and/or dilutions by one or more pharmaceutical processes ....................................................................................457.5. Compositions made by co-potentising................................................................................................................46

8. POTENTISED PREPARATIONS .................................................................................................................................468.1. Co-potentised preparations ..................................................................................................................................478.2. Potentising in an ointment base ...........................................................................................................................478.3. Triturations..............................................................................................................................................................48

9. MIXTURES ......................................................................................................................................................................48

PART IIb Individual monographs of starting materials and preparations ..................................................................... 50CYDONIA OBLONGATA, FRUIT ..................................................................................................................................51CYDONIA OBLONGA, FRUIT, HEAT TREATED AQUEOUS TINCTURE 1:2.1 .................................................51CYDONIA OBLONGATA, FRUIT, GLYCEROL EXTRACT WITH HEAT TREATMENT 1:2.1 ..........................52CYDONIA OBLONGATA, FRUIT, MOTHERTINCTURE OBTAIND BY RHYTHMIC APPLICATION OF HEAT AND COLD CYDONIA OBLONGATA E FRUCTIBUS FERM 33B .........................53LEVICO WATER .................................................................................................................................................................54

PART III Dosage forms ..................................................................................................................................................... 56INDEX LIST OF TERMS OF PART I, II AND III .........................................................................................................60

PART IVAppendices ........................................................................................................................................................ 64Note concerning appendix 2.3. ..........................................................................................................................................65 Note concerning appendices 2.1., 2.4. and 2.6. ................................................................................................................65 References concerning nomenclature in appendices 2.1. to 2.7 ....................................................................................65 Note concerning the references for use in anthroposophic medicine in appendices 2.1. to 2.7 ...............................65 References concerning the use in anthroposophic medicine in appendices 2.1. to 2.7 .............................................66

Appendix 2.1. List of minerals, rocks and natural waters ...............................................................................................73Appendix 2.2. List of starting materials of botanical origin ...........................................................................................83Appendix 2.3. List of starting materials of zoological origin ...................................................................................... 135 Appendix 2.4 List of starting materials that can be described chemically ............................................................... 167Appendix 2.5. List of starting materials that have undergone special treatment ..................................................... 185Appendix 2.6. List of compositions ................................................................................................................................ 189Appendix 2.7. Stocks with special manufacturing methods ....................................................................................... 201Appendix II .................................................................................................................................................................... 205Correlation table: Ph.Eur. / HAB manufacturing methods used in anthroposophic pharmacy and corresponding manufacturing methods in the HPUS ........................................................................................... 205

• Structure of A

PC

Structure of the Anthroposophic Pharma ceutical Codex, APC

Part I “Definitions” provides definitions and describes quality aspects as well as parameters related to anthroposophic medicinal products. The different stages incurred in the obtaining of a medicinal product, from the starting material to the dosage form, are described in this part.

Part IIa “General Monographs of specific production methods (Pharmaceutical processes)” contains general monographs concerning the types of preparations/ active substances that are prepared by specified procedures. Beneath the relevant general monograph(s), different specific production methods by which a particular type of a starting material can be prepared are either quoted from other pharmacopoeias or an APC production method is set out.

In this way, the relationship between the APC and other pharmacopoeias, as well as the option to define substances through their production methods are outlined.

Schematically the following order is applied:

General monographs

Definition, Identification, Tests, Assay, Storage, Recommended Designation

Specific production methods related to the particular general monograph

Ph.Eur. Methods

HAB Methods

Ph.fr. Methods

B.Hom.P. Methods 1, 2, 3, 4, 5a, 5b, 6,

8a, 12

APC Methods

12

Part IIb “Monographs of starting materials and preparations” sets standards for specific starting materials and preparations. In their last section the monographs of the starting materials list a) Some existing anthroposophic preparations that utilise the starting material and/ or b) Manufacturing methods, described in the Ph.Eur., the HAB or the APC commonly used for the processing of the particular starting material. That list is not meant to be exhaustive.

Part III, information about dosage forms in anthroposophic pharmacy as well as production methods of specific dosage forms for anthroposophic medicinal products.

Part IV “Appendices”

In appendix I starting materials for the preparation of anthroposophic medicinal products are listed (not excipients and vehicles). The appendices are numbered according to the related chapter in part I: 2.1., 2.2., 2.3., 2.4., 2.5., 2.6.

In appendix II a link to the HPUS is given:• Correlation table: Ph.Eur./HAB manufacturing

methods used in anthroposophic pharmacy and corresponding manufacturing in the HPUS.


• St

rucr

ure

of A

PC

13


List of Abbreviations and Symbols

* see p. 65

1 CH Symbol for the first centesimal potency, see also C1 and 1C

1 DH Symbol for the first decimal potency, see also D1 and 1X

1C Symbol for the first centesimal potency, see also 1 CH and C1

1X Symbol for the first decimal potency, see also 1 DH and D1

ABMA-Vade-mecum

Gardin NE, Schleier R: Medicamentos Antroposóficos: Vademecum. Associação Brasileira de Medicina Antroposófica. São Paolo:Editor João de Barro; 2009

APC Anthroposophic Pharmaceutical Codex

aph ad preparationes homoeopathicae

API Active Pharmaceutical Ingredient

B.Hom.P. British Homoeopathic Pharmacopoeia

B.P. British Pharmacopoeia

Br1 Numbering of the production methods of the B.Hom.P.

C1 Symbol for the first centesimal potency, see also 1 CH and 1C

CVD Chemical Vapour Decomposition

D1 Symbol for the first decimal potency, see also 1 DH and 1X

DAB Deutsches Arzneibuch(German Pharmacopoeia)

DAC Deutscher Arzneimittel-Codex(German Codex of Medicinal Products)

DER Drug extract ratio

EU European Union

fhp for homoeopathic preparations

GHP German Homoeopathic Pharmacopoeia. Unauthorized translation of the HAB. In case of differences between the GHP and the HAB the latter is decisive

Gl Symbol for mother tinctures prepared by HAB method 41 using glycerol

H 2.2.6 Analytical method specified in the HAB

HAB Deutsches Homöopathisches Arzneibuch(German Homoeopathic Pharmacopoeia)

HPUS The Homœopathic Pharmacopœia of the United States

IAAP International Association of Anthroposophic Pharmacists

IVAA statement2013

see p. 67

KC Mono-graph

Monograph of the “Kommission C” (Commission of the German Ministry of Health for the anthroposophic therapeutic system and substances), published in the official Gazette of the German government (in German: “Bundesanzeiger”)

Liste HAS Liste der Homöopathischen und Anthropo- sophischen Stoffe (Anhang 4 zurVerordnung des Schweizerischen Heilmittelinstituts über die vereinfachte Zulassung von Komplementär- und Phytoarzneimitteln (List of Homoeopathic and Anthroposophic Subtances (Appendix 4 in the Regulation of the Swissmedic concerning the simplified Authorisation of Complementary and Herbal Medicinal Products in Switzerland))

LM Symbol for potencies prepared according to Ph.Eur. (2371) 5.2

MT Mother tincture

Ph.Eur. European Pharmacopoeia

Ph.Eur. (2371)

Ph.Eur. Monograph 2371 “Methods of preparation of homoeopathic stocks and potentisation”

Ph.fr. Pharmacopée Française (french Pharma copoeia), including monographies de souches pour préparations homéopathiques (monographs of the stocks for homoeopathic preparations)

Ph.Helv. Pharmacopoea Helvetica(Swiss Pharmacopoeia)

pph pour préparation homöopathiques

• Structure of A

PC

Glossary

In this glossary only those terms are referred to, that need extra clarification prior to the definitions given in part I.

Composition Definition given in the monograph “Anthroposophische Zubereitungen”, (Anthroposophic preparations), Swiss Pharmacopoeia, Supplement 10.2, (translation by Swissmedic): “Compositions are active substances which are obtained, when two or more starting materials or preparations, with or without excipients, are processed together in a pharmaceutical process of anthroposophic pharmacy (e.g. Ferrum-Quarz).”

Excipient Excipients are auxiliary substances, which may be used for the production of pharmaceutical dosage forms. Excipients may beused in the production of mixtures.

Pharmaceutical process General term for substance transformations at different stages to obtain starting materials for medicinal products or a medicinal product.

Preparation/active substance

A class of processed starting material specified in the monographs of part II.

Production method A general manufacturing procedure specified in a pharmacopoeia (see e.g. HAB).

Raw material Substance which has not undergone any pharmaceutical process and meets a general quality characterisation, e.g. an optical identification.

Starting material A substance or a composition that meets a specification and can be used as active substance or can be further processed.

Vehicle Vehicles are auxiliary substances which may be used to produce an active substance. Vehicles may be used in the production of mixtures.

14


Q Symbol for potencies dilutedby the ratio 1: 50 000

Rh Symbol for mother tinctures prepared by HAB methods 21 and 22 (rhythmic procedure)

Vade-mecum

Gesellschaft Anthroposophischer Ärzte in Deutschland (ed.)Vademecum Anthroposophische Arzneimittel3.erg. Aufl. Der Merkurstab 2013; 66 (Suppl.)

• A

PC P

art I

15



PART IDefinitions

Table of ContentPart I1. Anthroposophic medicinal product .................. 162. Starting materials, general information ............ 16 2.1. Minerals, rocks, including natural waters . 16 2.2. Starting material of botanical origin .......... 16 2.3. Starting materials of zoological origin ....... 16 2.4. Starting materials that can be described chemically ........................................... 16 2.5. Starting materials that have undergone special treatment .............................. 16

2.6. Compositions (for further information see “Glossary”) .......... 163. Vehicles and excipients........................................ 184. Active substances ................................................. 18 4.1. Starting materials .......................................... 18 4.2. Preparations................................................... 18

• A

PC Part I

1. Anthroposophic medicinal product

definitionAn anthroposophic medicinal product is conceived, developed and produced in accordance with the anthroposophic knowledge of man, nature, substance and pharmaceutical processing1. The application within anthroposophic medicine results from that knowledge².

According to anthroposophic principles, active substances may be starting materials which are used as such or starting materials which have been transformed into active substances by a process of anthroposophic pharmacy, including compositions.

An anthroposophic medicinal product can contain one or more active substances (see also part I, chapter 4).

An anthroposophic medicinal product can fundamentally be employed in every dosage form, including external (topical), internal and parenteral dosage forms (see also part III).

productionThe active substances or dosage forms of anthroposophic medicinal products are produced:

• in accordance with classical homoeopathic or anthro-posophic-homoeopathic manufacturing methods as described in the Ph.Eur., HAB, Ph.fr., and B.Hom.P. (Methods 1, 2, 3, 4, 5a, 5b, 6, 8a, 12)

• in accordance with anthroposophic pharmaceutical codex production methods, i.e. “APC Methods”

and/or• in accordance with anthroposophic manufacturing

methods described in the individual monograph.

An anthroposophic medicinal product complies with the relevant specifications/ monographs set out in parts I and II.

1 See IAAP brochure: “Basic Information on the Working Principles of Anthroposophic Pharmacy”, 2005, http://www.iaap.org.uk/downloads/principles.pdf2 For clarification it has to be mentioned here, that anthroposophic medicine from the beginning includes “Over the Counter” products (OTC). A part of its medicinal products had been conceived right from the start for broad use for typical health disorders; see Chapter XX, “Typical Remedies”, in Rudolf Steiner/Ita Wegman: “Grundlegendes für eine Erweiterung der Heilkunst nach geisteswissenschaftlichen Erkenntnissen.” GA 27, publisher Rudolf Steiner Verlag, Dornach, CH, 1992.In English: “Extending Practical Medicine – Fundamental Principles based on the Science of the Spirit”. Rudolf Steiner Press , London, GB, 1996.

16

recommended designation Concerning the designation of anthroposophic medicinal products a reference to the APC is recommended.

2. Starting materials, general information

Starting materials for the production of anthroposophic medicinal products are:

2.1. Minerals, rocks, including natural waters

2.2. Starting materials of botanical origin Dried or fresh plants or parts of plants, including algae, fungi and lichens; Plant secretions, juices, extracts, oleoresins, essential oils or distillation products.

2.3. Starting materials of zoological origin Whole animals, organs, parts of organs dried or fresh; Animal secretions, extracts, blood products, calcareous products.

2.4. Starting materials that can be described chemically

2.5. Starting materials that have undergone special treatment

2.6. Compositions (for further information see “Glossary”)

Starting materials for the production of anthroposophic medicinal products comply with any relevant monograph in the European Pharmacopoeia or in the absence thereof, with the relevant monographs in national pharmacopoeias used in the Member States, or in absence thereof with the individual monograph.

Starting materials can be active substances themselves or can be processed into preparations (see also Part I, chapter 4).


• A

PC P

art I

17


2.1. Minerals, rocks, including natural watersMinerals are solid, crystalline components of natural origin belonging to the earth’s crust and other celestial bodies. A mineral has a defined crystal system and crystal class. Minerals are chemically and physically homogeneous to a significant extent. In reality, however, there are always deviations from the theoretical mineral formula. Many minerals may show differences in their colours. Form and habitus may be significantly different within the same type.

Rocks are composed of one or more minerals having a geological definition and distribution in their natural deposit with a certain statistical homogeneity.

Pieces that will be used for production should be big enough to allow mineralogical identification. If a powdered mineral is used, adequate documentation should ensure the quality and natural origin. In fact pieces used for production must be free from visible foreign matter. They have not undergone any unwanted mechanical or chemical treatment: in particular any chemical reaction, colouring, varnishing, heating and artificial radiation must be excluded. The amount of foreign matter accepted after chemical analysis is specified in the respective monograph.

Natural waters can come from a natural source (e.g. Levico), from the sea (e.g. aqua maris) or from mineral cavities (e.g. agate water).

List of minerals, rocks, including natural waters: see part IV, appendix 2.1.

2.2. Starting materials of botanical originStarting materials of botanical origin are:• Dried or fresh plants or parts of plants,

including algae, fungi and lichens;• Plant secretions, juices, extracts, oleoresins,

essential oils or distillation products.

Fresh plants should be used shortly after harvest. If this is not possible, the quality is guaranteed by appropriate measures, e.g. freezing.

If material from cultivated plants is used preference should be given to materials from plants cultivated by biodynamic cultivation (“Demeter” certified) or by other certified organic cultivation methods in accordance to the relevant European regulations ruling organic agricultural products (see also Council Directive (EEC) n° 2092/91).If wild plants are harvested protection of species according to relevant regulations is granted and special care is taken of the eco-system concerned.

Plants or parts of plants are, as far as possible, free from impurities such as soil, dust, dirt and other contaminants such as fungal, insect and other animal contaminations. They are not decayed.

Harvested plants or the mother tinctures made thereof are analysed for content of heavy metals and pesticides.The range and frequency of this testing can occur according to a monitoring plan based on risk assessment.

Unless otherwise stated, the collecting or harvesting times are generally:

Whole plants with underground partsand plants without underground parts

at flowering time

Leaves and shoots when fully developed

Flowers shortly after opening

Bark throughout the year

Underground parts of annual plants

at seed ripening time

Underground parts of biennial and perennial plants

in spring

Fruits and seeds at the time of ripening

Fungi when the fruiting bodies are fully developed

Particle size: according to Ph.Eur. 2.1.4 Sieves.

Starting materials of botanical origin see part IV, appendix 2.2.

2.3. Starting materials of zoological originStarting materials of zoological origin are:• Whole animals, organs, parts of organs

dried or fresh;• Animal secretions, extracts, blood products,

calcareous products. Lower animals as well as warm-blooded animals are used.

• A

PC Part I

Animal husbandry and keeping must be adequate for the animal species (see also Council Directive (EEC) n° 2092/91). In particular in the case of warm-blooded species animals from well-monitored “Demeter” or biodynamic herds are preferentially used.

The starting materials of zoological origin must meet the requirements of the European and/ or relevant national pharmacopoeias regarding the preparation of medicinal products from materials of animal origin and with EU directives and/or national guidelines of the appropriate regulatory authorities.In particular the Ph.Eur. monographs on TSE safety (Ph.Eur. 50208), and viral safety (Ph.Eur. 50107) apply.

Animals must be healthy and in good hygienic condition. The intervals given in legislation after the administration of drugs to animals must be observed before the animals are used.

Health requirements, animal keeping, protection of species and processing of animals must comply with the relevant guidelines of responsible national authorities and those of the European Union, where applicable.

List of starting materials of zoological origin see part IV, appendix 2.3.

2.4. Starting materials that can be described chemicallyStarting materials that can be described chemically are inorganic and organic substances.Organic substances are generally of natural origin, e.g. purified fractions.

Preference should be given to clearly traceable substances, that comply with the quality standards in 2.1, 2.2, 2.3.

List of starting materials that can be described chemically see part IV, appendix 2.4.

2.5. Starting materials that have undergone special treatmentStarting materials that have undergone a special treatment are: e.g. plants, parts of plants cultivated by special treatment (see part IIa, chapter 1.1. Vegetabilisation methods of substances used for mother tinctures).

List of starting materials that have undergone special treatment see part IV appendix 2.5.

18

2.6. CompositionsDifferent starting materials described in 2.1, 2.2, 2.3, 2.4, 2.5 undergo one or more pharmaceutical processes that will lead to a substance that cannot be described as an addition of its ingredients. The rationale for the synthesis is an anthroposophic formula, in accordance with the anthroposophic understanding of man and nature1.

List of compositions see part IV, appendix 2.6.

3. Vehicles and excipients

Vehicles are auxiliary substances, which may be used for the production of active substances (e.g. ethanol to obtain an extract or lactose monohydrate to obtain a potentised preparation). Vehicles are also used in the production of mixtures (see part IIa, chapter 9).

Excipients are auxiliary substances, which may be used for the production of the pharmaceutical dosage forms (e.g. NaCl to obtain an isotonic solution for parenteral preparations). Excipients are also used in the production of mixtures (see part IIa, chapter 9).

Vehicles and excipients used in the manufacture of anthroposophic medicinal products comply with the relevant requirements of the European Pharmacopoeia or of the national pharmacopoeias used in the EU Member States.

4. Active substances

4.1. Starting materialsActive substances can be starting materials themselves or preparations.Starting material used directly as active substances may be the final dosage form, e.g. a herbal tea.

4.2. PreparationsPreparations are obtained from one or more starting materials.

Preparations comply with the specifications described in part II or in the individual monograph.

Preparations can be the final dosage form or can be processed further, e.g. to obtain mixtures.

1 As an example see: “Biodoron/Kephalodoron” , in Persephone N° 12, M. Kohlhase editor; publisher Verlag am Goetheanum, Dornach, CH, 1998.


• A

PC P

art I

Ia

19



PART IIaGeneral monographs of preparations and specific production methods (Pharmaceutical processes)

Table of Content Part IIa1. SPECIAL TREATMENTS OF RAW MATERIALS .........................................................24 1.1. Vegetabilisation methods ............................242. METAL PREPARATIONS ..................................25 2.1. Metal mirrors ................................................253. TINCTURES, MOTHER TINCTURES, GLYCE- ROL MACERATES, VISCOUS EXTRACTS ...26 3.1. Cold treated mother tinctures and liquid preparations thereof .................................26 3.2. Tinctures and mother tinctures made by macerations with water or ethanol/water ....27 3.3. Glycerol macerates .......................................28 3.4. Liquid preparations made by maceration with oil ..............................................30 3.5. Mother tinctures made by percolation ......30 3.6. Buffered aqueous mother tinctures manufactured under exclusion of oxidative influence ...............................................31 3.7. Fermented mother tinctures .......................32 3.8. Tinctures and mother tinctures made by digestion (Digestio) .............................33 3.9. Tinctures and mother tinctures made by infusion (Infusum) .........................................34 3.10. Tinctures and mother tinctures made by decoction (Decoction) ........................35 3.11. Viscous extracts with heat treatment .......36 3.12. Preparations made by distillation .............37

3.13. Mother tinctures obtained by rhythmic application of heat and cold .........38 4. SOLID STARTING MATERIALS OBTAINED BY HEAT ........................................39 4.1. Toasted preparations – Tosta .......................39 4.2. Carbons – Carbo ...........................................40 4.3. Ashes – Cinis .................................................405. SOLID PREPARATIONS FROM PLANTS .....41 5.1. Solid preparations from fresh plants ..........41 5.2. Solid preparations from liquids, plant juices or aqueous extracts .........................416. LIQUID DILUTIONS .........................................427. COMPOSITIONS ................................................43 7.1. Compositions made by treating two or more starting materials by one or more pharmaceutical processes ...................................43 7.2. Compositions made by treating two or more extracts or mother tinctures of one plant by one or more pharmaceutical processes ........43 7.3. Compositions made by treating one or more starting materials with one or more mother tinctures which undergo one or more pharmaceutical processes together ..........45 7.4. Compositions made by treating two or more extracts or mother tinctures and/or dilutions by one or more pharmaceutical processes ........45 7.5. Compositions made by co-potentising ......468. POTENTISED PREPARATIONS ......................469. MIXTURES ..........................................................48

• A

PC Part IIa

20

IntroductionBrief description of the main pharmaceutical processes applied in anthroposophic pharmacy

Several pharmaceutical processes are described in existing homoeopathic pharmacopoeias as “production methods”. These homoeopathic pharmacopoeial production methods can be seen as examples of the general anthroposophic pharmaceutical principle described in the general APC monographs of part IIa.

In anthroposophic pharmacy the treatment of the raw or starting materials can already be part of the pharmaceutical processing, e.g. a plant can be cultivated under treatment with a metal or mineral preparation.

Metals can either be used as a concentrated starting material or undergo a pharmaceutical process depending on the rationale of the anthroposophic therapeutics.

Preparations can be differentiated according to the thermal condition or treatment in the pharmaceutical process. Hereby follows a scheme concerning the related pharmaceutical processes applied to plant material and the main sphere of action.

Preparations may be the final dosage form, be incor-porated into the final dosage form or be processed further, e.g. by potentisation.

Pharmaceutical process

Heat/cold degree

Starting material Main sphere of therapeutic action 1, 2

Cold maceration 2 – 8 °C fresh or dried plants, all parts System of nerves and senses throughout the whole organism

Maceration 15 – 25 °C fresh plants, all parts system of nerves and senses throughout the whole organism

Rhythmic processing

4/37 °C fresh plants, all parts rhythmic system

Digestion 37 °C fresh plants, leaves, flowers rhythmic system, circulation

Infusion 60 – 90 °C dried leaves, flowers metabolic system, any type of gland

Decoction ca 100 °C dried roots, barks, seeds metabolic system, digestive tract(stomach, intestine)

Distillation steam,ca 100 °C

fresh or dried plants, all parts metabolic system, digestion

Treatments in liquid phase

Pharmaceutical process

Heat degree Starting material Main sphere of therapeutic action 1, 2

Toasting 170 – 250 °C dried plants, all parts, dried zoological starting material

metabolic system, digestion (liver)

Carbonisation above 200 °C dried plants, all parts, zoological starting material

metabolic system, kidney organisation

Ash process above 500 °C dried plants, all parts, zoological starting material

region of the lungs (respiration)

Treatments in dry phase


A crucially important pharmaceutical process is potentisation:• Potentised preparations are gradually diluted sub-

stances, whereby at each diluting step a rhythmic succussion (liquid potencies) or trituration (solid potencies) has been carried out.

• During this process the surface of the vehicle and the substance to be potentised are expanded and the mixing is thorough. The potentising time differs for solid and liquid potentised preparations. Astrono-mical aspects may be considered (e.g. solar or lunar eclipse). Anthroposophic pharmacy mainly uses decimal attenuations. For co-potentised preparations the ratio between active substances to vehicle may vary, differing from 1:10 for homoeopathic co-potentising methods (see also Part IIa, 8 ”Potentised Preparations“).

• A

PC P

art I

Ia

21

1General scheme for the correlation between spheres of therapeutic action/ degree of potentisation:

Mother tincture – D10 Metabolic system

D11-D20 Rhythmic system

>D20 System of nerves and senses

See also:International Federation of Anthroposophic Medical Associations, “The System of Anthroposophic Medicine”, pp. 26-28 at http://www.ivaa.info/userfiles/file/SystemAnthroposMedicine2011_Interaktiv.pdf

2 See IAAP brochure: “Basic Information on the Working Principles of Anthroposophic Pharmacy”, 2005, http://www.iaap.org.uk/downloads/principles.pdf


• A

PC Part IIa

22

General method of the APC Related specific production method

Ph.Eur. (2371)

HAB Ph.Helv. B.Hom.P. APC

1. Special treatment of raw materials

1.1. Vegetabilisation methods of substances used for mother tinctures

17.7.1.1, 17.7.1.2

Br1 1.1.1, 1.1.2

2. Metal preparations

2.1. Metal mirrors 17.7.2.1 – 17.7.2.4

2.1.1, 2.1.2, 2.1.3, 2.1.4

3. Tinctures and oil extracts

3.1. Cold treated mother tinctures and liquid preparations thereof

38 17.7.6

3.2. Tinctures made by maceration with water or ethanol/water

1.1.1 – 1.1.111.3.1

12b, c, m, n, o, p, q

17.7.7.1 3.2.1, 3.2.2

3.3. Tinctures made by maceration with glycerol 2.1.1 – 2.1.3 2.2.1 – 2.2.4

3.3.1, 3.3.2, 3.3.3

3.4. Liquid preparations made by maceration with oil

3.4.1

3.5. Tinctures made by percolation 1.1.8 – 1.1.9 17.7.7.2 3.5.1

3.6. Buffered aqueous mother tinctures under exclusion of oxidative influence

32

3.7. Fermented tinctures 53 17.7.7.3 3.7.1

3.8. Tinctures made by digestion (Digestio) 1.2.1 – 1.2.61.4.1

17.7.8.1 3.8.1, 3.8.2

3.9. Tinctures made by infusion (Infusum) 1.2.13, 1.4.4

17.7.8.3 3.9.1, 3.9.2, 3.9.3

3.10. Tinctures made by decoction (Decoction) 1.2.7 – 1.2.121.4.2 – 1.4.3

12k, l 17.7.8.4 3.10.1

3.11. Oil extracts with heat treatment 12d – g, 57

Survey of general methods for the manufacturing of anthroposophic medicinal products and related specific production methods in pharmacopoeias


• A

PC P

art I

Ia

23

General method of the APC Related specific production method

Ph.Eur. (2371)

HAB Ph.Helv. B.Hom.P. APC

3.12. Preparations made by distillation 52 17.7.8.5 3.12.1, 3.12.2

3.13. Tinctures obtained with rhythmic application of heat and cold

21 – 22, 33 – 37, 51

17.7.9 3.13.1, 3.13.2.

4. Solid starting materials obtained by heat

4.1. Toasted preparations (Tosta) 17.7.4.1 4.1

4.2. Carbons (Carbo) 17.7.4.2 Br4 4.2

4.3. Ashes (Cinis) 17.7.4.3 Br3 4.3

5. Solid preparations from plants and liquids (drying onto a vehicle)

5.1. Solid preparations from fresh plants 4.1.1 – 4.1.2 17.7.5.1 5.1.1

5.2. Solid preparations from liquids, plant juices or aqueous extracts

4.2.1 – 4.2.2 17.7.5.2 5.2.1, 5.2.2, 5.2.3

6. Liquid dilutions 3.1.1 – 3.1.3

7. Compositions 17.7.3 7.2.1 – 7.2.4

8. Potentised preparations

Potentising specifications in: 1 – 5

12j

11, 15, 18, 19, 20 – 24, 32 – 38, 39a, 39b, 45, 51, 53

Br5 – 6 8.1.1, 8.1.2, 8.2.1, 8.2.2Other APC Methods8.3

9. Mixtures 12a, 12h, 12i, 16


Note: How to read the table: Specific production methods are published in different pharmacopoeias e.g. in the Ph.Eur. or in the HAB; it is not a correlation table. If a method (e.g. HAB 49), has been transferred into the Ph.Eur. (2371, 1.3.1), the number is no longer listed in the HAB column. Anthroposophic medicinal products may also be manufactured in accordance with individual specifications or monographs, see also Part I, chapter 1.

• A

PC Part IIa

24

monograph; the flowers or/and the leaves with petioles, possibly with stalks, but no woody parts are included. The plant material is mixed together with neutral plant-compost which activates the first composting processes. This metal plant-compost mixture is stored in terracotta pots which are buried almost completely in the soil in the same field used in that growing season. The composting process is continued during the whole winter until the next spring.In spring the compost is completed and ready to be used to treat the plants of the next growing season, the second life cycle.

2nd life cycle:Seeds of the same species are sown in cultivation substrate or soil, which was treated with the compost, made from the plant of the 1st growing season. These plants (of the second life cycle) are also grown to their specific plant development stage (i.e. flowering). Compost is made from these plants, which is prepared in a way similar to the compost of the plants of the first life cycle. This compost is stored in terracotta pots, buried in the soil, in the field of the plants of the second life cycle.

3rd life cycle:Seeds of the same species are sown in cultivation substrate or soil which was treated with compost made from the plants of the second vegetation period. The plants of the third growing season (third vegetation period) are cultivated to their specified harvest stage.

further processingThe harvested plants are processed into a mother tincture according to a manufacturing method of the Ph.Eur., HAB or the APC or are otherwise processed.

identification, tests, assayAccording to the relevant tincture monograph (See Part IIa, chapters in section 3) or dried herbal drug.

recommended designation The designation states:• the fertilised plant,• the substance used,• the designation “cultum”, “culta”,• the reference pharmacopoeia/codex.

Examples: Tabacum Cupro cultum APC, Equisetum arvense Silicea cultum APC

Specific pharmacopoeia/APC production methods to produce vegetabilised substancesAPC Method 1.1.1 Vegetabilisation of substances of metallic origin (“vegetabilised metals”)

1. SPECIAL TREATMENTS OF RAW MATERIALS

In anthroposophic pharmacy treatment of the raw materials can be part of the pharmaceutically relevant processing, e.g. a plant can be cultivated under treatment with a preparation of a mineral, normally containing a specific metal.

1.1. Vegetabilisation methods (“vegetabilised metals“)

definitionVegetabilisation of substances can be considered as a particular kind of potentising process of metals or minerals taking place through nature. The potentising process is carried out with plants and normally goes through three life cycles. The life cycle means one vegetation period (growing season) for annual, and two growing seasons for biennial plants. The substance and appropriate plant are chosen in accordance with the rationale of anthroposophic understanding of man and nature.

preparation of mineral substancesSee APC Method 1.1.1 and 1.1.2.

cultivationThe cultivation of vegetabilised metals is a three years process (for biennial plants 6 years), meaning three generations of plants are grown until the final plant can be further processed, for example to a mother tincture. This process is basically the same for each specific metal (mineral)-plant combination. Important for the cultivation process is, that each plant grows in the cultivation substrate and field soil specifically prepared for each vegetation period. The following is a cultivation description for each of the three growing seasons or life cycles.Exemptions have to be prescribed in individual monographs (e.g. Bryophyllum, Equisetum arvense and Thuja occidentalis).

1st life cycle: The seeds are sown in soil, which has been treated with a diluted preparation of the concerned inorganic substance (approximately 50 – 200 g/m²). Alternatively, jars with cultivation substrate, mixed with 5 – 20 g diluted preparation/L can be used. In this case, the young growing plants are transferred to soil, which has been treated as mentioned above.When the plants reach their full development, i.e. in the flowering stage, compost is made from these plants. For preparing that compost, the upper aerial parts of the specific plant are used as prescribed in the individual


• A

PC P

art I

Ia

25

2.1. Metal mirrors

definitionBy producing metal mirrors the metal is transformed through different states of aggregation.The metals or metal salts can be brought through a liquid state (melted or as solution), gas state or plasmatic state to be subsequently (obtained again) condensed in solid state as the pure metal.Metal mirrors are deposits of metals in reduced state onto a surface by a specific method of production.

Metal mirrors, produced according to APC methods 2.1.1, 2.1.2 and 2.1.3 can be removed from the surface and may be potentised according to Ph.Eur. method 4.1.1 and 4.1.2 and HAB method 48.

testsThe following analytical tests are always carried out for the metal which is used as starting material to produce the mirror. The metal mirror itself is only tested when it is produced by the method of reduction of metal salts (2.1.3), the method of chemical vapour decomposition (2.1.2) or the method of sputtering (2.1.4). The metal mirror produced by the method of distillation (2.1.1) is tested after further processing as the first or second produced dilution.

identificationAt least one suitable identification test is carried out.

testssee the individual monograph.

assayContent according to the individual monograph.

storageStore in a well-closed container.

recommended designation The designation states:• the metal used,• the designation ”metallicum praeparatum” or in the

case of metal mirror foil the name of the metal follo-wed of the word “foil”,

• the reference pharmacopoeia/codex,Examples: Argentum metallicum praeparatum APC Cuprum mirror foil APC.

Specific pharmacopoeial/APC production methods to prepare metal mirrors

For the vegetabilisation of substances of metallic origin plants are treated with a diluted substance, prepared from either a naturally occurring metal or a metal containing mineral (ore).

preparation of metallic substanceThe raw material for the manufacturing of the mineral substance is a naturally occurring metal or a metal containing mineral (ore). This is treated during several steps with mineral acids and other substances, containing the chemical elements C, H, N, O and S, to a complex composition containing the metal in a form whose chemical structure is not clearly defined. It is triturated with lactose monohydrate, the result being the metal substance D1: the content of the metal is 8 – 12 %. The metal substance D1 is diluted with a neutral material, e.g. cellulose or sucrose, to form the diluted metal substance that is ready for use. The calculated metal content of this diluted metal substance differs, according to the toxicity and natural abundance of the metal in the soil:Au, Ag, Pb, Sn, Hg: max. 100 ppmFe, Cu: max. 1000 ppm

APC Method 1.1.2 Vegetabilisation of silicatesFor the vegetabilisation of silicates plants are treated with appropriate mineral containing silica.

preparation of mineral substanceThe raw material for the manufacturing of the mineral substance is a pulverised mineral silicate. This is treated during several steps with mineral acids and other substances, containing the chemical elements C, H, N, O and S, to a complex composition containing silicium in a form whose chemical structure is not clearly defined. It is triturated with lactose monohydrate; the result is the silica, particularly quartz substance D1: the content of silicium is 8 – 12 %, calculated as silicium dioxide .The silica, particularly quartz substance D1 is diluted with a neutral material, e.g. cellulose or sucrose, to form the diluted silica, particularly quartz substance that is ready for use. The calculated content is max. 1 % silicium dioxide.

2. METAL PREPARATIONS

Metals can either be used as a concentrated starting material or undergo a pharmaceutical process depending on the rationale of the anthroposophic therapeutics.


• A

PC Part IIa

26

A magnetrom is comprised of a cathode (electron source) an anode (electron collector) and a combined electric and magnetic field. Vacuum conditions (0.5 – 5 x 10-3 mbar) are generated and an inert gas (e.g. Argon Ph.Eur.) is used as medium. The process begins as a result of a collision and momentum transfer from an incoming particle which impacts the inert gas molecules. Ions of the inert gas impact then the surface of the metal and the result is an ejection of metal atoms from the surface. The electric field leads to an ionisation of the metal which goes into a plasma aggregation state (at 30 – 45 °C) and condensates as a metal mirror on the substrate, in this case a plastic foil (e.g. PET). After this process the metal mirror foil is stitched to a special cotton tissue directly over the metal mirror.The metal mirror foils must not be further processed.

testsThickness of the mirror.

recommended designation the reference pharmacopoeia/codex,for external use only.

3. TINCTURES, MOTHER TINCTURES, GLYCEROL MACERATES AND VISCOUS EXTRACTS

Tinctures, mother tinctures, glycerol macerates and viscous extracts are obtained from starting materials from botanical or zoological origin by pharmaceutical processes under cold condition (2 – 8 °C), at ambient temperature (15 – 25 °C), with heat treatment at different temperatures, by rhythmic application of heat and cold, by fermentation as well as by distillation. If applicable, vehicles e.g. water, ethanol, water/ethanol mixtures, glycerol, oils may be used. They may be processed further.

3.1. Cold treated mother tinctures and liquid preparations thereof

definitionCold treated mother tinctures are prepared from fresh (frozen) or dried herbal drugs. The maceration is carried out at a temperature of 2 – 8 °C using purified water, water for injections or isotonic solution.

productionIf necessary, comminute the matter to be extracted. The prescribed quantity of extraction solvent according to the individual monograph is added to the starting

APC Method 2.1.1 Metal mirrors obtained by distillationMetal mirrors prepared by distillation are obtained from the pure metal.The pure metal is heated in appropriate equipment under vacuum until it evaporates. The temperature and the vacuum are to be chosen in such a way, that the metal is distilled. The metal vapour condenses onto the surface of the cooler parts of the distillation equipment, producing a metal mirror. The metal mirror is removed after cooling from the surface.The exact conditions of the distillation are described in the individual monograph.

APC Method 2.1.2. Metal mirrors obtained by Chemical Vapour Decomposition, CVDMetal mirrors prepared by chemical vapour decomposition are obtained from a volatile metal compound.A volatile metal compound is distilled under vacuum in appropriate equipment. The temperature and the vacuum are to be chosen in such a way, that the metal compound is distilled. The vapour is further heated until decomposition of the metal compound. As a result, the pure metal condenses onto the surface of the distillation equipment, producing a metal mirror. After cooling the metal mirror is removed from the surface.

APC Method 2.1.3. Metal mirrors obtained by reductionMetal mirrors prepared by reduction are obtained from an appropriate metal salt.To a solution of a metal salt an appropriate reducing agent and reagents are added. The pure metal precipitates onto the surface of the reaction vessel producing the metal mirror. The metal mirror is removed from the surface, filtered from the solution, washed with purified water and ethanol (the concentration of ethanol depending of the nature of the used reagents), until foreign matters are no longer detectable in the rinsing water and then dried.

APC Method 2.1.4. Metal mirror foilMetal mirror foils are prepared by a process which transforms the processed metal into a plasma aggre-gation and finally condenses as an approximate 55 – 65 nm thick metal mirror on to the substrate.To produce a metal mirror foil a process known as sputtering is used. In this vapour phase technique there is no melting of the metal. The sputtering process is most commonly used for thin-film deposition of many different metals. High energy ions impacting on the target can liberate sputtered atoms of the metal as well as positive ions and electrons. A metal target is put under the effect of a magnetrom.


• A

PC P

art I

Ia

27

productionIf necessary, comminute the matter to be extracted; animals are processed immediately after killing. The prescribed quantity of extraction solvent according to the individual monograph is added to the starting material. Mix thoroughly and allow to stand in a closed container at the required temperature, where applicable protected from light for an appropriate time. If necessary shake or stir occasionally. Express and filter, if necessary.Adjustment of the content of constituents may be carried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another macerate of the herbal or animal starting material used. If prescribed in the individual monograph, the tincture can be adjusted to the specified content by concentration, carried out generally under vacuum.

identificationAt least one chromatographic identification test is carried out.

testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). The pre-paration complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Ethanol content (Ph.Eur. 2.9.10). Where applicable, the ethanol content complies with that prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official Pharmacopoeia, or another limit is justified and authorised.

assayAn assay with quantitative limits is performed when starting materials with toxicologically or therapeutically relevant substances are used.

storageStore in a well-closed container, protected from light.

recommended designationThe designation states:• the herbal or animal matter used,• where applicable, the fresh herbal or animal matter

used,• where applicable, the ethanol content in the pre-

paration,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,the reference pharmacopoeia/codex.

material. Mix thoroughly and allow to stand in a closed container, where applicable protected from light, for an appropriate time (at least 7 days). Shake or stir occasionally. Express and filter.

identificationAt least one chromatographic identification test is carried out.testspH (Ph.Eur. 2.2.3). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). The pre-paration complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official Pharmacopoeia, or another limit is justified and authorised.


recommended designation The designation states:• the herbal drug used,• where applicable, the fresh herbal drug used,• where applicable, the ethanol content in the

preparation,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce mother tinctures obtained under cold conditions (2 – 8 °C)HAB Method 38

3.2. Tinctures and mother tinctures made by macera-tions with water or ethanol/water

definitionTinctures and mother tinctures made by maceration with water or ethanol/water are liquids and are obtained from fresh (frozen) or dried matter of botanical or zoological origin. The maceration is carried out at a temperature not above 25 °C by using ethanol of a suitable concentration or purified water.


• A

PC Part IIa

28

3.3. Glycerol macerates

definitionGlycerol macerates comply with the definition in Ph.Eur. monograph 1038. They are prepared from fresh (frozen) or dried matter of botanical or zoological origin. The maceration is carried out at the required temperature (not above 25 °C) using glycerol of a suitable concentration or a glycerol solution containing sodium chloride.

productionLower animals are killed immediately before processing; the parts of warm-blooded animals are processed immediately after being killed. Killing is carried out with respect for the animal suffering.Comminute the matter to be extracted. Add the prescribed quantity of extraction solvent according to the individual monograph to the raw material. Mix thoroughly and allow to stand in a closed container at a temperature not above 25 °C, protected from light for an appropriate time. If necessary shake or stir occasionally. Express and filter, if necessary.Adjustment of the content of constituents may be carried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another macera-te of the starting material of botanical or animal origin used.

identificationAt least one chromatographic or electrophoretic (animal matter) identification test is carried out.

testsConductivity (Ph.Eur. 2.2.38). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individual monograph. Alternatively, the refractive index can be used.Refractive index (Ph.Eur. 2.2.6). Where applicable (preparations according to APC Methods 3.3.1 and 3.3.2), the refractive index of the preparation is measured in appropriate equipment, this measure indicates the water content in the glycerol1, and this value is called ηm indicating the refractive index of the macerate. This

Specific pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by macerations with water or ethanol/water

Ph.Eur. (2371) Methods1.1.1 – 11HAB Methods1 – 4Ph.Eur. 1.3.1 (prev. HAB Method 49)12b, c, m, n, o

APC Method 3.2.1 (related to Ph.Eur. (2371) Method 1.1.8)Mother tinctures according to APC Method 3.2.1 are prepared using the maceration methods given in the Ph.Eur. monograph “Extracts” (0765). Use 1 part of dried plant or parts of plants to 20 parts of ethanol in suitable concentration (see HAB H 5.3), unless otherwise prescribed in the individual monograph.If adjustment to a given concentration is necessary, calculate the amount of ethanol required to obtain the concentration specified or used for production from the equation given in Ph.Eur. (2371) Method 1.1.1. Mix the calculated amount of ethanol with the filtrate. Allow to stand for not less than 5 days at a temperature not exceeding 20 °C, then filter if necessary.

potentisationThe 2nd decimal dilution (D2) is made from2 parts of the mother tincture and8 parts of ethanol of the same concentration.

The 3rd decimal dilution (D3) is made from1 part of 2nd decimal dilution and9 parts of ethanol of the same concentration.

Unless a different ethanol concentration is specified, use ethanol 36 per cent (V/V) for D4 and then 18 per cent (V/V) for subsequent dilutions from D5 onwards and proceed accordingly.

APC Method 3.2.2 (related to HAB Method 12a)Preparations according to APC Method 3.2.2 are tinctures for external use. They are prepared as follows:Use 1 part of dried plant or parts of plants to 10 parts of ethanol in suitable concentration (see HAB H 5.3), unless otherwise prescribed in the individual monograph.Glycerol may be added up to 10 per cent.

1 Miner, Carl S.& Dalton, N.N: (ed.). Glycerol, American Chemical Society, Monograph Series, n⁰ 117. Reinhold Publishing Corp., New York 1953.


• A

PC P

art I

Ia

29

APC Method 3.3.2Glycerol macerates according to APC Method 3.3.2 are prepared from 1 part of dried plants or parts of plants, 2 parts of purified water and 7 parts of glycerol by maceration.The prescribed quantity of purified water is added to the starting material. Allow standing in a closed container for 6 hours. After that, the prescribed quantity of glycerol is added to the mixture. Mix thoroughly and allow to stand in a closed container for an appropriate time according to the individual monograph. If necessary, shake or stir occasionally. Express and filter, if necessary.The content of glycerol is determined using measurement of refractive index and should be 75–85 % (m/m) of the total mass, calculated based on the equation above (refractive index). Adjustment of the final content of glycerol to 85 % is carried out using measurement of refractive index, and adding glycerol.Adjustment of the content of constituents may be carried out, if necessary by adding another macerate of the herbal or animal starting material used.

APC Method 3.3.3 Mother tinctures according to APC Method 3.3.3 are prepared from killed or freshly slaughtered animals or parts thereof by maceration with glycerol as vehicle (glycerol macerates).

To produce the first decimal dilution (D1), disperse 1 part of finely minced animal material in 9 parts of glycerol (85 per cent), allow to macerate for at least 2 h, then succuss. Where justified, the addition of 1 part of glycerol (85 per cent) to 1 part of animal material before the mincing is accepted. Filter when necessary. In the case of very small amounts of animal material, it is allowed to prepare the 2nd or the 3rd decimal dilution by dispersing 1 part of finely minced animal material in 99 resp. 999 parts (= D2 resp. D3) of glycerol (85 per cent).

potentisationWhere the mother tincture corresponds to the 1st decimal dilution (Ø = D1), the 2nd decimal dilution (D2) is produced from: 1 part of the mother tincture (D1); 9 parts of glycerol (85 per cent) or ethanol (18 per cent V/V).

The 3rd decimal dilution (D3) is produced from: 1 part of the 2nd decimal dilution; 9 parts of ethanol (18 per cent V/V).Subsequent dilutions are produced as stated for D3.

measure is used to calculate the proportion of glycerol of the macerate. This calculation is made based on the following equation:

(eq.1)1

Electrophoresis (Ph.Eur. 2.2.31). Where applicable, the preparation complies with the characteristics prescribed in the individual monograph.Microbiological examination (Ph.Eur. 2.6.12, 2.6.13). Where applicable, the macerate complies with the limits prescribed.

assayAn assay with quantitative limits is performed when starting materials with toxicologically or therapeutically relevant substances are used.storageStore in a well-closed container, protected from light.

recommended designation The designation states:• the dried herbal drug or animal matter used,• where applicable, the fresh herbal drug or animal

matter used,• the glycerol content of the solvent used for the prepa-

ration,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to macerate,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce glycerol maceratesPh.Eur. (2371) Methods2.1.1 – 2.1.3 (prev. HAB Methods 42)2.2.1 – 2.2.4 (prev. HAB Methods 41)

APC Method 3.3.1Glycerol macerates according to APC Method 3.3.1 are prepared from 3 parts of fresh (frozen) matter of botanical or zoological origin and 7 parts of glycerol by maceration.The prescribed quantity of glycerol is added to the starting material. Mix thoroughly and allow to stand in a closed container for an appropriate time according to the individual monograph. If necessary, shake or stir occasionally. Express and filter, if necessary.The content of glycerol is determined using measurement of refractive index and should be 70–85 % (m/m) of the total mass, calculated based on the equation above (refractive index). Adjustment of the final content of glycerol to 85 % is carried out using measurement of refractive index, and adding glycerol.Adjustment of the content of constituents may be carried out, if necessary by adding another macerate of the herbal or animal starting material used.

% Glycerol m⁄m = ηm – 1.3195

0.0016


• A

PC Part IIa

30


recommended designation The designation states:• the dried herbal drug or animal matter used,• where applicable, the fresh herbal drug or animal

matter used,• where applicable, the solvent used for the preparation,• where applicable, the ratio of starting material to ex-


Specific pharmacopoeial/APC production methods to produce liquid preparations made by maceration with oil

APC Method 3.4.1Preparations made according to APC Method 3.4.1 are oil extracts for external use prepared from 1 part of lower animals and 10 parts of arachis oil, refined (Ph.Eur.) as follows:

After having killed the animals with CO2, the animals are minced and mixed thoroughly with 10 parts of arachis oil, refined (Ph.Eur.). Protect the mixture from light. The extraction time should not exceed 8 hours. Then filter.

3.5. Mother tinctures made by percolation

definitionMother tinctures made by percolation are prepared from fresh (frozen) or dried herbal drugs. The percolation is carried out at room temperature using ethanol of suitable concentration or purified water.

productionIf necessary, comminute the herbal drug to be extracted to pieces of suitable size. Mix thoroughly with a potion of the prescribed extraction solvent and allow to stand for an appropriate time. Transfer to a percolator and allow the percolate to flow slowly making sure that the matter to be extracted is always covered with the remaining extraction solvent. The residue may be pressed out and the expressed liquid combined with the percolate.

Adjustment of the content of constituents may be carried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another percolate of the herbal drug used for the preparation.

Where the mother tincture corresponds to the 2nd or 3rd decimal dilution (Ø = D1), the 3rd or the 4th decimal dilution, respectively (D3 or D4) is produced from:1 part of the mother tincture (D2 or D3)9 parts of ethanol (18 per cent V/V).Subsequent dilutions are produced accordingly.

3.4. Liquid preparations made by maceration with oil

definitionLiquid preparations prepared by maceration with oil are prepared from fresh (frozen) or dried matter of botanical or zoological origin. The maceration is carried out at the required temperature (not above 25 °C) mostly by using arachis oil or olive oil.

productionIf necessary, comminute the matter to be extracted. When animal matter is used, lower animals are killed immediately before processing, the parts of warm-blooded animals being processed immediately after killing. Killing is carried out with respect for the animal suffering, e.g. according to HAB H 5.2.4.The prescribed quantity of extraction solvent according to the individual monograph is added to the starting material. Mix thoroughly and allow to stand in a closed container at the required temperature, protected from light for an appropriate time. If necessary shake or stir occasionally. Express and filter, if necessary.Adjustment of the content of constituents may be carried out, if necessary, either by adding the extraction solvent of suitable concentration or by adding another macerate of the herbal or animal starting material used.


tests Relative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individual monograph.Refractive index (Ph.Eur. 2.2.6). The preparation complies with the limits prescribed in the individual monograph.Peroxide value (Ph.Eur. 2.5.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.



• A

PC P

art I

Ia

31

Allow to stand for not less than 5 days at a temperature not exceeding 20 °C, then filter if necessary.

The 2nd decimal dilution (D2) is made from2 parts of the mother tincture and8 parts of ethanol of the same concentration.

The 3rd decimal dilution (D3) is made from1 part of 2nd decimal dilution and9 parts of ethanol of the same concentration.

Unless a different ethanol concentration is specified, use ethanol 50 per cent (V/V) for subsequent dilutions from D4 onwards and proceed accordingly.

3.6. Buffered aqueous mother tinctures manufactured under exclusion of oxidative influence

definitionBuffered aqueous mother tinctures manufactured under exclusion of oxidative influence are produced by exhaustive extraction of fresh (frozen) plants or parts of plants under the exclusion of atmospheric oxygen with a buffer.

If the fresh plant material is not processed immediately, it must be stored in liquid nitrogen. The loss on drying (H 2.8.1) must be determined before it is placed in liquid nitrogen.From 1 part of the plant material an amount of mother tincture, prescribed in the individual monograph, is produced according to HAB Method 32. This amount is determined in a validation and depends on the loss on drying of the harvested plant material.The mother tincture corresponds to the 2nd decimal dilution (mother tincture = D2).At first add a defined amount of ascorbate phosphate buffer solution to the plant material and then finely reduce this mixture to a slurry. Under further size reduction, add a quantity of ascorbate phosphate buffer solution, sufficient for achieving the required amount of extract. Express, filter and adjust to the required volume with ascorbate phosphate buffer solution.

According to the individual monograph the production of the mother tincture may require the addition of a second extract from material of the same plant species harvested at a different season. In this case mix the extracts in an appropriate apparatus to a composition (see Chapter 7) and then dilute in a defined proportion with ascorbate phosphate buffer solution. This composition is the mother tincture (=D2).Potentisation is generally carried out according to HAB Method 32.


testsRelative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). The pre-paration complies with the limits prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official Pharmacopoeia, or another limit is justified and authorised.



recommended designation The designation states:• the fresh herbal drug used,• where applicable, the dried herbal drug used,• where applicable, the ethanol content in the

preparation,• where applicable, the ratio of starting material

to extraction liquid or of starting material to preparation,

• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce mother tinctures made by percolation

Ph.Eur. (2371), Methods 1.1.8, 1.1.9HAB Methods 4

APC Method 3.5.1 (related to Ph.Eur. (2371) Method 1.1.8)

Mother tinctures according to APC Method 3.5.1 are prepared using the percolation methods given in the Ph.Eur. monograph “Extracts” (0765). Use 1 part of dried plant or parts of plants to 20 parts of ethanol in suitable concentration (see HAB H 5.3), unless otherwise prescribed in the individual monograph.If adjustment to a given concentration is necessary, calculate the amount of ethanol required to obtain the concentration specified or used for production from the equation given in Ph.Eur. (2371) Method 1.1.1. Mix the calculated amount of ethanol with the filtrate.


• A

PC Part IIa

32

productionIf necessary, comminute the herbal drug. Add purified water according to the individual monograph and mix thoroughly. If stated in the individual monograph, add the prescribed fermenting agent. Allow to stand at room temperature for the time prescribed in the individual monograph protected from air, from light and, if necessary, from oxidation. Hereafter express and filter, if necessary.

Adjustment of the content of constituents may be carried out with purified water or by adding purified water to the residue and expressing again.


testspH (Ph.Eur. 2.2.3). The preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). The preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official Pharmacopoeia, or another limit is justified and authorised.



recommended designation The designation states:• the fresh herbal drug used,• where applicable, the dried herbal drug used,• where applicable, the ratio of starting material to ex-


Specific pharmacopoeial/APC production methods to produce fermented mother tinctures

HAB Method 53APC Methods 7.2.1, 7.2.3, 7.2.4

Buffered aqueous mother tinctures and their liquid dilutions are exclusively intended for parenteral dosage forms. Before they are processed to finished products, the mother tincture (D2) and the liquid dilution D3 must be stored for between 6 weeks and 1 year. Any eventual sediment must be excluded from the further processing.


testsLoss on drying (H 2.8.1). Loss on drying of the residue after filtration.Sterility (Ph.Eur. 2.6.1). If buffered aqueous mother tinctures and their liquid dilutions are stored before further processing, they must comply with the test. Proportion of original extracts: Where applicable, the proportion of both extracts in the composition is determined e.g. by HPLC or by other suitable methods.Methanol and 2-propanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol and maximum 0.05 per cent V/V of 2-propanol, unless otherwise authorised by a national official Pharmacopoeia or another limit is justified and authorised.


storageStore in a well-closed, airtight container.

recommended designation The designation states:• the herbal drug used,• the amount of herbal drug used,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce buffered aqueous mother tinctures manufactured under exclusion of oxidative influence

HAB Method 32

3.7. Fermented mother tinctures

definitionFermented mother tinctures are aqueous preparations from fresh (frozen) or dried herbal drugs prepared by fermentation at room temperature.


• A

PC P

art I

Ia

33

35 – 39 °C in a covered container. Allow to stand at this temperature for the time prescribed in the individual monograph, stirring occasionally. After cooling, allow to stand at room temperature in a well-closed container, protected from light for the time described in the individual monograph. Add ethanol of appropriate concentration if prescribed. If necessary shake or stir occasionally. Express and filter, if necessary.Adjustment of the content of constituents may be carried out by diluting, either with the same liquid used for the digestion or with another digestion of the same raw material.If prescribed in the individual monograph, the tincture can be adjusted to the specified content by concentration, carried out carefully and generally under vacuum.


testspH (Ph.Eur. 2.2.3). Where applicable the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). The preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individualmonograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official pharmacopoeia, or another limit is justified and authorised.



recommended designation The designation states:• the dried herbal drug used,• where applicable, the fresh herbal drug used,• where applicable, the ethanol content in the

preparation,• where applicable, the ratio of starting material

to extraction liquid or of starting material to preparation,

• the designation “Digestio” or “ethanol. Digestio” if ethanol is used,


APC Method 3.7.1 (see also Compositions 7.2.1)Mother tinctures according to APC Method 3.7.1 are prepared from fresh plants or parts of plants following the procedure given below.Finely comminute the plants or parts of plants and mix 1 part of the plant mass with 1 part of purified water. Leave to ferment at 20 to 24 °C with the exclusion of air, ending the fermentation when the pH of the fermentation liquid has fallen to between 4 and 5. Then express and weigh the expressed liquid. The weight of the expressed liquid is equal to 2 parts and is mixed with 1 part of a mixture of 0.95 parts of ethanol 96 per cent (V/V) and 0.05 parts of purified water.This tincture can together with another tincture of the same plant undergo a special pharmaceutical process leading to a composition according to method 7.2.1.

This procedure is followed for plants harvested in the summer and for plants of the same species, harvested in the winter. The mother tincture is produced by composing equal parts of the two tinctures.

potentisationThe 1st decimal dilution (D1) is made from3 parts of the mother tincture and7 parts of ethanol 36 per cent (V/V).

The 2nd decimal dilution (D2) is made from1 part of the 1st decimal dilution and9 parts of ethanol 18 per cent (V/V).

Subsequent dilutions are produced as stated for D2.

recommended designation Preparations according to APC Method 3.7.1 carry the designation „ferm APC 3.7.1“.

3.8. Tinctures and mother tinctures made by digestion (Digestio)

definitionTinctures and mother tinctures made by digestion are liquids prepared from fresh (frozen) or dried plants or parts of plants by heat treatment usually at 37 °C and additional maceration. The digestion is carried out using ethanol of a suitable concentration or purified water.

productionIf necessary, comminute the plant or parts of plants to be extracted. The quantity of extraction liquid is added according to the individual monograph. Mix thoroughly and warm to 35 – 39 °C. Then keep at


• A

PC Part IIa

34

3.9. Tinctures and mother tinctures made by infusion (Infusum)

definitionTinctures and mother tinctures made by infusion are prepared from adequately prepared dried plant material by adding boiling purified water. If ethanol (of the prescribed concentration) is used, the quantities of ethanol and purified water are added separately.

productionIf necessary, comminute the plant material. Boiling purified water is used for extraction. If ethanol of suitable concentration is used, the quantity of ethanol is either used prior to extraction for moistening the dried plant material for the time prescribed or added to the mixture after cooling. Allow to stand in a well-closed container for the time prescribed. If only purified water is used as solvent, it is also used for moistening and to make up the final mass if prescribed. Express and filter, if necessary. If only purified water is used as solvent the preparation is processed further immediately.


testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). The preparation complies with the limits prescribed in the individual monograph. Relative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official Pharmacopoeia , or another limit is justified and authorised.Sterility (Ph.Eur. 2.6.1). Applicable only if the infusion is a stored aqueous preparation.


storageStore in a well-closed container, protected from light, if the tincture contains ethanol.If aqueous tinctures made by infusion are stored they must meet the requirements of sterility (Ph.Eur. 2.6.1).

Specific pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by digestion

Ph.Eur. (2371) 1.2.1 – 6 (prev. HAB Methods 18)Ph.Eur. (2371) 1.4.1 (prev. HAB Method 24b)

APC Method 3.8.1Tinctures according to APC Method 3.8.1 are prepared from fresh plants with purified water as follows:Comminute the plants or parts of plants unless other-wise prescribed in the monograph. The amount of plants or parts of plants and purified water are defined by the monograph. Introduce the amount of purified water into a round-bottomed flask, place in a water bath and heat up to 48 – 52 °C. Add the plants or parts of plants whereby the flask should be a half to three quarters full, mix thoroughly. Close the flask hermetically. Keep the mixture at 48 – 52 °C for 6 hours. Allow to cool to 35 – 39 °C in the course of 20 – 24 hours and maintain this temperature for 64 – 72 hours with occasional stirring. Allow to cool. If prescribed in the individual monograph add the amount of ethanol 96 per cent (V/V) prescribed then express and filter.Tinctures according to APC Method 3.8.1 which are prepared with purified water only, are generally processed immediately to solid preparations (see method 5.2 “Solid preparations from liquids, plant juices or aqueous extracts”).

recommended designation Preparations made according to APC Method 3.8.1 carry the designation “Digestio APC 3.8.1”. The same applies to preparations made from them. Preparations made according to APC Method 3.8.1 with addition of ethanol carry the designation “ethanol. stab. digestio APC 3.8.1”.

APC Method 3.8.2 Method 3.8.2 is used for fresh plants.Mother tinctures prepared according to APC Method 3.8.2 are ethanolic digestions prepared by heat treatment with additional maceration as described below.Comminute appropriately the plant or the parts of plants. To 1 part of the comminuted plant add 3.1 parts of ethanol 24 per cent V/V. Warm the mixture in a well-closed container to 37 ˚C and maintain this temperature for 1 h. Cool, allow to stand for not less than 10 days, stirring the mixture or swirling the container from time to time, then express the mixture and filter the resulting liquid. The filtrate is the mother tincture.


• A

PC P

art I

Ia

35

APC Method 3.9.2 (related to HAB Method 20) deleted

APC Method 3.9.3Mother tinctures according to APC Method 3.9.3 are prepared from fresh or dried plants or parts of plants, using 1 part of the plant material and 10 parts of water (m/m) or according to the individual monograph.Comminute the starting material and add the total amount of boiling purified water, cover and allow to stand until room temperature is reached, for not more than 12 h. Compensate any water loss. Allow to stand in a well-closed container for 24 – 36 h, stirring occasionally. Express and filter.

potentisationThe mother tincture corresponds to the 1st decimal dilution (Ø= D1).The 2nd decimal dilution (D2) is made from1 part of the mother tincture and9 parts of glycerol 85 % (m/m).

Subsequent dilutions are produced as stated for D2.

3.10. Tinctures and mother tinctures made by decoction (Decoction)

definitionTinctures and mother tinctures made by decoction are prepared from fresh or dried plants or parts of plants that have been allowed to boil with ethanol of a suitable concentration or purified water or extracted with glycerol 85 % at 100⁰C.

productionIf necessary, comminute the plants or parts of plants, add the prescribed quantity of extraction solvent according to the individual monograph and mix thoroughly. Heat the mixture to boiling (in the case of glycerol 85 % to 100⁰C), if necessary under reflux, maintaining at boiling temperature (in the case of glycerol 85 % at 100⁰C) for the time prescribed, usually 30 min. After cooling allow to stand in a well-closed container protected from light at room temperature for the time described in the individual monograph. If necessary, shake or stir occasionally. Express and filter, if necessary.

Adjustment of the content of constituents may be carried out by diluting, either with the same liquid used for the decoction or with another decoction of the same raw material.If prescribed in the individual monograph, the tincture

recommended designation The designation states:• the herbal drug used,• where applicable, the ethanol content in the


traction liquid or of starting material to preparation,• the designation “Infusum” or “ethanol. Infusum”, if

ethanol is used,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by infusionPh.Eur. (2371) 1.2.13 (prev. HAB Method 20)Ph. Eur. (2371) 1.4.4 (prev. HAB Method 24a)

APC Method 3.9.1 (related to Ph.Eur. Method 1.12.13)Mother tinctures according to APC Method 3.9.1 are prepared from dried plants or parts of plants, using 1 part of the plant material and 10 parts of ethanol of the concentration, prescribed in the individual monograph as follows:Add the amounts of ethanol and purified water required to obtain the prescribed ethanol concentration separately.Unless a degree of comminution is specified in the monograph, comminute the herbal drug appropriately, add the total amount of boiling purified water, cover and allow to stand until room temperature is reached, for not more than 12 h. Compensate any water loss by evaporation and add the required amount of ethanol. Allow to stand in a well-closed container for 24 – 36 h, stirring occasionally. Express and filter.

potentisationThe mother tincture corresponds to the 1st decimal dilution (Ø = D1).The 2nd decimal dilution (D2) is made from1 part of the mother tincture and9 parts of ethanol of the same concentration as calculated for the mother tincture.

Subsequent decimal dilutions are produced accordingly; in this process the ethanol concentration is reduced with each step in the succession – 50 – 36 – 18 per cent (V/V) until the 18 per cent level is reached.

recommended designation Preparations made according to APC Method 3.9.1 carry the designation “ethanol. stab. infusum”. The same applies to preparations made from them.


• A

PC Part IIa

36

ethanol of the appropriate concentration (anhydrous, 96 per cent V/V – 94 per cent m/m, 90 per cent V/V – 86 per cent m/m, 80 per cent V/V – 73 per cent m/m, 70 per cent V/V – 62 per cent m/m, 50 per cent V/V – 43 per cent m/m, 36 per cent V/V – 30 per cent m/m, 18 per cent V/V – 15 per cent m/m), unless otherwise prescribed in the individual monograph.

Unless otherwise prescribed, comminute the herbal drug, mix thoroughly with the total amount of ethanol of the appropriate concentration and heat to boiling under reflux, maintaining at boiling temperature for 30 min unless otherwise specified in the individual monograph. Cool or allow to cool and leave the mixture to stand in a closed container for 12 – 36 h. Separate the residue from the ethanol and, if necessary, press out. In the latter case, combine the 2 liquids obtained.Adjust to the concentrations required in the individual monograph in accordance with Ph.Eur. (2371) Method 1.1.8.

potentisationThe 2nd decimal dilution (D2) is made from2 parts of the mother tincture and8 parts of ethanol of the same concentration.

The 3rd decimal dilution (D3) is made from1 part of the 2nd decimal dilution and9 parts of ethanol of a reduced concentration as given below.

Subsequent decimal dilutions are produced accordingly; in this process the alcohol concentration is reduced with each step in the succession 96 – 90 – 80 – 70 – 50 – 36 – 18 per cent (V/V) until the 18 per cent level is reached.

3.11. Viscous extracts with heat treatment

definitionViscous extracts with heat treatment are prepared from fresh or dried herbal drugs using a fatty or mineral oil or glycerol 85 % as extraction liquid with heat.

productionIf necessary, comminute the herbal drug. Ethanol 96 per cent (V/V) may be added to moisten the plant material. The prescribed quantity of the extraction liquid (mostly peanut, olive, sesame or sunflower oil, liquid paraffin, or glycerol 85 %) is added and mixed thoroughly with the herbal drug. The mixture is heated at the prescribed temperature and allowed to stand in a closed container for an appropriate time. Extraction temperature and

can be adjusted to the specified content by concentration, carried out carefully and generally under vacuum.


testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). The pre-paration complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official pharmacopoeia, or another limit is justified and authorised.



recommended designation The designation states:• the herbal substance used,• where applicable, the fresh or dried herbal drug used,• where applicable, the ethanol content in the


traction liquid or of starting material to preparation,• the designation “Decoctum” or “ethanol. Decoctum”,

if ethanol is used,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce tinctures and mother tinctures made by decoction

HAB Methods 12k, 12l, 12qPh.Eur. (2371) 1.2.7 – 12 (prev. HAB Methods 19)Ph.Eur. (2371) 1.4.2 – 3 (prev. HAB Methods 23)

APC Method 3.10.1 (related to Ph.Eur. Method 1.2.12)APC Method 3.10.1. is used for dried herbal drugs.Mother tinctures according to APC Method 3.10.1 are ethanolic decoction prepared by heat treatment with ethanol of an appropriate concentration as specified in the individual monograph with additional maceration as described below.1 part of dried herbal drug is macerated with 20 parts of


• A

PC P

art I

Ia

37

by steam distillation or water-and-steam distillation.The distillation can be done in the presence of other substances that will not interfere with the final composition of the distillate. This process can be repeated several times in a rhythmic sequence of evaporation/condensation. Distillated preparations can be part of a more complex formulation that is composed by several fractions. Distillated preparations can be used as starting materials or finished products and can be potentised.

productionAccording to the specific methods or the individual monograph.


testsDry residue (Ph.Eur. 2.8.16 or H 2.2.6). The preparation complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official pharmacopoeia or another limit is justified and authorised.

recommended designation Distillates and derived dosage forms carry the designation „destillata“.

Specific pharmacopoeial/APC production methods to produce preparations made by distillation

APC Method 3.12.1 Preparations made by ethanolic distillation (related to HAB Method 52)

Distillates according to APC method 3.12.1 are prepared from fresh plants or parts of plants following the procedure given below.Comminute the plant material. Pour 8 parts of ethanol 90 per cent (V/V) over 100 parts of plant mass. Leave to stand in a closed container for at least 24 h, then steam distil, ending the steam distillation when 50 parts of distillate have been collected.

The mother tincture is made from1 part of distillate and1 part of ethanol 18 per cent (V/V).

time are prescribed in the individual monograph. Finally express and filter. If necessary, the empty space of the container is filled with a protecting gas.


testsRelative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individual monograph.Refractive index (Ph.Eur. 2.2.6). The preparation complies with the limits prescribed in the individual monograph.Peroxide value (Ph.Eur. 2.5.5). Where applicable, the preparation made with a vegetable oil complies with the limits prescribed in the individual monograph.


storageStore in a well-filled, airtight container, protected from light and heat. If necessary, the empty space in the container of oil extracts is filled with an inert gas.

recommended designation The designation states:• the fresh herbal drug used,• where applicable, the dried herbal drug used,• the extraction liquid used,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,• an indication of the extraction temperature,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce viscous extracts with heat treatment

HAB Methods 12 d-gHAB Method 57

Individual Monographs:Cydonia oblonga, fruit, glycerol extract with heat treatment 1:2.1.

3.12. Preparations made by distillation (Distillates)

definitionDistillates are prepared from fresh plants or parts of plants or dried plants, organic or inorganic substances


• A

PC Part IIa

38

complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Methanol (Ph.Eur. 2.9.11). Maximum 0.05 per cent V/V of methanol, unless otherwise authorised by a national official pharmacopoeia, or another limit is justified and authorised.

assayAn assay with quantitative limits is performed when starting materials with toxicologically or therapeutically relevant substances are used.storageStore in a well-closed container, protected from light, at 8 – 15 °C.

recommended designation The designation states:• the herbal drug used,• where applicable, the fresh herbal drug used,• where applicable, the name of the salt, metal or

mineral added,• where applicable, the ratio of starting material to ex-

traction liquid or of starting material to preparation,• the designation „ferm“ (with water and fermenting

agents) or „Rh“ (fermented plant sap without fermenting agents),


Specific pharmacopoeial/APC production methods to produce mother tinctures obtained with rhythmic application of heat and cold

HAB Method 21HAB Method 22HAB Methods 33HAB Methods 34HAB Methods 35HAB Method 36HAB Methods 37HAB Methods 51

APC Method 3.13.1 (related to HAB Method 21)Rh mother tinctures according to APC Method 3.13.1 are prepared from fresh plants generally yielding more than 50 per cent of expressed liquid, as follows:

Comminute the plants immediately after harvesting and express. Transfer the expressed juice to containers and subject to the diurnal hot-cold rhythm (“Rh”) described below until fermentation is complete.Each morning, warm the expressed liquid to 35 – 39 °C over a period of 30 – 90 min and maintain

potentisationThe 1st decimal dilution (D1) is made from1 part of the mother tincture and9 parts of alcohol 18 per cent (V/V).Subsequent dilutions are produced as stated for D1.

APC Method 3.12.2 Preparations made by aqueous distillation

Distillates according to APC Method 3.12.2 are preparations of fresh or dried starting materials from mineral, vegetal and animal source, obtained by aqueous distillation.Comminute the material. To 1 part of material add water according to the individual monograph, then heat with flame source, ending the distillation when 50 parts of distillated have been collected or according to the individual monograph.

The aqueous distillation can be done in the presence of other substances that will not interfere with the final composition of the final distillate.

3.13. Mother tinctures obtained by rhythmic application of heat and cold

definitionMother tinctures obtained by rhythmic application of heat and cold are aqueous preparations from fresh or dried herbal drugs or saps from fresh herbal drugs, obtained by fermentation under cold and heat appli-cation.

productionComminute the herbal drug if necessary. Add purified water. If stated in the individual monograph, add the prescribed fermenting agent.It is also possible to ferment the expressed plant sap or the finely minced fresh plant without addition of purified water. Treat rhythmically with application of heat (generally 37 °C) and cold (generally 4 °C). Where required, express and filter after the time prescribed in the individual monograph. Salts, specific plant ashes, metals or minerals may be added according to the individual monograph.


testspH (Ph.Eur. 2.2.3). The preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). The preparation


• A

PC P

art I

Ia

39

Subsequent decimal dilutions are produced as stated for D1.

Ethanolic dilutionsThe 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of ethanol 18 per cent (V/V).


recommended designation Mother tinctures made according to APC Method 3.13.2 carry the designation “Rh”; the same applies to preparations made from them. If ethanol 18 per cent (V/V) is used from the 1st decimal dilution onwards, state this on the label.

4. SOLID STARTING MATERIALS OBTAINED BY HEAT

Heat treatment can be applied directly to solid starting materials from botanical or zoological origin without addition of a vehicle. The heat treatment may be performed under presence or reduced presence of oxygen. Solid starting materials obtained by heat include toasted preparations (Tosta), carbons (Carbo) and ashes (Cinis).

4.1. Toasted preparations – Tosta

definitionToasted preparations are obtained from dried plants or parts of plants or solid, dried animal matter by toasting. Toasted preparations are dry, usually brownish and have an intense and characteristic odour.

The substances to be toasted are crushed, if necessary, and are exposed to a heat source for the prescribed time. During the process water evaporates and the matter becomes brown or brownish. This is achieved through control of the heat supply, usually 170 – 250 °C and by tossing the material during this procedure. The toasted substance is powdered.Particle size of the raw material, temperature and heating time are prescribed in the individual monograph.

Toasted substances may be potentised according to Ph.Eur. 4.1.1.

at this temperature. Each evening, cool the expressed liquid to 2 – 6 °C over a period of 30 – 90 min and maintain at this temperature.Stir the liquid for 60 – 200 min during both temperature phases at the beginning, gradually decreasing to 10 min at the end of the fermentation process. Filter as soon as fermentation has ceased.

potentisationAqueous dilutions

The 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of water for injections.


Ethanolic Dilutions The 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of ethanol 18 per cent (V/V).


recommended designation Preparations made according to APC Method 3.13.1 carry the designation “Rh”; the same applies to prepa-rations made from them. If ethanol 18 per cent (V/V) is used from the 1st decimal dilution onwards, state this on the label.

APC Method 3.13.2 (related to HAB Method 22)Rh mother tinctures according to APC Method 3.13.2 are prepared from fresh plants, generally yielding distinctly less than 50 per cent of expressed liquid, as follows:

Comminute the plants immediately after harvesting. Subject the plant material to the diurnal hot-cold rhythm (“Rh”) for 7 – 10 days. Each morning, warm the plant material to approximately 35 – 39 °C and maintain at this temperature. Each evening, cool the plant material to 2 – 6 °C and maintain at this temperature.Then express. Transfer the expressed juice to containers and subject to the diurnal hot-cold rhythm (“Rh”) as described under method 3.13.1.

potentisationAqueous dilutionsThe 1st decimal dilution (D1) is made from1 part of Rh mother tincture and9 parts of water for injections.


• A

PC Part IIa

40

• Sulfated ash (Ph.Eur. 2.4.14),• Sulfide,• Total ash (Ph.Eur. 2.4.16),• Zinc.

assayAn assay is carried out according to the individual monograph, where applicable.

storageStore in a well-closed container.recommended designation The designation states:• the name of the herbal or animal matter used,• the designation ”Carbo”, example: Carbo Gentianae,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce carbons

Ph.Helv. 17.7.4.2B.Hom.P. Method Br4

4.3. Ashes – Cinis

definitionAshes are obtained from dried plants or parts of plants or dried animal matter. They are generally fine, amorphous, white, grey, beige or brown powders.

The herbal or animal matter is incinerated generally at a temperature above 500 °C.

Ashes may be potentised according to Ph.Eur. 4.1.1.

identificationThe identification is carried out according to the individual monograph.

testsThe tests are carried out according to the individual monograph, where applicable:• Acid insoluble substances,• Arsenic (e.g. Ph.Eur. 2.4.2),• Heavy metals (e.g. Ph.Eur. 2.4.8),• Loss on drying (Ph.Eur. 2.2.32).

assayWhere applicable the Cinis complies with the individual monograph.

identificationAccording to the individual monograph.

testsThe tests are carried out according to the individual monograph, where applicable.

assayAn assay is carried out according to the individual monograph, where applicable.


recommended designation The designation states:• the name of herbal or animal matter used,• the designation “tostus/a/um/”, example: Spongia

tosta,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce toasted preparations.

According to the individual monograph.Ph.Helv 17.7.4.1

4.2. Carbons – Carbo

definitionCarbons are obtained from dried plants or parts of plants or dried animal matter. They are dry, brittle, and generally black substances.The plant or animal matter is heated to a temperature usually above 200 °C under reduced presence of oxygen to produce the carbonised deposit. The carbonised substance is powdered.Carbons may be potentised according to Ph.Eur 4.1.1.

identificationThe identification is carried out according to the individual monograph.

testsThe tests are carried out according to the individual monograph, where applicable:• Acidity or Alkalinity,• Acid-soluble substances,• Adsorption power,• Alkali-soluble coloured matter,• Cyanide,• Ethanol-soluble substances,• Fluorescent substances,• Heavy metals (e.g. Ph.Eur. 2.4.8),• Loss on drying (Ph.Eur. 2.2.32),


• A

PC P

art I

Ia

41

recommended designation The designation states:• the name of the plant material used,• the quantity used,• the vehicle used,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce solid preparations from fresh plants

Ph.Eur. (2371) Method4.1.1

APC Method 5.1.1Preparations according to APC Method 5.1.1 are solid preparations of fresh plants prepared by drying fresh herbal drugs onto lactose monohydrate.Comminute the plants or parts of plants. To 1 part of the plant material add the required amount of lactose mono hydrate, usually 2.9 parts unless otherwise prescribed in the individual monograph. Mix thoroughly. Dry the moist mixture gently until it reaches the dryness required. Mill, if necessary, then sieve as specified in the individual monograph and remix thoroughly.

potentisationThe preparation can be potentised according to Ph.Eur. (2371) Methods 4.1.1 and 4.1.2.The 1st decimal dilution (D1) is made from 3 parts of the solid preparation and7 parts of lactose monohydrate

5.2. Solid preparations from liquids, plant juices or aqueous extracts

definitionSolid preparations of liquids are prepared by drying plant juices, tinctures, aqueous extracts or solutions or their dilutions onto suitable vehicles e.g. lactose monohydrate. The expressed juice or the tincture from the fresh plant material or the solution is mixed thoroughly with the vehicle. The mixture is dried gently and milled if necessary.The preparation can be potentised according to Ph.Eur. (2371) Methods 4.1.1 and 4.1.2.


identificationAt least one chromatographic test is carried out.

storageStore in a well-closed container with a desiccant if necessary.

recommended designation The designation states:• the name of the herbal or animal substance used,• the designation ”Cinis”, example: Cinis Tabaci,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce ashes

Ph. Helv. 17.7.4.3B.Hom.P. Method Br3

5. SOLID PREPARATIONS FROM PLANTS (DRYING ONTO A VEHICLE)

Solid preparations from plants are obtained either by drying fresh plants, plant juices or aqueous extracts onto a vehicle.

5.1. Solid preparations from fresh plants

definitionSolid preparations of fresh plants are prepared by drying fresh plant material onto suitable vehicles e.g. lactose monohydrate.

productionComminute the fresh plant material, and mix thoroughly with the vehicle in order to adsorb its liquid part. Dry the mixture gently and mill if necessary.The preparation can be potentised according to Ph.Eur. (2371) Methods 4.1.1 and 4.1.2.

identificationAt least one chromatographic test is carried out.

testsLoss on drying (Ph.Eur. 2.2.32): The solid preparation complies with the limits prescribed in the individual monograph.Microbiological quality (Ph.Eur. 5.1.4): (Non-aqueous preparations for oral use).

assayAn assay with quantitative limits is performed when raw materials with toxicologically or therapeutically relevant substances are used.



• A

PC Part IIa

42

necessary to concentrate the plant juice under reduced pressure.

APC Method 5.2.3Preparations according to APC Method 5.2.3 are solid preparations from aqueous extracts prepared by drying aqueous extracts of fresh plants onto lactose monohydrate or another excipient.Mix 1 part of the comminuted fresh plants with 0.15 parts of purified water. Then express the mixture. The expressed aqueous extract is added to 4 parts of lactose monohydrate unless otherwise prescribed in the individual monograph to obtain a wet granulate. Dry the wet granulate gently until it reaches the dryness required. Mill, if necessary, then sieve as specified in the individual monograph and remix thoroughly. Before granulation it may be necessary to concentrate the aqueous extract under reduced pressure.

6. LIQUID DILUTIONS

definitionLiquid dilutions are prepared by dissolving one or more starting materials in an appropriate vehicle. The liquid obtained may be directly potentised.

productionThe starting material is dissolved in the appropriate vehicle. Dissolution may require heating or stirring. The separation of a residue may be necessary.

Where necessary, immediately after the dissolution the first potentisation step is carried out in accordance with the individual monograph.

identificationLiquid dilutions are identified using a suitable method.

testsAppearance (Ph.Eur. 2.2.1, 2.2.2). Where applicable, the preparation complies with the limits described in the individual monograph.pH (Ph.Eur. 2.2.3). Where applicable, the preparation complies with the limits prescribed in the individual monograph.Dry residue (Ph.Eur. 2.8.16 or H 2.2.6). Where applicable, the liquid solution complies with the limits prescribed in the individual monograph.Relative density (Ph.Eur. 2.2.5). The preparation complies with the limits prescribed in the individual monograph.

assayWhere applicable, liquid solutions of chemically

testsLoss on drying (Ph.Eur. 2.2.32). The solid preparation complies with the limits prescribed in the individual monograph.Microbiological quality (Ph.Eur. 5.1.4). (Non-aqueous preparations for oral use)

assayAn assay with quantitative limits is performed when raw or starting materials with toxicologically or therapeutically relevant substances are used.


recommended designation The designation states:• the name of the plant material used,• the quantity used,• the vehicle used,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce solid preparations from liquid extracts/ plant juicesPh.Eur. (2371) Methods (refer to potentisation)4.1.14.1.2

APC Method 5.2.1Preparations according to APC Method 5.2.1 are solid preparations from fresh plant juices prepared by drying the fresh plant juice onto lactose monohydrate or another excipient.Add 1 part of the expressed plant juice or aqueous extract to 1.9 parts of lactose monohydrate unless otherwise prescribed in the individual monograph to obtain a wet granulate. Dry the wet granulate gently until it reaches the dryness required. Mill, if necessary, then sieve as specified in the individual monograph and remix thoroughly. For granulation it may be necessary to concentrate the plant juice under reduced pressure.

APC Method 5.2.2Preparations according to APC Method 5.2.2 are solid preparations from fresh plant juices prepared by drying the fresh plant juice onto lactose monohydrate or another excipient.The expressed plant juice of 1 part of the fresh plant is added to 3 parts of lactose monohydrate unless otherwise prescribed in the individual monograph to obtain a wet granulate. Dry the wet granulate gently until it reaches the dryness required. Mill, if necessary, then sieve as specified in the individual monograph and remix thoroughly. Before granulation it may be


• A

PC P

art I

Ia

43

recommended designation The designation states:• the name of the composition,• the composition of the product

(quantity of the ingredients),• reference pharmacopoeia/codex.

Specific APC production methods to produce compositions according to 7.1

Examples (see appendix 2.6): Anis-Pyrit, Ferrum-Quarz, Hepar-Magnesium, Hepar sulfuris, Kalium aceticum comp., Plumbum mellitum, Solutio Sacchari comp. (mineral compositions according to the model of a plant).

7.2. Compositions made by treating two or more extracts or mother tinctures of one plant by one or more pharmaceutical processes

definitionCompositions made by treating two or more mother tinctures of one plant by pharmaceutical processes are prepared from extracts (mother tinctures) of the same plant species harvested at different seasons, i.e. at different stages of development. According to the individual monograph the extracts are combined in a defined ratio by a specific pharmaceutical process possibly using specific equipment. Adjustment of concentration, of pH, and of osmolality may be carried out.


identification/testsAccording to the nature of the composition. The components of the composition comply with the requirements of the relevant monographs.



Specific pharmacopoeial APC production methods to produce compositions according to 7.2

HAB Method 32HAB Method 38

defined starting materials are assayed.


recommended designation The designation states:• the name of the substance dissolved,• the quantity dissolved,• where applicable, the degree of potentisation,• the reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce liquid dilutions

Ph.Eur. (2371) Methods3.1.13.1.2

HAB Methods 5

7. COMPOSITIONS

Compositions are active substances which are obtained when two or more starting materials and/or preparations with or without excipients and/or vehicles are processed together in a pharmaceutical process that will lead to a new substance (unit). The rationale for composing is the anthroposophic understanding of man, nature, substance and processing. Compositions may be directly used as an active substance or can be potentised or diluted for any dosage form.

7.1. Compositions made by treating two or more starting materials by one or more pharmaceutical processes

definitionCompositions made by treating two or more starting materials or preparations by one or more pharmaceutical processes are prepared by combining starting materials in a defined ratio according to the individual monograph using a specified process (e.g. specified mixing, heat treatment, chemical process).




• A

PC Part IIa

44

or plant parts are separated by centrifugation. The centrifugate is filled up to 100 parts with 0.09 percent sodium chloride solution and filtered. The winter formulation produces the so called winter extract, the summer formulation the so called summer extract. If the extract is to be stored, sterile filtration must take place.The composition is produced by composing three parts of winter extract and one part of summer extract as described below.The winter extract is stirred in a specially constructed gilded mixing vessel. The summer extract is allowed to drop from the top of the vessel into the vortex of the winter extract. The osmolality is adjusted by adding sodium chloride and the pH is adjusted to 6.1 – 6.3 by adding sodium hydroxide solution. If the composition is to be stored, sterile filtration must take place. The composition (mother tincture) can be used directly or can be used for further dilutions. The addition of anti oxidants or substances for pH adjustment is allowed.

Dilutions are obtained by diluting the composition. At a temperature between 10 °C and 25 °C the necessary amount of 0.9 percent sodium chloride solution is stirred in a vessel; the composition is dropped from the top into the vortex. The dilution series is: (Composition + sodium chloride solution) e.g. 3+2 (30 mg), 2+3 (20 mg), 1+4 (10 mg), 1+9 (5 mg), 1+49 (1mg), 1+499 (0.1 mg); 1+4999 (0.01 mg). If the dilution is to be stored, sterile filtration must take place.

recommended designation The amount of herbal drug (fresh plant) which was extracted to achieve 1 mL/2 mL of the final preparation.

APC Method 7.2.3 and 7.2.4 Compositions of fermented aqueous extracts and liquid preparations thereofCompositions according to APC Method 7.2.3 and 7.2.4 are mother tinctures produced from fresh plants or parts of plants by the following procedure.Finely comminute the plants or parts of plants and mix 1 part of the plant mass with 1.318 parts of purified water, 0.03 parts of sucrose, and 0.002 parts of a Lactobacillus plantarum suspension, 109 – 1010 cfu/mL and mix thoroughly. Leave to ferment for 3 days at 20 to 27 °C with the exclusion of air. Then express and weigh the expressed liquid. If (except for the berries) gentle pressure applied to the plant residue does not achieve a final mass of extract equal to 2 parts, pour a sufficient amount of purified water over the plant residue and express gently. Use the resulting extract to make the extract up to 2 parts. If prescribed in the

See appendix 2.6, for example Viscum album compositions.

APC Method 7.2.1 (see also APC Method 3.7.1)Compositions according to APC Method 7.2.1 are produced from fresh plants or parts of plants by the following procedure:Finely comminute the plants or parts of plants and mix 1 part of the plant mass with 1 part of purified water. Leave to ferment at 20 to 24 °C with the exclusion of air, ending the fermentation when the pH of the fermentation liquid has fallen to between 4 and 5. Then express and weigh the expressed liquid. The weight of the expressed liquid is equal to 2 parts and is mixed with 1 part of a mixture of 0.95 parts of ethanol 96 per cent (V/V) and 0.05 parts of purified water. This tincture is stored until it will undergo another pharmaceutical process with a second tincture of the same plant.This procedure is followed for plants harvested in summer and for plants of the same species, harvested in winter.The mother tincture is a composition, produced by unifying equal parts of the two tinctures.

The mother tincture can be potentised as follows:

The 1st decimal dilution (D1) is made from3 parts of the mother tincture and7 parts of alcohol 36 per cent (V/V).

The 2nd decimal dilution (D2) is made from1 part of the 1st decimal dilution and9 parts of alcohol 18 per cent (V/V).Subsequent dilutions are produced as stated for D2.

recommended designation Preparations according to APC Method 7.2.1 carry the designation „ferm APC 7.2.1“.

APC Method 7.2.2 Compositions of aqueous extracts and liquid preparations thereofCompositions according to APC Method 7.2.2 are mother tinctures produced from fresh (frozen) plants or parts of plants by the following procedure.The plants or parts of plants are comminuted in a grinder, pressed in appropriate boxes and frozen at – 10 °C to – 30 °C. The plants or parts of plants are combined to a specific formulation: Plants and parts of plants from winter harvest with plants from spring harvest to give the so called winter formulation. Plants from summer harvest with plants from autumn harvest to give the so called summer formulation. 5 parts of frozen plants are extracted for 1 – 4 h at 10 – 20 °C with 95 parts of 0.09 % sodium chloride solution in a container with stirring. The coarse plants


• A

PC P

art I

Ia

45

Compositions produced according to methods 7.2.3 and 7.2.4 may be potentised according to chapter 8.

recommended designation The amount of herbal drug (fresh plant) which was extracted to achieve 1 mL of the final preparation.

storageStore the mother tincture in a well-closed container at 2 – 8 °C.

7.3. Compositions made by treating one or more starting materials with one or more mother tinctures which undergo one or more pharmaceutical processes together

definitionCompositions made by treating one or more starting materials with one or more mother tinctures are obtained by combining one or more starting materials with one or more stocks in a defined ratio according to the individual monograph.





Specific pharmacopoeial/APC production methods to produce compositions according to 7.3

Examples (see appendix 2.6): Cinis e fructibus Avenae sativae cum Magnesio phosphorico (1:1), Cissus-Ossa.

7.4. Compositions made by treating two or more extracts or mother tinctures and/or dilutions by one or more pharmaceutical processes

definitionComposition made by treating two or more extracts or mother tinctures and/or dilutions by pharmaceutical

individual monograph, adjust the pH to 5.0 – 6.5 by adding sodium hydroxide.Follow the same procedure for plant material harvested in the summer and for plant material of the same species, harvested in the winter. However, for the winter harvest, process the berries and the other plant parts separately according to the method described above and use 1.328 parts of purified water and 0.02 parts of sucrose. Also, leave the berry mixture to ferment for 4 days.If the extracts are stored for further processing, they must comply with the test for sterility (Ph.Eur. 2.6.1).

The composition is produced by composing equal parts of the summer and the combined winter extracts as described below.

Method 7.2.3Mix two parts of summer extract with 3 parts of water for injections.Mix one part of winter extract of plant material and one part of extract of berries with 3 parts of water for injections.

Method 7.2.4Mix two parts of summer extract with 3 parts of water for injections. Mix one part of winter extract of plant material and one part of extract of berries with a mixture of 0.002 parts of a metal salt trituration from the D4 potentisation step and 2.998 parts of water for injections.

Methods 7.2.3 and 7.2.4Feed the mixture of the winter extracts continuously onto the centre of a rotating disk. At the same time, feed the summer extracts continuously onto the slightly raised edge of the disk. The blended mixture flows continually off over the edge of the disk. Filter the mixture; the filtrate is the mother tincture. If the mother tincture is stored for further processing, it must comply with the test for sterility (Ph.Eur. 2.6.1).The dilution series is (composition or dilution + water for injections): 1+9 (20 mg), 1+19 (10 mg, corresponding to a 1:20 dilution); 1+39 (5 mg); 1 + 99 (2 mg); 1 part 1:20 dilution + 9 parts water for injections (1:200 or 1 mg); 1 part 1:200 dilution + 9 parts water for injections (1:2,000 or 0.1 mg); 1 part 1:2,000 dilution + 9 parts water for injections (1:20,000 or 0.01 mg); 1 part 1:20,000 dilution + 9 parts water for injections (1:200,000 or 0.001 mg); 1 part 1:200,000 dilution + 9 parts water for injections (0.0001 mg). To prepare the final preparation, add sodium chloride to the water for injections to obtain an isotonic solution.


• A

PC Part IIa

46

Specific pharmacopoeial/APC production methods to produce compositions according to 7.5Ph.Eur. (2371) Methods5.1.15.1.25.1.5

8. POTENTISED PREPARATIONS

Potentised preparations are gradually diluted substances, whereby at each diluting step a rhythmic succussion (liquid potencies) or trituration (solid or semi-solid potencies) has been carried out for a defined time. The potentising time differs for solid and liquid potentised preparations. Astronomical aspects may be considered (e.g. solar or lunar eclipse ).The preparations are defined by the number of liquid potentising or trituration steps respectively and by the ratio between the vehicle (diluting agent) and the substance to be potentised.

The potentising ratio is usually:1 part of substance9 parts of vehicle.

The potentising ratio for co-potentised preparations is usually:1 part of a mixture of equal parts of active substances9 parts of vehicle.

liquid potencies:The substance or mixture to be potentised is dissolved in the vehicle in the chosen ratio. Usual vehicles for liquid potencies are water (purified or water for injections), ethanol of various concentrations, glycerol or vegetable oils. Excipients might be necessary, for example to emulsify an aqueous substance into oil. After dissolution, rhythmic succussion is carried out. For the next poten-tising step one part of the first potency and the prescribed amount of vehicle are brought together and succussed. Further potentising is carried out in likewise manner.

solid potencies (triturations):Potencies of solid substances are prepared by trituration of the substance to be potentised usually with lactose monohydrate in the prescribed ratio in a mortar with a pestle or in an adequate trituration machine.Solid potencies can be further potentised in liquid phase, if they are soluble in a vehicle.

semi-solid potencies:Semi-solid potencies are prepared by trituration of a liquid or a solid substance to be potentised with an

processes are prepared according to an individual monograph prescribing the combination of the ingredients in a defined ratio by a specific pharmaceutical process using specific equipment.

productionAccording to the individual monograph.


recommended designation The designation states:• the name of the preparation,• the composition of the product

(quantity of the ingredients),• reference pharmacopoeia/codex.Specific pharmacopoeial/APC production methods to produce compositions according to 7.4

Examples (see appendix 2.6): Onopordum acanthium, Folium rec., ethanol. Digestio (1:3.1) with 1 – 2 % Hyoscyamus niger, Herba rec. Ø, see also Plantago lanceolata and Primula.

7.5. Compositions made by co-potentising

definitionCompositions made by co-potentising are prepared from two or more starting materials and/or preparations (e.g. mother tinctures, potencies) by co-poten tising over one or more steps.

productionAccording to APC Method 8.1 or the individual monograph.


recommended designation The designation states:• the name, quantity and potency degree of each

ingredient,• how many potentising steps were carried out on the

mixture as a whole,• reference pharmacopoeia/codex.


• A

PC P

art I

Ia

47

identification, test, assayare carried out according to the individual monograph.


recommended designation The designation states:• the name of the potentised substance(s),• where applicable, the ethanol content,• the potentising ratio; decimal potencies may be

designated as D or DH or X,• the potency degree, example: D3 or 3 DH or 3X,• the reference pharmacopoeia/codex.• APC Method 8.1.1 (Ph.Eur. (2371) Method 5.1.5)Co-potentised preparations according to APC Method 8.1.1 are liquid dilutions potentised with a suitable vehicle from two or more (n) preparations, each making up 1 part of the final 10 parts. Consequently the vehicle is 10 minus n parts.

potentisationFor the first co-potentisation step combine and succuss 1 part of each of the n preparations with 10 minus n parts of water or ethanol of the appropriate concentration specified under HAB H 5.3. For each further co-potentisation step the ratio is 1 part of the given composed potency and 9 parts of vehicle.

recommended designation The designation of co-potentised compositions according to APC Method 8.1.1 and derived dosage forms states how many potentising steps were carried out on the mixture as a whole adding the expressions “rhythmically diluted”.

APC Method 8.1.2 (related to Ph.Eur. (2371) Methods 5.1.1 and 5.1.2)

Co-potentised preparations according to APC Method 8.1.2. are liquid dilutions potentised with a suitable vehicle from two or more (n) preparations, each making up 1/n part of the final 10 parts. Consequently the vehicle is 9 parts.

potentisationFor the first co-potentisation step combine and succuss 1/n part of each of the n preparations with 9 parts of water or ethanol of the appropriate concentration specified under HAB H 5.3. For each further co-potentisation step the ratio is 1 part of the given composed potency and 9 parts of vehicle.

ointment base in the prescribed ratio in a mortar with a pestle or in an adequate trituration machine.

Specific pharmacopoeial/APC production methods to produce potentised preparationsPh.Eur. (2371) Methods3.2.1 – 34.1.1 – 24.2.1 – 25.1.1 – 5

HAB Method 12jHAB Method 17B.Hom.P. Method Br5B.Hom.P. Method Br6

The potentising specifications in Ph.Eur. monograph 2371 of Methods 1.1.1 – 1.1.11, 2.1.1, 2.1.2, 2.2.1 – 2.2.4 and 5.1.1 – 5.1.5.

The potentising specifications in HAB methods5, 11, 15, 18, 19, 20, 21, 22, 23, 24, 32, 33, 34, 35, 36, 37, 38, 39a, 39b, 45, 51, 53.

The potentising specifications in APC Methods.

8.1. Co-potentised preparations

definitionMethod 8.1 is used for preparing dilutions by co- potentising two or more stocks and/or dilutions thereof, where co-potentisation consists of mixing several stocks or dilutions of stocks then potentising them together in one or more potentisation steps.

productionCo-potentised compositions according to APC Method 8.1 may be prepared from starting materials and/or solutions, potentised preparations and mother tinctures whose method of production is specified by a ratio of 1 part of starting material and 10 parts of extraction solvent.When a solid potency D4 shall be potentised with liquids, it can be potentised one step according to Ph.Eur. (2371) Methods 3.2, and then be used as D5 for co-potentisation or dilution to a final concentration of 1 ppm.

Co-potentised compositions may be used to produce all types of dosage forms. Co-potentisation of mixtures according to APC Method 8.1 to produce parenteral preparations or eye drops is carried out with water for injections or an isotonic solution as diluting agent.



48

recommended designation The designation of co-potentised compositions according to APC Method 8.1.2. and derived dosage forms states how many potentising steps were carried out on the mixture as a whole.

8.2. Potentising in an ointment base

definitionLiquid and solid starting materials can be potentised within an ointment base.

productionAccording to the specific methods or the individual monograph.identification, tests, assayare carried out according to the individual monograph.


recommended designation The designation states:• the name of the potentised substance(s),• the potentising ratio; decimal potencies may be

designated as D or DH or X,• the potency degree in the ointment,• the reference pharmacopoeia/codex.

APC Method 8.2.1 (Ointments containing powdered solid starting materials, related to HAB Method 48)Ointments containing powdered solid starting materials are produced with 1 part of a powdered metal, powdered mineral or a composition containing minerals and 9 parts of an ointment base leading to a homogeneous ointment. This potentising step in an ointment base results in the first decimal dilution (D1). The particle size of the powdered solid starting material must be smaller than 100 mm.Ointments according to APC Method 8.2.1 must meet the requirements of the Ph.Eur. monograph "Semi-solid preparations for cutaneous application" (0132).Ointments according to APC Method 8.2.1 can be used further to produce ointments according to HAB Method 13.

recommended designation Ointments according to APC Method 8.2.1 carry the designation “APC M” and the resulting decimal dilution “D1”.

APC-Method 8.2.2 Ointments containing solid or liquid dilutionsOintments containing solid or liquid dilutions are

produced with 1 part of a decimal solid or liquid dilution (Dn) and 9 parts of an ointment base leading to a homogeneous ointment. The resulting decimal dilution degree is (Dn+1).Ointments according to APC Method 8.2.2. must meet the requirements of the Ph.Eur. monograph “Semi-solid preparations for cutaneous application” (0132).

recommended designation Ointments according to APC Method 8.2.2 carry the designation of the resulting degree of decimal dilution. Example: D3 or 3 DH or 3X APC 8.2.2.

8.3. Triturations

definitionPreparations according to APC Method 8.3 are triturations of solid substances with lactose monohydrate as potentising vehicle unless otherwise specified in a ratio of 1:10.

productionTriturate using a machine that ensures even trituration. Suitable machines include mixers with rhythmic, pul sating spatial inversion (e.g. “Turbula”), in combination with a sealable mixing vessel and appropriate grinding balls as well as other machines with rotating movements such as the ball mill.Triturate the whole amount of vehicle with the substance to be potentised.The trituration time depends on the machine and the chosen parameters. Trituration must be between 15 and 60 minutes. It has to be ensured, that the trituration is homogeneous and that particle size reduction is achieved.

testsare carried out according to the individual monograph.

recommended designation Preparations according to APC Method 8.3 carry the designation of the resulting degree of decimal dilution. Example: D3 or 3 DH or 3X APC 8.3.

9. MIXTURES

definitionMixtures are produced from usually two or more active substances.Vehicles and/or excipients may be added. Mixtures contain the sum of the active substances mixed together. Mixtures can also be produced from one active substance and a vehicle. A special manufacturing method is not needed (cf. compositions). Mixtures are used to

• A

PC Part IIa


49

facilitate the administration of more than one active substance in one single finished product. The mixture itself may be the final dosage form.

Mixtures can be classified into four categories:9.1. Mixtures of preparations without a vehicle9.1a. Mixtures of liquid preparations produced according to Ph.Eur., HAB or APC Methods.9.1b. Mixtures of solid preparations produced according to Ph.Eur., HAB or APC Methods.9.1c. Liquid and solid preparations, produced according to Ph.Eur., HAB or APC Methods, resulting in a liquid preparation.

9.2. Mixtures of preparations with a vehicle9.2a. Liquid preparations produced according to Ph.Eur., HAB or APC Methods in which the vehicle is added in a ratio other than 1 to 10 or 1 to 100.9.2b. Solid preparations produced according to Ph.Eur., HAB or APC Methods in which the vehicle is added in a ratio other than 1 to 10 or 1 to 100.9.2c. Liquid and solid preparations, produced according to Ph.Eur., HAB or APC Methods, resulting in a liquid preparation, in which the vehicle is added in a ratio other than 1 to 10 or 1 to 100.9.3. Mixtures of preparations with excipients and vehicles.9.3a. Liquid preparations produced according to Ph.Eur., HAB or APC Methods with an excipient(s).Vehicles may be added.9.3b. Liquid and solid preparations, produced according to Ph.Eur., HAB or APC Methods, resulting in a liquid preparation with an excipient(s). Vehicles may be added.9.4. Mixtures of starting materials used as active substances and mother tinctures or preparations with or without vehicles and/or excipients.

recommended labelling• the ingredients mixed and their quantity,• reference pharmacopoeia/codex.

Specific pharmacopoeial/APC production methods to produce mixturesHAB Method 12HAB Method 16

• A

PC P

art I

Ia

• A

PC Part IIb

50



PART IIbIndividual monographs of starting materials and preparations

Table of ContentPart IIbCYDONIA OBLONGA, FRUIT ............................ 51CYDONIA OBLONGA, FRUIT, HEAT TREATED AQUEOUS TINCTURE 1:2.1 ............ 51CYDONIA OBLONGA, FRUIT, GLYCEROL EXTRACT WITH HEAT TREATMENT 1:2.1 ..................................... 52

CYDONIA OBLONGA, FRUIT, MOTHER TINCTURE OBTAINED BY RHYTHMIC APPLICATION OF HEAT AND COLD CYDONIA OBLONGA E FRUCTIBUS FERM 33B ..................................... 53LEVICO WATER ..................................................... 54


51

CYDONIA OBLONGATA, FRUITCydonia oblonga, FructusCydonia

definitionFresh, ripe fruit of Cydonia oblonga Mill. collected during late summer and autumn.

charactersThe odour is characterised by a typical flowery scent.

identificationThe pear-shaped variety (var. pyriformis) is yellow, fragrant, fuzzy, 7 – 15 cm in diameter. The gentle soft pulp is golden yellow.The apple-shaped variety (var. maliformis) is yellow to greenish yellow, fuzzy, 7-15 cm in diameter and less fragrant. The pulp is characterised by stone cells.Both varieties obtain five oblong-ovate sepals with serrate margins which are located in a depression. They are completely adnate with the 5 carpels. The 5 loculi of the core generally each contain 5 to 15 or sometimes more brown, cuneate seeds arranged in 2 vertical rows and stuck together with a mucilaginous coat.

testsForeign matter (Ph.Eur. 2.8.2).As low as possible. The whole batch is checked during manufacture. Foreign matter is sorted out.

Adulteration.Fruits from Japanese quince [Choenomeles japonica (Thunb.) Lindl. ex Spach, syn. Cydonia japonica Pers., Rosaceae] and Chinese quince [Choenomeles speciosa (Sweet) Nakai, Rosaceae] are 4 to 5 cm in diameter with a smooth peel and being devoid of stone cells.

preparations1. Heat treated aqueous preparation according to the individual monograph,2. Heat treated preparation with glycerol according to the individual monograph,3. Tincture obtained by rhythmic application of heat and cold according to APC method 3.13 and method HAB 33b.

CYDONIA OBLONGA, FRUIT, HEAT TREATED AQUEOUS TINCTURE 1:2.1

definitionThe heat treated aqueous tincture is prepared from the fresh cut fruit of Cydonia oblonga Mill., see Cydonia oblonga, Fruit (Cydonia oblonga, Fructus; Cydonia) APC

productionThe heat treated aqueous tincture is prepared in a ratio of fresh fruits to purified water 1:2.1 and by heat treatment at 65 – 70 °C as follows:

The whole fresh ripe fruit are cut into pieces (2 – 4 cm). To 1 part of the cut fruit add 2.1 parts of purified water and mix thoroughly. Heat to 65 – 70 °C in a closed container and keep at this temperature for one hour swirling repeatedly. After cooling to 40 – 45 °C separate by straining the mixture through gauze, filter the resulting liquid and process immediately.

charactersAppearance: light yellow, slightly turbid liquid.Odour: fruity.

identificationThin-layer chromatography (Ph.Eur. 2.2.27).

Test solution. Apply 10 mL onto a cartridge filled with octadecylsilylated silica gel RH (particle size 55 – 110 µm, 360 mg), preconditioned sequentially with 10 mL of methanol R and 10 mL of water R. Wash the cartridge with 10 mL of water R. Elute with 10 mL of methanol R. Evaporate the eluate to dryness under reduced pressure. Dissolve the residue in 1 mL of methanol R.

Reference solution. Dissolve 5 mg of rutin R, 5 mg of hyperoside R and 5 mg of scopoletin R in 10 mL of methanol R.

Plate: TLC silica gel plate R.

Mobile phase: anhydrous formic acid R, water R, ethyl acetate R (15:15:70 V/V/V).

Application: 20 µL as bands.

Development: over a path of 10 cm.

Drying: at 105 °C for 5 min.

Detection: spray the plate while still warm with a 10 g/L solution of diphenylboric acid aminoethyl ester R in methanol R. Subsequently spray with a 50 mL/L solution of macrogol 400 R. Examine in ultraviolet light at 365 nm within 30 min.

Results: see below the sequence of the zones present in the chromatograms obtained with the reference solution and the test solution. Other faint zones may be present in the chromatogram obtained with the test solution.

• A

PC P

art I

Ib

• A

PC Part IIb

52

separate the mixture by straining through gauze, then filter if necessary.charactersAppearance: light yellow, slightly turbid, viscous liquid.Odour: fruity.

identificationThin-layer chromatography (Ph.Eur. 2.2.27).

Test solution. To 5 mL add 15 mL of water R. Apply the mixture onto a cartridge filled with octadecylsilylated silica gel RH (particle size 55 – 110 µm, 360 mg), preconditioned sequentially with 10 mL of methanol R and 10 mL of water R. Wash the cartridge with 10 mL of water R. Elute with 10 mL of methanol R. Evaporate the eluate to dryness under reduced pressure. Dissolve the residue in 0.5 mL of methanol R.

Reference solution. Dissolve 10 mg of rutin R, 10 mg of hyperoside R and 2 mg of scopoletin R in 10 mL of methanol R.


Mobile phase: anhydrous formic acid R, water R, ethylacetate R (15:15:70 V/V/V).

Application: 20 µL as bands.


Drying: at 105 °C for 5 min.

Detection: spray the plate while still warm with a 10 g/L solution of diphenylboric acid aminoethyl ester R in methanol R. Subsequently spray with a 50 mL/L solution of macrogol 400 R. Examine in ultraviolet light at 365 nm within 30 min.

Results: see below the sequence of the zones present in the chromatograms obtained with the reference solution and the test solution. Other faint zones may be present in the chromatogram obtained with the test solution.

Top of the plate

Scopoletin: a blue zone A blue zone

A blue zone

__________________ __________________

Hyperoside: an orange zone

A strong light blue zone

Rutin: an orange zone An orange zone

__________________ __________________

Reference solution Test solution

testsRelative density (Ph.Eur. 2.2.5): 1.002 to 1.022.pH (Ph.Eur. 2.2.3): 3.0 to 4.0.Dry residue (Ph.Eur. 2.8.16): min. 2.5 % (3 g initial weight and dry at 105 °C for 2 hours).

storageIf stored it must meet the requirements of sterility, store in well closed containers, protected from light.

CYDONIA OBLONGATA, FRUIT, GLYCEROL EXTRACT WITH HEAT TREATMENT 1:2.1

definitionThe glycerol extract with heat treatment is prepared from the fresh cut fruit of Cydonia oblonga Mill., see Cydonia oblonga, Fruit (Cydonia oblonga, Fructus; Cydonia) APC.

productionThe glycerol extract with heat treatment is prepared in a ratio of fresh fruits to glycerol (85 per cent) 1:2.1 and by heat treatment at 65 – 70 °C as follows:

The whole fresh ripe fruit is cut into pieces (2 – 4 cm). To 1 part of the cut fruit add 2.1 parts of glycerol (85 per cent) and mix thoroughly. Heat to 60 – 70 °C in a closed container and keep at this temperature for one hour swirling repeatedly. After cooling to 40 – 45 °C


• A

PC P

art I

Ib

53


identificationThin-layer chromatography (Ph.Eur. 2.2.27)Test solution. Apply 2 mL of the tincture onto a cartridge filled with octadecylsilylated silica gel RH (sorbens mass 500 mg, 3 mL reservoir) preconditioned sequentially with 2 mL of methanol R and 2 mL of water R. Wash the cartridge with 10 mL of water R. Elute with 10 mL of ether R. The eluate is evaporated to dryness. Dissolve the residue in 0.5 mL of methanol R.

Reference solution. Dissolve 10 mg of caffeic acid R and 10 mg of hyperoside R in 10 mL of methanol R.


Mobile phase: anhydrous formic acid R, water R, ethyl acetate R (10:10:80 V/V/V).

Application: 60 µL of test solution and 10 µL of reference solution, as bands.


Drying: in air.

Detection: spray with a 10 g/L solution of diphenylboric acid aminoethyl ester R in methanol R. Subsequently spray with a 50 g/L solution of macrogol 400 R in methanol R. Examine in ultraviolet light at 365 nm after 30 min.

Results: See below the sequence of the zones present in the chromatograms obtained with the reference solution and the test solution. Other faint zones may be present in the chromatogram obtained with the test solution.

Top of the plate

Scopoletin: a blue zone A blue zone

A blue zone

__________________ __________________

Hyperoside: an orange zone

A strong light blue zone

Rutin: an orange zone An orange zone

__________________ __________________


testsRelative density (Ph.Eur. 2.2.5): 1.170 to 1.185.pH (Ph.Eur. 2.2.3): 3.5 to 5.0.

storageProtected from light.

CYDONIA OBLONGATA, FRUIT, MOTHERTINCTURE OBTAIND BY RHYTHMIC APPLICATION OF HEAT AND COLD CYDONIA OBLONGATA E FRUCTIBUS FERM 33B

definitionThe tincture obtained by rhythmic application of heat and cold is prepared from the fresh minced fruit of Cydonia oblonga Mill., see Cydonia oblonga, Fruit (Cydonia oblonga, Fructus; Cydonia) APC.

productionThe tincture obtained by rhythmic application of heat and cold is prepared according to HAB method 33b (APC method 3.13).

charactersAppearance: slightly yellow liquid.Odour: sour, fruity.

• A

PC Part IIb

54

LEVICO WATERAqua LeviciLevico

definitionNaturally occurring spring water from the source Levico (Italy).Content:• Arsenic: 4 – 8 ppm• Iron: 1000 – 2500 ppm

charactersAppearance: colourless to yellowish-brown liquid, usually clear, a slight sediment may occur.Odour: almost odourless.

identificationA. Identification of arsenic by atomic absorption spectrometry (Ph.Eur. 2.2.23), see Assay.Results: the absorbance obtained with the test solution is not below the absorbance obtained with the reference solution with the lowest concentration.B. Identification of iron by atomic absorption spectrometry (Ph.Eur. 2.2.23), see Assay.Results: the absorbance obtained with the test solution is not below the absorbance obtained with the reference solution with the lowest concentration.C. Identification of copper by atomic absorption spectrometry (Ph.Eur. 2.2.23, Method I).Test solution. To 1.0 mL add 0.200 mL nitric acid R and dilute to 10.0 mL with water R.Reference solution. Prepare the reference solutions (0.5, 1.0, 2.0 and 4.0 ppm Cu) using copper standard solution R, diluted as necessary with a 5 per cent (V/V) solution of nitric acid R. Alternatively, commercially available copper standard solutions for atomic absorption spectrometry can be used.Source: copper hollow-cathode lamp using a transmission band preferably of 0.5 nm.Wavelength: 324.8 nm.Flame: air-acetylene.Results: the absorbance obtained with the test solution is not below the absorbance obtained with the reference solution with the lowest concentration.D. To 0.5 mL add 4.5 mL of water R. The solution gives reaction a on sulfates (Ph.Eur. 2.3.1).

testsRelative density (Ph.Eur. 2.2.5): 1.004 to 1.015.pH (Ph.Eur. 2.2.3): 1.5 to 2.5.

assayArsenic: 4 ppm to 8 ppm.Atomic absorption spectrometry (Ph.Eur. 2.2.23, Method I).

Top of the plate

Caffeic acid: a light blue zone A light blue zone

__________________ __________________

Hyperoside: an orange yellow zone A light blue zone

__________________ __________________


testsRelative density (Ph.Eur. 2.2.5): 1.001 to 1.013.Dry residue (based on Ph.Eur. 2.2.32 d): minimum 1.0 per cent, determined on 1.000 g of mother tincture by drying for 4 to 5 hours at 105 °C.Calculate the dry residue (per cent m/m) from the expression:

∙ 100(m₃ - m₁)m₂∙

m1 = mass of the crucible used, in grams;m2 = mass of the mother tincture used, in grams;m3 = mass of the crucible containing the mother tincture after drying, in grams.pH (Ph.Eur. 2.2.3): 3.0 to 4.2.

storageIn a well closed container at a temperature of max 15 °C.


• A

PC P

art I

Ib

55


preparationsAccording to Ph.Eur., monograph 2371 Methods3.1.1, 3.1.2.

Test solution. To 0.200 mL add 2.00 mL nitric acid R and dilute to 100 mL with water R.Reference solutions. Prepare the reference solutions (5.0, 10.0, 15.0 and 20.0 ppb As) using arsenic standard solution R, diluted as necessary with a 5 per cent (V/V) solution of nitric acid R. Alternatively, commercially available arsenic standard solutions for atomic absorption spectrometry can be used.Source: arsenic hollow-cathode lamp using a trans-miss$ion band preferably of 0.5 nm.Wavelength: 193.7 nm.Atomisation device: graphite furnace.Calculate the content of arsenic in mg/kg from the expression:

X [ppm] = ( ) /1000A₁ ∙ F₁

F₂∙

A1: measured concentration of arsenic in µg/LF1: 100 mL (dilution factor) F2: 0.200 mL

Iron: 1000 ppm to 2500 ppm.Atomic absorption spectrometry (Ph.Eur. 2.2.23, Method I).Test solution. To 0.500 mL add 2.00 mL nitric acid R and dilute to 100 mL with water R.Reference solutions. Prepare the reference solutions (5.0, 10.0, 15.0 and 20.0 ppm Fe) using iron standard solution R, diluted as necessary with a 5 per cent (V/V) solution of nitric acid R. Alternatively, commercially available iron standard solutions for atomic absorption spectrometry can be used.Source: iron hollow-cathode lamp using a transmission band preferably of 0.2 nm.Wavelength: 372.0 nm. Flame: air-acetylene.Calculate the content of iron in mg/kg from the expression:

X [ppm] = A₂ ∙ F₁

F₂∙

A2: measured concentration of iron in mg/LF1: 100 mL (dilution factor) F2: 0.500 mL


• A

PC Part III

56



PART IIIDosage forms

Table of ContentPart IIIDosage forms ............................................................ 56 Index list of terms of part I, II and III .................... 60


57

Dosage formsPrincipally an anthroposophic medicinal product can be administered in every dosage form, including external (topical), internal and parenteral dosage forms, with or without excipients.A dosage form of an anthroposophic medicinal product complies with any relevant dosage form monograph

Main dosage forms for oral use Relevant monograph(s) in (Monograph number):

Standard term Traditional name

Capsules Capsules Ph.Eur. (0016)

Granules Granules Ph.Eur. (0499)

Homoeopathic Pillules, coated

Globuli velati Ph.Eur. (1038, 2786), HAB Method 39

Homoeopathic Pillules, impregnated

Pillules Ph.Eur. (1038, 2079), HAB Method 10

Tablets Tablets Ph.Eur. (1038, 0478), HAB Method 9

Powders, oral Trituration Ph.Eur. (1165)

Oral drops Oral drops Ph.Eur. (0672)

Syrups Syrups Ph.Eur. (0672)

Oral solution Mother tincture, Dilution

Ph.Eur. (0672)

Main dosage forms for cutaneous use Relevant monograph(s) in (Monograph number):


Creams Creams Ph.Eur. (0132)

Ointments Ointments Ph.Eur. (0132), HAB Methods 13 and 48

Gels Gels Ph.Eur. (0132), HAB Method 13

Lotions Lotions B.P., Ph.Eur. (0927)

Oils Oils HAB Methods 12, Ph.Eur. (0927)

and any relevant test for that dosage form as described in the European Pharmacopoeia or in pharmacopoeias currently used officially in the EU Member States.

Main dosage forms for anthroposophic medicinal products and concerning references to official pharmacopoeias:

• A

PC P

art I

II

• A

PC Part III

58

Main dosage forms for cutaneous use Relevant monograph(s) in (Monograph number):

Liquid preparations (other)

Tinctures for external use, external emulsions, suspensions

Ph.Eur. (0927), HAB Methods 12

Powders Powders Ph.Eur. (1166)

Main dosage forms for auricular use Relevant monograph(s) in (Monograph number):


Ear drops Ear drops Ph.Eur. (0652)

Main dosage forms for ophthalmic use Relevant monograph(s) in (Monograph number):


Eye drops Eye drops Ph.Eur. (1163), HAB Method 15

Semi-solid eye preparations

Eye ointments Ph.Eur. (1163)

Main dosage forms for nasal use Relevant monograph(s) in (Monograph number):


Nasal drops, solution Nasal drops Ph.Eur. (0676), HAB Method 45

Nasal spray, solution Nasal spray Ph.Eur. (0676)

Main dosage forms for oromucosal use Relevant monograph(s) in (Monograph number):


Gels Gels Ph.Eur. (1807)

Solutions Solutions Ph.Eur. (1807)

Sprays Sprays Ph.Eur. (1807)

Pillules Pillules Ph.Eur. (1038, 2079, 2786), HAB Methods 10 and 39


• A

PC P

art I

II

59


Main dosage forms for vaginal use Relevant monograph(s) in (Monograph number):


Gels Gels Ph.Eur. (1164)

Semi-solid vaginal preparations

Globules Ph.Eur. (1164)

Vaginal tablets Vagitories Ph.Eur. (1164)

Main dosage forms for rectal use Relevant monograph(s) in (Monograph number):


Suppositories Suppositories Ph.Eur. (1145), HAB Method 14

Main dosage forms for parenteral use Relevant monograph(s) in (Monograph number):


Injections Liquid dilutions for injection, ampoules, Solutions for injection

Ph.Eur. (0520), HAB Method 11

APC Pillules containing lactose (related to HAB Method 10)APC Pillules containing lactose are pillules made by applying one or more potentised liquid preparations to saccharose pillules, which may contain up to 5 per cent of lactose. The potentising ratio usually is 1:100 (v/m or m/m). The ethanol concentration of the potentised liquid preparation(s) is at least 70 per cent (V/V). If this is not the case and interactions are excluded, the last potentisation step for decimal potentised prepa rations must be carried out with ethanol of at least 70 per cent (V/V). In case incompatibilities are expected, use ethanol of lower concentration.Preformed pillule sizes Ph.Eur. 3 and 6:Ph.Eur. size 3: 110 to 130 pillules weigh 1 gPh.Eur. size 6: 20 to 28 pillules weigh 1 g.Dry the pillules after impregnation in air.

recommended designation the designation states:the amount of potentised preparation(s),the potency degree,the potentising ratio in case other than 1:100.

60


Creams 57Crystal 17Cuprum mirror foil 25Cutaneous application 48Cydonia oblonga 37, 51, 52, 53

D

DAB 13DAC 13Demeter 17, 18Digestion 19, 20, 22, 33, 34Directive 2001/83/EEC 7Distillate 37, 38Distillation products 16, 17Dornach 7, 16, 18Dosage forms 12, 14, 16, 18, 32, 37, 47, 48, 57, 58, 59

E

Ear drops 58Equisetum arvense Silicea cultum 24Essential oils 16, 17European Pharmacopoeia 7, 8, 9, 13, 16, 18, 57Excipient 14, 18Extracts 16, 17, 19, 22, 23, 30, 31, 32, 34, 36, 37, 41,

42, 43, 44, 45Eye drops 47, 58

F

Ferm 33, 38, 44, 53Fermentation 26, 32, 33, 38, 39, 44fermented tinctures 22Ferrum-Quartz 14Ferrum-Quarz 43Flowers 17French Pharmacopoeia 8, 13Fungi 16, 17

G

Gels 57, 58, 59German Homoeopathic Pharmacopoeia 7, 8, 13German Pharmacopoeia 8, 13GHP 13Glycerol macerates 26, 29Granules 57Growing season 24

H

Heat treatment 19, 22, 26, 33, 36, 37, 39, 43, 51, 52Hepar-Magnesium 43Hepar sulfuris 43Herbal Medicinal Products 7Homoeopathic manufacturing method 7Homoeopathic manufacturing procedure 7, 8Homoeopathic preparations 8

INDEX LIST OF TERMS OF PART I, II AND III

A

Active substances 16, 18Agate water 17Algae 16, 17Animal matter 27, 28, 29, 30, 39, 40Animal origin 18, 28Anis-Pyrit 43Anode 26Anthroposophic medicinal products 7, 8, 12, 16, 18,

57Anthroposophic Pharmaceutical Codex 7, 8, 12, 13Anthroposophic pharmacy 7, 8, 12, 14, 16, 20, 24Anthroposophic preparations 8, 12APC 13Aqua maris 17Argentum metallicum praeparatum 25Argon 26Ascorbate phosphate buffer solution 31Ash process 20Astronomical aspects 21, 46

B

Bark 17Biennial 17, 24Biodoron 18Biodynamic cultivation 17Blood products 16, 17Botanical origin 16, 17Brazilian Pharmacopoeia 9British Homoeopathic Pharmacopoeia 8, 9, 13

C

Calcareous products 16, 17Capsules 57Carbo 19, 23, 39, 40Carbo Gentianae 40Carbonisation 20Carbons 19, 23, 39, 40Cathode 26, 54, 55Cinis 23, 39, 40, 41, 45Cinis e fructibus Avenae sativae cum Magnesio

phosphorico 45Cinis Tabaci 41Cissus-Ossa 45Cold maceration 20Compositions 14, 45Composting process 24Contaminants 17Co-potentisation 47Co-potentising 19, 21, 46, 47Council Directive (EEC) 17, 18

• Index

• In

dex

61


Homoeopathic stocks 7HPUS 12, 13

I

IAAP 5, 8, 9, 13, 16, 21Infusion 19, 20, 22, 34, 35Infusum 19, 22, 34, 35Injections 59Isotonic solution 18, 26, 45, 47

J

Juices 16, 17, 19, 23, 34, 41, 42

K

Kalium aceticum comp. 43KC Monograph 13Kommission C 13

L

Lactobacillus plantarum suspension 44Leaves and shoots 17Levico 17, 54Lichens 16, 17Life cycle 24Liquid dilutions 42, 59Liquid potencies 21, 46Liquid preparations 19, 22, 30, 49, 58Liquid solutions 23, 42Lotions 57Lunar eclipse 21, 46

M

Maceration 19, 20, 22, 26, 27, 28, 29, 30Magnetrom 26Medicinal Products Act 8Metabolic system 20Metallicum praeparatum 25Metal mirrors 25, 26Metal plant-compost 24Metal preparations 22Metal salts 25Metal vapour 26Minerals 15, 16, 17Miner, Carl S. 28Mixtures 23, 48, 49Mother tinctures 13, 17, 18, 19, 22, 26, 27, 28, 31, 32,

33, 34, 35, 36, 38, 39, 43, 44, 45, 46, 47, 49

N

Nasal drops 58Nasal spray 58Nitrogen 31

O

Oils 57Ointments 48, 57Oleoresins 16, 17Oral drops 57Oral solution 57Organs 16, 17

P

Parenteral preparations 18, 47Percolate 30Percolation 19, 30, 31Perennial plants 17Petioles 24Pharmaceutical processes 18, 19, 20, 26, 43, 45, 46Pharmaceutical quality 8Pharmacopoea Helvetica 13Pharmacopoeia 7, 8, 14, 24, 25, 26, 27, 29, 30, 31, 32,

33, 35, 36, 37, 38, 40, 41, 42, 43, 45, 46, 47, 48, 49Ph.Helv. 22, 23Pillules 57, 58, 59Plant secretions 16, 17Plumbum mellitum 43Potentised preparations 21, 46Powders 57, 58Preparations 20

Q

Quartz 25

R

Rh 13, 38, 39Rhythmically diluted 47Rhythmic application 19, 23, 26, 38, 51, 53Rhythmic processing 20Rhythmic succussion 21, 46Rhythmic system 20Rocks 15, 16, 17Rotating disk 45

S

Semi-solid vaginal preparations 59Silica 25, 51, 52, 53Silicium 25Silicium dioxide 25Solar or lunar eclipse 21, 46Solid or semi-solid potencies 46Solid preparations from plants 23, 41Solid starting materials obtained by heat 23, 39Solutions 58, 59Solutio Sacchari comp. 43Sprays 58Sputtering 25, 26

• Index

62


Starting material of botanical origin 15Summer extract 44, 45Suppositories 59Swiss Pharmacopoeia 13, 14Syrups 57

T

Tabacum Cupro cultum 24Tablets 57Thuja 24Tincture 13, 21, 24, 27, 31, 33, 34, 35, 41, 44, 45, 51,

53, 57Toasted preparations 39, 40Toasting 20Tosta 19, 23, 39Triturations 46, 48

V

Vaginal tablets 59Vapour decomposition 25, 26Vegetabilisation 18, 24Vegetabilised metals 24Vegetation period 24Viscous extracts 26, 37

W

Waters, natural 16, 17

Z

Zoological origin 15, 16, 17, 18, 26, 27, 28, 29, 39

• In

dex

63




PART IVAppendices

• Appendix

64

Table of ContentPart IVNote concerning appendix 2.3. .................................65Note concerning appendices 2.1., 2.4. and 2.6. .......65References concerning nomenclature in appendices 2.1. to 2.7.............................................65Note concerning the references for use in anthro-posophic medicine in appendices 2.1. to 2.7. .........65References concerning use in anthroposophic medicine in appendices 2.1. to 2.7. .........................66IVAA statement concerning starting materials of animal origin not yet mentioned in published anthroposophic medical literature or in published official regulatory documents concerning anthroposophic medicinal products ........................69Appendix 2.1. List of minerals, rocks and natural waters...............73 Appendix 2.2. List of starting materials of botanical origin ...........83

Appendix 2.3. List of starting materials of zoological origin .......135Appendix 2.4. List of starting materials that can be described chemically ................................................167Appendix 2.5. List of starting materials that have undergone special treatment.......................................................185Appendix 2.6. List of compositions .................................................189Appendix 2.7. Stocks with special manufacturing methods ........201

Appendix II ...............................................................205Correlation table: Ph.Eur. / HAB manufacturing methods used in anthroposophic pharmacy and corresponding manufacturing methods in the HPUS ..............................................205


• Ap

pend

ix

65

Note concerning the references for use in anthroposophic medicine in appendices 2.1. to 2.7.The references given in the columns to the right in the appendices 2.1 to 2.6 aim to provide evidence, that the particular starting material is known and has been part of the medicinal tradition in anthroposophic medicine.

Where available, the monographs of the Commission C for medicinal products for human use dealing with the anthroposophic therapeutic direction (according to §25 of the German Drug Law) published in the German Federal Gazette (Bundesanzeiger) have been referred to. Some starting materials are mentioned in monographs of combined products only (e.g. Amethyst in Tropaeolum comp.)Not all starting materials are mentioned in the Commission C monographs, because on the one hand its work stopped in 1994 after the 5th amendment of the German Drug law prior to completion work. On the other hand a number of starting materials in the lists are only known in the anthroposophic medicine tradition in countries other than Germany. The Commission C monographs also refer to specific and composed active substances as well as existing pharmaceutical products. A number of references from other sources may refer generically to particular raw or starting materials, sometimes without linking to specific active substances. The latter references show that the raw or starting material has been considered in therapeutic and pharmaceutical grounds in anthroposophic medicine. They may however also refer to specific active substances.

Where there is no reference, the particular starting material has not yet been presented or discussed in publications. However anthroposophic pharmaceutical manufacturers place medicinal products on the market obtained from those starting materials. The IAAP sees it as its task to promote the writing of publications, to support the relevance of the starting material in anthroposophic medicine. Much work still needs to be done.

Note concerning appendix 2.3.Animal substances marked with “*” belong to category A materials according to “Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products” if sourced e.g. from cattle Bos taurus L. Though sourcing from animals below 6 months of age from herds not fed with meat bone meal has been practice up to now in the field of concerning anthroposophic quality management, pharmaceutical manufacturers must continuously adapt their sourcing to the requirements of the Note for guidance, such as changing the donor animal. The APC Committee needs to reflect the existing practice and will adapt to implemented changes.

Note concerning appendices 2.1., 2.4. and 2.6.Unfortunately chemical formulae and concentrations have not always been written in the conventional format (e.g. H2O and 10-5). This will be corrected in the next APC edition 4.1.

References concerning nomenclature in appendices 2.1. to 2.7.

Erhardt W, Götz E, Bödeker N, Seybold S. Zander: Handwörterbuch der Pflanzennamen. Stuttgart: Eugen Ulmer; 2008.

Roberts WL, Rapp GR Jr, Weber J. Encyclopedia of Minerals. New York: Van Nostrand; 1974.

Schindler H, Helma F. Tiere in der Pharmazie und Medizin. Stuttgart: Hippokrates-Verlag; 1961.

Teuscher E. Biogene Arzneimittel.Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1997.


• Appendix

66

International Federation of Anthroposophic Medical Associations, IVAA. Statement concerning starting materials of animal origin not yet mentioned in published anthroposophic medical literature or in published official regulatory documents concerning anthroposophic medicinal products. Brussels: printed in APC Appendix I; 2013.

Monographs of the Commission C for medicinal products for human use dealing with the anthroposophic therapeutic direction (according to §25 of the German Drug Law) published in the German Federal Gazette (Bundesanzeiger). Publication as compilation: Anthroposophische Arzneimittel, Aufbereitungsmonographien der Kommission C, published by Gesellschaft Anthroposophischer Ärzte in Deutschland e.V. (Society of anthroposophic doctors in Germany registered association) on behalf of the Medical Section at the Goetheanum, Dornach/ Switzerland; 1999.

Gesellschaft Anthroposophischer Ärzte in Deutschland e.V. and Medizinische Sektion der Freien Hochschule für Geisteswissenschaft Dornach. Vademecum Anthroposophische Arzneimittel. Munich (Germany); 2013; 3rd edition 2013. Abbr. Vademecum

Les Associations francaises de médecine anthroposophique: Répertoire de médecine d’orientation anthroposophique. Edition Juin 2016. (abbr. Répertoire de med. anthr.)

References concerning the use in anthroposophic medicine in appendices 2.1. to 2.7.Der Merkurstab (Zeitschrift für anthroposophische Medizin – Journal of Anthroposophic Medicine). Munich: Gesellschaft Anthroposophischer Ärzte in Deutschland (Society of anthroposophic doctors in Germany).

Gardin N, Schleier R. Vademecum, medicamentos antroposoficos. São Paulo-SP: João de Barra Editora Ltda; 2009. Portugese. Abbr. ABMA Vademecum

Glöckler M. Anthroposophische Arzneitherapie (Anthroposophic Therapy with Medicinal Products). Stuttgart: Publisher Wissenschaftliche Verlagsgesellschaft; 2010.


• Ap

pend

ix

67

Statement concerning starting materials of animal origin not yet mentioned in published anthroposophic medical literature or in published official regulatory documents concerning anthroposophic medicinal products

Anthroposophic medicinal products containing preparations from starting materials of animal origin belong to the range of anthroposophic therapeutics.1

Most of these starting materials and/or the anthroposophic medicinal products concerned are mentioned in anthroposophic medical literature or in official regulatory documents. A certain number of these however are not mentioned in such references, although belonging to the range of anthroposophically used starting materials of animal origin. The anthroposophic medicinal products concerned are available to doctors.2

This statement confirms the anthroposophic therapeutic usage and relevance of these starting materials.3

The starting materials of animal origin are listed on the following papers.4

For the IVAA

Dr. Peter ZimmermannDr. Andreas Arendt

15.02.2013

1 Girke M. Innere Medizin. 2. edition. Berlin: Salumed Verlag; 2012.2 Jütte R. Organpräparate in der Geschichte der „Schulmedizin“, der Homöopathie und der Anthroposophischen Medizin. Der Merkurstab 2009; 1: 49–60.3 Roemer F. Sommer M. Zur Bedeutung der potenzierten Organpräparate in der anthroposophischen Therapierichtung. Der Merkurstab 1998; Sonderheft Organpräparate.4 Gesellschaft Anthroposophischer Ärzte in Deutschland e.V. and Medizinische Sektion der Freien Hochschule für Geisteswissenschaft Dornach. Vademecum Anthroposophische Arzneimittel. 2. edition. Filderstadt (Germany); 2011.


• Appendix

68

Scientific name Scientific name of the animal

Abbreviated definition

Aorta Oryctolagus cuniculus L.

Aorta from the rabbit

Aranea avicularis Avicularia avicularia L Whole bird spiderArteria basilaris Bos taurus L. Arteria basilaris from the calfArteria brachialis Bos taurus L. Arteria brachialis from the calfArteria coeliaca see Truncus coeliacusArteria pulmonalis Bos taurus L. Arteria pulmonalis from the calfArteria renalis Bos taurus L. Arteria renalis from the calfArticulatio cubiti Bos taurus L. Elbow joint with parts from the bones that form the joint, joint

cartilage, parts of joint capsule, synovia and parts of the ligaments from the calf

Articulatio radiocarpea

Bos taurus L. Radiocarpal joint with parts of the bones, cartilage, ligaments and joint capsule that form the proximal carpal joint from the calf

Articulatio tem-poromandibularis

Bos taurus L. Parts of the os mandibulare and of the os temporale in the joint area, of the joint capsule, of the ligaments, of cartilage, as well as synovia from the calf

Articulationes intercarpeae

Bos taurus L. Parts of the bones forming the joint, of the cartilage like surface of the articulation, as well as synovia from the calf

Articulationes intervertebrales cervicales

Bos taurus L. Region of the cervix: Parts of the bone process that participate to the intervertebral joints, cartilage and joint capsules, as well as synovia from the calf

Articulationes intervertebrales lumbales

Bos taurus L. Region of the loin: Parts of the bone process that participate to the intervertebral joints, cartilage and joint capsules, as well as synovia from the calf

Asterias rubens Asterias rubens L. The whole starfish Atlas Bos taurus L. Parts of the Atlas (1. cervical) from the calfAxis Bos taurus L. Parts of the Axis (2. cervical) from the calfBlatta orientalis Blatta orientalis L The whole fresh or dried animalCartilago articularis coxae

Bos taurus L. Cartilage of the hip joint from the calf

Cervix uteri Bos taurus L. Parts of the neck of the womb from the cowCirculus arteriosus cerebri

Bos taurus L. Circulus arteriosus cerebri of the pituitary shaft from the calf

Coccus cacti Dactylopius coccus Costa

The dried, fertilized, female of Dactylopius coccus Costa

Columna anterior Bos taurus L. Parts of the columna anterior of the spinal chord from the calf

Columna posterior Bos taurus L. Parts of the columna posterior of different parts of the spinal chord from the calf

Cornu Caprae ibecis Capra ibex L. Horn from the ibex




Dactylopius coccus see Coccus cactiDens Bos taurus L. Teeth from the calfDiencephalon Bos taurus L. Diencephalon from the calfDuctus deferens Bos taurus L. Ductus deferens from the calfDura mater encephali

Bos taurus L. Dura mater encephali from the calf

Elaps Micrurus corallinus Merrem

Poison from Micrurus corallinus Merrem

Endocardium Bos taurus L. Endocardium from the calfEpididymis Bos taurus L. Left epididymis from the bullErytrocytes Equus przewalskii f.

caballus PoliakovErythrocytes from the blood of the horse

Favus Apis mellifera L. Honey combs with pollenFolliculi lymphatici aggregati

Sus scrofa domestica L. Parts of Peyers’s patch of the small intestine from the pig

Galea aponeurotica Bos taurus L. Parts of the superficial fascia of the forehead from the calf Glandula parotis Bos taurus L. Glandular tissue of the body of the parotid gland

from the calfGlandula suprarenalis (Cortex)

Bos taurus L. Glandula suprarenalis (cortex) from the calf

Glandula suprarenalis (Medulla)

Bos taurus L. Medulla glandulae suprarenalis of both adrenal glands from the calf

Glucogenum Oryctolagus cuniculus L.

Glycogen from the rabbit liver

Gyrus cinguli Bos taurus L. Gyrus cinguli from the calfHepar Oryctolagus cuniculus

L.Liver from the rabbit

Jejunum Sus scrofa domestica L. Jejunum from the pigKeratinum Equi Equus przewalskii f.

caballus PoliakovHoof from the horse

Lac vaccae Bos taurus L. Fresh cow’s milkLigamentum longitudinale anterius

Bos taurus L. Parts of the ligamentum longitudinale anterius of thoracic and lumbar regions of the spine from the calf

Lingua Bos taurus L. Parts of the tongue muscles, mucous membrane and papillae from the calf

Liquor cerebrospinalis

Bos taurus L. Liquor cerebrospinalis from the calf

Mephitis putorius Mephitis mephitis Schreb.

Liquid secretion of anal glands from Mephitis mephitis Schreb.

• Ap

pend

ix

69


70

Moschus Moschus moschiferus L. Secretion of bursa from male Moschus moschiferus L.



Musculi glutaei Bos taurus L. Gluteal muscles from the calf Musculus soleus-Komplex

Bos taurus L. Parts of the musculus soleus-complex, musculus soleus, musculus fibularis (peronaeus) longus, musculus gastrocnemius from the calf

Mygale avicularis see Aranea avicularisNaja tripudians Naja naja L. Carefully dried poison from Naja naja L.Nervus abducens Bos taurus L. Nervus abducens from the calfNervus accessorius Bos taurus L. Nervus accessorius from the calfNervus femoralis Bos taurus L. Nervus femoralis from the calfNervus hypoglossus Bos taurus L. Nervus hypoglossus from the calfNervus pudendus Bos taurus L. Nervus pudendus from the calfNervus radialis Bos taurus L. Nervus radialis from the calfNervus tibialis Bos taurus L. Nervus tibialis from the calfNervus ulnaris Bos taurus L. Nervus ulnaris from the calfOesophagus Sus scrofa domestica L. Oesophagus from the pigOssa longa Bos taurus L. Ossa longa from the calfOssicula auditus Bos taurus L. Auditory bones from the calfPapillae duodeni Sus scrofa domestica L. Papilla duodeni region of the small intestine

from the pigPars pallida Bos taurus L. Parts of the base of the brain from the calfPatella Bos taurus L. Patella from the calfPelvis renalis (et Ureter)

Bos taurus L. Parts of the pelvis renalis and ureter from the calf

Penis Bos taurus L. Penis from the bullPia mater encephali Bos taurus L. Pia mater encephali from the calfPlexus lumbalis Bos taurus L. Plexus lumbalis from the calfPlexus rectalis see Plexus haemorr

hoidalisPortio vaginalis Bos taurus L. Portio vaginalis from the cowRenes, regio pyelorenalis

Bos taurus L. Parts of tissue from the pelvis renalis and medulla renalis from the calf

Sclera Bos taurus L. Sclera from the calfSinus cavernosus-Komplex

Bos taurus L. Parts of the sinus cavernosus-complex; sinus cavernosus, nervus opticus, nervus oculomotorius, nervus trochlearis, nervus trigeminus and nervus abducens from the calf

Tarantula hispanica Lycosa hispanica The whole spider Lycosa tarantula L., Allocosa fasciiventris Duf., or Hogna hispanica Walck.

Thrombocytes Equus przewalskii f. caballus Poliakov

Thrombocytes from the blood of the horse

Tonsilla pharyngea Bos taurus L. Tonsilla pharyngea from the calf

• Appendix


• Ap

pend

ix

71



Trachea Bos taurus L. Trachea from the calfTruncus coeliacus Bos taurus L. Arteria coeliaca (Truncus coeliacus) from the calfTruncus encephali Bos taurus L. Brain stem from the calfTruncus encephali Bos taurus L. Hypothalamus, thalamus, corpora quadrigemina, pons,

medulla oblongata from the calfTunica mucosa intestini tenuis

Sus scrofa domestica L. Mucosa from the different regions of the small intestine from the pig

Tunica mucosa recti Sus scrofa domestica L. Tunica mucosa recti from the pigTunica mucosa ventriculi

Sus scrofa domestica L. Mucosa from the different regions of the stomach from the pig

Ureter Bos taurus L. Ureter from the calfVagina Bos taurus L. Vagina from the cowValva trunci pulmonalis

Bos taurus L. Valva trunci pulmonalis from the calf

Valvula aortae Bos taurus L. Valva aortae from the calfValvula mitralis Bos taurus L. Valva mitralis from the calfVena cava Bos taurus L. Parts of the vena cava cranialis and vena cava caudalis

from the calfVena portae Bos taurus L. Vena portae from the calfVena tibialis Bos taurus L. Vena tibialis from the calfVertebra cervicalis Bos taurus L. Vertebra cervicalis from the calfVertebra coccygea Bos taurus L. Vertebra coccygea from the calfVertebra lumbalis Bos taurus L. Vertebra lumbalis from the calf


72

•

Appendix 2.1


73

APPENDIX 2.1

List of minerals, rocks and natural waters Additional Information, see p. 17

•

Ap

pend

ix 2

.1


74

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

Agat

e wat

er(A

chat

wass

er)

Wat

er ex

istin

g in

side a

n un

dam

aged

Ag

ate g

eode

Ph.E

ur. 3

.1.2

Der

Mer

kurs

tab

2009

; 62(

6): 6

05-6

19

Ambe

rSu

ccin

um (B

erns

tein

)Fo

ssili

zed

tree r

esin

HAB

Ph.E

ur. 4

.1.1

(and

3.

1.1

or 3

.1.2

), 4.

1.2

Corp

us vi

treum

/Suc

cinu

m;

Olib

anum

com

p./S

ucci

num

; Ro

smar

inus

com

p.; S

tann

um/

Succ

inum

; Suc

cinu

m

Amet

hyst

(Am

ethy

st)A

viol

et va

riety

of q

uart

z (Si

O2)

API,

Ph.E

ur. 4

.1.1

, 4.

1.2

Trop

aeol

um co

mp.

Antim

onite

See S

tibni

te

Apat

iteAp

atit

Apat

iteTh

e nat

ural

min

eral

(cal

cium

fluo

r-ph

osph

ate c

hem

.: Ca5

[(PO

4)3,

(OH

,F,Cl

)])

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Ap

atit;

Apa

tit/C

onch

ae; A

patit

/Ph

osph

orus

com

p.; A

patit

/Sta

nnum

; Ce

rebe

llum

com

p.; C

onch

ae/

Ferr

um u

stum

com

p.; F

erru

m

prae

para

tum

com

p.; S

tann

um co

mp.

Aqua

mar

is(M

eerw

asse

r)Se

e Sea

wate

r

Arag

onite

(Ara

goni

t9Ar

agon

iteTh

e nat

ural

min

eral

(cal

cium

ca

rbon

ate;

chem

.: CaC

O3)

Ph.E

ur. 4

.1.1

, 4.1

.2Ré

perto

ire d

e méd

. an

thr.

Aran

disit

e(A

rand

isit)

Aran

disit

eTh

e nat

ural

min

eral

(com

plex

tin

silic

ate)

Ph.E

ur. 4

.1.1

, 4.1

.2Ar

andi

sitVa

dem

ecum

Arge

ntite

Arge

ntit

Arge

ntite

The n

atur

al m

iner

alH

ABPh

.Eur

. 4.1

.1, 4

.1.2

Arge

ntit

Vade

mec

um

Arse

nopy

rite

Arse

nopy

ritAr

seno

pyrit

eTh

e nat

ural

min

eral

(ars

enic

-iron

su

lfide

; che

m.: F

eAsS

)Ph

.Eur

. 4.1

.1, 4

.1.2

Vade

mec

um:

Arse

nopy

rit

Auru

m m

etal

licum

na

tura

le(G

old,

gedi

egen

)O

r nat

ifTh

e nat

ural

min

eral

(nat

ural

ly

occu

rrin

g go

ld w

ith tr

aces

of o

ther

ele

men

ts)

Ph.E

ur. 4

.1.1

(and

3.

2.2)

, 4.1

.2Au

rum

met

allic

um; A

urum

/Pru

nus

Bary

silite

Bary

silit

The n

atur

al m

iner

al (L

ead

man

gane

se

silic

ate;c

hem

.: Pb8

Mn(

Si2O

7)3)

Ph.E

ur. 4

.1.1

, 4.1

.2Ba

rysil

itVa

dem

ecum

Bert

hier

iteBe

rthi

erit

Bert

hier

iteTh

e nat

ural

min

eral

(ant

imon

y-iro

n su

lfide

; che

m.: F

eSb2

S4)

Ph.E

ur. 4

.1.1

, 4.1

.2Va

dem

ecum

Bolu

s alb

a(B

olus

)Se

e Kao

linite

Cass

iterit

e(K

assit

erit,

Zin

nste

in)

Cass

itérit

eTh

e nat

ural

min

eral

(tin

oxi

de; c

hem

.: Sn

O2)

Ph.E

ur. 4

.1.1

, 4.1

.2Ka

ssite

ritVa

dem

ecum

: Ka

ssite

rit

•

Appendix 2.1


75

Cerit

e(C

erit)

The n

atur

al m

iner

al (c

ompl

ex si

licat

e of

rare

eart

h ele

men

ts (c

eriu

m,

lant

hanu

m an

d ot

hers

) and

calci

um,

mag

nesiu

m an

d iro

n)

Ph.E

ur. 4

.1.1

, 4.1

.2Co

r/Cr

atae

gus c

omp.

Vade

mec

um

Ceru

ssite

Ceru

ssit

Céru

ssite

The n

atur

al m

iner

al (l

ead

carb

onat

e; ch

em.: P

bCO

3)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

; ra

w m

ater

ial f

or

prod

uctio

n of

Pl

umbu

m si

licic

um

Ceru

ssit;

Plu

mbu

m si

licic

umVa

dem

ecum

Chal

cedo

ny(C

halce

don)

The n

atur

al m

iner

al (s

ilicic

acid

; ch

em.: S

iO2)

Ph.E

ur. 4

.1.1

(and

th

en 3

.1.1

), 4.

1.2

Chal

cocit

e(C

halk

osin

)Ch

alco

sine

The n

atur

al m

iner

al (c

oppe

r sul

fide;

chem

.: Cu2

S)H

ABPh

.Eur

. 4.1

.1 (a

nd

then

3.2

.2),

4.1.

2Ch

alko

sin; Th

yreo

idea

com

p.

Chal

copy

rite

(Cha

lkop

yrit)

Chal

copy

rite

The n

atur

al m

iner

al (c

oppe

r-iro

n su

lfide

; che

m.: C

uFeS

2)Ph

.Eur

. 4.1

.1, 4

.1.2

Chlo

rarg

yrite

(Chl

orar

gyrit

, Hor

nerz

, Si

lber

horn

erz)

The n

atur

al m

iner

al (s

ilver

chlo

ride;

chem

.: AgC

l)Ph

.Eur

. 4.1

.1, 4

.1.2

Cart

ilago

/Hor

nerz

com

p.; C

orpu

s vi

treum

/Hor

nerz

com

p.

Chry

solit

e(C

hrys

olith

)Ch

ryso

lithe

The n

atur

al m

iner

al (m

agne

sium

-iron

sil

icat

e; ch

em.: (

Mg,

Fe)2

SiO

4)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Chry

solit

h; C

hrys

olith

com

p.Va

dem

ecum

Chry

sopr

ase

(Chr

ysop

ras)

The n

atur

al m

iner

al (s

ilicic

acid

with

sm

all a

mou

nts o

f nick

el)Ph

.Eur

. 4.1

.1 (a

nd

then

3.2

.2),

4.1.

2

Cinn

abar

(Zin

nobe

r)Ci

nnab

aris

natu

rale

The n

atur

al m

iner

al (m

ercu

ry su

lfide

; ch

em.: H

gS)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Ag

ropy

ron

com

p.; B

ariu

m co

mp.

; Py

rit/Z

inno

ber;

Zinn

ober

; Zin

nobe

r co

mp.

Vade

mec

um

Cupr

iteCu

prit

Cupr

iteTh

e nat

ural

min

eral

(cop

per o

xide

; ch

em.: C

u2O

)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Cupr

it

Dia

spor

e(D

iasp

or)

The n

atur

al m

iner

al (a

lum

iniu

m

oxid

e hyd

roxi

de; c

hem

.: AlO

OH

)Ph

.Eur

. 4.1

.1, 4

.1.2

Dio

ptas

eD

iopt

asD

iopt

ase

The n

atur

al m

iner

al (c

oppe

r sili

cate

; ch

em.: C

u6Si

6O18

·6H

2O)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2D

iopt

as

Dys

cras

iteD

yskr

asit

Dys

cras

iteTh

e nat

ural

min

eral

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2D

yskr

asit

Emer

ald

(Sm

arag

d)A

gree

n va

riety

of b

eryl

(alu

min

ium

-be

rylli

um si

licat

e; ch

em.:

Al2B

e3(S

i6O

18),

colo

ured

by t

race

am

ount

s of c

hrom

ium

and

som

etim

es

vana

dium

Ph.E

ur. 4

.1.1

, 4.1

.2

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.1


76

Ferr

um si

dere

um(M

eteo

reise

n)Fe

rrum

sid

ereu

mSe

e Iro

n m

eteo

rite =

met

eoric

iron

Ferr

um si

licic

um

natu

rale

See N

ontro

nite

Flin

t(F

lint,

Feue

rste

in)

Silex

The n

atur

al m

iner

al (c

hem

.: sili

cic

acid

SiO

2)Ph

.Eur

. 4.1

.1, 4

.1.2

(in

Lap

is ca

ncri/

Flin

tstei

n to

geth

er

with

Lap

is ca

ncri)

, Ra

w m

ater

ial f

or

prep

arin

g Si

lex -

Lapi

s can

cri s

olut

us

(see

app.

2.6

)

Lapi

s Can

cri/F

lintst

ein

Fluo

rite

Flus

sspa

tFl

uorit

eTh

e nat

ural

min

eral

(cal

cium

fluo

ride;

chem

.: CaF

2)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Cera

tum

Rat

anhi

ae co

mp.

; Flu

orit;

Ra

tanh

ia co

mp.

; Sal

Mar

is co

mp.

; Sa

lvia

com

p.

Gal

ena

Blei

glan

zG

alèn

eTh

e nat

ural

min

eral

(lea

d su

lfide

; ch

em.: P

bS)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Be

tula

/Man

drag

ora c

omp.

; Bl

eigl

anz/

Seca

le co

mp.

; Gal

enit/

Retin

a com

p.; R

etin

a com

p.; R

etin

a/Se

cale

com

p.

Gar

net

(Gra

nat)

The n

atur

al m

iner

al: A

lman

dine

(ir

on-a

lum

iniu

m si

licat

e; ch

em.:

Fe3A

l2(S

iO4)

3 ) o

r oth

er va

rietie

s

Ph.E

ur. 4

.1.1

, 4.1

.2D

er M

erku

rsta

b 20

04; 5

7(1)

: 57-

58

(Gla

cies

Mar

iae)

See s

eleni

te

Gne

iss(G

neis)

The n

atur

al p

ale r

ock

(Gne

iss fr

om

Gas

tein

(A);

cons

istin

g of

qua

rtz,

feld

spar

, mic

a and

oth

ers)

; syn

. Lap

is al

bus

Ph.E

ur. 4

.1.1

, 4.1

.2

Gra

nite

(Gra

nit)

Gra

nit

The n

atur

al ro

ck (c

onsis

ting

of q

uart

z, fe

ldsp

ar an

d m

ica a

nd o

ther

s)Ph

.Eur

. 4.1

.1, 4

.1.2

Berb

eris/

Pros

tata

com

p.; B

erbe

ris/

Ute

rus c

omp.

; Disc

i/Rhu

s to

xico

dend

ron

com

p.; R

hus

toxi

code

ndro

n co

mp.

Gra

phite

Gra

phite

s (G

raph

it)G

raph

ites

The n

atur

al m

iner

al (h

exag

onal

Ca

rbon

; che

m.: C

, with

trac

es o

f iro

n an

d ot

her e

lemen

ts)

HAB

; Ph.

fr.Ph

.Eur

. 4.1

.1, 4

.1.2

Ferr

um ro

satu

m/G

raph

ites;

Gra

phite

s; Pu

lvis

stom

achi

cus c

um

Bism

uto

prae

para

to; T

ropa

eolu

m

com

p.

Hal

iteH

alit

The n

atur

al m

iner

al (s

odiu

m ch

lorid

e; ch

em.: N

aCl)

HAB

Ph.E

ur. 3

.1.1

, API

Hal

it

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.1


77

Hek

la L

ava

See L

ava

Hem

atite

Häm

atit

Hém

atite

The n

atur

al m

iner

al (i

rone

oxi

de;

chem

.: Fe2

O3)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2

raw

mat

eria

l for

pr

epar

atio

ns ac

c. to

H

AB 3

7a

Hya

cinth

See Z

ircon

Hyd

rarg

yrum

m

etal

licum

nat

ural

e(Q

ueck

silbe

r)Se

e Mer

curiu

s viv

us n

atur

alis

Iron

met

eorit

eFe

rrum

side

reum

(M

eteo

reise

n)Fe

rrum

sid

ereu

mTh

e nat

ural

met

eoric

iron

(a k

ind

of

allo

y with

iron

, nick

el an

d co

balt)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Ap

atit/

Phos

phor

us co

mp.

; Aur

um/

Ferr

um si

dere

um; C

rata

egus

/Fe

rrum

side

reum

/Sac

char

um

tostu

m; F

erru

m si

dere

um; F

erru

m

sider

eum

com

p.; F

erru

m si

dere

um/

Pank

reas

; Met

eore

isen/

Phos

phor

/Q

uarz

Vade

mec

um

Jasp

er(Ja

spis)

A re

d va

riety

of c

halce

dony

(sili

cic

acid

; che

m.: S

iO2

with

iron

oxi

de)

Ph.E

ur. 4

.1.1

, 4.1

.2

Kaol

inite

(Kao

lin, w

eiße

r Ton

)Ka

olin

lour

dTh

e nat

ural

min

eral

(alu

min

ium

sil

icat

e; ch

em.: A

l4[(O

H)8

/Si4

O10

]; sy

n.: C

hina

clay

Ph.E

ur.

API,

Excip

ient

Bolu

s alb

a com

p.; B

olus

Euc

alyp

ti co

mp.

Kass

iterit

eSe

e Cas

siter

ite

Kato

ptrit

e(K

atop

trit)

The n

atur

al m

iner

al (c

ompl

ex

man

gane

se-a

ntim

ony-

iron

silic

ate)

Ph.E

ur. 4

.1.1

, 4.1

.2

Kies

erite

(Kie

serit

)Ki

esér

iteTh

e nat

ural

min

eral

(mag

nesiu

m

sulfa

te; c

hem

.: MgS

O4

·H2O

)H

ABPh

.Eur

. 3.1

.1 (s

ee

mon

ogra

ph: D

1 wi

th w

ater

)

Cera

tum

Rat

anhi

ae co

mp.

; Kie

serit

; Ra

tanh

ia co

mp.

; Sal

via c

omp.

Lapi

s alb

us(G

neiss

)Se

e Gne

iss

Lapi

s sec

tilis

(Ton

schi

fer)

See A

rgill

aceo

us S

hale

Lava

Hek

la L

ava (

Lava

)H

ekla

lava

The n

atur

al ro

ck fr

om vo

lcano

Hek

la

(Icela

nd) w

ith a

cont

ent o

f at l

east

50%

silic

on d

ioxi

de, S

iO2

(Mr 6

0.1)

an

d at

leas

t 18%

iron

(III)

oxid

e

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2

Levi

co w

ater

Levi

coM

iner

al w

ater

from

the s

ourc

e Lev

ico,

Italy

APC

Ph.E

ur. 3

.1.1

, 3.1

.2Aq

ua M

aris

com

p.; L

evico

; Lev

ico

com

p.Va

dem

ecum

Mag

nesit

eM

agne

sitM

agné

site

The n

atur

al m

iner

al (m

agne

sium

ca

rbon

ate;

chem

.: MgC

O3)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2M

agne

sit; M

agne

sit/M

amm

a com

p.;

Saba

l/Sol

idag

o co

mp.

Vade

mec

um

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.1


78

Mal

achi

teM

alac

hit

Mal

achi

teTh

e nat

ural

min

eral

(bas

ic co

pper

ca

rbon

ate;

chem

.: Cu2

(CO

3)(O

H)2

)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

, ra

w m

ater

ial f

or th

e pr

oduc

tion

of A

PI

(for e

.g.V

iscum

Mal

i c.

Cupr

o, ap

p. 2

.6)

Anag

allis

/Mal

achi

t com

p.;

Cham

omill

a/M

alac

hit c

omp.

; M

alac

hit

Vade

mec

um

Mar

ble

(Mar

mor

)M

arbr

eTh

e nat

ural

gra

ined

, whi

te ro

ck

(mai

nly c

onsis

ting

of ca

lcite

)Ph

.Eur

. 4.1

.1, 4

.1.2

, ra

w m

ater

ial f

or th

e pr

oduc

tion

of

Solu

tio S

ilice

a co

mp.

(app

. 2.6

)

Disc

us in

terv

erte

bral

is em

bryo

nalis

/So

lutio

Sili

ceae

com

p.; M

arm

or/

Stib

ium

; Sol

utio

Sili

cea c

omp.

Vade

mec

um:

Mar

mor

/Stib

ium

Mer

curiu

s viv

us

natu

ralis

Mer

curiu

s viv

us;

(Que

cksil

ber,

gedi

egen

)M

ercu

re

mét

alliq

ue P

PHN

atur

ally

occ

urrin

g m

ercu

ry w

ith

99,5

-100

,5%

Hg

HAB

; Ph.

fr.Ph

.Eur

. 4.1

.1, 4

.1.2

Gla

ndul

a sup

rare

nalis

/Mer

curiu

s; M

ercu

rius v

ivus

; Mer

curiu

s viv

us

com

p.; M

ercu

rius v

ivus

/ Euc

aply

ti ae

ther

oleu

m; Th

uja c

omp.

Vade

mec

um

Met

eore

isen

See F

erru

m si

dere

um

Non

troni

teN

ontro

nit

Non

troni

teTh

e nat

ural

min

eral

(com

plex

iron

sil

icat

e)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Conc

hae/

Ferr

um u

stum

com

p.;

Ferr

um si

licic

um co

mp.

; Fer

rum

us

tum

com

p.; N

ontro

nit

Vade

mec

um

Oliv

enite

Oliv

enit

Oliv

énite

The n

atur

al m

iner

al (b

asic

copp

er

arse

nate

; che

m.: C

u2As

O4(

OH

))H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Oliv

enit;

Sen

ecio

com

p.Va

dem

ecum

Oliv

ine

See C

hrys

olite

Ony

xO

nyx

Ony

xA

blac

k-wh

ite st

riped

varie

ty o

f ch

alce

dony

(sili

cic a

cid;

chem

.: SiO

2 )

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2G

naph

aliu

m co

mp.

; Ony

x

Opa

l(O

pal)

The n

atur

al m

iner

al (s

ilici

c aci

d,

cont

aini

ng w

ater

)Ph

.Eur

. 4.1

.1 (a

nd

then

3.2

.2),

4.1.

2D

er M

erku

rsta

b 20

09; 6

2(6)

: 605

-619

Ort

hocla

se(O

rtho

klas

)Th

e nat

ural

min

eral

(pot

assiu

m-

alum

iniu

m si

licat

e; ch

em.: K

AlSi

3O8)

Ph.E

ur. 4

.1.1

, 4.1

.2,

API

Ort

hokl

as

Palla

site

(Pal

lasit

)St

one-

Iron

-Met

eorit

e (ol

ivin

e cry

stals

in an

iron

-nick

el m

atrix

)Ph

.Eur

. 4.1

.1, 4

.1.2

Vade

mec

um

Phar

mac

olite

Phar

mak

olith

Phar

mac

olith

eTh

e nat

ural

min

eral

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Ph

arm

akol

ith co

mp.

Vade

mec

um

Phos

phor

ocal

cite

(Pho

spho

roch

alcit

, Ps

eudo

mal

achi

t)Ph

osph

oroc

halc

iteTh

e nat

ural

min

eral

(alk

alin

e cop

per

phos

phat

e; ch

em.: C

u5[(O

H)4

/(P

O4)

2])

Ph.E

ur. 4

.1.1

, 4.1

.2Va

dem

ecum

Plat

inum

(Plat

in, g

edie

gen)

Plat

ina

The n

atur

al m

iner

al (n

atur

ally

oc

curr

ing

plat

inum

with

trac

es o

f ot

her e

lemen

ts)

Ph.E

ur. 4

.1.1

, 4.1

.2Ba

silic

um co

mp.

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.1


79

Pyra

rgyr

ite(P

yrar

gyrit

)Py

rarg

yrite

The n

atur

al m

iner

al (s

ilver

-ant

imon

y su

lfide

; che

m.: A

g3Sb

S3)

Ph.E

ur. 4

.1.1

, 4.1

.2

Pyrit

ePy

ritPy

rite d

e fer

The n

atur

al m

iner

al (i

ron

sulfi

de;

chem

.: FeS

2)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Anis-

Pyrit

; Arc

hang

elica

/Pyr

it co

mp.

; Ber

beris

/Pyr

it co

mp.

; Br

onch

i/Pla

ntag

o co

mp.

; Br

onch

ialp

astil

len; P

yrit;

Pyr

it/Zi

nnob

er

Vade

mec

um

Pyro

lusit

ePy

rolu

sitPy

rolu

site

The n

atur

al m

iner

al (m

anga

nese

di

oxyd

e; ch

em.: M

nO2)

Ph.E

ur. 4

.1.1

; 4.1

.2

Pyro

mor

phite

Pyro

mor

phit

Pyro

mor

phite

The n

atur

al m

iner

al (l

ead

phos

phat

e; ch

em.: P

b5(P

O4)

3Cl)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Py

rom

orph

it

Qua

rtz

Qua

rzSi

licea

nat

ural

eTh

e nat

ural

min

eral

(sili

cic ac

id;

chem

.: SiO

2)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

, AP

I, ra

w m

ater

ial

for t

he p

rodu

ctio

n of

oth

er ch

emic

al

entit

ies (

app.

2.6

)

Acon

itum

/Cam

phor

a com

p.;

Antim

onit/

Rosa

e aet

hero

leum

co

mp.

; Arg

entu

m/B

erbe

ris co

mp.

; Ar

gent

um/Q

uarz

; Arn

ica/

Echi

nace

a co

mp.

; Bell

adon

na/Q

uarz

; Ber

beris

/Q

uarz

; Car

tilag

o/Ec

hina

cea c

omp.

; Co

njun

ctiv

a com

p.; C

upru

m/Q

uarz

co

mp.

; Disc

us in

terv

erte

bral

is em

bryo

nalis

/Sol

utio

Sili

ceae

com

p.;

Echi

nace

a/Q

uarz

com

p.;

Endo

met

rium

com

p.; F

erru

m

sider

eum

com

p.; F

erru

m/Q

uarz

; Fe

rrum

/Sul

fur c

omp.

; Flo

res

Sam

buci

com

p./Q

uarz

; Kal

ium

ph

osph

oric

um co

mp.

; Met

eore

isen/

Phos

phor

/Qua

rz; N

icotia

na/Q

uarz

; O

variu

m co

mp.

; Oxa

lis/Q

uarz

co

mp.

; Per

iodo

ntiu

m/S

ilice

a com

p.;

Prim

ula c

omp.

; Qua

rz; Q

uarz

/Re

sina L

arici

s; Q

uarz

/Sec

ale;

Sang

uina

ria co

mp.

; Sili

cea c

omp.

; So

lutio

Sac

char

i com

p.; S

olut

io

Silic

ea co

mp.

; Tar

taru

s stib

iatu

s co

mp.

Vade

mec

um

Real

gar

(Rea

lgar

)Ré

alga

rTh

e nat

ural

min

eral

(ars

enic

sulfi

de;

chem

.: As4

S4)

Ph.E

ur. 4

.1.1

, 4.1

.2Re

alga

rVa

dem

ecum

Rose

qua

rtz

(Ros

enqu

arz)

The n

atur

al m

iner

al (s

ilicic

acid

; ch

em.: S

iO2)

; syn

.: Qua

rz ro

sae

Ph.E

ur. 4

.1.1

, 4.1

.2

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.1


80

Rube

llite

(Rub

ellit)

Pink

to re

d to

urm

alin

e (co

mpl

ex

silic

ate w

ith al

umin

ium

, bor

on,

fluor

ine,

lithi

um, i

ron,

sodi

um an

d ot

her e

lemen

ts)

Ph.E

ur. 4

.1.1

, 4.1

.2Va

dem

ecum

: Rub

ellit

Ruby

(Rub

in)

The n

atur

al re

d co

rund

um

(alu

min

ium

oxi

de; c

hem

.: Al2

O3

with

tra

ces o

f Chr

omiu

m)

Ph.E

ur. 4

.1.1

, 4.1

.2

Sal M

aris

See S

ea sa

lt

Sapp

hire

(Sap

hir)

The n

atur

al b

lue m

iner

al co

rund

um

(alu

min

ium

oxi

de; c

hem

.: Al2

O3

with

tra

ces o

f iro

n an

d/or

tita

nium

)

Ph.E

ur. 4

.1.1

, 4.1

.2

Scor

odite

Skor

odit

Scor

odite

The n

atur

al m

iner

al (b

asic

iron

ar

sena

te; c

hem

.: FeA

sO4·

2H2O

)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Bora

go co

mp.

; Cer

ebell

um co

mp.

; Pa

rath

yreo

idea

com

p.; S

koro

dit;

Skor

odit

com

p.

Vade

mec

um

Sea s

alt

(Mee

rsal

z)So

dium

(c

hlor

ure d

e)

natu

rel p

ph, S

el m

arin

non

ra

ffiné

de

lAtla

ntiq

ue

Sea s

alt (

chem

.: com

plex

mix

ture

with

ch

lorid

es an

d su

lfate

s of m

ainl

y so

dium

, mag

nesiu

m, c

alciu

m an

d po

tass

ium

bes

ide m

inor

com

pone

nts)

; sy

n.: S

al M

aris

Ph.fr

.Ph

.Eur

. 3.1

.1 (D

1 wi

th w

ater

), AP

I (in

Sa

l Mar

is co

mp.

)

Sal M

aris

com

p.

Seaw

ater

Aqua

mar

isAq

ua m

arin

aO

cean

ic w

ater

(che

m.: d

issol

ved

mix

ture

of c

hlor

ides

and

sulfa

tes o

f m

ainl

y sod

ium

, mag

nesiu

m, c

alciu

m

and

pota

ssiu

m b

esid

e min

or

com

pone

nts)

Ph.E

ur. 3

.1.1

(D1

with

etha

nol 1

8%),

3.1.

2

Aqua

Mar

is co

mp.

; Aqu

a Mar

is/Pr

unus

spin

osa,

Sum

mita

tes

Der

Mer

kurs

tab

2009

; 62(

6): 6

05-6

19

Selen

ite(G

laci

es m

aria

s, G

ips,

Mar

ieng

las)

The n

atur

al m

iner

al: T

rans

pare

nt,

colo

urles

s, va

riety

of G

ypsu

m

(cal

cium

sulfa

te; c

hem

.: Ca

SO4·

2H2O

)

Ph.E

ur. 4

.1.1

, 4.1

.2;

raw

mat

eria

l for

the

prod

uctio

n of

Ka

lium

chlo

ratu

m

com

p.

Side

rite

Side

ritSi

dérit

eTh

e nat

ural

min

eral

(iro

n ca

rbon

ate;

chem

.: FeC

O3)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Av

ena/

Conc

hae c

omp.

; Sid

erit

Vade

mec

um

Silex

Silex

See F

lint

Silic

ea n

atur

ale

Silic

ea n

atur

ale

See Q

uart

z

Smar

agd

See E

mer

ald

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.1


81

Stib

nite

Antim

onit,

(G

raus

pieß

glan

z)St

ibin

eTh

e nat

ural

min

eral

(ant

imon

y su

lfide

; che

m.: S

b2S3

)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Achi

llea c

omp.

; Ana

galli

s/M

alac

hit

com

p.; A

ntim

onit;

Ant

imon

it co

mp.

; Ant

imon

it/An

isum

; An

timon

it/Ro

sae a

ethe

roleu

m

com

p.; B

irken

kohl

e com

p.;

Cart

ilago

/Man

drag

ora c

omp.

; Ch

amom

illa/

Mal

achi

t com

p.;

Echi

nace

a/Pa

ram

etriu

m co

mp.

; Ka

lium

acet

icum

com

p.; P

ulvi

s St

omac

hicu

s cum

Bell

adon

na; V

itis

com

p.

Vade

mec

um:

Antim

onit

Succ

inum

See A

mbe

r

Sulfu

r(S

chwe

fel)

Sulfu

rse

e Sul

fur a

ph (A

pp. 2

.4)

Sulfu

r

Sylv

ite(S

ylvi

n)Th

e nat

ural

min

eral

(pot

assiu

m

chlo

ride;

chem

.: KCl

)Ph

.Eur

. 3.1

.1Va

dem

ecum

: Syl

vin

(Ter

ra m

edici

nalis

)(H

eiler

de)

Drie

d, fi

nely

-div

ided

, nat

ural

ly

occu

rrin

g cla

y and

silt

with

a va

ried

com

posit

ion

of al

umin

ium

oxi

de,

silic

a, iro

n ox

ide a

nd li

mes

tone

; Ter

ra

med

icina

lis

Excip

ient

Plac

enta

/Tro

paeo

lum

Then

ardi

te(Th

enar

dit)

Thén

ardi

teTh

e nat

ural

min

eral

(sod

ium

sulfa

te;

chem

.: Na2

SO4)

Ph.E

ur. 3

.1.1

(D1

with

wat

er),

4.1.

1,

4.1.

2

Répe

rtoire

de m

éd.

anth

r.

Topa

z(T

opas

)Th

e nat

ural

min

eral

(alu

min

ium

-flu

orin

silic

ate;

chem

.: sili

cate

of

alum

iniu

m an

d flu

orin

e, Al

2[(F

,OH

)2/S

iO4.

)]

Ph.E

ur. 4

.1.1

, 4.1

.2

Tron

a(T

rona

)Th

e nat

ural

min

eral

(sod

ium

ca

rbon

ate-

hydr

ogen

carb

onat

e; ch

em.: N

a3(C

O3)

(HCO

3)·2

H2O

raw

mat

eria

l for

the

prod

uctio

n of

co

mpo

sitio

ns, e

.g.

Solu

tio S

ilice

a co

mp.

(app

. 2.6

)

Aqua

Mar

is co

mp.

; Cin

is Ar

nica

e co

mp.

; Disc

us in

terv

erte

bral

is em

bryo

nalis

/Sol

utio

Sili

ceae

com

p.;

Gla

ndul

a sup

rare

nalis

/Sol

utio

Fer

ri co

mp.

; Sol

utio

Fer

ri co

mp.

; Sol

utio

Sa

ccha

ri co

mp.

; Sol

utio

Sili

cea

com

p.

Vivi

anite

Vivi

anit

Vivi

anite

The n

atur

al m

iner

al (i

ron

phos

phat

e; ch

em.: F

e2(P

O4)

2·8H

2O)

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2D

isci c

omp.

cum

Pul

satil

la;

Frag

aria

/Urt

ica c

omp.

; Gels

emiu

m

com

p.; L

evist

icum

com

p.; P

ulm

o/Vi

vian

it co

mp.

; Viv

iani

t

Vade

mec

um

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.1


82

With

erite

With

erit

With

érite

The n

atur

al m

iner

al (B

ariu

m

carb

onat

e; ch

em.: B

aCO

3)H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Carb

ones

/Pan

krea

s/W

ither

itVa

dem

ecum

Zinn

ober

See C

inna

bar

Engl

ish n

ame:

Ph.E

ur. o

r sci

entifi

cG

erm

an n

ame:

HA

B (a

nd/o

r Ger

man

)Fr

ench

nam

e or

oth

ers

Abbr

evia

ted

defin

ition

Fu

rthe

r syn

onym

sRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.1


83

APPENDIX 2.2

List of starting materials of botanical origin Additional Information, see p. 17

•

Ap

pend

ix 2

.2


84

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

Abie

s alb

a Mill

.Fr

esh

tops

of A

bies

alba

Mill

.H

AB 3

3dPe

tasit

es co

mp.

; Pet

asite

s com

p. cu

m

Que

rcu;

Pet

asite

s com

p. cu

m V

eron

ica

Abie

s pec

tinat

a (La

m.)

DC

Youn

g, fr

esh,

leaf

y bra

nche

s of A

bies

alba

Mill

. (Ab

ies p

ectin

ata

(Lam

.) D

C)Ph

.fr.

Ph.E

ur. 1

.1.1

0 (s

ee

mon

ogra

ph: e

than

ol

65%

)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Abro

tanu

mse

e Arte

misi

a abr

otan

um L

.

Absin

thiu

mse

e Arte

misi

a abs

inth

ium

L.

Acet

um V

ini

see V

itis v

inife

ra L

.

Acet

um V

ini d

estil

latum

see V

itis v

inife

ra L

.

Achi

llea m

illef

oliu

m L

.Fr

esh,

who

le flo

werin

g pl

ant o

f Ach

illea

mill

efol

ium

L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(see

m

onog

raph

: eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Achi

llea m

illef

oliu

m L

.Fr

esh,

leav

es o

f Ach

illea

mill

efol

ium

L., c

ollec

ted

in Sp

ring

Ph.E

ur. 1

.1.3

Mill

efol

ium

/ H

yper

icum

Achi

llea m

illef

oliu

m L

.Fr

esh

aeria

l par

ts of

Ach

illea

mill

efol

ium

L., c

ollec

ted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.5

, HAB

33d

Achi

llea c

omp.

; Can

thar

is co

mp.

Achi

llea m

illef

oliu

m L

.W

hole

or cu

t, dr

ied

flowe

ring

tops

of A

chill

ea m

illef

oliu

m L

.Ph

.Eur

.Ph

.Eur

. 1.2

.13

(eth

anol

36

%),

API

Cent

auriu

m co

mp.

; Cich

oriu

m/

Tara

xacu

m co

mp.

; Mal

va/M

illef

oliu

m/

Oxa

lis

Achi

llea m

illef

oliu

m L

.D

ried

flowe

rs o

f Ach

illea

mill

efol

ium

L.

Ph. H

elv.

Ph.E

ur. 1

.2.1

3 (e

than

ol

50%

), aq

ueou

s ext

ract

ion

toge

ther

with

oth

er d

ried

herb

al d

rugs

Caps

ella/

Majo

rana

com

p.; V

erba

scum

co

mp.

Acon

itum

nap

ellus

L.

Who

le, fr

esh,

flow

erin

g pl

ants

of A

coni

tum

nap

ellus

L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(see

m

onog

raph

: eth

anol

45

%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Acon

itum

nap

ellus

L.

Fres

h wh

ole p

lant

s of A

coni

tum

nap

ellus

L., c

ollec

ted

at th

e sta

rt

of fl

ower

ing

HAB

Ph.E

ur. 1

.1.3

, HAB

21

Acon

itum

nap

ellus

; Aco

nitu

m n

apell

us

Plum

bo cu

ltum

; Aco

nitu

m/A

rnic

a co

mp.

/Api

s; Ac

onitu

m/A

rnic

a com

p./

Form

ica;

Acon

itum

/Arn

ica/

Betu

la

com

p.; A

coni

tum

/Arn

ica/

Bryo

nia;

Acon

itum

/Bry

onia

; Arn

ica/

Sym

phyt

um

com

p.; B

ryon

ia/E

upat

oriu

m co

mp.

; Fe

rrum

pho

spho

ricum

com

p.

Acon

itum

nap

ellus

L.

Drie

d tu

bers

of A

coni

tum

nap

ellus

L.

HAB

12d

, 12e

, 12g

Acon

itum

nap

ellus

; Aco

nitu

m/

Nic

otia

na co

mp.

•

Appendix 2.2


85

Acon

itum

nap

ellus

L.

Fres

h un

derg

roun

d pa

rts o

f Aco

nitu

m n

apell

us L

.H

AB 3

3cAc

onitu

m co

mp.

; Aco

nitu

m n

apell

us;

Acon

itum

/Cam

phor

a com

p.;

Acon

itum

/Chi

na co

mp.

; Bry

onia

co

mp.

; Disc

i/Rhu

s tox

icode

ndro

n co

mp.

; Meli

ssa/

Sepi

a com

p.; R

hus

toxi

code

ndro

n co

mp.

; Rhu

s/Sa

lix co

mp.

Acor

us ca

lam

us L

Peele

d, d

ried

rhiz

ome o

f Aco

rus c

alam

us L

., with

root

s and

leaf

re

sidue

s rem

oved

.H

ABPh

.Eur

. 1.1

.8, 1

.2.1

2,

aque

ous e

xtra

ctio

n to

geth

er w

ith o

ther

pl

ants

Cala

mus

, Rhi

zom

a; G

entia

na/Z

ingi

ber

com

p.; Th

ymus

serp

yllu

m co

mp.

Acor

us ca

lam

us L

.Fr

esh

unde

rgro

und

part

s of A

coru

s cal

amus

L.

HAB

33d

Berb

eris/

Juni

peru

s com

p.; B

olus

alba

co

mp.

Acta

ea ra

cem

osa

see C

imici

fuga

race

mos

a (L.

) Nut

t.

Acta

ea sp

icat

a L.

Fres

h, u

nder

grou

nd p

arts

of A

ctae

a spi

cata

L. c

ollec

ted

after

shot

s ha

ve em

erge

d, b

ut b

efor

e flow

erin

gH

ABPh

.Eur

. 1.1

.3

Adon

is ve

rnal

is L.

Fres

h ae

rial p

arts

of A

doni

s ver

nalis

L. c

ollec

ted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.3

, 1.2

.4Ad

onis

com

p.; A

doni

s/Sc

illa c

omp.

; O

nopo

rdon

com

p./A

doni

s

Aesc

ulus

hip

poca

stanu

m L

.Fr

esh

bark

from

youn

ger b

ranc

hes o

f Aes

culu

s hip

poca

stanu

m L

.H

AB 1

2k (D

ecoc

tum

LA

10%

)Ae

scul

us, C

orte

x; C

alen

dula

/Tr

opae

olum

com

p.

Aesc

ulus

hip

poca

stanu

m L

.Fr

esh

buds

of A

escu

lus h

ippo

casta

num

L.

For S

al m

aris

com

p. 1

pa

rt o

f bud

s is e

xtra

cted

wi

th 2

par

ts of

oil.

Sal M

aris

com

p.

Aesc

ulus

hip

poca

stanu

m L

.Fr

eshl

y pee

led se

eds o

f Aes

culu

s hip

poca

stanu

m L

.H

ABPh

.Eur

. 1.1

.5, H

AB 1

2g,

34c

Aesc

ulus

, Sem

en; A

escu

lus/

Cera

com

p.;

Aesc

ulus

/Que

rcus

com

p.; B

orag

o co

mp.

; Disc

i com

p. cu

m A

escu

lo;

Hiru

do co

mp.

; Sol

um u

ligin

osum

co

mp.

Aesc

ulus

hip

poca

stanu

m L

.Fr

esh

unpe

eled

seed

s of A

escu

lus h

ippo

casta

num

L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(see

m

onog

raph

: eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Aesc

ulus

hip

poca

stanu

m L

.D

ried

bark

from

bra

nche

s of A

escu

lus h

ippo

casta

num

L.

HAB

Ph.E

ur. 1

.2.1

2 (e

than

ol

36%

)Ac

hille

a com

p.; A

escu

lus,

Corte

x;

Aesc

ulus

, Cor

tex/

Bor

ago/

Ham

ameli

s, Fo

lium

; Aes

culu

s, Co

rtex/

Rosm

arin

i ae

ther

oleu

m; A

escu

lus/

Lava

ndul

a sic

cata

; Cer

atum

Rat

anhi

ae co

mp.

; Ra

tanh

ia co

mp.

; Sal

via c

omp.

; Stib

ium

co

mp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


86

Aesc

ulus

hip

poca

stanu

m L

.D

ried

seed

s of A

escu

lus h

ippo

casta

num

L.

DAB

HAB

12g

, 12m

Aesc

ulus

, Sem

en; A

escu

lus/

Prun

us

com

p.; S

olum

ulig

inos

um co

mp.

Agar

icus

bul

bosu

sse

e Am

anita

pha

lloid

es (V

aill.

ex F

r.) L

ink.

Ph.E

ur.

Agar

icus

mus

cariu

sse

e Am

anita

mus

caria

(L.)

Pers

.

Aman

ita m

usca

ria (L

. ex

Fr.)

Hoo

k.Th

e red

skin

(cut

is ru

bra)

of t

he fr

uitin

g bo

dy o

f Am

anita

m

usca

ria (L

. ex

Fr.)

Hoo

k.Ph

.Eur

. 1.1

.11

(eth

anol

45

%)

Agnu

s cas

tus

see V

itex

agnu

s-ca

stus L

.

Agro

pyro

n re

pens

(L.)

P. Be

auv.

Who

le or

cut,

wash

ed an

d dr

ied

rhiz

ome o

f Agr

opyr

on re

pens

(L

.) P.

Beau

v. (E

lym

us re

pens

[L.]

Gou

ld);

the a

dven

titio

us ro

ots

are r

emov

ed

Ph.E

ur.

Ph.E

ur. 1

.2.1

2 (e

than

ol

36%

)Fl

ores

Sam

buci

com

p./Q

uarz

Agro

pyro

n re

pens

see E

lym

us re

pens

(L.)

Gou

ld

Alce

a ros

ea L

. (Al

thae

a ros

ea (L

.) Ca

v.D

ried,

fully

dev

elope

d flo

wers

with

calic

es o

f Alce

a ros

ea L

.H

AB 1

2gM

alva

com

p.

Alfa

lfase

e Med

icag

o sa

tiva L

.

Alliu

m ce

pa L

.Fr

esh

bulb

s of A

llium

cepa

L.

HAB

; Ph.

fr.H

AB A

llium

cepa

(and

Ph

.Eur

. 1.1

.3),

HAB

34a

, Ph

.Eur

. 1.1

.10

(see

m

onog

raph

: Eth

anol

45

%) (

Ph.fr

.)

Alliu

m ce

pa/ M

ercu

rialis

com

p.; A

llium

ce

pa/T

endo

com

p.; A

rcha

ngeli

ca co

mp.

; Ar

ticul

atio

talo

crur

alis

com

p.;

Cart

ilago

com

p.; C

epa;

Kasta

nien

-H

aarto

niku

m; M

ercu

rialis

/Stib

ium

co

mp.

; Sta

nnum

/Sym

phyt

um co

mp.

; Sy

mph

ytum

com

p.; V

espa

crab

ro co

mp.

Alliu

m sa

tivum

L.

Fres

h bu

lbs o

f Alli

um sa

tivum

L.

(HAB

); Ph

.Eur

.; USP

acc.

to m

onog

raph

Ph

.Eur

. or H

AB (a

nd

Ph.E

ur. 1

.1.5

)

Arch

ange

lica c

omp.

Alliu

m u

rsin

um L

.Fr

esh

whol

e pla

nts o

f Alli

um u

rsin

um L

. at t

he st

art o

f flow

erin

gH

ABPh

.Eur

. 1.1

.3, 1

.1.1

0 (e

than

ol 4

5%)

Aloe

fero

x M

ill. a

nd o

ther

Alo

e sp

ecie

sCo

ncen

trate

d an

d dr

ied

juic

e of t

he le

aves

of v

ario

us sp

ecie

s of

Aloe

, mai

nly A

loe f

erox

Mill

er an

d its

hyb

rids

(HAB

); Ph

.Eur

.Ph

.Eur

. 1.1

.8 (E

than

ol

70%

), 4.

1.1

Alth

aea o

ffici

nalis

L.

Peele

d or

unp

eeled

, who

le or

cut,

drie

d ro

ot o

f Al

thae

a offi

cina

lis L

.Ph

.Eur

.aq

uous

extra

ct D

ER

1:8-

12Si

rupu

s Thym

i com

p.

Aman

ita m

usca

ria (L

.) La

m.

Fres

h fr

uitin

g bo

dies

of A

man

ita m

usca

ria (L

.) La

m. C

ham

pign

on

(car

poph

ore)

entie

r, fra

is fro

m A

man

ita m

usca

ria (L

. ex

Frie

s)

Hoo

ker

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

1 (s

ee

mon

ogra

ph: e

than

ol

45%

), H

AB 3

3b

Agar

icus

com

p./P

hosp

horu

s; Ag

aric

us

mus

cariu

s; Co

ncha

e com

p.; M

ygal

e co

mp.

Aman

ita p

hallo

ides

(Vai

ll. ex

Fr.)

Li

nkW

hole,

fres

h m

ushr

oom

(fru

iting

bod

y) A

man

ita p

hallo

ides

(V

aill.

ex F

r.) L

ink)

Ph.E

ur.

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

45%

)

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


87

Amm

i visn

aga (

L.) L

am.

Drie

d rip

e fru

its o

f Am

mi v

isnag

a (L.

) Lam

.H

ABPh

.Eur

. 1.1

.8 (e

than

ol

70%

), H

AB 3

5bAm

mi v

isnag

a com

p.

Amyg

dala

e am

arae

see P

runu

s dul

cis va

r. am

ara (

DC.

) Buc

hhei

m

Anac

ardi

umse

e Sem

ecar

pus a

naca

rdiu

m L

.

Anag

allis

arve

nsis

L.Fr

esh

aeria

l par

ts of

Ana

galli

s arv

ensis

L., c

ollec

ted

at fl

ower

ing

(HAB

)Ph

.Eur

. 1.1

.3, H

AB 2

1An

agal

lis/M

alac

hit c

omp.

Anag

allis

arve

nsis

L.D

ried

aeria

l par

ts of

Ana

galli

s arv

ensis

L., h

avin

g be

en co

llect

ed

at fl

ower

ing

Ph.E

ur. 1

.2.1

3 (e

than

ol

50%

)An

agal

lis/M

alac

hit c

omp.

Répe

rtoire

de m

éd.

anth

r.

Anam

irta c

occu

lus W

ight

et A

rn.

Drie

d, ri

pe fr

uits

of A

nam

irta c

occu

lus (

L.) W

ight

et A

rn.

Ph.E

ur.

Ph.E

ur. 1

.1.8

(Eth

anol

90

%)

Cocc

ulus

/Oleu

m P

etra

e com

p.

Anan

as co

mos

us (L

.) M

err.

Fres

hly p

ress

ed ju

ice o

f fru

it of

Ana

nas c

omos

us (L

.) M

err.

Ph.E

ur. 3

.1.1

Resin

a Lar

icis c

omp.

Anan

as co

mos

us (L

.) M

err.

Fres

h fr

uit o

f Ana

nas c

omos

us (L

.) M

err.

Mac

erat

ion

with

etha

nol

96%

(Fru

it: et

hano

l 96%

: 4:

1)

Anan

assa

com

p.; R

esin

a Lar

icis c

omp.

Ange

lica a

rcha

ngeli

ca L

.Fr

esh

root

s and

rhiz

omes

of A

ngeli

ca ar

chan

gelic

a L.

HAB

Ph.E

ur. 1

.2.1

1, H

AB 3

3cAr

chan

gelic

a; Ar

chan

gelic

a com

p.;

Arch

ange

lica/

Pyrit

com

p.

Ange

lica a

rcha

ngeli

ca L

.W

hole

or cu

t, ca

refu

lly d

ried

rhiz

ome a

nd ro

ot o

f Ang

elica

ar

chan

gelic

a L. (

syn.

A. o

fficin

alis

Hoff

m.)

Ph.E

ur.

Etha

nolic

dist

illat

ion

toge

ther

with

oth

er

drug

s

Spiri

tus c

ontra

tuss

im; S

pirit

us M

eliss

ae

com

p.

Anha

loni

umse

e Lop

hoph

ora w

illia

msii

Cou

lt.

Anisu

mse

e Pim

pine

lla an

isum

L.

Anth

yllis

vuln

erar

ia L

.Fr

esh

aeria

l par

ts of

Ant

hylli

s vul

nera

ria L

. at fl

ower

ing

HAB

12c

Calen

dula

/Tro

paeo

lum

com

p.

Apoc

ynum

cann

abin

um L

.Fr

esh

unde

rgro

und

part

s of A

pocy

num

cann

abin

um L

.H

ABPh

.Eur

. 1.1

.5, 1

.2.9

Scill

a com

p.

Aral

ia ra

cem

osa L

.Fr

esh

unde

rgro

und

part

s of A

ralia

race

mos

a L.

HAB

Ph.E

ur. 1

.1.5

Arct

ium

lapp

a L.

Drie

d wh

ole o

r cut

root

s of A

rctiu

m la

ppa L

. (A.

majo

r Gae

rtn.

), A.

min

us (H

ill) B

ernh

. and

A. t

omen

tosu

m M

ill. a

lso re

lated

sp

ecie

s or h

ybrid

s (As

tera

ceae

), co

llect

ed in

autu

mn

of th

e firs

t ye

ar o

r spr

ing

of th

e sec

ond

year

DAC

HAB

12g

Arni

ca/L

appa

com

p.; B

etul

a/La

ppa

com

p.

Arct

osta

phyl

os u

va-u

rsi (

L.)

Spre

ng.

Drie

d lea

ves o

f Arc

tosta

phyl

os u

va-u

rsi (

L.) S

pren

g.Ph

.Eur

. 1.2

.12

(eth

anol

36

%)

Uva

urs

i com

p.

Arisa

ema t

riphy

llum

(L.)

Torr.

Fres

h un

derg

roun

d pa

rts o

f Aris

aem

ia tr

iphy

llum

(L.)

Torr.

, co

llect

ed b

efor

e the

leav

es d

evelo

p.H

ABPh

.Eur

. 1.1

.5

Arni

ca m

onta

na L

.Vo

latile

oil

from

the u

nder

grou

nd p

arts

of A

rnic

a mon

tana

L.

see A

pp. 2

.6 (C

alciu

m

silici

cum

com

p.)

Vade

mec

um: C

alciu

m

silici

cum

com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


88

Arni

ca m

onta

na L

.Fr

esh

flowe

r-he

ads o

f Arn

ica m

onta

na L

.H

AB 1

2cAr

gent

um/U

rtic

a com

p.; A

rnic

a, Fl

os;

Calen

dula

/Urt

ica c

omp.

Arni

ca m

onta

na L

.W

hole

fresh

flow

erin

g pl

ants

of A

rnic

a mon

tana

L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.4, 1

.1.5

, 1.1

.7,

1.1.

10 (e

than

ol 4

5%

Ph.fr

.), H

AB 1

2a, 2

1, 3

3c.

See a

lso A

pp. 2

.7: A

rnic

a m

onta

na 1

:1,1

Acon

itum

/Arn

ica c

omp.

/Api

s; Ac

onitu

m/A

rnic

a com

p./F

orm

ica;

Acon

itum

/Arn

ica/

Betu

la co

mp.

; Ac

onitu

m/A

rnic

a/Br

yoni

a; Al

lium

ce

pa/T

endo

com

p.; A

pis/

Arni

ca; A

rnic

a co

mp.

; Arn

ica,

Plan

ta to

ta; A

rnic

a, Pl

anta

tota

/Aur

um; A

rnic

a, Pl

anta

tota

/Co

r; Ar

nica

, Pla

nta t

ota/

Equi

setu

m

arve

nse;

Arni

ca, P

lant

a tot

a/Fo

rmic

a; Ar

nica

, Pla

nta t

ota/

Vesp

a Cra

bro;

Ar

nica

-Cer

ebru

m; A

rnic

a/Be

tula

co

mp.

; Arn

ica/

Cact

us co

mp.

; Arn

ica/

Echi

nace

a com

p.; A

rnic

a/Ep

iphy

sis/

Plum

bum

mell

itum

com

p.; A

rnic

a/Fo

rmic

a com

p.; A

rnic

a/H

ypop

hysis

/Pl

umbu

m m

ellitu

m co

mp.

; Arn

ica/

Levi

sticu

m co

mp.

; Arn

ica/

Plum

bum

m

ellitu

m; A

rnic

a/Sy

mph

ytum

com

p.;

Arni

ca/U

rtic

a ure

ns; A

rtic

ulat

io

talo

crur

alis

com

p.; A

urum

/Ono

pord

on

com

p.; B

etul

a/Ar

nica

com

p.; C

actu

s/M

agne

sium

pho

spho

ricum

; Cer

ebell

um

com

p.; C

rata

egus

/Pru

nus c

omp.

; Disc

i co

mp.

cum

Aes

culo

; Disc

i com

p. cu

m

Arge

nto;

Disc

i com

p. cu

m A

uro;

Disc

i co

mp.

cum

Stib

io; D

isci/R

hus

toxi

code

ndro

n co

mp.

; Disc

i/Visc

um

com

p. cu

m A

rgen

to; M

agne

sium

ph

osph

oric

um co

mp.

; Mag

nesiu

m

sulfu

ricum

/Ova

ria co

mp.

; Man

drag

ora

com

p.; M

edul

la sp

inal

is co

mp.

; Ner

vus

optic

us co

mp.

; Ono

pord

on co

mp.

/O

leand

er/ A

rnic

a; St

annu

m/

Sym

phyt

um co

mp.

; Sym

phyt

um co

mp.

Arni

ca m

onta

na L

.Fr

esh

unde

rgro

und

part

s of A

rnic

a mon

tana

L.

HAB

21,

33c

Apis

com

p.; A

rnic

a

Arni

ca m

onta

na L

.W

hole

or p

artia

lly b

roke

n, d

ried

flowe

r-he

ads o

f Ar

nica

mon

tana

L.

HAB

; Ph

.Eur

.H

AB 1

2d (o

live o

il), 1

2gAp

is/Ar

nica

com

p.; A

rnic

a com

p./

Cupr

um; A

rnic

a com

p./F

orm

ica;

Arni

ca, F

los;

Arni

ca/L

appa

com

p.;

Lotio

Pru

ni co

mp.

; Oleu

m la

ctag

ogum

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


89

Arni

ca m

onta

na L

.D

ried

unde

rgro

und

part

s of A

rnic

a mon

tana

L.

HAB

Ph.E

ur. 1

.1.8

(Eth

anol

90

%);

Ph.H

elv. 1

7.7.

4.3/

APC

4.3

Arni

ca; C

inis

Arni

cae c

omp.

Arte

misi

a abr

otan

um L

.Fr

esh

youn

g sh

oots

and

leave

s of A

rtem

isia a

brot

anum

L. H

AB

Fres

h, n

on-w

oody

aeria

l par

t of A

rtem

isia a

brot

anum

L. P

h.fr.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (E

than

ol 6

5%) H

AB 3

3cAb

rota

num

; Bol

us al

ba co

mp.

Arte

misi

a abs

inth

ium

L.

Fres

h up

per s

hoot

s with

atta

ched

leav

es an

d flo

wers

and

basa

l lea

ves o

f Arte

misi

a abs

inth

ium

L. s

epar

ately

or a

s a m

ixtu

re.

HAB

Ph.E

ur. 1

.1.5

, Ext

ract

ion

with

etha

nol 3

6% (1

:2,3

)Ci

chor

ium

/Tar

axac

um co

mp.

Arte

misi

a abs

inth

ium

L.

Basa

l lea

ves o

r slig

htly

leaf

y, flo

werin

g to

ps, o

r mix

ture

of t

hese

dr

ied,

who

le or

cut o

rgan

s of A

rtem

isia a

bsin

thiu

m L

.(H

AB);

Ph.E

ur.

Ph.E

ur. 1

.2.1

3 (e

than

ol

50%

), 1.

4.4,

Ext

ract

ion

with

wat

er (t

oget

her

with

oth

er h

erba

l dru

gs)

Absin

thiu

m/C

aryo

phyl

li co

mp.

; Ab

sinth

ium

/Res

ina L

arici

s; Ar

tem

isia

com

p.; C

inis

Caps

ellae

com

p.;

Cocc

ulus

/Oleu

m P

etra

e com

p.;

Gen

tiana

com

p.; G

entia

na/Z

ingi

ber

com

p.; U

va u

rsi c

omp.

Arum

mac

ulat

um L

.Fr

esh

unde

rgro

und

part

s of A

rum

mac

ulat

um L

., col

lecte

d be

fore

th

e lea

ves d

evelo

p.H

ABPh

.Eur

. 1.1

.5, 1

.2.4

Arum

mac

ulat

um/P

terid

ium

aqui

linum

Arum

trip

hyllu

mse

e Aris

aem

a trip

hyllu

m (L

.) To

rr.

Arun

do d

onax

L.

Fres

h un

derg

roun

d pa

rts o

f Aru

ndo

dona

x L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Asa f

oetid

ase

e Fer

ula a

ssa-

foet

ida L

.

Asar

um eu

ropa

eum

L.

Fres

h un

derg

roun

d pa

rts o

f phe

nylp

ropa

ne-c

onta

inin

g su

bspe

cies

of A

saru

m eu

ropa

eum

L.

HAB

Ph.E

ur. 1

.1.5

Aspe

rula

odo

rata

see G

aliu

m o

dora

tum

Aspi

dium

filix

-mas

see D

ryop

teris

filix

-mas

(L.)

Scho

tt.

Aspl

eniu

m sc

olop

endr

ium

see P

hylit

is sc

olop

endr

ium

Astra

galu

s exs

capu

s L.

Fres

h flo

werin

g an

d in

frui

t ros

ette

s of A

strag

alus e

xsca

pus L

.Ph

.Eur

. 1.1

.5Va

dem

ecum

: As

traga

lus e

xsca

pus

Atro

pa b

ella-

donn

a L.

Fres

h fr

uits

of A

tropa

bell

a-do

nna L

.Ph

.Eur

. 1.1

.6, H

AB 3

3aAp

is/Be

llado

nna;

Apis/

Bella

donn

a/M

ercu

rius;

Bella

donn

a; Be

llado

nna /

Rosa

e aet

hero

leum

; Ech

inac

ea/

Mer

curiu

s com

p.; R

hus/

Salix

com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


90

Atro

pa b

ellad

onna

L.

Who

le, fr

esh,

flow

erin

g pl

ant o

f Atro

pa b

ellad

onna

L., h

arve

sted

at th

e end

of fl

ower

ing,

with

the l

igne

ous b

ase o

f the

stem

s re

mov

ed

(HAB

); Ph

.Eur

.; Ph

.fr.

Ph.E

ur. 1

.1.3

, 1.1

.10

(eth

anol

45%

), H

AB 2

1Ac

idum

hyd

roch

loric

um co

mp.

; Api

s/Be

llado

nna;

Arge

ntum

com

p.; A

urum

/Be

llado

nna c

omp.

; Bell

adon

na;

Bella

donn

a/Be

tula

/For

mic

a; Be

llado

nna/

Lens

crist

allin

a Col

umba

e/

Resin

a Lar

icis;

Bell

adon

na/O

xalis

; Be

llado

nna/

Papa

ver c

omp.

; Be

llado

nna/

Qua

rz; B

olus

Euc

alyp

ti co

mp.

; Bry

onia

/Gels

emiu

m co

mp.

; Br

yoni

a/Sp

ongi

a com

p.; C

actu

s/M

agne

sium

pho

spho

ricum

; Ch

amom

illa c

omp.

; Dro

sera

/Ip

ecac

uanh

a com

p.; E

ucal

yptu

s com

p.;

Oxa

lis co

mp.

; Pul

vis S

tom

achi

cus c

um

Bella

donn

a; Zi

nnob

er co

mp.

Atro

pa b

ella-

donn

a L.

Fres

h ae

rial p

arts

of A

tropa

bell

a-do

nna L

. with

out w

oody

lowe

r ste

m se

ctio

ns, c

ollec

ted

at th

e beg

inni

ng o

f flow

erin

gH

AB 3

3aAm

mi v

isnag

a com

p.; A

ntim

onit/

Rosa

e ae

ther

oleu

m co

mp.

; Api

s/Be

rber

is co

mp.

; Aur

um/P

lum

bum

mell

itum

co

mp.

; Bell

adon

na; B

ellad

onna

/Ros

ae

aeth

erol

eum

; Bell

adon

na co

mp.

; Car

um

carv

i com

p.; C

onju

nctiv

a com

p.;

Echi

nace

a/Q

uarz

com

p.; L

ache

sis

com

p.; P

erio

dont

ium

/Sili

cea c

omp.

; Si

licea

com

p.; Th

yreo

idea

com

p.;

Vera

trum

com

p.

Atro

pa b

ella-

donn

a L.

Fres

h un

derg

roun

d pa

rts o

f Atro

pa b

ella-

donn

a L.

HAB

21,

33b

Acon

itum

com

p.; B

ellad

onna

; Be

llado

nna/

Cham

omill

a; Br

yoni

a/Pu

lsatil

la co

mp.

; Visc

um co

mp.

Aven

a sat

iva L

.W

hole

fresh

pla

nts o

f Ave

na sa

tiva L

., col

lecte

d wh

en th

e gra

in

has r

ipen

ed to

the m

ilky s

tage

HAB

HAB

33c

Apis

regi

na/A

urum

com

p.; A

vena

co

mp.

; Ave

na/P

assifl

ora c

omp.

Aven

a sat

iva L

.Fr

esh

aeria

l par

ts of

Ave

na sa

tiva L

., col

lecte

d wh

en th

e gra

in h

as

ripen

ed to

the m

ilky s

tage

Aque

ous e

xtra

ct (w

ith

sucr

ose)

1:5

(see

mon

. KC

)

Hyp

eric

um/P

assifl

ora c

omp.

Aven

a sat

iva L

.Fr

esh

aeria

l par

ts of

Ave

na sa

tiva L

., col

lecte

d at

flow

erin

g tim

eH

AB; P

h.fr.

Ph.E

ur. 1

.1.1

, 1.1

.4,

1.1.

10 (e

than

ol 4

5%)

Aven

a sat

iva;

Aven

a sat

iva c

omp.

Aven

a sat

iva L

.G

erm

inat

ed fr

uits

of A

vena

sativ

a L.

APC

4.3

Cor/

Crat

aegu

s com

p.; F

raga

ria/U

rtic

a co

mp.

; Mag

nesiu

m p

hosp

horic

um

com

p.; M

agne

sium

pho

spho

ricum

cum

ci

nere

Ave

nae;

Vera

trum

com

p.

Aven

a sat

iva L

.D

ried

mill

ed fr

uits

of A

vena

sativ

a L.

API

Aven

a/Co

ncha

e com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


91

Balsa

mum

per

uvia

num

see M

yrox

ylon

bal

sam

um (L

.) H

arm

s

Bam

busa

see P

hyllo

stach

ys vi

ridig

lauce

scen

s (Ca

rr.) A

. et C

. Riv.

Bella

donn

ase

e Atro

pa b

ella-

donn

a L.

Belli

s per

enni

s L.

Who

le fre

sh fl

ower

ing

plan

ts of

Bell

is pe

renn

is L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.3, 1

.1.1

0 (e

than

ol 4

5%)

Sym

phyt

um co

mp.

Belli

s per

enni

s L.

Fres

h ae

rial p

arts

of B

ellis

pere

nnis

L. at

flow

erin

gH

AB 1

2cBe

llis/

Trop

aeol

um; C

alen

dula

/Tr

opae

olum

com

p.

Styr

ax to

nkin

ensis

(Pie

rre)

Cra

ib

ex H

artw

ichRe

sin o

btai

ned

by in

cisin

g th

e tru

nk o

f Sty

rax

tonk

inen

sis (P

ierr

e)

Crai

b ex

Har

twich

Ph.E

ur.

Ph.E

ur. 1

.1.1

0 (e

than

ol

90%

)Ce

ratu

m b

enzo

inat

um

Berb

eris

aqui

foliu

mse

e Mah

onia

aqui

foliu

m (P

ursh

) Nut

t.

Berb

eris

vulg

aris

L.Fr

esh

aeria

l par

ts of

Ber

beris

vulg

aris

L. at

flow

erin

gH

AB 3

3cBe

rber

is/Pr

osta

ta co

mp.

; Ber

beris

/U

teru

s com

p.

Berb

eris

vulg

aris

L.Fr

esh

unde

rgro

und

part

s of B

erbe

ris vu

lgar

is L.

Ph.E

ur. 1

.4.3

, HAB

33d

Apis/

Berb

eris

com

p.; B

erbe

ris/

Hyp

eric

um co

mp.

; Ber

beris

/Pro

stata

co

mp.

; Ber

beris

/Sab

al co

mp.

; Ber

beris

/Se

pia c

omp.

; Ber

beris

/Urt

ica u

rens

, H

erba

; Ber

beris

/Ute

rus c

omp.

; Ly

copo

dium

com

p.; S

abal

/Sol

idag

o co

mp.

Berb

eris

vulg

aris

L.W

hole,

fully

ripe

ned

berr

ies o

f Ber

beris

vulg

aris

L. st

rippe

d off

th

e fru

it sta

lks

HAB

Ph.E

ur. 1

.1.4

, HAB

21,

33

cAl

umen

/Hell

ebor

us co

mp.

; Arg

entu

m/

Berb

eris

com

p.; B

erbe

ris e

fruc

tibus

co

mp.

; Ber

beris

, Fru

ctus

; Ber

beris

/Eu

caly

ptus

/ Sili

cea c

omp.

; Ber

beris

/M

ercu

rialis

per

enni

s; Be

rber

is/N

icotia

na co

mp.

; Ber

beris

/Pru

nus;

Berb

eris/

Pyrit

com

p.; B

erbe

ris/Q

uarz

; Be

rber

is/Si

licea

com

p.; E

chin

acea

co

mp.

; Ech

inac

ea/P

runu

s com

p.;

Sam

bucu

s/Te

ucriu

m co

mp.

; Uva

urs

i co

mp.

Berb

eris

vulg

aris

L.Fr

esh

whol

e pla

nt in

cludi

ng b

errie

s of B

erbe

ris vu

lgar

is L.

HAB

21

Berb

eris,

Pla

nta t

ota/

Urtic

a ure

ns

Berb

eris

vulg

aris

L.D

ried

bark

of a

eria

l and

und

ergr

ound

par

ts of

Ber

beris

vulg

aris

L.H

ABPh

.Eur

. 1.1

.8, 1

.2.1

2 (e

than

ol 7

0%),

1.4.

2Ap

is co

mp.

; Bar

ium

com

p.; B

erbe

ris,

Corte

x; B

erbe

ris/U

rtic

a ure

ns, H

erba

Berb

eris

vulg

aris

L.D

ried

bark

of u

nder

grou

nd p

arts

of B

erbe

ris vu

lgar

is L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

55

%)

Répe

rtoire

de m

éd.

anth

r. (2

010)

Berb

eris

vulg

aris

L.D

ried

unde

rgro

und

part

s of B

erbe

ris vu

lgar

is L.

HAB

12f

Berb

eris/

Cheli

doni

um co

mp.

; Ber

beris

/Ju

nipe

rus c

omp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


92

Beto

nica

see S

tach

ys o

ffici

nalis

(L.)

Trev

.

Betu

la p

endu

la R

oth

Fres

h yo

ung

leave

s of B

etul

a pen

dula

Rot

h.H

AB1.

1.7,

HAB

22,

34e

Bella

donn

a/Be

tula

/For

mic

a; Be

tula

, Fo

lium

; Bet

ula/

Arni

ca co

mp.

; Bet

ula/

Juni

peru

s; Ca

rtila

go co

mp.

; Car

tilag

o/M

andr

agor

a com

p.; M

andr

agor

a com

p.;

Trop

aeol

um co

mp.

Betu

la p

endu

la R

oth

Drie

d ba

rk fr

om w

hite

par

ts on

ly o

f tru

nk an

d br

anch

es o

f Bet

ula

pend

ula R

oth

HAB

Ph.E

ur. 1

.2.1

2 (e

than

ol

50%

)Ar

nica

/Bet

ula c

omp.

; Arn

ica/

Epip

hysis

/Pl

umbu

m m

ellitu

m co

mp.

; Arn

ica/

Form

ica c

omp.

; Arn

ica/

Hyp

ophy

sis/

Plum

bum

mell

itum

com

p.; B

etul

a co

mp.

; Bet

ula,

Corte

x; B

etul

a/M

andr

agor

a com

p.; R

etin

a/Se

cale

com

p.

Betu

la p

endu

la R

oth,

Bet

ula

pube

scen

s Ehr

h.W

hole

or fr

agm

ente

d dr

ied

leave

s of B

etul

a pen

dula

Rot

h an

d /o

r Be

tula

pub

esce

ns E

hrh.

, as w

ell as

hyb

rids o

f bot

h sp

ecie

s.Ph

.Eur

.Ph

.Eur

. 1.2

.12

(eth

anol

36

%),

HAB

12g

Acon

itum

/Arn

ica c

omp.

/Api

s; Ac

onitu

m/A

rnic

a com

p./F

orm

ica;

Acon

itum

/Arn

ica/

Betu

la co

mp.

; Api

s/Ar

nica

com

p.; A

rnic

a com

p./C

upru

m;

Arni

ca co

mp.

/For

mic

a; Ar

nica

/Lap

pa

com

p.; A

rnic

a/Sy

mph

ytum

com

p.;

Betu

la, F

oliu

m; B

etul

a/La

ppa c

omp.

; Bl

eigl

anz/

Seca

le co

mp.

; Man

drag

ora

com

p.; M

edul

la sp

inal

is co

mp.

; Oleu

m

lact

agog

um

Betu

la p

endu

la R

oth,

Bet

ula

pube

scen

s Ehr

h.Ca

rbon

obt

aine

d fro

m w

ood

of B

etul

a pen

dula

Rot

h or

B.

pube

scen

s Ehr

h.H

ABPh

.Eur

. 4.1

.1 se

e app

. 2.7

Bariu

m/P

ancr

eas c

omp.

; Bas

ilicu

m

com

p.; B

irken

kohl

e com

p.; B

olus

alba

co

mp.

; Car

bo B

etul

ae; C

arbo

Bet

ulae

cu

m M

etha

no; C

arbo

Bet

ulae

/Car

vi

aeth

erol

eum

; Car

bo B

etul

ae/C

rata

egus

; Ca

rbo

Betu

lae/

Sulfu

r; N

icot

iana

com

p.;

Nic

otia

na/N

ux vo

mic

a com

p.;

Panc

reas

/Plat

inum

chlo

ratu

m co

mp.

; So

lutio

Sac

char

i com

p.; T

ropa

eolu

m

com

p.

Bold

ose

e Peu

mus

bol

dus M

ol.

Bora

go o

ffici

nalis

L.

Fres

h lea

ves o

f Bor

ago

offici

nalis

L.

(HAB

192

4)Ph

.Eur

. 1.1

.4, H

AB 3

4bAe

scul

us, C

orte

x/ B

orag

o/H

amam

elis,

Foliu

m; A

escu

lus/

Prun

us co

mp.

; Ae

scul

us/Q

uerc

us co

mp.

; Bor

ago;

Bo

rago

com

p.; B

orag

o/Re

nes c

omp.

; Q

uerc

us co

mp.

Bora

go o

ffici

nalis

L.

Fres

h ae

rial p

arts

of B

orag

o offi

cina

lis L

. at fl

ower

ing

HAB

12a

, 12c

Bora

go

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


93

Bosw

ellia

carte

ri Bi

rdwo

od

(Bos

welli

a sac

ra F

luec

kige

r)

Boss

welli

a fre

rean

a Bird

wood

Solid

ified

gum

-res

in o

btai

ned

from

incis

ions

in th

e shr

ubs o

r tre

es o

f mem

bers

of t

he ge

nus B

oswe

llia,

part

icul

arly

Bos

welli

a ca

rteri

Bird

wood

(Syn

. Bos

welli

a sac

ra F

luec

kige

r) an

d/or

Bo

sswe

llia f

rere

ana B

irdwo

od

Ph.E

ur. 1

.1.8

(eth

anol

90

%),

4.1.

1Au

rum

com

p.; A

urum

/Epi

phys

is co

mp.

; Au

rum

/Hyp

ophy

sis co

mp.

; Olib

anum

co

mp.

/Suc

cinum

Bras

sica n

igra

(L.)

W.D

.J. K

och

Ripe

drie

d se

eds o

f Bra

ssic

a nig

ra (L

.) Ko

chD

ACH

AB 1

2fAe

scul

us/C

era c

omp.

Bryo

nia c

retic

a L. s

sp. d

ioic

a (Ja

cq.)

Tutin

Bry

onia

alba

L.

Fres

h ro

ot o

f Bry

onia

cret

ica L

. ssp

. dio

ica (

Jacq

.) Tu

tin o

r Bry

onia

al

ba L

., har

veste

d be

fore

the p

lant

com

es in

to fl

ower

HAB

Ph.E

ur. 1

.1.3

Acon

itum

/Arn

ica/

Bryo

nia;

Acon

itum

/Br

yoni

a; Ap

is/Br

yoni

a; Ap

is/Rh

us

toxi

code

ndro

n co

mp.

; Bry

onia

; Br

yoni

a/Eu

pato

rium

com

p.; B

ryon

ia/

Form

ica c

omp.

; Bry

onia

/Gels

emiu

m

com

p.; B

ryon

ia/S

pong

ia co

mp.

; Ec

hina

cea/

Prun

us co

mp.

; Fer

rum

ph

osph

oric

um co

mp.

Bryo

nia c

retic

a L. s

sp. d

ioic

a (Ja

cq.)

Tutin

Fres

h ro

ot o

f Bry

onia

cret

ica L

. ssp

. dio

ica (

Jacq

.) Tu

tin, h

arve

sted

befo

re sh

oots

are p

rodu

ced

HAB

HAB

33b

Acon

itum

/Chi

na co

mp.

; Aes

culu

s/Ce

ra

com

p.; A

pis/

Bryo

nia;

Apis/

Lary

nx

com

p.; B

ronc

hi/P

lant

ago

com

p.;

Bryo

nia;

Bryo

nia c

omp.

; Bry

onia

/Pu

lsatil

la co

mp.

; Bry

onia

/Sta

nnum

; Br

yoni

a/Vi

scum

com

p.; G

elsem

ium

co

mp.

; Mag

nesiu

m su

lfuric

um/O

varia

co

mp.

; Pul

mo/

Vivi

anit

com

p.; R

hus/

Salix

com

p.

Bryo

nia a

lba L

. or B

ryon

ia cr

etic

a L.

ssp.

dio

ica (

Jacq

.) Tu

tinFr

esh

unde

rgro

und

part

s of B

ryon

ia cr

etic

a L. s

sp. d

ioic

a (Ja

cq.)

Tutin

or B

ryon

ia al

ba L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (E

than

ol

45%

)Ré

perto

ire d

e méd

. an

thr.

(201

6)

Bryo

phyl

lum

dai

grem

ontia

num

(R

aym

.-Ham

et et

H. P

errie

r) A

. Be

rger

Bry

ophy

llum

pin

natu

m

(Lam

.) O

ken

Fres

h lea

ves o

f Bry

ophy

llum

dai

grem

ontia

num

(Ray

m.-H

amet

et

H. P

errie

r) A

. Ber

ger a

nd K

alan

choe

pin

nata

(Lam

.) Pe

rs.,

harv

este

d in

the fi

rst y

ear o

f gro

wth

HAB

Ph.E

ur. 1

.1.7

, 1.1

.10

(eth

anol

30%

), 33

bBr

yoph

yllu

m; B

ryop

hyllu

m co

mp.

; Ci

mici

fuga

com

p.; I

gnat

ia co

mp.

Bryo

phyl

lum

pin

natu

m (L

am.)

Oke

nFr

esh

pres

sed

juice

from

leav

es o

f Bry

ophy

llum

pin

natu

m (L

am.)

Oke

n(H

AB)

APC

5.2.

1Br

yoph

yllu

m

Bryo

phyl

lum

pin

natu

m (L

am.)

Oke

nFr

esh

leave

s of B

ryop

hyllu

m p

inna

tum

(Lam

.) O

ken,

har

veste

d in

th

e firs

t yea

r of g

rowt

hH

ABPh

.Eur

. 1.1

.7, H

AB 2

1,

see a

lso A

pp. 2

.7:

Bryo

phyl

lum

pin

nata

1:

1,1

Bryo

phyl

lum

; Bry

ophy

llum

/Con

chae

Buxu

s sem

perv

irens

L.

Fres

h, yo

ung

leafy

bra

nche

s of B

uxus

sem

perv

irens

L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Cact

us g

rand

iflor

usse

e Sele

nice

reus

gra

ndifl

orus

(L.)

Britt

. et R

ose

Cajep

uti a

ethe

roleu

mse

e Mela

leuca

leuc

aden

dra (

L.) L

.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


94

Cala

mus

see A

coru

s cal

amus

L.

Calen

dula

offi

cina

lis L

.Fr

esh

flowe

r hea

ds o

f Cal

endu

la o

ffici

nalis

L.

HAB

12c

Arge

ntum

/Urt

ica c

omp.

; Cal

endu

la;

Calen

dula

/Ech

inac

ea co

mp.

; Ca

lendu

la/T

ropa

eolu

m co

mp.

; Ca

lendu

la/U

rtic

a com

p.; E

chin

acea

/Vi

scum

com

p.; Th

ymus

serp

yllu

m

com

p.

Calen

dula

offi

cina

lis L

.Fr

esh

aeria

l par

ts of

Cal

endu

la o

ffici

nalis

L., c

ollec

ted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.3

, 1.1

.5; H

AB

33c,

expr

essin

g th

e jui

ceAl

lium

cepa

/ Mer

curia

lis co

mp.

; Ar

gent

um/Q

uerc

us co

mp.

; Arn

ica/

Echi

nace

a com

p.; C

alen

dula

; Cal

endu

la

com

p.; C

alen

dula

Pre

sssa

ft/Ec

hina

cea;

Calen

dula

/Ech

inac

ea p

urpu

rea;

Calen

dula

/Mer

curia

lis co

mp.

; Ca

lendu

la/S

tibiu

m; M

ajora

na/Th

uja

com

p.; M

ercu

rialis

com

p.; M

ercu

rialis

/St

ibiu

m co

mp.

; Sym

phyt

um co

mp.

Calen

dula

offi

cina

lis L

.D

ried

flowe

r hea

ds o

f Cal

endu

la o

ffici

nalis

L.

HAB

12f

, 57

Calen

dula

; Eup

hras

ia co

mp.

; Oleu

m

rhin

ale

Calen

dula

offi

cina

lis L

.D

ried

aeria

l par

ts of

Cal

endu

la o

ffici

nalis

L., c

ollec

ted

at fl

ower

ing

time

HAB

12

d, ex

tract

ion

with

oil

toge

ther

with

ot

her s

tart

ing

mat

eria

ls (1

.2:1

0)

Apis/

Arni

ca co

mp.

; Arn

ica c

omp.

/Cu

prum

; Arn

ica c

omp.

/For

mic

a; Ca

lendu

la/M

ercu

rialis

com

p.; O

leum

la

ctag

ogum

Cam

panu

la ro

tund

ifolia

L.

Fres

h, fl

ower

ing

aeria

l par

ts of

Cam

panu

la ro

tund

ifolia

L.

Ph.E

ur. 1

.1.1

0 (e

than

ol

45%

)

Caps

ella b

ursa

-pas

toris

(L.)

Med

ik.

Drie

d ae

rial p

arts

of C

apse

lla b

ursa

-pas

toris

(L.)

Med

ik, c

ollec

ted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.3

, 1.2

.13

(eth

anol

36%

)Ca

psell

a bur

sa-p

asto

ris; C

apse

lla/

Majo

rana

com

p.; C

inis

Caps

ellae

co

mp.

; Hyd

rasti

s com

p.

Caps

icum

annu

um L

.D

ried

ripe f

ruits

of C

apsic

um an

nuum

L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.8 (e

than

ol

90%

), 1.

1.10

(eth

anol

90

%)

Caps

icum

annu

um; K

asta

nien

-H

aarto

niku

m

Cara

mel

see S

acch

arum

offi

cina

rum

L.

Card

uus b

ened

ictu

sse

e Cni

cus b

ened

ictu

s L.

Card

uus m

aria

nus

see S

ilybu

m m

aria

num

(L.)

Gae

rtn.

Care

x ar

enar

ia L

.D

ried

rhiz

ome o

f Car

ex ar

enar

ia L

., col

lecte

d in

sprin

gAp

p. 2

.7: C

arex

aren

aria

, et

hano

l. D

ecoc

tum

1:4

Sold

ner /

Stell

man

n (2

011)

, Ind

ivid

uelle

Pä

diat

rie, p

. 190

-198

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


95

Caru

m ca

rvi L

.O

il ob

tain

ed b

y ste

am d

istill

atio

n fro

m th

e dry

frui

ts of

Car

um

carv

i L.

Ph.E

ur.

API

Berb

eris/

Cheli

doni

um co

mp.

; Bol

us

alba

com

p.; C

arbo

Bet

ulae

/Car

vi

aeth

erol

eum

; Meli

ssa c

omp.

; Oleu

m

lact

agog

um; T

ropa

eolu

m co

mp.

Caru

m ca

rvi L

.W

hole,

dry

mer

icar

p of

Car

um ca

rvi L

.(H

AB);

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

90

%),

1.2.

12 (e

than

ol

70%

), aq

ueou

s ext

ract

1.

8:1,

extra

ct w

ith

etha

nol 3

6%, A

PI, A

PC

4.2

Arte

misi

a com

p.; B

asili

cum

com

p.;

Caru

m ca

rvi;

Caru

m ca

rvi c

omp.

; Ce

ntau

rium

com

p.

Cary

ophy

llus

see S

yzyg

ium

arom

atic

um (L

.) M

err.

et L

. M. P

erry

Cass

ia an

gusti

folia

Vah

l., C

assia

se

nna L

.D

ried

leafle

ts of

Cas

sia se

nna L

. (C.

acut

ifolia

Deli

le), k

nown

as

Alex

andr

ian

or K

harto

um se

nna,

or C

assia

angu

stifo

lia V

ahl.,

kn

own

as T

inne

velly

senn

a, or

a m

ixtu

re o

f the

2 sp

ecie

s.

Ph.E

ur.

API

Cent

auriu

m co

mp.

Cass

ia se

nna L

. (Ca

ssia

acut

ifolia

D

elile)

Drie

d fr

uit o

f Cas

sia se

nna L

. (C.

acut

ifolia

Deli

le)Ph

.Eur

.Ph

.Eur

. 1.2

.12

(eth

anol

50

%)

Arte

misi

a com

p.

Caul

ophy

llum

thal

ictro

ides

(L.)

Mich

x.Fr

esh

unde

rgro

und

part

s of C

aulo

phyl

lum

thal

ictro

ides

(L.)

Mich

x., h

arve

sted

in la

te su

mm

erH

ABPh

.Eur

. 1.1

.5

Caul

ophy

llum

thal

ictro

ides

(L.)

Mich

x.D

ried

unde

rgro

und

part

s of C

aulo

phyl

lum

thal

ictro

ides

(L.)

Mich

aux.

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Cean

othu

s am

eric

anus

L.

Drie

d lea

ves o

f Cea

noth

us am

eric

anus

L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

), 1.

1.10

(eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Cent

auriu

m er

ythr

aea R

afn.

Fres

h ae

rial p

arts

of C

enta

uriu

m er

ythr

aea R

afn.

Ph. E

ur. 1

.1.4

, eth

anol

ic ex

tract

1:2

.3 (e

than

ol

36%

)

Cich

oriu

m/T

arax

acum

com

p.

Cent

auriu

m er

ythr

aea R

afn.

Who

le or

frag

men

ted

drie

d flo

werin

g ae

rial p

arts

of C

enta

uriu

m

eryt

hrae

a Raf

n s.

l. in

cludi

ng C

. maju

s (H

. et L

.) Ze

ltner

and

C.

suffr

utico

sum

(Gris

eb.)

Ronn

. (sy

n.: E

ryth

raea

cent

auriu

m

Pers

oon;

C. u

mbe

llatu

m G

ilibe

rt; C

. min

us G

ars.)

Ph.E

ur.

API

Cent

auriu

m co

mp.

Cent

ella a

siatic

a (L.

) Urb

anD

ried,

who

le pl

ant o

f Cen

tella

asia

tica (

L.) U

rban

(Hyd

roco

tyle

asia

tica L

.)Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

45%

)

Cepa

see A

llium

cepa

L.

Ceph

aelis

ipec

acua

nha

see P

sych

otria

ipec

acua

nha (

Brot

.) St

okes

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


96

Ceph

aelis

ipec

acua

nha (

Brot

.) A.

Ri

ch, C

epha

elis a

cum

inat

a H.

Kars

t.)

Frag

men

ted

and

drie

d un

derg

roun

d or

gans

of C

arap

ichea

ip

ecac

uanh

a (Br

ot.)

L. A

nder

sson

(syn

. Cep

haëli

s ipe

cacu

anha

(B

rot.)

A. R

ich.; C

epha

ëlis a

cum

inat

a H. K

arst.

) fro

m M

ato

Gro

sso

or C

osta

Ric

a.

Ph.E

ur.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Ré

perto

ire d

e méd

. an

thr.

(201

6)

Cetra

ria is

land

ica (

L.) A

char

ius

s.l.

Who

le or

cut,

drie

d th

allu

s of C

etra

ria is

land

ica (

L.) A

char

ius s

.l.(H

AB);

Ph.E

ur.

Ph.E

ur. 1

.2.1

2 (e

than

ol

70%

), aq

ueou

s ext

ract

Cetra

ria is

land

ica;

Lich

enes

com

p.;

Verb

ascu

m co

mp.

Cham

omill

a rec

utita

see M

atric

aria

recu

tita L

.

Cheli

doni

um m

ajus L

.Fr

esh

rhiz

ome a

nd ad

here

nt ro

ots o

f Che

lidon

ium

maju

s L.,

colle

cted

dur

ing

late a

utum

n or

on

the a

ppea

ranc

e of t

he fi

rst

shoo

ts

HAB

Ph.E

ur. 1

.1.5

, HAB

21,

34

bBe

llado

nna/

Papa

ver c

omp.

; Ber

beris

/Ch

elido

nium

com

p.; C

helid

oniu

m;

Cheli

doni

um co

mp.

; Che

lidon

ium

/Co

locy

nthi

s; Ch

elido

nium

/Cur

cum

a; Ch

elido

nium

/Ter

ebin

thin

a lar

icin

a co

mp.

; Col

chic

um co

mp.

Cheli

doni

um m

ajus L

.Fr

esh

flowe

rs o

f Che

lidon

ium

maju

s L.

HAB

Ph.E

ur. 1

.2.3

Aqui

linum

com

p.; C

helid

oniu

m;

Cheli

doni

um/O

xalis

com

p.;

Colch

icum

/Che

lidon

ium

; Col

chic

um/

Spon

gia c

omp.

Cheli

doni

um m

ajus L

.Fr

esh

aeria

l par

ts of

Che

lidon

ium

maju

s L., c

ollec

ted

at fl

ower

ing

time

HAB

34b

Berb

eris/

Cheli

doni

um co

mp.

; Ch

elido

nium

; Che

lidon

ium

/Co

locy

nthi

s; Ch

elido

nium

/Te

rebi

nthi

na la

ricin

a com

p.

Cheli

doni

um m

ajus L

.Fr

esh

whol

e flow

erin

g pl

ants

of C

helid

oniu

m m

ajus L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

45%

)

Chim

aphi

la u

mbe

llata

(L.)

Barto

nD

ried

aeria

l par

ts of

Chi

map

hila

um

bella

ta (L

.) Ba

rton

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Chin

ase

e Cin

chon

a pub

esce

ns V

ahl

Chlo

roph

ycea

e (cla

ss),

Clad

opho

ra o

r Oed

ogon

ium

(g

ener

a)

Fres

h th

alli

of al

gae f

rom

the g

enus

Cla

doph

ora o

r Oed

ogon

ium

or

oth

er ge

nera

of fi

lam

ento

us o

rgan

ised

gree

n al

gae f

rom

the

class

Chl

orop

hyce

ae.

HAB

33e

Arge

ntum

nitr

icum

com

p.

Chry

sosp

leniu

m al

tern

ifoliu

m L

.W

hole

fresh

pla

nts o

f Chr

ysos

plen

ium

alte

rnifo

lium

L.

HAB

33b

Chry

sosp

leniu

m co

mp.

Cich

oriu

m in

tybu

s L.

Who

le fre

sh fl

ower

ing

plan

ts of

Cich

oriu

m in

tybu

s L.

HAB

Ph.E

ur. 1

.1.7

, HAB

21,

33

c; ex

tract

with

etha

nol

(36%

) 1:2

.3

Anag

allis

com

p.; B

ariu

m/P

ancr

eas

com

p.; B

erbe

ris/C

helid

oniu

m co

mp.

; Ch

ryso

splen

ium

com

p.; C

ichor

ium

; Ci

chor

ium

Plu

mbo

cultu

m; C

ichor

ium

St

anno

cultu

m; C

ichor

ium

/Pan

crea

s co

mp.

; Cich

oriu

m/T

arax

acum

com

p.;

Frag

aria

/Urt

ica c

omp.

; Lie

n co

mp.

; Pa

ncre

as/P

latin

um ch

lora

tum

com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


97

Cich

oriu

m in

tybu

s L. v

ar. i

ntyb

us

& C

ichor

ium

inty

bus L

. var

. sa

tivum

DC

Drie

d wh

ole p

lant

s of C

ichor

ium

inty

bus L

. var

. int

ybus

and

Cich

oriu

m in

tybu

s L. v

ar. s

ativ

um D

C, co

llect

ed at

flow

erin

g tim

e. Th

e tou

gh m

iddl

e ste

m se

ctio

ns ar

e not

use

d.

HAB

Ph.E

ur. 1

.2.1

2 (e

than

ol

70%

), AP

C 4.

2, 4

.3Ac

idum

hyd

roch

loric

um co

mp.

; Ba

silic

um co

mp.

; Cich

oriu

m;

Cich

oriu

m co

mp.

Cim

icifu

ga ra

cem

osa (

L.) N

utt.

Fres

h rh

izom

e and

adhe

rent

root

s of C

imifu

ga ra

cem

osa (

L.)

Nut

t.H

ABPh

.Eur

. 1.1

.5, 1

.2.9

, HAB

33

cCi

mici

fuga

com

p.; C

imici

fuga

ra

cem

osa

Cinc

hona

pub

esce

ns V

ahl

Who

le or

cut,

drie

d ba

rk o

f Cin

chon

a pub

esce

ns V

ahl (

Cinc

hona

su

cciru

bra P

av.),

of C

inch

ona c

alisa

ya W

edd.

, of C

inch

ona

ledge

riana

Moe

ns ex

Trim

en o

r of t

heir

varie

ties o

r hyb

rids.

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

70

%),

HAB

35b

Acon

itum

/Chi

na co

mp.

; Dro

sera

/Ip

ecac

uanh

a com

p.

Cine

raria

mar

itim

ase

e Sen

ecio

bico

lor (

Will

d.) T

od.

Cinn

amom

um ve

rum

J. S

. Pre

slD

ried

bark

, fre

ed fr

om th

e out

er co

rk an

d th

e und

erly

ing

pare

nchy

ma,

of th

e sho

ots g

rown

on

cut s

tock

of C

inna

mom

um

veru

m J.

S. P

resl.

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

70

%);

disti

llatio

nSp

iritu

s con

tra tu

ssim

; Spi

ritus

Meli

ssae

co

mp.

Ciss

us go

ngyl

odes

(Bak

.) Bu

rch.

Fres

h ae

rial r

oots

of C

issus

gong

ylod

es (B

ak.)

Burc

h.Ph

.Eur

. 1.1

.7Ci

ssus

-Oss

a

Citr

ullu

s col

ocyn

this

(L.)

Schr

ad.

Drie

d pu

lp o

f Citr

ullu

s col

ocyn

this

(L.)

Schr

ad. w

ithou

t see

dsPh

.fr.

Ph..E

ur. 1

.1.1

0 (e

than

ol

65%

)Ré

perto

ire d

e méd

. an

thr.

(201

6)

Citr

ullu

s col

ocyn

this

(L.)

Schr

ad.

Fres

h pe

eled

unrip

e fru

it of

Citr

ullu

s col

ocyn

this

(L.)

Schr

ad.

with

out s

eeds

HAB

33a

Berb

eris/

Cheli

doni

um co

mp.

; Ch

elido

nium

/Col

ocyn

this;

Col

ocyn

this

Citr

ullu

s col

ocyn

this

(L.)

Schr

ad.

Drie

d pe

eled

frui

t of C

itrul

lus c

oloc

ynth

is (L

.) Sc

hrad

. with

out

seed

sH

ABPh

.Eur

. 1.1

.8 (e

than

ol

90%

)Co

locy

nthi

s

Citr

us li

mon

(L.)

Burm

an fi

l.Es

sent

ial o

il ob

tain

ed b

y sui

tabl

e mec

hani

cal m

eans

, with

out t

he

aid

of h

eat,

from

the f

resh

pee

l of C

itrus

lim

on (L

.) Bu

rman

fil.

Ph.E

ur.

API

Citri

aeth

erol

eum

; Sili

cea c

ollo

idal

is co

mp.

; Spi

ritus

cont

ra tu

ssim

; Spi

ritus

M

eliss

ae co

mp.

Citr

us li

mon

(L.)

Burm

an fi

l.Fr

esh

pres

sed

juice

from

the f

ruit

of C

itrus

lim

on (L

.) Bu

rman

fil.

API

Arge

ntum

/Que

rcus

com

p.; C

itrus

/Cy

doni

a; Fl

ores

Sam

buci

com

p./Q

uarz

; Lo

tio P

runi

com

p.

Citr

us li

mon

(L.)

Burm

an fi

l.Fr

esh

frui

t of C

itrus

lim

on (L

.) Bu

rman

fil.

HAB

33c

, API

, see

also

Ap

p. 2

.7: C

itrus

lim

on,

Fruc

t. re

c. 1:

0.41

Citr

us/C

ydon

ia

Citr

us m

edic

a var

. lim

onum

see C

itrus

lim

on (L

.) Bu

rman

fil.

Clad

ina r

angi

ferin

a (L.

) Nyl

. (C

lado

nia r

angi

ferin

a (L.

) Web

.)D

ried

thal

lus o

f Cla

dina

rang

iferin

a (L.

) Nyl

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%);

extra

ctio

n wi

th

wate

r (to

geth

er w

ith

othe

r ing

redi

ents)

Lich

enes

com

p.

Clad

onia

rang

iferin

ase

e Cla

dina

rang

iferin

a

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


98

Clav

icep

s pur

pure

a (Fr

.) Tu

l.D

ried

scler

otum

of C

lavic

eps p

urpu

rea (

Frie

s) T

ulas

ne, g

rown

on

rye p

lant

s (Se

cale

cere

ale L

.) an

d dr

ied

at a

tem

pera

ture

not

ex

ceed

ing

40°C

HAB

Ph.E

ur. 1

.1.8

(Eth

anol

70

%),

HAB

35b

Arge

ntum

/Sec

ale;

Blei

glan

z/Se

cale

com

p.; G

alen

it/Re

tina c

omp.

; Hyd

rasti

s co

mp.

; Qua

rz/S

ecal

e; Re

tina/

Seca

le co

mp.

Clem

atis

rect

a L.

Fres

h, yo

ung

leafy

bra

nche

s of C

lemat

is re

cta L

., col

lecte

d at

flo

werin

g tim

ePh

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)

Clem

atis

rect

a L.

Fres

h ae

rial p

arts

of o

f Clem

atis

rect

a L., c

ollec

ted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.5

Vade

mec

um:

Clem

atis

rect

a

Cnic

us b

ened

ictu

s L.

Fres

h ae

rial p

arts

of C

nicu

s ben

edic

tus L

., col

lecte

d at

flow

erin

g tim

eH

ABPh

.Eur

. 1.1

.3, 1

.2.1

1,

HAB

33d

Bora

go co

mp.

; Car

duus

ben

edic

tus/

Paeo

nia o

ffici

nalis

Cocc

ulus

see A

nam

irta c

occu

lus W

ight

et A

rn.

Coch

learia

arm

orac

iase

e Arm

orac

ia ru

stica

na P

h. G

ärtn

., B. M

ey. e

t Sch

erb.

Coch

learia

offi

cina

lis L

.Fr

esh

aeria

l par

ts of

Coc

hlea

ria o

ffici

nalis

L., c

ollec

ted

at th

e sta

rt

of fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

45%

), H

AB 2

1,

33b

Basil

icum

com

p.; C

ochl

earia

offi

cina

lis;

Torm

entil

la co

mp.

; Tro

paeo

lum

com

p.

Coch

learia

offi

cina

lis L

.D

ried

aeria

l par

ts of

Coc

hlea

ria o

ffici

nalis

L., c

ollec

ted

at th

e be

ginn

ing

of th

e flow

erin

g tim

eAP

ICo

chlea

ria o

ffici

nalis

; Lev

istic

um

com

p.

Coffe

a ara

bica

L.

Drie

d, ro

aste

d se

eds o

f Coff

ea ar

abic

a L.

Ph.E

ur. 1

.2.1

2 (e

than

ol

18%

)Av

ena s

ativ

a com

p.; C

upru

m

sulfu

ricum

com

p.; Z

incu

m

valer

iani

cum

com

p.

Coffe

a ara

bica

L.

Ripe

, drie

d, u

nroa

sted

seed

s of C

offea

arab

ica L

. with

the s

eed

coat

(silv

er sk

in) l

arge

ly re

mov

edH

ABPh

.Eur

. 1.1

.8 (e

than

ol

70%

), Ph

.Helv

.17.

7.4.

2/AP

C 4.

2

Colch

icum

autu

mna

le L.

Fres

h co

rms o

f Col

chic

um au

tum

nale

L., c

ollec

ted

at fl

ower

ing

time a

nd fr

ee fr

om fi

brou

s roo

tsH

ABPh

.Eur

. 1.1

.3, 1

.2.4

, HAB

21

Apis

com

p.; C

olch

icum

; Col

chic

um

com

p.; C

olch

icum

/Sab

ina;

Colch

icum

/Sp

ongi

a com

p.

Colch

icum

autu

mna

le L.

Fres

h wh

ole,

flowe

ring

plan

t of C

olch

icum

autu

mna

le L.

HAB

34c

Colch

icum

; Col

chic

um/C

helid

oniu

m

Colo

cynt

his

see C

itrul

lus c

oloc

ynth

is (L

.) Sc

hrad

.

Com

mip

hora

mol

mol

Eng

ler

and/

or o

ther

spec

ies

Gum

-res

in, h

arde

ned

in ai

r, ob

tain

ed b

y inc

ision

or p

rodu

ced

by

spon

tane

ous e

xuda

tion

from

the s

tem

and

bran

ches

of

Com

mip

hora

mol

mol

Eng

ler an

d/or

oth

er sp

ecie

s of

Com

mip

hora

.

Ph.E

ur.

Myr

rhae

tinc

tura

Ph.

Eur.

Auru

m co

mp.

; Aur

um/E

piph

ysis

com

p.;

Auru

m/H

ypop

hysis

com

p.; C

erat

um

Rata

nhia

e com

p.; R

atan

hia c

omp.

; Re

sina L

aric

is/So

lutio

Myr

rhae

ba

lsam

ica;

Salv

ia co

mp.

; Sol

utio

M

yrrh

ae b

alsa

mic

a

Coni

um m

acul

atum

L.

Fres

h flo

werh

eads

of C

oniu

m m

acul

atum

L., c

ollec

ted

at th

e end

of

flow

erin

g tim

ePh

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Ré

perto

ire d

e méd

. an

thr.

(201

0)

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


99

Coni

um m

acul

atum

L.

Fres

h, ae

rial p

arts

of th

e flow

erin

g, b

ut n

ot ye

t fru

iting

spec

imen

s of

Con

ium

mac

ulat

um L

.H

ABPh

.Eur

. 1.1

.3Co

nium

mac

ulat

um

Conv

alla

ria m

ajalis

L.

Fres

h ae

rial p

arts

of C

onva

llaria

maja

lis L

., col

lecte

d at

flow

erin

g tim

eH

ABPh

.Eur

. 1.1

.5, 1

.2.3

Conv

alla

ria; O

nopo

rdon

com

p./

Olea

nder

/ Con

valla

ria; S

cilla

com

p.

Conv

alla

ria m

ajalis

L.

Fres

h wh

ole,

flowe

ring

plan

ts of

Con

valla

ria m

ajalis

L.

HAB

33c

Adon

is/Sc

illa c

omp.

; Con

valla

ria/

Prim

ula c

omp.

Conv

alla

ria m

ajalis

L.

Fres

h flo

wers

with

ped

icels

of C

onva

llaria

maja

lis L

.Ph

.Eur

. 1.1

.7 w

ith

exte

nsio

n: d

urin

g th

e pr

escr

ibed

mac

erat

ion

time t

he m

ixtu

re is

ex

pose

d fo

r 3 d

ays t

o su

nlig

ht fi

ltere

d th

roug

h a s

atur

ated

solu

tion

of

alum

.

Conv

alla

ria

Coria

ndru

m sa

tivum

L.

Drie

d cr

emoc

arp

of C

oria

ndriu

m sa

tivum

L.

Ph.E

ur.

Dist

illat

ion

(toge

ther

wi

th o

ther

ingr

edie

nts)

Spiri

tus c

ontra

tuss

im; S

pirit

us M

eliss

ae

com

p.

Crat

aegu

s lae

viga

ta (P

oir.)

DC.

, Cr

atae

gus m

onog

yna J

acq.

em

end.

Lin

dm.

Fres

h lea

ves a

nd ri

pe fr

uit o

f Cra

taeg

us la

evig

ata (

Poir.

) DC.

and

Crat

aegu

s mon

ogyn

a Jac

q. em

end.

Lin

dman

HAB

33d

Adon

is co

mp.

; Ado

nis/

Scill

a com

p.;

Arni

ca/C

actu

s com

p.; A

urum

/Val

eria

na

com

p.; C

actu

s/M

eliss

a com

p.; C

or/

Crat

aegu

s com

p.; C

rata

egus

; Cra

taeg

us/

Visc

um; P

assifl

ora c

omp.

Crat

aegu

s lae

viga

ta (P

oir.)

DC.

, Cr

atae

gus m

onog

yna J

acq.

em

end.

Lin

dm.

Fres

h rip

e fru

its o

f Cra

taeg

us la

evig

ata (

Poir)

DC.

, Cra

taeg

us

mon

ogyn

a Jac

q. em

end.

Lin

dm., t

heir

hybr

ids a

nd m

ixtu

res

ther

eof

HAB

See M

onog

raph

HAB

(P

h.Eu

r. 1.

1.3)

, Ph.

Eur.

1.2.

4, 1

.2.5

; aqu

eous

ex

tract

with

sucr

ose a

nd

citric

acid

(3:4

.95:

2:0.

05)

Auru

m/C

rata

egus

; Cac

tus/

Crat

aegu

s; Ca

ctus

/Cra

taeg

us co

mp.

; Cac

tus/

Mag

nesiu

m p

hosp

horic

um; C

arbo

Be

tula

e/Cr

atae

gus;

Crat

aegu

s; Cr

atae

gus c

omp.

; Cra

taeg

us/F

erru

m

sider

eum

/Sac

char

um to

stum

; Cr

atae

gus/

Kalm

ia; C

rata

egus

/Pru

nus

com

p.; H

yper

icum

/Pas

siflor

a com

p.;

Ono

pord

on co

mp.

/Olea

nder

/ Arn

ica;

Ono

pord

on co

mp.

/Olea

nder

/ Co

nval

laria

Crat

aegu

s lae

viga

ta (P

oir.)

DC.

, Cr

atae

gus m

onog

yna J

acq.

em

end.

Lin

dm.

Drie

d lea

ves o

f Cra

taeg

us m

onog

yna J

acq.

(Lin

dm.),

C. l

aevi

gata

(P

oir.)

DC.

(syn

. C. o

xyac

anth

oide

s Thui

ll.; C

. oxy

acan

tha a

uct.)

or

thei

r hyb

rids o

r, m

ore r

arely

, oth

er E

urop

ean

Crat

aegu

s spe

cies

inclu

ding

C. p

enta

gyna

Wal

dst.

et K

it. ex

Will

d., C

. nig

ra W

alds

t. et

Kit.

and

C. az

arol

us L

Extra

ctio

n wi

th et

hano

l 36

% (D

ER 1

:1.5

-2.5

)Cr

atae

gus

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


100

Crat

aegu

s lae

viga

ta (P

oir.)

DC.

, Cr

atae

gus m

onog

yna J

acq.

em

end.

Lin

dm. a

nd o

ther

Who

le or

cut,

drie

d flo

wer-

bear

ing

bran

ches

of C

rata

egus

m

onog

yna J

acq.

(Lin

dm.),

C. l

aevi

gata

(Poi

r.) D

C. (s

yn.

C.ox

yaca

ntho

ides

Thui

ll.; C

. oxy

acan

tha a

uct.)

or t

heir

hybr

ids o

r, m

ore r

arely

, oth

er E

urop

ean

Crat

aegu

s spe

cies

inclu

ding

C.

pent

agyn

a Wal

dst.

et K

it. ex

Will

d., C

. nig

ra W

alds

t. et

Kit.

and

C.

azar

olus

L.

Ph.E

ur.

Ph.E

ur. 1

.2.1

3Cr

atae

gus

Croc

us sa

tivus

L.

Drie

d sti

gmas

of C

rocu

s sat

iva L

., usu

ally

join

ed b

y the

bas

e to

a sh

ort s

tyle.

(HAB

); Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

90%

acc.

to H

AB),

1.1.

10

(eth

anol

80%

); et

hano

lic

extra

ct 1

:20

(see

App

. 2.

6: K

aliu

m ac

etic

um

com

p.)

Anag

allis

/Mal

achi

t com

p.;

Cham

omill

a/M

alac

hit c

omp.

; Kal

ium

ac

etic

um co

mp.

Cucu

rbita

pep

o L.

Fres

h flo

wers

of C

ucur

bita

pep

o L.

Ph.E

ur. 1

.1.7

, 4.2

.1Ap

atit/

Conc

hae;

Apat

it/Ph

osph

orus

co

mp.

; Con

chae

/Fer

rum

ustu

m co

mp.

Cucu

rbita

max

ima D

uch.

Drie

d pu

lp o

f pum

pkin

s of C

ucur

bita

max

ima D

uch.

API

Vade

mec

um:

Cheli

doni

um/

Curc

uma c

omp.

Curc

uma z

anth

orrh

iza R

oxb.

(s

yn. C

. zan

thor

rhiz

a D.

Die

trich

).

Drie

d rh

izom

e, cu

t in

slice

s, of

Cuc

urm

a zan

thor

rhiz

a Rox

b. (s

yn.

C. za

ntho

rrhi

za D

. Die

trich

).Ph

.Eur

.Ph

.Eur

. 1.2

.12

(eth

anol

70

%),

also

API

Cheli

doni

um/C

urcu

ma

Cydo

nia o

blon

ga M

ill.

Fres

h rip

e fru

its o

f Cyd

onia

obl

onga

Mill

.AP

Cex

tract

acco

rdin

g to

m

onog

raph

s APC

, HAB

33

b

Citr

us/C

ydon

ia; C

ydon

ia, F

ruct

us;

Flor

es S

ambu

ci co

mp.

/Qua

rz

Cym

bopo

gon

wint

eria

nus J

owitt

Oil

obta

ined

by s

team

dist

illat

ion

from

the f

resh

or p

artia

lly d

ried

aeria

l par

ts of

Cym

bopo

gon

wint

eria

nus J

owitt

.Ph

.Eur

.H

AB 1

2hCi

trone

llae a

ethe

roleu

m; Th

ymus

se

rpyl

lum

com

p.

Cyna

ra sc

olym

us L

.Fr

esh

leave

s of C

ynar

a sco

lym

us L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

55%

)Ré

perto

ire d

e méd

. an

thr.

(201

6)

Cytis

us sc

opar

ius (

L.) L

ink.

Fres

h yo

ung

tips o

f sho

ots o

f Cyt

isus s

copa

rius (

L.) L

ink.

with

flo

wers

and

leave

sPh

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Ré

perto

ire d

e méd

. an

thr.

(201

0)

Cytis

us sc

opar

ius (

L.) L

ink.

Fres

h ae

rial p

arts

of C

ytisu

s sco

pariu

s (L.

) Lin

k at

flow

erin

g tim

eH

AB 3

3cSa

roth

amnu

s com

p.; S

cilla

com

p.

Dap

hne m

ezer

eum

L.

Fres

h ba

rk fr

om th

e bra

nche

s of D

aphn

e mez

ereu

m L

., col

lecte

d pr

ior t

o flo

werin

gH

ABPh

.Eur

. 1.1

.5M

ezer

eum

Dat

ura s

tram

oniu

m L

.Fr

esh

aeria

l par

ts of

Dat

ura s

tram

oniu

m L

., col

lecte

d at

flow

erin

g tim

eH

AB; P

h.fr.

Ph.E

ur. 1

.1.3

, 1.1

.10

(see

m

onog

raph

: eth

anol

45

%),

HAB

21

Myg

ale c

omp.

; Stra

mon

ium

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


101

Delp

hini

um st

aphi

sagr

ia L

.D

ried

ripe s

eeds

of D

elphi

nium

stap

hisa

gria

L.

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

90

%),

1.1.

10 (e

than

ol

65%

)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Dig

italis

pur

pure

a L.

Fres

h lea

ves f

rom

two-

year

-old

spec

imen

s of D

igita

lis p

urpu

rea

L., c

ollec

ted

befo

re fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.3

, 1.2

.4D

igita

lis p

urpu

rea

Dol

ichos

pru

riens

see M

ucun

a pru

riens

(L.)

DC.

Dro

sera

rotu

ndifo

lia L

., Dro

sera

in

term

edia

Hay

ne, D

rose

ra

angl

ica H

uds

Who

le dr

ied

plan

ts of

diff

eren

t Dro

sera

spec

ies,

mai

nly D

rose

ra

rotu

ndifo

lia L

., Dro

sera

angl

ica H

uds.

(D. l

ongi

folia

L.),

Dro

sera

m

adag

asca

riens

is D

C, D

rose

ra p

eltat

a Sm

, Dro

sera

ram

enta

cea

Burc

h. ex

har

v. et

Son

d., s

ingl

e spe

cies o

r mix

ed

Ph.fr

.Ph

.Eur

. 1.1

.3, 1

.1.1

0 (e

than

ol 4

5%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Dro

sera

rotu

ndifo

lia L

., Dro

sera

in

term

edia

Hay

ne, D

rose

ra

angl

ica H

uds.

Who

le fre

sh p

lant

s of D

rose

ra ro

tund

ifolia

L., D

rose

ra in

term

edia

H

ayne

and

Dro

sera

angl

ica H

uds.,

sing

le sp

ecie

s or m

ixed

, co

llect

ed at

the s

tart

of fl

ower

ing

HAB

Ph.E

ur. 1

.1.3

, HAB

33c

Dro

sera

/Ipec

acua

nha c

omp.

; Pla

ntag

o co

mp.

; Siru

pus Th

ymi c

omp.

Dry

opte

ris fi

lix-m

as (L

.) Sc

hott.

Fres

h rh

izom

e of D

ryop

teris

filix

-mas

(L.)

Scho

tt, w

ith ro

ots

HAB

33c

Aqui

linum

com

p.; C

helid

oniu

m co

mp.

; Co

ncha

e com

p.; R

hus/

Salix

com

p.

Dry

opte

ris fi

lix-m

as (L

.) Sc

hott.

Fres

h ae

rial p

arts

of D

ryop

teris

filix

-mas

(L.)

Scho

tt.AP

C 3.

8.1

(toge

ther

with

ot

her f

resh

her

bal d

rugs

1:

4.1

part

s eth

anol

25%

), 3.

8.2

Aspi

dium

/Sal

ix co

mp.

; Che

lidon

ium

co

mp.

Dry

opte

ris fi

lix-m

as (L

.) Sc

hott.

Ripe

spor

es o

f Dry

opte

ris fi

lix-m

as (L

.) Sc

hott.

Ph.E

ur. 1

.1.8

(eth

anol

70

%)

Agar

icus

com

p./P

hosp

horu

s

Dul

cam

ara

see S

olan

um d

ulca

mar

a L.

Echi

nace

a ang

ustif

olia

DC.

(R

udbe

ckia

angu

stifo

lia L

.)W

hole

fresh

flow

erin

g pl

ants

of E

chin

acea

angu

stifo

lia D

C.H

ABPh

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 5

5%),

HAB

21,

33

c

Arge

ntum

/Ech

inac

ea; A

rgen

tum

/Q

uerc

us co

mp.

; Arn

ica/

Echi

nace

a co

mp.

; Cha

mom

illa c

omp.

; Ech

inac

ea;

Echi

nace

a com

p.

Echi

nace

a ang

ustif

olia

DC.

, Ec

hina

cea p

allid

a (N

utt.)

Nut

t.W

hole

fresh

flow

erin

g pl

ants

of E

chin

acea

angu

stifo

lia D

C. an

d Ec

hina

cea p

allid

a (N

utt.)

Nut

t., si

ngle

spec

ies o

r mix

edH

ABPh

.Eur

. 1.1

.5, H

AB 3

3cAr

gent

um/E

chin

acea

; Cal

endu

la

Pres

ssaft

/Ech

inac

ea; E

uphr

asia

com

p.

Echi

nace

a pal

lida (

Nut

t.) N

utt.

Fres

h flo

werin

g pl

ants

of E

chin

acea

pal

lida (

Nut

t.) N

utt.

HAB

HAB

33c

Antim

onit/

Rosa

e aet

hero

leum

com

p.;

Arge

ntum

nitr

icum

com

p.; C

artil

ago/

Echi

nace

a com

p.; C

onju

nctiv

a com

p.;

Echi

nace

a; Ec

hina

cea/

Para

met

rium

co

mp.

; Ech

inac

ea/Q

uarz

com

p.;

Echi

nace

a/Ro

sae a

ethe

roleu

m;

Echi

nace

a/Vi

scum

; End

omet

rium

co

mp.

; Majo

rana

/Thuj

a com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


102

Echi

nace

a pal

lida (

Nut

t.) N

utt.

Fres

h ae

rial p

arts

of E

chin

acea

pal

lida (

Nut

t.) N

utt.,

colle

cted

at

flowe

ring

time

HAB

12c

Calen

dula

/Ech

inac

ea co

mp.

; Ca

lendu

la/T

ropa

eolu

m co

mp.

; Ec

hina

cea;

Echi

nace

a/Vi

scum

com

p.

Echi

nace

a pal

lida (

Nut

t.) N

utt.

Fres

h un

derg

roun

d pa

rts o

f Ech

inac

ea p

allid

a (N

utt.)

Nut

t.H

AB 3

3dAr

gent

um/E

chin

acea

; Ech

inac

ea/

Mer

curiu

s com

p.

Echi

nace

a pur

pure

a (L.

) Moe

nch

Who

le fre

sh fl

ower

ing

plan

ts of

Ech

inac

ea p

urpu

rea (

L.) M

oenc

hH

ABPh

.Eur

. 1.1

.6Ar

nica

/Ech

inac

ea co

mp.

; Cal

endu

la/

Echi

nace

a pur

pure

a; Ch

amom

illa

com

p.; E

chin

acea

; Ech

inac

ea/P

runu

s co

mp.

Echi

nace

a pur

pure

a (L.

) Moe

nch

Fres

h flo

wers

of E

chin

acea

pur

pure

a (L.

) Moe

nch

Ph.E

ur. 1

.1.5

Echi

nace

a

Elym

us re

pens

(L.)

Gou

ldFr

esh

unde

rgro

und

part

s of E

lym

us re

pens

(L.)

Gou

ldH

ABPh

.Eur

. 1.1

.5Ag

ropy

ron

com

p.

Equi

setu

m ar

vens

e L.

Fres

h, g

reen

, ste

rile s

hoot

s of E

quise

tum

arve

nse L

.H

ABH

AB 1

2c, 2

1 (s

ee

mon

ogra

ph),

35b

Arni

ca, P

lant

a tot

a/Eq

uise

tum

arve

nse;

Auru

m/E

quise

tum

; Can

thar

is co

mp.

; D

isci c

omp.

cum

Nic

otia

na; D

isci

com

p. cu

m P

ulsa

tilla

; Disc

i com

p. cu

m

Stan

no; D

isci/P

ulsa

tilla

com

p. cu

m

Stan

no; D

isci/V

iscum

com

p. cu

m

Stan

no; E

quise

tum

arve

nse;

Equi

setu

m

arve

nse S

ilice

a cul

tum

; Equ

isetu

m

arve

nse/

Form

ica;

Equi

setu

m/S

tann

um;

Man

drag

ora c

omp.

; Sol

um u

ligin

osum

co

mp.

Equi

setu

m ar

vens

e L.

Who

le or

cut,

drie

d ste

rile a

eria

l par

ts of

Equ

isetu

m ar

vens

e L.

HAB

; Ph

.Eur

.Ph

.Eur

. 1.2

.12,

HAB

12d

, 12

g, ex

tract

ion

with

gl

ycer

ol, A

PC 4

.2, 4

.3

Aesc

ulus

/Cer

a com

p.; C

arbo

Equ

iseti

arve

nsis;

Car

bone

s/Pa

nkre

as/W

ither

it;

Equi

setu

m ar

vens

e; Eq

uise

tum

arve

nse/

Form

ica;

Equi

setu

m ar

vens

e/Ta

bacu

m;

Equi

setu

m co

mp.

; Equ

isetu

m cu

m

Sulfu

re to

stum

; Equ

isetu

m/P

ancr

eas;

Equi

setu

m/R

enes

com

p.; E

quise

tum

/St

annu

m; E

quise

tum

/Visc

um; L

ens

crist

allin

a/Vi

scum

com

p. cu

m St

anno

; Li

en co

mp.

; Man

drag

ora c

omp.

; Sol

um

ulig

inos

um co

mp.

Equi

setu

m fl

uvia

tile

see E

quise

tum

lim

osum

Equi

setu

m li

mos

um L

.Fr

esh

aeria

l par

ts of

Equ

isetu

m li

mos

um L

.St

artin

g m

ater

ial f

or th

e pr

epar

atio

n of

Eq

uise

tum

lim

osum

-Ru

belli

t (ap

p. 2

.6)

Sold

ner/

Stell

man

n (2

011)

Indi

vidu

elle

Pädi

atrie

Eryt

hrae

a cen

taur

ium

see C

enta

uriu

m er

ythr

aea R

afn.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


103

Esch

scho

lzia c

alifo

rnic

a Cha

m.

Who

le fre

sh fl

ower

ing

plan

ts of

Esc

hsch

olzi

a cal

iforn

ica C

ham

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

45%

)

Euca

lypt

us g

lobu

lus L

abill

.Es

sent

ial o

il ob

tain

ed b

y ste

am d

istill

atio

n an

d re

ctifi

catio

n fro

m

the f

resh

leav

es o

r the

fres

h te

rmin

al b

ranc

hlet

s of v

ario

us sp

ecie

s of

Euc

alyp

tus r

ich in

1,8

-cin

eole.

The s

pecie

s mai

nly u

sed

are

Euca

lypt

us g

lobu

lus L

abill

., Euc

alyp

tus p

olyb

ract

ea R

.T.B

aker

and

Euca

lypt

us sm

ithii

R.T.

Bake

r.

Ph.E

ur.

API

Arge

ntum

/Que

rcus

com

p.; B

erbe

ris/

Euca

lypt

us/ S

ilice

a com

p.; B

erbe

ris/

Juni

peru

s com

p.; C

erat

um R

atan

hiae

co

mp.

; Ech

inac

ea/P

runu

s com

p.;

Euca

lypt

i aet

hero

leum

; Euc

alyp

ti ae

ther

oleu

m co

mp.

; Euc

alyp

tus c

omp.

; M

ajora

na/Th

uja c

omp.

; Mer

curiu

s vi

vus/

Euc

aply

ti ae

ther

oleu

m; O

leum

ca

mph

orat

um co

mp.

; Oleu

m rh

inal

e; Pl

anta

go co

mp.

; Rat

anhi

a com

p.;

Salv

iae a

ethe

roleu

m co

mp.

Euca

lypt

us g

lobu

lus L

abill

.Fr

esh

leave

s of E

ucal

yptu

s glo

bulu

s Lab

ill.

HAB

33d

Acon

itum

/Chi

na co

mp.

; Arg

entu

m

nitri

cum

com

p.; C

alen

dula

/Ech

inac

ea

com

p.; C

upru

m su

lfuric

um/E

ucal

yptu

s

Euca

lypt

us g

lobu

lus L

abill

.W

hole

or cu

t, dr

ied

leave

s of o

lder

bra

nche

s of E

ucal

yptu

s gl

obul

us L

abill

.(H

AB);

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

90

%)

Bolu

s Euc

alyp

ti co

mp.

; Bry

onia

/Eu

pato

rium

com

p.; F

erru

m

phos

phor

icum

com

p.

Euge

nia c

aryo

phyl

lata

see S

yzyg

ium

arom

atic

um (L

.) M

err.

et L

. M. P

erry

Eupa

toriu

m ca

nnab

inum

L.

Fres

h flo

werin

g ae

rial p

arts

of E

upat

oriu

m ca

nnab

inum

L.

HAB

33c

Acon

itum

/Chi

na co

mp.

; Bro

nchi

/Pl

anta

go co

mp.

Eupa

toriu

m p

erfo

liatu

m L

.Fr

esh

aeria

l par

ts of

Eup

ator

ium

per

folia

tum

L., c

ollec

ted

at st

art

of fl

ower

ing

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 6

5%)

Bryo

nia/

Eupa

toriu

m co

mp.

; Fer

rum

ph

osph

oric

um co

mp.

Euph

rasia

stric

ta D

. Wol

ff ex

F.J.

Lehm

. and

/or E

uphr

asia

ro

stkov

iana

Hay

ne

Who

le, fr

esh,

flow

erin

g pl

ants

of E

uphr

asia

stric

ta D

. Wol

ff ex

F.J.

Lehm

. and

/or E

uphr

asia

rostk

ovia

na H

ayne

and/

or th

eir h

ybrid

s an

d/or

thei

r mix

ture

s

Ph.fr

.Ph

.Eur

. 1.1

.10

(Eth

anol

55

%)

Répe

rtoire

de m

éd.

anth

r. (2

016)

Euph

rasia

stric

ta W

olff

ex F.

J. Le

hm. a

nd E

uphr

asia

offi

cinal

is L.

su

bsp.

rostk

ovia

na (H

ayne

) To

wns

Who

le fre

sh p

lant

s of E

uphr

asia

stric

ta W

olff

ex F.

J. Le

hm. a

nd

Euph

rasia

offi

cinal

is L.

subs

p. ro

stkov

iana

(Hay

ne) T

owns

, the

ir hy

brid

s and

mix

ture

s the

reof

, col

lecte

d at

flow

erin

g tim

e

HAB

Ph.E

ur. 1

.1.5

, 1.1

.7 (H

AB

3c),

33c

Euph

rasia

; Eup

hras

ia co

mp.

; Eup

hras

ia/

Rosa

e aet

hero

leum

Fagu

s syl

vatic

a L.

Bran

ch an

d tr

unk

wood

of F

agus

silv

atic

a L.

Ph.H

elv. 1

7.7.

4.3

(APC

4.

3); r

aw m

ater

ial f

or th

e pr

epar

atio

n of

Kal

ium

ca

rbon

icum

e Fa

gi (a

pp.

2.4)

Agro

pyro

n co

mp.

; Ana

galli

s com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


104

Fagu

s syl

vatic

aW

ood

of F

agus

sylv

atic

aRa

w m

ater

ial f

or th

e pr

epar

atio

n of

Kal

ium

ca

rbon

icum

e ci

nere

Fag

i (a

pp. 2

.4)

Feru

la as

sa-fo

etid

a L.

Drie

d gu

m re

sin fr

om F

erul

a spe

cies

such

as F

erul

a ass

a-fo

etid

a L.

and

Feru

la fo

etid

a (Bu

nge)

Reg

el. (A

sa fo

etid

a)H

ABPh

.Eur

. 1.1

.8 (e

than

ol

90%

)

Filip

endu

la u

lmar

ia (L

.) M

axim

.Fr

esh

aeria

l par

ts of

Fili

pend

ula u

lmar

ia (L

.) M

axim

. col

lecte

d at

flo

wein

g tim

e.H

ABPh

.Eur

. 1.1

.5, H

AB 3

4cBe

tula

/Man

drag

ora c

omp.

Filix

-mas

see D

ryop

teris

filix

-mas

(L.)

Scho

tt.

Foen

icul

um vu

lgar

e Mill

.Es

sent

ial o

il ob

tain

ed b

y ste

am d

istill

atio

n fro

m th

e rip

e fru

its o

f Fo

enic

ulum

vulg

are M

iller

ssp.

vulg

are v

ar. v

ulga

re.

Ph.E

ur.

API

Berb

eris/

Juni

peru

s com

p.; M

eliss

a co

mp.

; Sal

viae

aeth

erol

eum

com

p.;

Trop

aeol

um co

mp.

Foen

icul

um vu

lgar

eD

ried

crem

ocar

ps an

d m

eric

arps

of F

oeni

culu

m vu

lgar

e Mill

. sp.

vu

lgar

e var

. vul

gare

HAB

; Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

90%

), 1.

2.12

(eth

anol

70

%),

API

Spec

ies C

arvi

com

p.

Frag

aria

vesc

a L.

Fres

h, ri

pe fa

lse-fr

uits

of F

raga

ria ve

sca L

HAB

21,

extra

ct w

ith

etha

nol (

66%

m/m

) and

su

cros

e 3:2

(DER

1:0

,9)

Aqua

Mar

is co

mp.

; Fra

garia

/Urt

ica;

Frag

aria

/Urt

ica c

omp.

; Fra

garia

/Urt

ica/

Gen

tiana

; Lev

istic

um co

mp.

Frag

aria

vesc

a L.

Drie

d, w

hole

or cu

t lea

ves,

colle

cted

at fl

ower

ing

time o

f Fra

garia

ve

sca L

., Fra

garia

mos

chat

a Wes

t., F

raga

ria vi

ridis

Wes

t., F

raga

ria

x an

anas

sa (D

uch.

) Gue

des (

Rosa

ceae

), th

eir h

ybrid

s as w

ell as

hy

brid

s with

oth

er F

raga

ria sp

ecie

s or m

ixtu

res o

f the

m

DAC

API

Conc

hae/

Ferr

um u

stum

com

p.;

Frag

aria

/Urt

ica c

omp.

; Fra

garia

/Viti

s; Vi

tis co

mp.

Fran

gula

alnu

sse

e Rha

mnu

s fra

ngul

a L.

Fucu

s ves

icul

osus

L.

Fres

h th

allu

s of F

ucus

vesic

ulos

us L

.H

AB 5

1Tr

opae

olum

com

p.

Fum

aria

offi

cina

lis L

.Fr

esh

aeria

l par

ts of

Fum

aria

offi

cina

lis L

., col

lecte

d at

flow

erin

g tim

eH

ABH

AB 1

.1.3

, 33c

Trop

aeol

um co

mp.

Vade

mec

um

(com

bina

tion

see

Hip

poca

mpu

s)

Gal

anth

us n

ival

is L.

Fres

h wh

ole fl

ower

ing

plan

t of G

alan

thus

niv

alis

L.Ph

.Eur

. 1.1

.6Va

dem

ecum

(see

H

ippo

cam

pus)

Que

rcus

infe

ctor

ia O

livie

rO

ak ap

ples

pro

duce

d on

youn

g sh

oots

of Q

uerc

us in

fect

oria

O

livie

r by t

he st

ing

of th

e dye

rs g

all w

asp

Andr

icus

gal

lae

tinct

oria

e Oliv

ier

HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%)

Gels

emiu

m se

mpe

rvire

ns (L

.) Ja

ume S

t.-H

il.Fr

esh

unde

rgro

und

part

s of G

elsem

ium

sem

perv

irens

(L.)

Jaum

e St

.-Hil.

HAB

Ph.E

ur. 1

.1.5

, 1.2

.9, H

AB

35b

Apis

com

p.; B

ryon

ia/G

elsem

ium

com

p.;

Gels

emiu

m; O

xalis

com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


105

Gels

emiu

m se

mpe

rvire

ns (L

.) Ja

ume S

t.-H

il.D

ried

unde

rgro

und

part

s of G

elsem

ium

sem

perv

irens

(L.)

Jaum

e St

.-Hil.

Ph.E

ur. 2

.1.1

2 (e

than

ol

70%

), H

AB 3

5bD

isci/R

hus t

oxico

dend

ron

com

p.;

Gels

emiu

m; G

elsem

ium

com

p.; R

hus

toxi

code

ndro

n co

mp.

Gen

ista s

copa

riase

e Cyt

isus s

copa

rius (

L.) L

ink.

Gen

tiana

lute

a L.

Fres

h un

derg

roun

d pa

rts o

f Gen

tiana

lute

a L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 5

5%),

1.2.

10,

HAB

21,

33c

Achi

llea c

omp.

; Bol

us al

ba co

mp.

; Ci

chor

ium

/Tar

axac

um co

mp.

; Gen

tiana

lu

tea;

Nux

vom

ica c

omp.

Gen

tiana

lute

a L.

Drie

d, fr

agm

ente

d un

derg

roun

d or

gans

of G

entia

na lu

tea L

.Ph

.Eur

.Ph

.Eur

. 1.4

.3, a

queo

us

extra

ct (W

ALA)

, APC

4.

2

Aqua

Mar

is co

mp.

; Fra

garia

/Urt

ica/

Gen

tiana

; Gen

tiana

com

p.; G

entia

na/

Zing

iber

com

p.

Ger

ania

ceae

see P

elarg

oniu

m sp

ecie

s

Geu

m u

rban

um L

.Fr

esh

unde

rgro

und

part

s of G

eum

urb

anum

L.

HAB

Ph.E

ur. 1

.2.1

1, H

AB 2

1,

33c

Arte

misi

a com

p.; B

olus

alba

com

p.;

Geu

m u

rban

um

Gin

kgo

bilo

ba L

.Fr

esh

leave

s of G

inkg

o bi

loba

L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (E

than

ol 6

5%)

Gin

seng

see P

anax

gin

seng

C.A

. Mey

.

Glec

hom

a hed

erac

ea L

.D

ried

flowe

ring

plan

t of G

lecho

ma h

eder

acea

L.

Ph.H

elv. 1

7.7.

4.3

(APC

4.

3)Ci

nis G

lecho

mat

is

Gna

phal

ium

see L

eont

opod

ium

alpi

num

Cas

s.

Gos

sypi

um L

., G. h

irsut

um L

.D

ried

seed

s, de

void

of fi

bres

, of G

ossy

pium

her

bace

um L

. or G

. hi

rsut

um L

.M

acer

atio

n 1:

3 wi

th

etha

nol 7

3% m

/m (8

0%

V/V

)

ABM

A-Va

dem

ecum

Ham

ameli

s virg

inia

na L

.Fr

esh

bark

and

leave

s of H

amam

elis v

irgin

iana

L.

HAB

12c

(bar

k:lea

ves

1:9)

Ham

ameli

s

Ham

ameli

s virg

inia

na L

.Fr

esh

bark

from

root

s and

bra

nche

s of H

amam

elis v

irgin

iana

L.

HAB

Ph.E

ur. 1

.1.5

, HAB

33e

Ham

ameli

s

Ham

ameli

s virg

inia

na L

.Fr

esh

leave

s of H

amam

elis v

irgin

iana

L.

HAB

Ph.E

ur. 1

.1.7

, HAB

33d

Aesc

ulus

/Que

rcus

com

p.; B

orag

o co

mp.

; Ham

ameli

s; Q

uerc

us co

mp.

Ham

ameli

s virg

inia

na L

.Fr

esh

flowe

ring

bran

ches

of H

amam

elis v

irgin

iana

L., c

ollec

ted

in

late a

utum

nH

AB 3

4H

AB 5

2H

amam

elis c

omp.

; Ham

ameli

s de

stilla

ta

Ham

ameli

s virg

inia

na L

.D

ried

bark

from

the s

tem

s and

bra

nche

s of

Ham

ameli

s virg

inia

na L

.H

ABPh

.Eur

. 1.2

.12

(eth

anol

36

%)

Achi

llea c

omp.

; Ham

ameli

s; H

ydra

stis

com

p.; S

ymph

ytum

com

p.

Ham

ameli

s virg

inia

na L

.W

hole

or cu

t, dr

ied

leaf o

f Ham

ameli

s virg

inia

na L

.Ph

.Eur

.Ex

tract

with

etha

nol 3

6%

(DER

1:1

)Ae

scul

us, C

orte

x/ B

orag

o/H

amam

elis,

Foliu

m; C

alen

dula

com

p.; S

tibiu

m

com

p.

Ham

ameli

s virg

inia

na L

.Fr

esh

bark

from

bra

nche

s of H

amam

elis v

irgin

iana

L.

HAB

33e

Hiru

do co

mp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


106

Ham

ameli

s virg

inia

na L

.D

ried

leave

s and

drie

d ba

rk fr

om th

e ste

ms a

nd b

ranc

hes o

f H

amam

elis v

irgin

iana

L.

Dist

illat

e with

etha

nol

12%

(1 p

art e

than

ol 9

6%,

8.7

part

s wat

er)(D

ER

1:15

)

Lotio

Pru

ni co

mp.

Har

pago

phyt

um p

rocu

mbe

ns

(Bur

ch.)

DC

Cut a

nd d

ried,

tube

rous

seco

ndar

y roo

ts of

Har

pago

phyt

um

proc

umbe

ns D

C. an

d/or

Har

pago

phyt

um ze

yher

i Dec

ne.

Ph.E

ur.;

Ph.fr

.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

), 1.

1.10

(eth

anol

45

%),

HAB

35b

Har

pago

phyt

um, R

adix

Répe

rtoire

de m

éd.

anth

r. (2

010)

Heli

anth

us tu

bero

sus L

.Fr

esh

tube

rs o

f Heli

anth

us tu

bero

sus L

., col

lecte

d in

late

autu

mn

HAB

Ph.E

ur. 1

.1.3

Hell

ebor

us fo

etid

us L

.W

hole

fresh

pla

nt co

llect

ed in

sum

mer

and

fresh

flow

erin

g sh

oots

colle

cted

in w

inte

r of H

elleb

orus

foet

idus

L.

Ph.E

ur. 1

.3.1

, see

also

ap

p. 2

.6 (

Hell

ebor

us

foet

idus

)

Der

Mer

kurs

tab

6/20

10 p

. 565

Hell

ebor

us n

iger

L.

Fres

h wh

ole fl

ower

ing

plan

ts of

Hell

ebor

us n

iger

L.

Ph.E

ur. 1

.1.5

, HAB

21,

34

c; fe

rmen

tate

d,

aque

ous e

xtra

ct

Alum

en/H

elleb

orus

com

p.; H

elleb

orus

ni

ger

Hell

ebor

us n

iger

L.

Fres

h wh

ole p

lant

s of H

elleb

orus

nig

er L

.Ph

.Eur

. 1.1

.10

(eth

anol

45

%)

Hell

ebor

us n

iger

Hell

ebor

us n

iger

L.

Who

le fre

sh p

lant

colle

cted

in su

mm

er an

d fre

sh fl

ower

ing

shoo

ts co

llect

ed in

win

ter o

f Hell

ebor

us n

iger

L.

Ph.E

ur. 1

.3.1

; see

also

ap

p. 2

.6 (H

elleb

orus

ni

ger)

Der

Mer

kurs

tab

6/20

10 p

. 500

-566

Helo

nias

dio

ica

see C

ham

aelir

ium

lute

um (L

.) A.

Gra

y

Hip

poph

aë rh

amno

ides

L.

Fres

h fr

uits

of H

ippo

phaë

rham

noid

es L

.pr

essin

g to

obt

ain

the

juic

e (=A

PI)

Hip

poph

aë rh

amno

ides

L.

Fatty

oil

obta

ined

from

the s

eeds

and/

or fr

uit o

f Hip

poph

aë

rham

noid

es L

.AP

I

Hor

deum

vulg

are L

.Ex

tract

obt

aine

d fro

m d

ried

germ

inat

ed fr

uits

of H

orde

um

vulg

are L

. (m

alt)

conv

entio

nal m

etho

d fo

r m

akin

g m

alt

Aven

a/Co

ncha

e com

p.;

Bron

chia

lpas

tillen

; Siru

pus Th

ymi

com

p.

Hum

ulus

lupu

lus L

.Fr

esh

bine

s with

leav

es an

d ho

p co

nes o

f Hum

ulus

lupu

lus L

.H

ABH

AB 3

4d; e

xtra

ct w

ith

wate

r and

sucr

ose (

2:4:

4)Av

ena/

Pass

iflor

a com

p.; H

yper

icum

/Pa

ssifl

ora c

omp.

Hum

ulus

lupu

lus L

Fres

h, ri

pe fe

mal

e infl

ores

cenc

es o

f Hum

ulus

lupu

lus L

., col

lecte

d be

fore

the s

eeds

hav

e rip

ened

and

cont

aini

ng as

few

seed

s as

poss

ible

HAB

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

55%

)Av

ena s

ativ

a com

p.

Hyd

rasti

s can

aden

sis L

.W

hole

or cu

t, dr

ied

rhiz

ome a

nd ro

ot o

f Hyd

rasti

s can

aden

sis L

.Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

), 1.

1.10

(eth

anol

65

% fo

r 3-5

wee

ks)

Calen

dula

com

p.; E

chin

acea

com

p.;

Hyd

rasti

s can

aden

sis; H

ydra

stis c

omp.

; Li

lium

tigr

inum

com

p.

Hyd

roco

tyle

asia

tica

see C

ente

lla as

iatic

a (L.

) Urb

.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


107

Hyo

scya

mus

nig

er L

.Fr

esh

flowe

ring

aeria

l par

ts of

Hyo

scya

mus

nig

er L

.Ph

.Eur

. 1.1

.3, H

AB 2

1,

33d

Arch

ange

lica/

Pyrit

com

p.; A

urum

/O

nopo

rdon

com

p.; C

imici

fuga

com

p.;

Conv

alla

ria/P

rimul

a com

p.; C

rata

egus

co

mp.

; Hyo

scya

mus

; Ono

pord

on

com

p.; O

nopo

rdon

com

p./A

doni

s; O

nopo

rdon

com

p./M

agne

sium

ph

osph

oric

um ac

idum

; Ono

pord

on

com

p./O

leand

er; O

nopo

rdon

com

p./

Olea

nder

/ Arn

ica;

Ono

pord

on co

mp.

/O

leand

er/ C

onva

llaria

; Ono

pord

on

com

p./P

lum

bum

; Ono

pord

um/P

rimul

a co

mp.

; Pla

ntag

o-Pr

imul

a cum

H

yosc

yam

o; P

rimul

a com

p.

Hyo

scya

mus

nig

er L

.W

hole,

fres

h flo

werin

g pl

ants

of H

yosc

yam

us n

iger

L.

Ph.E

ur.

acc.

to m

onog

raph

Ph

.Eur

. or H

AB: P

h.Eu

r. 1.

1.3

Arge

ntum

/Hyo

scya

mus

; Aur

um/

Bella

donn

a com

p.; A

urum

/H

yosc

yam

us co

mp.

; Hyo

scya

mus

; H

yosc

yam

us/V

aler

iana

Hyp

eric

um p

erfo

ratu

m L

.Fr

esh

flowe

rs o

f Hyp

eric

um p

erfo

ratu

m L

.se

e App

. 2.7

: Hyp

eric

um

perfo

ratu

m; F

los;

Extr.

ol

eos 1

:2

Hyp

eric

um; M

illef

oliu

m /

Hyp

eric

um

Hyp

eric

um p

erfo

ratu

m L

.Fr

esh

aeria

l par

ts of

Hyp

eric

um p

erfo

ratu

m L

., col

lecte

d at

flo

werin

g tim

eH

ABPh

.Eur

. 1.1

.5, H

AB 2

1Ap

is re

gina

/Aur

um co

mp.

; Ber

beris

/H

yper

icum

com

p.; C

amph

ora/

Hyp

eric

um; H

yper

icum

; Hyp

eric

um

com

p.; H

yper

icum

/Pas

siflor

a com

p.;

Levi

co co

mp.

; Mal

va co

mp.

; Prim

ula

com

p.

Hyp

ogym

nia p

hyso

des (

L.) N

yl.

Drie

d th

allu

s of H

ypog

ymni

a phy

sode

s (L.

) Nyl

. (Pa

rmeli

a ph

ysod

es (L

.) Ac

h.)

Ph.E

ur. 1

.2.1

2 (e

than

ol

36%

)

Igna

tiase

e Str

ychn

os ig

natii

Ber

gius

Illici

um ve

rum

Hoo

k.f.

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

from

the d

ry ri

pe fr

uits

of Il

liciu

m ve

rum

Hoo

k.f.

Ph.E

ur.

API

Lich

enes

com

p.

Impe

rato

ria o

strut

hium

see P

euce

danu

m o

strut

hium

(L.)

W. D

. J. K

och

Ipec

acua

nha

see P

sych

otria

ipec

acua

nha (

Brot

.) St

okes

Ipec

acua

nha

see C

epha

elis i

peca

cuan

ha (B

rot.)

A. R

ich., C

epha

elis a

cum

inat

a Ka

rste

n

Iris

germ

anic

a L.

Fres

h rh

izom

e of I

ris ge

rman

ica L

.Ph

.Eur

. 1.2

.11,

HAB

21

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


108

Iris

germ

anic

a L., I

ris ge

rman

ica

var.

flore

ntin

a L. a

nd Ir

is pa

llida

La

mar

ck

Drie

d pe

eled

rhiz

ome o

f Iris

germ

anic

a L., I

ris ge

rman

ica v

ar.

flore

ntin

a L. a

nd Ir

is pa

llida

Lam

arck

HAB

12q

(eth

anol

25%

)Lo

tio P

runi

com

p.

Iris

vers

icol

or L

.Fr

esh

unde

rgro

und

part

s (rh

izom

e inc

ludi

ng ro

ots)

of I

ris

vers

icol

or L

. col

lecte

d at

flow

erin

g tim

ePh

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)

Iris

vers

icol

or L

.Fr

esh

unde

rgro

und

part

s of I

ris ve

rsic

olor

L.

HAB

Ph.E

ur. 1

.1.5

Jugl

ans r

egia

L.

Drie

d ou

ter m

embr

ane f

rom

the s

eed

of Ju

glan

s reg

ia L

.Ph

.Eur

. 4.1

.1Ca

rpell

um M

ali c

omp.

Jugl

ans r

egia

L.

Fres

h lea

ves a

nd u

nrip

e fru

it of

Jugl

ans r

egia

L.

HAB

33c

Jugl

ans r

egia

com

p.

Jugl

ans r

egia

L.

Drie

d lea

ves o

f Jug

lans

regi

a L.

DAC

Ph.E

ur. 1

.2.1

3 (e

than

ol

36%

)

Juni

peru

s com

mun

is L.

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

from

the r

ipe,

non-

ferm

ente

d be

rry c

ones

of J

unip

erus

com

mun

is L.

Ph.E

ur.

API

Berb

eris/

Juni

peru

s com

p.; E

ucal

ypti

aeth

erol

eum

com

p.; J

unip

erus

de

stilla

ta; S

alvi

ae ae

ther

oleu

m co

mp.

Juni

peru

s com

mun

is L.

Fres

h rip

e con

e ber

ry o

f Jun

iper

us co

mm

unis

L.H

ABPh

.Eur

. 1.1

.5, H

AB 3

5aTr

opae

olum

com

p.

Juni

peru

s com

mun

is L.

Drie

d tip

s of s

hoot

s of J

unip

erus

com

mun

is L.

Ph.E

ur. 1

.2.1

3 (e

than

ol

36%

)Ci

chor

ium

/Tar

axac

um co

mp.

Juni

peru

s com

mun

is L.

Drie

d rip

e con

e ber

ry o

f Jun

iper

us co

mm

unis

L.Ph

.Eur

.Ph

.Eur

. 1.1

.8; E

xtra

ctio

n wi

th w

ater

and

sucr

ose

Betu

la/Ju

nipe

rus;

Olib

anum

com

p./

Succ

inum

Juni

peru

s sab

ina L

.Fr

esh,

still

unl

igni

fied,

gro

wing

tips

of t

wigs

of J

unip

erus

sabi

na

L., w

ith ad

here

nt le

aves

HAB

Ph.E

ur. 1

.1.5

Colch

icum

/Sab

ina;

Prim

ula A

uro

culta

co

mp.

; Sab

ina

Kala

ncho

e dai

grem

ontia

nase

e Bry

ophy

llum

dai

grem

ontia

num

(Ray

m.-H

amet

et H

. Per

rier)

A.

Ber

ger

Kala

ncho

e pin

nata

see B

ryop

hyllu

m p

inna

tum

(Lam

.) O

ken

Kalm

ia la

tifol

ia L

.Fr

esh

leave

s of K

alm

ia la

tifol

ia L

.H

AB; P

h.fr.

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

65%

)Cr

atae

gus/

Kalm

ia

Kram

eria

tria

ndra

Rui

z et P

av.

Drie

d, u

sual

ly fr

agm

ente

d, u

nder

grou

nd o

rgan

s of K

ram

eria

tr

iand

ra R

uiz e

t Pav

., kno

wn as

Per

uvia

n rh

atan

y.(H

AB);

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

70

%);

extra

ct w

ith

etha

nol 5

0% (D

ER 1

:1)

Cera

tum

Rat

anhi

ae co

mp.

; Rat

anhi

a co

mp.

; Sal

via c

omp.

Lam

ium

albu

m L

.Fr

esh

leave

s, flo

wers

and

youn

g tip

s sho

ots o

f Lam

ium

albu

m L

., co

llect

ed at

flow

erin

g tim

e H

ABPh

.Eur

. 1.1

.3Ar

gent

um/Q

uerc

us co

mp.

Lam

ium

albu

m L

.D

ried

flowe

rs o

f Lam

ium

albu

m L

.H

ABPh

.Eur

. 1.2

.13

(eth

anol

36

%)

Lapp

a majo

rse

e Arc

tium

lapp

a L.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


109

Larix

dec

idua

Mill

.Ba

lsam

obt

aine

d fro

m h

oles

dril

led in

the t

runk

s of

Larix

dec

idua

Mill

.H

ABPh

.Eur

. 1.1

.8 (e

than

ol

96%

), 3.

2.1,

4.1

.1,

(Ph.

Eur.

1.1.

8, et

hano

l 50

%),

API

Absin

thiu

m/R

esin

a Lar

icis;

Anan

assa

co

mp.

; Api

s/Be

rber

is co

mp.

; Arn

ica/

Sym

phyt

um co

mp.

; Bell

adon

na/L

ens

crist

allin

a Col

umba

e/ R

esin

a Lar

icis;

Berb

eris/

Juni

peru

s com

p.; B

erbe

ris/

Saba

l com

p.; C

alen

dula

/Mer

curia

lis

com

p.; C

erat

um R

atan

hiae

com

p.;

Cheli

doni

um/T

ereb

inth

ina l

arici

na

com

p.; C

hrys

olith

com

p.; E

chin

acea

/Vi

scum

com

p.; F

lore

s Sam

buci

com

p./

Qua

rz; G

alen

it/Re

tina c

omp.

; M

ercu

rialis

com

p.; P

lant

ago

com

p.;

Qua

rz/R

esin

a Lar

icis;

Resin

a Lar

icis;

Resin

a Lar

icis c

omp.

; Res

ina L

arici

s/O

leum

Ter

ebin

thin

ae; R

esin

a Lar

icis/

Retin

a; Re

sina L

arici

s/So

lutio

Myr

rhae

ba

lsam

ica;

Retin

a com

p.; S

al M

aris

com

p.; S

ambu

cus c

omp.

; Uva

urs

i co

mp.

Lava

ndul

a ang

ustif

olia

Mill

. (L

avan

dula

offi

cinal

is Ch

aix)

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

from

the fl

ower

ing

tops

of

Lav

andu

la an

gusti

folia

Mill

. (La

vand

ula o

fficin

alis

Chai

x)Ph

.Eur

.H

AB 1

2h, A

PIAc

onitu

m/C

amph

ora c

omp.

; Api

s/Ar

nica

com

p.; A

rcha

ngeli

ca co

mp.

; Ar

nica

com

p./C

upru

m; A

rnic

a com

p./

Form

ica;

Auru

m/L

avan

dula

e ae

ther

oleu

m/R

osa;

Cera

tum

be

nzoi

natu

m; C

erat

um R

atan

hiae

co

mp.

; Lav

ende

löl;

Oleu

m la

ctag

ogum

; Pr

unus

/Ros

mar

inus

com

p.; R

atan

hia

com

p.; R

esin

a Lar

icis c

omp.

; Res

ina

Laric

is/So

lutio

Myr

rhae

bal

sam

ica;

Solu

m u

ligin

osum

com

p.; S

olut

io

Myr

rhae

bal

sam

ica;

Thym

us se

rpyl

lum

co

mp.

Lava

ndul

a ang

ustif

olia

Mill

. (L.

offi

cinal

is Ch

aix)

Drie

d flo

wer o

f Lav

andu

la an

gusti

folia

Mill

. (L.

offi

cinal

is Ch

aix)

.Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

)Ae

scul

us/L

avan

dula

sicc

ata;

Lava

ndul

a sic

cata

Ledu

m p

alustr

e L.

Drie

d tip

s of t

wigs

of L

edum

palu

stre L

.H

ABPh

.Eur

. 1.1

.8 (e

than

ol

70%

)Pr

imul

a Aur

o cu

lta co

mp.

Ledu

m p

alustr

e L.

Fres

h, le

afy t

wig

of L

edum

palu

stre L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)

Leon

topo

dium

niv

ale s

ubsp

. alp

inum

(Cas

s) G

reut

er)

Who

le fre

sh p

lant

s of L

eont

opod

ium

alpi

num

Cas

s.Ph

.Eur

. 1.1

.7, 1

.1.1

0 (E

than

ol 6

5%),

App.

2.7

Apis

com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


110

Leon

topo

dium

alpi

num

Cas

s. ( L

. ni

vale

subs

p. al

pinu

m (C

ass)

G

reut

er)

Who

le dr

ied

flowe

ring

plan

ts of

Leo

ntop

odiu

m al

pinu

m C

ass.

HAB

36

Disc

i/Rhu

s tox

icod

endr

on co

mp.

; G

naph

aliu

m co

mp.

; Rhu

s to

xico

dend

ron

com

p.

Leon

urus

card

iaca

L.

Fres

h ae

rial p

arts

of L

eonu

rus c

ardi

aca L

., col

lecte

d at

flow

erin

g tim

eH

ABPh

.Eur

. 1.1

.5, 1

.1.6

, 1.

1.10

(eth

anol

65%

),Ci

mic

ifuga

com

p.

Levi

sticu

m o

ffici

nale

W.D

.J. K

och

Who

le or

cut,

drie

d rh

izom

e and

root

of L

evist

icum

offi

cina

le Ko

ch.

HAB

; Ph

.Eur

.Ph

.Eur

. 1.2

.12

(eth

anol

70

%),

HAB

12d

, 12g

; see

al

so A

pp. 2

.7.: M

ucila

go

Levi

stici

D1

Apis

cum

Lev

istic

o; L

evist

icum

; Le

visti

cum

com

p.; M

eliss

a/Ph

osph

orus

co

mp.

Levi

sticu

m o

ffici

nale

W. D

. J.

Koch

Fres

h un

derg

roun

d pa

rts o

f Lev

istic

um o

ffici

nale

W. D

. J. K

och

HAB

HAB

21,

33c

Apis/

Lary

nx co

mp.

; Api

s/Le

visti

cum

; Ar

nica

/Lev

istic

um co

mp.

; Ave

na/

Conc

hae c

omp.

; Cer

ebell

um co

mp.

; Co

rnea

/Lev

istic

um co

mp.

; Lar

ynx

com

p.; L

evist

icum

Liliu

m la

ncifo

lium

Thun

b.Fr

esh

plan

ts of

Lili

um la

ncifo

lium

Thun

b., w

ithou

t bul

bs,

colle

cted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.3

Arge

ntum

/Que

rcus

com

p.

Liliu

m la

ncifo

lium

Thun

b.Fr

esh

aeria

l par

ts of

Lili

um la

ncifo

lium

Thun

b., c

ollec

ted

at

flowe

ring

time a

nd in

cludi

ng b

ulbi

lsH

AB 3

3cLi

lium

tigr

inum

com

p.; M

ajora

na/

Thuj

a com

p.

Liliu

m ti

grin

umse

e Lili

um la

ncifo

lium

Thun

b.

Linu

m u

sitat

issim

um L

.Fa

tty o

il ob

tain

ed b

y col

d ex

pres

sion

from

ripe

seed

s of L

inum

us

itatis

simum

L.

Ph.E

ur.

API

Berb

eris/

Cheli

doni

um co

mp.

Litse

a cub

eba P

ers.

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

from

the f

ruit

of L

itsea

cu

beba

Per

s.Ex

cipie

nt

Loba

ria p

ulm

onar

ia (L

.) H

offm

./ St

icta

pul

mon

aria

Ach

.D

ried

thal

lus o

f Lob

aria

pul

mon

aria

(L.)

Hoff

m.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.8 (e

than

ol

90%

), 1.

1.10

(eth

anol

65

%)

Lich

enes

com

p.

Lobe

lia in

flata

L.

Fres

h flo

werin

g ae

rial p

arts

of L

obeli

a infl

ata L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Lo

belia

com

p.Ré

perto

ire d

e méd

. an

thr.

(201

6)

Lobe

lia in

flata

L.

Who

le fre

sh fl

ower

ing

plan

ts of

Lob

elia i

nflat

a L.

HAB

Ph.E

ur. 1

.1.5

Lobe

lia co

mp.

; Lob

elia i

nflat

a

Lyco

pers

icon

lyco

pers

icum

(L.)

Kars

t. ex

Far

w.Fr

esh

aeria

l par

ts of

Lyc

oper

sicon

lyco

pers

icum

(L.)

Kars

t. ex

Fa

rw., c

ollec

ted

at fl

ower

ing

time.

HAB

34

Ph.E

ur. 1

.1.3

and

4.2.

1D

er M

erku

rsta

b 19

99

Hep

atiti

s, 4/

2002

: p.

271-

7

Lyco

podi

um cl

avat

um L

.W

hole

spor

e-be

arin

g pl

ant o

f Lyc

opod

ium

clav

atum

L.

HAB

33e

Lyco

podi

um; L

ycop

odiu

m co

mp.

Lyco

podi

um cl

avat

um L

.D

ried

ripe s

pore

s of L

ycop

odiu

m cl

avat

um L

.H

AB; P

h.fr.

Ph.E

ur. 1

.1.8

(eth

anol

90

%),

Ph.E

ur. 1

.1.1

0 (e

than

ol 9

0%)

Lyco

podi

um

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


111

Lyco

pus v

irgin

icus

L.

Fres

h ae

rial p

arts

of L

ycop

us vi

rgin

icus

L., c

ollec

ted

at fl

ower

ing

time

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 6

5%)

Lyco

pus v

irgin

icus

L.

Who

le fre

sh p

lant

of L

ycop

us vi

rgin

icus

L., c

ollec

ted

at fl

ower

ing

time.

HAB

33d

Der

Mer

kurs

tab

5/20

04: p

. 359

Lysim

achi

a num

mul

aria

L.

Fres

h flo

werin

g ae

rial p

arts

of L

ysim

achi

a num

mul

aria

L.

Ph.E

ur. 1

.2.1

1;

Dec

octio

n wi

th

wate

r:eth

anol

96%

(1

2:9.

5) (D

ER 1

:2.1

5)

Dul

cam

ara/

Lysim

achi

a

Mah

onia

aqui

foliu

m (P

ursh

) N

utt.

Drie

d ba

rk fr

om b

ranc

hes a

nd tw

igs a

nd d

ried

tips o

f twi

gs o

f M

ahon

ia aq

uifo

lium

(Pur

sh) N

utt.

HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%)

Majo

rana

see O

rigan

um m

ajora

na L

.

Malt

umse

e Hor

deum

vulg

are L

.

Malu

s dom

estic

a Bor

kh.

Core

from

fres

h fr

uit o

f Malu

s dom

estic

a Bor

kh. w

ithou

t ker

nel

Ph.E

ur. 4

.1.1

Carp

ellum

Mal

i com

p.

Malu

s dom

estic

a Bor

kh.

sour

appl

es o

f Malu

s dom

estic

a Bor

kh.

see F

erru

m p

omat

um

(App

. 2.6

)M

erku

rsta

b 67

(201

4)(4

)270

-282

Mal

va sy

lves

tris L

.W

hole

or fr

agm

ente

d dr

ied

flowe

r of M

alva

sylv

estri

s L. o

r its

culti

vate

d va

rietie

s.H

AB;

Ph.E

ur.

Ph.E

ur. 1

.2.1

3 (e

than

ol

50%

), H

AB 1

2gM

alva

/Mill

efol

ium

/ Oxa

lis;

Phos

phor

us/M

alva

Mal

va sy

lves

tris L

., Mal

va

negl

ecta

Wal

lr.D

ried

leave

s of M

alva

sylv

estri

s L., M

alva

neg

lecta

Wal

lr. o

r a

mix

ture

of b

oth

spec

ies

Ph.E

ur.

Extra

ctio

n to

geth

er w

ith

leave

s acc

. to

Ph.E

ur.

1.2.

13 (E

than

ol 5

0%)

Mal

va/M

illef

oliu

m/ O

xalis

Man

drag

ora a

utum

nalis

see M

andr

agor

a offi

cinar

umH

ABPh

.Eur

. 1.1

.8 o

r 1.2

.12

Man

drag

ora o

fficin

arum

L.

Fres

h ro

ot o

f Man

drag

ora o

fficin

arum

L.

HAB

34d

Betu

la/M

andr

agor

a com

p.; C

artil

ago/

Man

drag

ora c

omp.

; Disc

i/Rhu

s to

xico

dend

ron

com

p.; M

andr

agor

a; Rh

us to

xico

dend

ron

com

p.

Man

drag

ora o

fficin

arum

L.

Man

drag

ora a

utum

nalis

Ber

tol.

Drie

d ro

ots o

f Man

drag

ora o

fficin

arum

L. a

nd M

andr

agor

a au

tum

nalis

Ber

tol.

HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%) o

r 1.2

.12

(eth

anol

50

%)

Acon

itum

/Arn

ica c

omp.

/Api

s; Ac

onitu

m/A

rnic

a com

p./F

orm

ica;

Acon

itum

/Arn

ica/

Betu

la co

mp.

; Ar

nica

/Sym

phyt

um co

mp.

; Bet

ula

com

p.; M

andr

agor

a; M

andr

agor

a co

mp.

; Man

drag

ora/

Men

iscus

Gen

us

Mar

acuj

a doc

ese

e Pas

siflor

a alat

a Cur

tis

Mar

rubi

um vu

lgar

e L.

Who

le or

frag

men

ted

drie

d flo

werin

g ae

rial p

arts

of M

arru

bium

vu

lgar

e L.

Ph.E

ur.

aque

ous e

xtra

ct to

geth

er

with

oth

er d

rugs

Siru

pus Th

ymi c

omp.

Mar

um ve

rum

see T

eucr

ium

mar

um L

.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


112

Mat

ricar

ia re

cutit

a L.

(Cha

mom

illa r

ecut

ita (L

.) Ra

usch

ert)

Fres

h flo

wer h

eads

of M

atric

aria

recu

tita L

. (Ch

amom

illa r

ecut

ita

(L.)

Raus

cher

t)Ph

.Eur

. 1.1

.3, H

AB 2

1An

agal

lis/M

alac

hit c

omp.

Mat

ricar

ia re

cutit

a L.

(Cha

mom

illa r

ecut

ita (L

.) Ra

usch

ert

Who

le fre

sh fl

ower

ing

plan

ts of

Mat

ricar

ia re

cutit

a L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 4

5%),

HAB

21,

33

c

Bolu

s alb

a com

p.; C

ham

omill

a; Pu

lvis

Stom

achi

cus c

um B

ellad

onna

Mat

ricar

ia re

cutit

a L.

(Cha

mom

illa r

ecut

ita (L

.) Ra

usch

ert)

Fres

h un

derg

roun

d pa

rts o

f Mat

ricar

ia re

cutit

a L. (

Cham

omill

a re

cutit

a (L.

) Rau

sche

rt) b

efor

e flow

erin

g tim

ePh

.Eur

. 1.2

.11,

1.4

.2,

HAB

21,

33c

Amm

i visn

aga c

omp.

; Bell

adon

na

com

p.; B

ellad

onna

/Cha

mom

illa;

Caru

m ca

rvi c

omp.

; Cha

mom

illa,

Radi

x; C

ham

omill

a/M

alac

hit c

omp.

; Ch

amom

illa/

Nic

otia

na;

Chry

sosp

leniu

m co

mp.

; Meli

ssa/

Sepi

a co

mp.

; Nic

otia

na co

mp.

; Nic

otia

na/N

ux

vom

ica c

omp.

; Ver

atru

m co

mp.

Mat

ricar

ia re

cutit

a L.

(Cha

mom

illa r

ecut

ita (L

.) Ra

usch

ert).

Drie

d ca

pitu

la o

f Mat

ricar

ia re

cutit

a L. (

Cham

omill

a rec

utita

(L.)

Raus

cher

t).Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

50%

), H

AB 1

2fAr

gent

um/Q

uerc

us co

mp.

; Birk

enko

hle

com

p.; O

leum

rhin

ale

Mat

ricar

ia re

cutit

a L.

(Cha

mom

illa r

ecut

ita (L

.) Ra

usch

ert)

Drie

d ro

ot o

f Mat

ricar

ia re

cutit

a L. (

Cham

omill

a rec

utita

(L.)

Raus

cher

t)Ph

.Eur

. 1.2

.12

(eth

anol

36

%)

Acid

um h

ydro

chlo

ricum

com

p.;

Birk

enko

hle c

omp.

; Cha

mom

illa c

omp.

; Ch

amom

illa,

Radi

x; C

ham

omill

a/M

alac

hit c

omp.

; Kal

ium

acet

icum

co

mp.

; Oxa

lis co

mp.

Mela

leuca

caju

puti

Powe

ll,

Mela

leuca

leuc

aden

dra (

L.) L

.Re

ctifi

ed es

sent

ial o

il ob

tain

ed fr

om fr

esh

leave

s and

bra

nche

s of

Mela

leuca

caju

puti

Powe

ll or

Mela

leuca

leuc

aden

dra (

L.) L

.AP

IBe

rber

is/Eu

caly

ptus

/ Sili

cea c

omp.

; Re

sina L

aric

is/So

lutio

Myr

rhae

ba

lsam

ica;

Solu

tio M

yrrh

ae b

alsa

mic

a

Meli

ssa i

ndic

umse

e Cym

bopo

gon

wint

eria

nus J

owitt

and

othe

r Cym

bopo

gon

sp.

Meli

ssa o

ffici

nalis

L.

Fres

h lea

ves a

nd yo

ung

tips o

f Meli

ssa o

ffici

nalis

L.

(HAB

)Ph

.Eur

. 1.1

.5, H

AB 2

1,

steam

dist

illat

ion

Arge

ntum

/Que

rcus

com

p.; M

eliss

a Cu

pro

culta

; Meli

ssa/

Phos

phor

us co

mp.

Meli

ssa o

ffici

nalis

L.

Fres

h ae

rial p

arts

of M

eliss

a offi

cina

lis L

., bef

ore fl

ower

ing

time

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r.

Meli

ssa o

ffici

nalis

L.

Fres

h ae

rial p

arts

of M

eliss

a offi

cina

lis L

.H

AB 3

3cCa

ctus

/Meli

ssa c

omp.

; Meli

ssa/

Sepi

a co

mp.

Meli

ssa o

ffici

nalis

L.

Drie

d lea

f of M

eliss

a offi

cina

lis L

.Ph

.Eur

.Ex

tract

s with

etha

nol

(DER

1:1

), to

geth

er w

ith

Majo

rana

with

Oleu

m

Caca

o (D

ER 1

:1:1

0),

steam

dist

illat

ion

Cera

et M

el co

mp.

; Majo

rana

/Meli

ssa;

Spiri

tus c

ontra

tuss

im; S

pirit

us M

eliss

ae

com

p.

Meli

ssa o

ffici

nalis

L.

Drie

d ae

rial p

arts

of M

eliss

a offi

cina

lis L

.H

AB 1

2gM

eliss

a com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


113

Men

tha p

iper

ita L

.Es

sent

ial o

il ob

tain

ed b

y ste

am d

istill

atio

n fro

m th

e fre

sh ae

rial

part

s of t

he fl

ower

ing

plan

t of M

enth

a x p

iper

ita L

.Ph

.Eur

.AP

IBe

rber

is/Ch

elido

nium

com

p.; C

arbo

Sa

ngui

nis c

omp.

; Cer

atum

Rat

anhi

ae

com

p.; E

chin

acea

/Pru

nus c

omp.

; O

leum

rhin

ale;

Rata

nhia

com

p.; S

alvi

ae

aeth

erol

eum

com

p.

Men

tha p

iper

ita L

.W

hole

or cu

t drie

d lea

ves o

f Men

tha x

pip

erita

L.

Ph.E

ur.

API

Cent

auriu

m co

mp.

; Majo

rana

/Men

tha/

Ruta

Men

tha p

iper

ita L

.W

hole

fresh

flow

erin

g pl

ant o

f Men

tha x

pip

erita

L.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

) Ré

perto

ire d

e méd

. an

thr.

Mer

curia

lis p

eren

nis L

.Fr

esh

aeria

l par

ts of

Mer

curia

lis p

eren

nis L

., col

lecte

d at

flow

erin

g tim

eH

ABH

AB 3

4cAl

lium

cepa

/ Mer

curia

lis co

mp.

; La

ches

is co

mp.

; Mer

curia

lis /

Rosa

e ae

ther

oleu

m; M

ercu

rialis

/Stib

ium

co

mp.

Mer

curia

lis p

eren

nis L

.W

hole

fresh

flow

erin

g pl

ant o

f Mer

curia

lis p

eren

nis L

.H

ABPh

.Eur

. 1.1

.4, 1

.1.1

0 (e

than

ol 4

5%)

Berb

eris/

Mer

curia

lis p

eren

nis;

Calen

dula

/Mer

curia

lis co

mp.

; M

ercu

rialis

com

p.; M

ercu

rialis

pe

renn

is; M

ercu

rialis

/Mel

Mer

curia

lis p

eren

nis L

.W

hole

drie

d flo

werin

g pl

ant o

f Mer

curia

lis p

eren

nis L

.Ex

tract

ion

with

ve

geta

ble o

ilCa

lendu

la/M

ercu

rialis

com

p.

Mez

ereu

mse

e Dap

hne m

ezer

eum

L.

Mill

efol

ium

see A

chill

ea m

illef

oliu

m L

.

Muc

una p

rurie

ns (L

.) D

CD

ried

hairs

from

the f

ruits

of M

ucun

a pru

riens

(L.)

DC

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.8 (e

than

ol

90%

)

Myr

istic

a fra

gran

s Hou

tt.D

ried

seed

ker

nel o

f Myr

istic

a fra

gran

s Hou

tt.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Ré

perto

ire d

e méd

. an

thr.

(201

6)

Myr

istic

a fra

gran

s Hou

tt.D

ried,

usu

ally

lim

e-tre

ated

seed

s of M

yrist

ica f

ragr

ans H

outt.

, wi

th ar

il an

d te

sta re

mov

edH

ABPh

.Eur

. 1.1

.8 (e

than

ol

90%

); et

hano

lic d

istill

ate

(toge

ther

with

oth

er

drug

s)

Nux

vom

ica c

omp.

; Spi

ritus

cont

ra

tuss

im; S

pirit

us M

eliss

ae co

mp.

Myr

istic

a seb

ifera

see V

irola

sebi

fera

Aub

l.

Myr

oxyl

on b

alsa

mum

(L.)

Har

ms

var.

pere

irae (

Royl

e) H

arm

s.Ba

lsam

obt

aine

d fro

m th

e sco

rche

d an

d wo

unde

d tr

unk

of

Myr

oxyl

on b

alsa

mum

(L.)

Har

ms v

ar. p

erei

rae (

Royl

e) H

arm

s.Ph

.Eur

.AP

IBe

rber

is/Eu

caly

ptus

/ Sili

cea c

omp.

; Be

rber

is/Si

licea

com

p.; C

alen

dula

/M

ercu

rialis

com

p.; M

ercu

rialis

com

p.

Myr

rha

see C

omm

ipho

ra Ja

cq. s

pecie

s

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


114

Nas

turt

ium

offi

cina

le R.

Br.

Who

le fre

sh p

lant

of N

astu

rtiu

m o

ffici

nale

R. B

r.Ph

.Eur

. 1.1

.11

(Eth

anol

45

%)

Nas

turt

ium

offi

cina

le R.

Br.

Fres

h ae

rial p

arts

of N

astu

rtiu

m o

ffici

nale

R. B

r., co

llect

ed at

flo

werin

g tim

eH

ABPh

.Eur

. 1.1

.5, H

AB 2

1,

(Ph.

Eur.

1.1.

3)N

astu

rtiu

m M

ercu

rio cu

ltum

Nas

turt

ium

offi

cina

le R.

Br.

Drie

d ae

rial p

arts

of N

astu

rtiu

m o

ffici

nale

R. B

r.AP

IM

ercu

rius v

ivus

com

p.

Nic

otia

na ta

bacu

m L

.Fr

esh

leave

s of N

icot

iana

taba

cum

L.

HAB

HAB

21,

33b

Amm

i visn

aga c

omp.

; Bell

adon

na

com

p.; B

erbe

ris/N

icot

iana

com

p.;

Blei

glan

z/Se

cale

com

p.; B

orag

o co

mp.

; Ca

rum

carv

i com

p.; C

ham

omill

a/N

icot

iana

; Cor

/Cra

taeg

us co

mp.

; Cu

prum

acet

icum

com

p.; C

upru

m/

Nic

otia

na; D

isci c

omp.

cum

Nic

otia

na;

Nic

otia

na co

mp.

; Nic

otia

na/N

ux

vom

ica c

omp.

; Nic

otia

na/Q

uarz

; N

icot

iana

/Stro

phan

tus c

omp.

; Oxa

lis/

Qua

rz co

mp.

; Ret

ina/

Seca

le co

mp.

; Ro

bini

a com

p.; T

abac

um; T

abac

um

Cupr

o cu

ltum

Nic

otia

na ta

bacu

m L

.D

ried

ferm

ente

d lea

ves o

f Nic

otia

na ta

bacu

m L

.Ph

.Eur

. 1.2

.13

(eth

anol

18

%)

Taba

cum

Nic

otia

na ta

bacu

m L

.D

ried

unfe

rmen

ted

leave

s of N

icot

iana

taba

cum

L.

HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%),

HAB

12d

, 12f

, AP

C 4.

2, 4

.3

Acon

itum

/Nic

otia

na co

mp.

; Car

bone

s/Pa

nkre

as/W

ither

it; C

ham

omill

a/M

alac

hit c

omp.

; Cup

rum

/Nic

otia

na;

Equi

setu

m ar

vens

e/Ta

bacu

m;

Equi

setu

m co

mp.

; Mag

nesiu

m

phos

phor

icum

acid

um/T

abac

um;

Rosm

arin

i aet

hero

leum

/Tab

acum

; Ta

bacu

m

Nux

mos

chat

ase

e Myr

istic

a fra

gran

s Hou

tt.

Nux

vom

ica

see S

tryc

hnos

nux

-vom

ica L

.

Oci

mum

bas

ilicu

m L

.Fr

esh

aeria

l par

ts of

Oci

mum

bas

ilicu

m L

., col

lecte

d pr

ior t

o flo

werin

gH

ABPh

.Eur

. 1.1

.5, 1

.1.1

1 (e

than

ol 6

5%)

Basil

icum

com

p.

Olib

anum

see B

oswe

llia s

peci

es

Ono

nis s

pino

saW

hole

or cu

t, dr

ied

root

of O

noni

s spi

nosa

L.

HAB

; Ph

.Eur

.Ph

.Eur

. 1.2

.12

(eth

anol

70

%)

Ono

pord

um ac

anth

ium

L.

Fres

h lea

ves o

f Ono

pord

um ac

anth

ium

L.

Ph.E

ur. 1

.1.7

, 1.1

.10

(eth

anol

45%

)Ch

elido

nium

com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


115

Ono

pord

um ac

anth

ium

L.

Fres

h flo

werh

ead

of O

nopo

rdum

acan

thiu

m L

.H

AB 3

3c; s

ee A

pp. 2

.6:

Ono

pord

um ac

anth

ium

, Fl

os re

c., et

hano

l. D

iges

tio (1

:3.1

) with

0.

1-1%

Hyo

scya

mus

ni

ger,

Her

ba re

c. Ø

, also

ex

tract

s with

Eth

anol

24

,5%

or W

FI

Auru

m/O

nopo

rdon

com

p.; C

imici

fuga

co

mp.

; Con

valla

ria/P

rimul

a com

p.;

Crat

aegu

s com

p.; O

nopo

rdon

com

p.;

Ono

pord

on co

mp.

/Ado

nis;

Ono

pord

on

com

p./M

agne

sium

pho

spho

ricum

ac

idum

; Ono

pord

on co

mp.

/Olea

nder

; O

nopo

rdon

com

p./O

leand

er/ A

rnic

a; O

nopo

rdon

com

p./O

leand

er/

Conv

alla

ria; O

nopo

rdon

com

p./

Plum

bum

; Ono

pord

um/P

rimul

a com

p.

Orc

his L

. or O

phry

deae

trib

e (O

rchi

dace

ae)

Filia

l tub

ers o

f diff

eren

t spe

cies o

f the

genu

s Orc

his L

. (O

rchi

dace

ae) o

r oth

er su

itabl

e int

ra- a

nd in

terg

ener

ic O

rchi

s-H

ybrid

s of t

he tr

ibe O

phry

deae

, whi

ch h

ave b

een

blan

ched

in

boili

ng w

ater

and

drie

d

Ph.E

ur. 1

.4.3

Cere

bellu

m co

mp.

Orig

anum

majo

rana

L.

Fres

h ae

rial p

arts

of O

rigan

um m

ajora

na L

., col

lecte

d at

flow

erin

g tim

eH

ABPh

.Eur

. 1.1

.5, 2

1, 3

3cM

ajora

na; M

ajora

na/Th

uja c

omp.

; M

eliss

a/Ph

osph

orus

com

p.

Orig

anum

majo

rana

L.

Drie

d ae

rial p

arts

of O

rigan

um m

ajora

na L

.Ph

.Eur

. 1.2

.13

(eth

anol

36

%),

HAB

12g

, ex

tract

ion

with

Eth

anol

(D

ER 1

:1);

toge

ther

with

M

eliss

a with

Oleu

m

Caca

o (D

ER 1

:1:1

0)

Caps

ella/

Majo

rana

com

p.; M

ajora

na;

Majo

rana

/Meli

ssa;

Majo

rana

/Men

tha/

Ruta

; Meli

ssa c

omp.

Orig

anum

majo

rana

L.

Ripe

frui

t of O

rigan

um m

ajora

na L

.Et

hano

lic d

ecoc

tion

(DER

1:3

), pe

rcol

atio

n wi

th et

hano

l 96%

and

aque

ous d

ecoc

tion

of th

e re

sidue

Caps

ella/

Majo

rana

com

p.

Oxa

lis ac

etos

ella L

.Fr

esh

leave

s of O

xalis

acet

osell

a L.

HAB

Ph.E

ur. 1

.1.3

, 1.1

.7,

1.1.

11 (e

than

ol 4

5%),

HAB

12a

(afte

r Ph.

Eur.

1.1.

3), 2

1; m

acer

atio

n wi

th et

hano

l 36%

(DER

1:

1.3)

.

Bella

donn

a/O

xalis

; Bell

adon

na/P

apav

er

com

p.; C

helid

oniu

m/O

xalis

com

p.;

Form

ica/

Oxa

lis; M

alva

/Mill

efol

ium

/ O

xalis

; Oxa

lis; O

xalis

com

p.

Oxa

lis ac

etos

ella L

.W

hole

fresh

flow

erin

g pl

ant o

f Oxa

lis ac

etos

ella L

.H

AB 1

2c, 3

4bBa

rium

/Pan

crea

s com

p.; B

erbe

ris/

Pros

tata

com

p.; B

erbe

ris/U

teru

s com

p.;

Card

uus m

aria

nus/

Oxa

lis; F

orm

ica/

Oxa

lis; O

xalis

; Oxa

lis/Q

uarz

com

p.;

Panc

reas

/Plat

inum

chlo

ratu

m co

mp.

; Tr

opae

olum

com

p.

Oxa

lis ac

etos

ella L

.D

ried

flowe

ring

plan

t of O

xalis

acet

osell

a LH

AB 1

2fO

xalis

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


116

Paeo

nia o

ffici

nalis

L. e

men

d.

Will

d.Fr

esh

unde

rgro

und

part

s of P

aeon

ia o

ffici

nalis

L. e

men

d. W

illd.

, co

llect

ed d

urin

g sp

ring

HAB

Ph.E

ur. 1

.1.5

, 1.2

.11,

H

AB 3

3cCa

rduu

s ben

edic

tus/

Paeo

nia o

ffici

nalis

; H

irudo

com

p.

Pana

x gi

nsen

g C.

A. M

ey.

Who

le or

cut d

ried

root

, des

igna

ted

white

gin

seng

; tre

ated

with

ste

am an

d th

en d

ried,

des

igna

ted

red

gins

eng,

of P

anax

gin

seng

C.

A. M

ey.

(HAB

); Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

90%

), 1.

2.12

(eth

anol

36

%)

Vade

mec

um: G

inse

ng

Papa

ver r

hoea

s L.

Fres

h flo

wers

of P

apav

er rh

oeas

L.

HAB

Ph.E

ur. 1

.1.3

, HAB

12a

(P

h.Eu

r. 1.

1.3)

, 33c

Papa

ver r

hoea

s

Papa

ver s

omni

feru

m L

.Fr

esh

latex

obt

aine

d fro

m in

cisio

ns in

unr

ipe f

ruit

of P

apav

er

som

nife

rum

L.

Extra

ctio

n wi

th et

hano

l 36

% (D

ER 1

:100

)Pa

pave

r som

nife

rum

Papa

ver s

omni

feru

m L

.Fr

esh

unrip

e fru

it of

Pap

aver

som

nife

rum

L.

Ph.E

ur. 1

.1.7

, 1.1

.10

(eth

anol

45%

), H

AB 3

3cBe

llado

nna/

Papa

ver c

omp.

; Ch

amom

illa c

omp.

; Pap

aver

so

mni

feru

m

Paris

qua

drifo

lia L

.W

hole

fresh

pla

nts o

f Par

is qu

adrif

olia

L., c

ollec

ted

when

the

frui

ts ha

ve ri

pene

dH

ABPh

.Eur

. 1.1

.3

Parm

elia

see H

ypog

ymni

a phy

sode

s (L.

) Nyl

.

Pass

iflor

a alat

a Cur

tisdr

ied

leave

s of P

assifl

ora a

lata C

urtis

cont

aini

ng at

leas

t 1.0

% o

f to

tal fl

avon

oids

, exp

ress

ed in

apig

enin

Farm

acop

éia

Bras

ileira

Pass

iflor

a alat

a Cur

tisFr

esh

aeria

l par

ts of

Pas

siflor

a alat

a Cur

tisPh

.Eur

. 1.1

.5AB

MA-

Vade

mec

um

Pass

iflor

a cae

rulea

L.

Fres

h ae

rial p

arts

of P

assifl

ora c

aeru

lea L

. col

lecte

d at

flow

erin

g tim

eH

AB 3

3c, e

xtra

ctio

n wi

th w

ater

and

sucr

ose

(2:4

:4)

Aven

a/Pa

ssifl

ora c

omp.

; Hyp

eric

um/

Pass

iflor

a com

p.; P

assifl

ora c

omp.

Pass

iflor

a inc

arna

ta L

.Fr

esh

aeria

l par

ts of

Pas

siflor

a inc

arna

ta L

.H

AB; P

h.fr.

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

65%

)Av

ena s

ativ

a com

p.; P

assifl

ora i

ncar

nata

Peat

see S

olum

ulig

inos

um

Pela

rgon

ium

gra

veol

ens A

it. an

d ot

her P

elarg

oniu

m sp

ecie

sEs

sent

ial o

il ob

tain

ed b

y ste

am d

estil

latio

n fro

m th

e aer

ial p

arts

of

suita

ble s

peci

es o

f Pela

rgon

ium

e.g.

Pela

rgon

ium

gra

veol

ens A

it.AP

IM

alva

com

p.; R

osae

aeth

erol

eum

/Si

licea

collo

idal

is co

mp.

Peta

sites

hyb

ridus

(L.)

Ph.

Gae

rtn.

B. M

ey. e

t Sch

erb

Fres

h rh

izom

e of P

etas

ites h

ybrid

us (L

.) Ph

. Gae

rtn.

B. M

ey. e

t Sc

herb

. with

atta

ched

root

sH

AB 3

3cPe

tasit

es co

mp.

; Pet

asite

s com

p. cu

m

Que

rcu;

Pet

asite

s com

p. cu

m V

eron

ica;

Peta

sites

, Rad

ix; P

etas

ites/

Plan

tago

co

mp.

; Pla

ntag

o co

mp.

Peta

sites

hyb

ridus

(L.)

Ph.

Gae

rtn.

B. M

ey. e

t Sch

erb.

Who

le fre

sh fl

ower

ing

plan

t of P

etas

ites h

ybrid

us (L

.) Ph

. Gae

rtn.

B.

Mey

. et S

cher

b.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 4

5%)

Peta

sites

, Pla

nta t

ota

Petro

selin

um cr

ispum

(Mill

.) N

ym. e

x A.

W. H

illW

hole

fresh

flow

erin

g pl

ants

of P

etro

selin

um cr

ispum

(Mill

.) N

ym. e

x A.

W. H

ill co

nvar

. cris

pum

, col

lecte

d at

the s

tart

of

flowe

ring

HAB

Ph.E

ur. 1

.1.5

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


117

Peuc

edan

um o

strut

hium

(L.)

W.

D. J

. Koc

hFr

esh

rhiz

ome o

f Peu

ceda

num

ostr

uthi

um (L

.) W

.D.J.

Koc

hPh

. Eur

. 1.2

.10,

etha

nolic

de

coct

ion

(1:2

.15)

(e

than

ol 5

0%)

Cich

oriu

m/T

arax

acum

com

p.

Peum

us b

oldu

s Mol

ina

Who

le or

frag

men

ted

drie

d lea

f of P

eum

us b

oldu

s Mol

ina.

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

70

%),

1.1.

10 (e

than

ol

55%

)

Répe

rtoire

de m

éd.

anth

r.: B

oldo

Phyl

litis

scol

open

driu

m L

. (A

splen

ium

scol

open

driu

m L

.)Fr

esh

spor

e-be

arin

g lea

ves o

f Phy

llitis

scol

open

driu

m L

.H

AB 3

4h, A

PC 3

.8.1

(to

geth

er w

ith o

ther

fre

sh h

erba

l dru

gs, 1

:4.1

pa

rts e

than

ol 2

5%),

3.8.

2

Aqui

linum

com

p.; A

spid

ium

/Sal

ix

com

p.; C

helid

oniu

m co

mp.

; Con

chae

co

mp.

; Rhu

s/Sa

lix co

mp.

Phyl

losta

chys

virid

iglau

cesc

ens

(Car

r.) A

. et C

. Riv.

Nod

es fr

om th

e ste

m o

f Phy

llosta

chys

spec

ies,

espe

cial

ly

Phyl

losta

chys

virid

iglau

cesc

ens (

Carr.

) A. e

t C. R

iv., c

ollec

ted

in

sum

mer

Ph.E

ur. 1

.1.1

0 (e

than

ol

45%

), H

AB 3

5cBa

mbu

sa; D

isci c

omp.

cum

Aes

culo

; D

isci c

omp.

cum

Arg

ento

; Disc

i com

p.

cum

Aur

o; D

isci c

omp.

cum

Nico

tiana

; D

isci c

omp.

cum

Pul

satil

la; D

isci c

omp.

cu

m St

anno

; Disc

i com

p. cu

m St

ibio

; D

isci/P

ulsa

tilla

com

p. cu

m St

anno

; D

isci/R

hus t

oxico

dend

ron

com

p.;

Disc

i/Visc

um co

mp.

cum

Arg

ento

; D

isci/V

iscum

com

p. cu

m St

anno

; Len

s cr

istal

lina/

Visc

um co

mp.

cum

Stan

no

Phyt

olac

ca am

eric

ana L

. (Ph

. de

cand

ra)

Fres

h ro

ots o

f Phy

tola

cca a

mer

ican

a L., c

ollec

ted

durin

g au

tum

nH

ABPh

.Eur

. 1.1

.5, H

AB 3

3cPh

ytol

acca

; Phy

tola

cca c

omp.

Phyt

olac

ca am

eric

ana L

.Fr

esh

ripe f

ruits

of P

hyto

lacc

a am

eric

ana L

.H

ABPh

.Eur

. 1.1

.5

Pice

a abi

es (L

.) Ka

rst.,

Abi

es

sibiri

ca L

edeb

our &

oth

er sp

ecie

sEs

sent

ial o

il ob

tain

ed b

y ste

am d

istill

atio

n of

nee

dles

and

tips o

f br

anch

es o

r bra

nche

s of P

icea a

bies

(L.)

Kars

t. an

d of

Abi

es

sibiri

ca L

edeb

our o

r oth

er sp

ecie

s of t

he ge

nera

Abi

es an

d Pi

cea

DAB

API

Salv

iae a

ethe

roleu

m co

mp.

Pice

a abi

es (L

.) Ka

rst.

Fres

h yo

ung

tips o

f sho

ots o

f Pice

a abi

es (L

.) Ka

rst.

Extra

ctio

n wi

th

Wat

er:S

ucro

se (1

:1)

(DER

1:5

)

Peta

sites

/Pla

ntag

o co

mp.

Pim

pine

lla an

isum

L.

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

of th

e dry

ripe

frui

ts of

Pi

mpi

nella

anisu

m L

.Ph

.Eur

.AP

IAr

nica

/Lap

pa co

mp.

; Ber

beris

/Ch

elido

nium

com

p.; B

erbe

ris/

Juni

peru

s com

p.; B

etul

a/La

ppa c

omp.

; Bo

lus a

lba c

omp.

; Car

bo S

angu

inis

com

p.; L

ichen

es co

mp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


118

Pim

pine

lla an

isum

L.

Who

le dr

y cre

moc

arp

of P

impi

nella

anisu

m L

.H

AB;

Ph.E

ur.

Ph.E

ur. 1

.2.1

2 (e

than

ol

70%

), 1.

4.4

Absin

thiu

m/C

aryo

phyl

li co

mp.

; Ani

s-Py

rit; A

ntim

onit/

Anisu

m; C

enta

uriu

m

com

p.; C

onch

ae/F

erru

m u

stum

com

p.;

Ferr

um si

licic

um co

mp.

; Fer

rum

ustu

m

com

p.; F

erru

m/A

nisu

m; L

evist

icum

co

mp.

; Siru

pus Th

ymi c

omp.

; Ve

rbas

cum

com

p.

Pinu

s mug

o Tu

rra

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

of th

e fre

sh le

aves

and

twig

s of P

inus

mug

o Tu

rra.

Ph.E

ur.

API

Arch

ange

lica c

omp.

; Ber

beris

/Juni

peru

s co

mp.

Pinu

s pin

aste

r Aito

n an

d/or

Pin

us

mas

soni

ana D

.Don

.Es

sent

ial o

il ob

tain

ed b

y ste

am d

istill

atio

n, fo

llowe

d by

re

ctifi

catio

n at

a te

mpe

ratu

re b

elow

180

°C, f

rom

the o

leore

sin

obta

ined

by t

appi

ng P

inus

pin

aste

r Aito

n an

d/or

Pin

us

mas

soni

ana D

.Don

.

Ph.E

ur.

API

Berb

eris/

Juni

peru

s com

p.

Pinu

s syl

vestr

is L.

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

of th

e fre

sh le

aves

and

bran

ches

of P

inus

sylv

estr

is L.

Ph.E

ur.

API

Arch

ange

lica c

omp.

; Oleu

m

cam

phor

atum

com

p.

Pinu

s syl

vestr

is L.

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

of fr

esh

need

les an

d tip

s or f

resh

bra

nche

s with

nee

dles

and

tips o

f the

twig

s of P

inus

sy

lves

tris

L. o

r oth

er sp

ecie

s of t

he ge

nus P

inus

.

DAB

API

Pipe

r nig

rum

L.

Drie

d, ri

pe o

r nea

rly ri

pe fr

uit o

f Pip

er n

igru

m L

. with

an

unbr

oken

per

icar

p (b

lack

pep

per)

or w

ith th

e out

er la

yers

of t

he

peric

arp

rem

oved

(whi

te p

eppe

r)

Ph.E

ur.

aque

ous e

xtra

ctio

n to

geth

er w

ith o

ther

dr

ugs,

aque

ous

extra

ctio

n wi

th su

cros

e

Gen

tiana

/Zin

gibe

r com

p.

Pix

betu

lina

Birc

h ta

r see

Bet

ula p

endu

la R

oth,

Bet

ula p

ubes

cens

Ehr

hart

Plan

tago

lanc

eolat

a L.

Fres

h lea

ves o

f Pla

ntag

o la

nceo

lata L

.Ph

.Eur

. 1.1

.11

(eth

anol

45

%),

HAB

34c

, App

. 2.6

: Pl

anta

go la

nceo

lata,

Foliu

m re

c.,

etha

nol.D

iges

tio (1

:3.1

) wi

th 1

-2%

Hyo

scya

mus

ni

ger,

Her

ba re

c. Ø

; aq

ueou

s ext

ract

ion

with

su

cros

e (1:

1) (D

ER 1

:5)

Bron

chi/P

lant

ago

com

p.; P

etas

ites

com

p.; P

etas

ites c

omp.

cum

Que

rcu;

Pe

tasit

es co

mp.

cum

Ver

onic

a; Pe

tasit

es/P

lant

ago

com

p.; P

hyto

lacc

a co

mp.

; Pla

ntag

o co

mp.

; Pla

ntag

o la

nceo

lata;

Plan

tago

-Prim

ula c

um

Hyo

scya

mo

Poly

gala

sene

ga L

.D

ried

and

usua

lly fr

agm

ente

d ro

ot an

d ro

ot cr

own

of P

olyg

ala

sene

ga L

. or o

f cer

tain

oth

er cl

osely

relat

ed sp

ecie

s or o

f a m

ixtu

re

of th

ese P

olyg

ala s

peci

es.

(HAB

); Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

90%

), 1.

2.12

(eth

anol

50

%)

Répe

rtoire

de m

éd.

anth

r.: S

eneg

a

Poly

gona

tum

odo

ratu

m (M

ill.)

Dru

ceFr

esh,

und

ergr

ound

par

ts of

Pol

ygon

atum

odo

ratu

m (M

ill.)

Dru

cePh

. Eur

. 1.1

.7, H

AB 3

3dVe

spa c

rabr

o co

mp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


119

Poly

podi

um vu

lgar

e L.

Fres

h lea

ves o

f Pol

ypod

ium

vulg

are L

.Ph

.Eur

. 1.2

.5, A

PC 3

.8.1

(to

geth

er w

ith o

ther

fre

sh h

erba

l dru

gs 1

:4.1

pa

rts e

than

ol 2

5%),

3.8.

2.

Aspi

dium

/Sal

ix co

mp.

; Che

lidon

ium

co

mp.

Popu

lus t

rem

ula L

.Fr

esh

leave

s of P

opul

us tr

emul

a L.

Ph. E

ur. 1

.1.5

, 1.1

.10

(eth

anol

65%

) tog

ethe

r wi

th fr

esh

bark

1:1

(see

Po

pulu

s tre

mul

a, fre

sh

bark

), H

AB 3

3d

Berb

eris/

Saba

l com

p.; S

abal

/Sol

idag

o co

mp.

Popu

lus t

rem

ula L

.fre

sh b

ark

of P

opul

us tr

emul

a L.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

) tog

ethe

r with

lea

ves 1

:1 (s

ee P

opul

us

trem

ula,

fresh

leav

es)

Pote

ntill

a ere

cta (

L.) R

aeus

ch.

Who

le or

cut,

drie

d rh

izom

e, fre

ed fr

om th

e roo

ts, o

f Pot

entil

la

erec

ta (L

.) Ra

eusc

h. (P

. tor

men

tilla

Stok

es)

HAB

; Ph

.Eur

.Ph

.Eur

. 1.2

.12

(eth

anol

50

%)

Cora

llium

com

p.; H

ydra

stis c

omp.

; To

rmen

tilla

Pote

ntill

a ere

cta (

L.) R

aeus

ch.

Fres

h un

derg

roun

d pa

rts o

f Pot

entil

la er

ecta

(L.)

Raeu

sch.

, co

llect

ed d

urin

g sp

ring

HAB

Ph.E

ur. 1

.1.5

, HAB

21,

34

dTo

rmen

tilla

; Tor

men

tilla

com

p.

Pote

rium

see S

arco

pote

rium

spin

osum

(L.)

Spac

h.

Prim

ula f

arin

osa L

.Fr

esh

root

s of P

rimul

a far

inos

a L.

Ph.E

ur. 1

.4.2

Prim

ula v

eris

L.Fr

esh

flowe

rs o

f Prim

ula v

eris

L.Ph

.Eur

. 1.2

.5, H

AB 2

1,

33c.

See A

pp.2

.6:

Prim

ula v

eris,

Flo

s rec

., et

hano

l. D

iges

tio (1

:3.1

) wi

th 0

.1-1

% H

yosc

yam

us

nige

r, H

erba

rec.

Ø;

Prim

ula v

eris,

Flo

s rec

., et

hano

l. D

iges

tio (1

: 12

.35)

with

0.6

%

Hyo

scya

mus

nig

er,

Her

ba re

c. Ø

;

Auru

m/O

nopo

rdon

com

p.; C

imici

fuga

co

mp.

; Con

valla

ria/P

rimul

a com

p.;

Crat

aegu

s com

p.; O

nopo

rdon

com

p.;

Ono

pord

on co

mp.

/Ado

nis;

Ono

pord

on

com

p./M

agne

sium

pho

spho

ricum

ac

idum

; Ono

pord

on co

mp.

/Olea

nder

; O

nopo

rdon

com

p./O

leand

er/ A

rnic

a; O

nopo

rdon

com

p./O

leand

er/

Conv

alla

ria; O

nopo

rdon

com

p./

Plum

bum

; Ono

pord

um/P

rimul

a com

p.;

Plan

tago

-Prim

ula c

um H

yosc

yam

o;

Prim

ula A

uro

culta

; Prim

ula A

uro

culta

co

mp.

Prim

ula v

eris

L.D

ried

flowe

rs o

f Prim

ula v

eris

L.D

ACH

AB 1

2gPr

imul

a com

p.

Prun

us d

ulcis

(Mill

er) D

. A.

Web

b va

r. du

lcis a

nd/o

r am

ara

(D. C

.) Bu

chhe

im

Fatty

oil

otai

ned

by co

ld ex

pres

sion

from

the r

ipe s

eeds

of P

runu

s du

lcis (

Mill

.) D

.A. W

ebb

var.

dulci

s or P

runu

s dul

cis (M

ill.)

D.A

. W

ebb

var.

amar

a (D

C.) B

uchh

eim

or a

mix

ture

of b

oth

varie

ties

Ph.E

ur.

API (

and

excip

ient

)O

leum

Pet

rae c

omp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


120

Prun

us d

ulcis

(Mill

.) D

.A.W

ebb

var.

amar

a (D

C.) B

uchh

eim

Drie

d, ri

pe se

eds o

f Pru

nus d

ulcis

(Mill

.) D

.A.W

ebb,

var.

amar

a (D

C.) B

uchh

eim

HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%)

Prun

us la

uroc

eras

us L

.Fr

esh

leave

s of P

runu

s lau

roce

rasu

s L.

HAB

Ph.E

ur. 1

.1.3

, see

also

Ap

p. 2

.7: L

auro

cera

sus

100%

Prun

us sp

inos

a L.

Juic

e fro

m th

e fru

it of

Pru

nus s

pino

sa L

.AP

ILo

tio P

runi

com

p.; P

runu

s spi

nosa

; Th

ymus

serp

yllu

m co

mp.

Prun

us sp

inos

a L.

Fres

h flo

wers

and

youn

g tip

s of s

hoot

s of P

runu

s spi

nosa

L.,

harv

este

d at

the b

egin

ning

of t

he b

loom

ing

seas

onPh

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Au

rum

/Pru

nus;

Levi

co co

mp.

; Pru

nus

spin

osa;

Prun

us sp

inos

a cum

Fer

ro;

Skor

odit

com

p.

Répe

rtoire

de m

éd.

anth

r.

Prun

us sp

inos

a L.

Fres

h flo

wers

of P

runu

s spi

nosa

L., c

ollec

ted

befo

re th

e pet

als

drop

off

HAB

Ph.E

ur. 1

.1.5

Prun

us sp

inos

a L.

Fres

h fr

uit o

f Pru

nus s

pino

sa L

.Ph

.Eur

. 1.1

.10

(eth

anol

45

%) H

AB 1

2o;

extra

ctio

n wi

th et

hano

l 24

,5%

(DER

1:4

)

Aesc

ulus

/Pru

nus c

omp.

; Ber

beris

/Eu

caly

ptus

/ Sili

cea c

omp.

; Ber

beris

/Pr

unus

; Ber

beris

/Sili

cea c

omp.

; Cac

tus/

Crat

aegu

s com

p.; E

chin

acea

/Pru

nus

com

p.; P

runu

s spi

nosa

; Pru

nus/

Rosm

arin

us co

mp.

Répe

rtoire

de m

éd.

anth

r.

Prun

us sp

inos

a L.

Fres

h yo

ung

tips o

f sho

ots o

f Pru

nus s

pino

sa L

., col

lecte

d so

me

week

s afte

r flow

erin

gH

ABPh

.Eur

. 1.1

.7, H

AB 2

2Aq

ua M

aris

com

p.; A

qua M

aris/

Prun

us

spin

osa,

Sum

mita

tes;

Auru

m/P

runu

s; Cr

atae

gus/

Prun

us co

mp.

; For

mic

a/Pr

unus

spin

osa;

Prun

us sp

inos

a

Prun

us sp

inos

a L.

Fully

ope

ned

drie

d flo

wers

of P

runu

s spi

nosa

L.

DAC

HAB

12g

Mal

va co

mp.

; Pru

nus s

pino

sa

Psyc

hotr

ia ip

ecac

uanh

a (Br

ot.)

Stok

esD

ried

unde

rgro

und

orga

ns o

f Psy

chot

ria ip

ecac

uanh

a (Br

ot.)

Stok

es.

HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%),

1.2.

12 (e

than

ol

(70%

)

Acid

um h

ydro

chlo

ricum

com

p.;

Cocc

ulus

/Oleu

m P

etra

e com

p.;

Dro

sera

/Ipec

acua

nha c

omp.

; Ip

ecac

uanh

a; Si

rupu

s Thym

i com

p.

Répe

rtoire

de m

éd.

anth

r.: Ip

eca

Pter

idiu

m aq

uilin

um (L

.) Ku

hnFr

esh

leave

s of P

terid

ium

aqui

linum

(L.)

Kuhn

Ph.E

ur. 1

.2.5

, HAB

34c

, AP

C 3.

8.1

(toge

ther

with

ot

her f

resh

her

bal d

rugs

1:

4.1

part

s eth

anol

25%

), 3.

8.2

Aqui

linum

com

p.; A

rum

mac

ulat

um/

Pter

idiu

m aq

uilin

um; C

onch

ae co

mp.

; Rh

us/S

alix

com

p.

Pulm

onar

ia o

ffici

nalis

L.

Fres

h ae

rial p

arts

of P

ulm

onar

ia o

ffici

nalis

L., c

ollec

ted

at

flowe

ring

time

HAB

Ph.E

ur. 1

.1.3

Pulsa

tilla

vulg

aris

Mill

.W

hole

fresh

flow

erin

g pl

ants

of P

ulsa

tilla

vulg

aris

Mill

.H

AB; P

h.fr.

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

55%

)Ec

hina

cea c

omp.

; Meli

ssa/

Phos

phor

us

com

p.; P

ulsa

tilla

; Siru

pus Th

ymi c

omp.

Répe

rtoire

de m

éd.

anth

r.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


121

Pulsa

tilla

vulg

aris

Mill

.Fr

esh

flowe

rs o

f Pul

satil

la vu

lgar

is M

ill. w

ith ap

ical

leaf

hus

k.H

AB 3

3cAu

rum

/Pul

satil

la/S

pong

ia co

mp.

; Be

rber

is/N

icotia

na co

mp.

; Bry

onia

/Pu

lsatil

la co

mp.

; Disc

i com

p. cu

m

Pulsa

tilla

; Disc

i/Pul

satil

la co

mp.

cum

St

anno

; Disc

i/Visc

um co

mp.

cum

Ar

gent

o; H

irudo

com

p.; P

ulsa

tilla

Pyru

s malu

sse

e Malu

s syl

vestr

is M

ill.

Que

brac

hose

e Asp

idos

perm

a que

brac

ho-b

lanc

o Sc

hlec

hten

d.

Que

rcus

robu

r L. a

nd Q

uerc

us

petra

ea (M

att.)

Lie

bl.

Fres

h ba

rk fr

om yo

ung

twig

s, br

anch

es an

d sh

oots

of Q

uerc

us

robu

r L. a

nd Q

uerc

us p

etra

ea (M

att.)

Lie

bl.

HAB

12k

Aesc

ulus

/Pru

nus c

omp.

; Que

rcus

, Co

rtex

Que

rcus

robu

r L., Q

uerc

us

petra

ea (M

att.)

Lie

bl., Q

uerc

us

pube

scen

s Will

d.

Cut a

nd d

ried

bark

from

the f

resh

youn

g br

anch

es o

f Que

rcus

ro

bur L

., Q. p

etra

ea (M

att.)

Lie

bl. o

r Que

rcus

pub

esce

ns W

illd.

HAB

; Ph

.Eur

.Ph

.Eur

. 1.2

.12

(eth

anol

36

%),

1.4.

3, H

AB 1

2q,

APC

4.3

Aesc

ulus

/Que

rcus

com

p.; A

patit

/Co

ncha

e; Ar

gent

um/Q

uerc

us co

mp.

; Ca

lcium

carb

onic

um cu

m Q

uerc

u;

Caps

ella/

Majo

rana

com

p.; C

onch

ae/

Que

rcus

com

p.; C

orne

a/Le

visti

cum

co

mp.

; Lob

elia c

omp.

; Pet

asite

s com

p.

cum

Que

rcu;

Pha

rmak

olith

com

p.;

Que

rcus

com

p.; Q

uerc

us, C

orte

x

.

Ranu

ncul

us b

ulbo

sus L

.W

hole

fresh

flow

erin

g pl

ants

of R

anun

culu

s bul

bosu

s L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 4

5%)

Prim

ula A

uro

culta

com

p.

Raph

anus

sativ

us L

. var

nig

er

(Mill

.) J.

Kern

Fres

h un

derg

roun

d pa

rts o

f Rap

hanu

s sat

ivus

L. v

ar. n

iger

(Mill

.) J.

Kern

.H

ABPh

.Eur

. 1.1

.5

Raph

anus

sativ

us L

. var

. nig

er

(Mill

er) K

erne

rD

ried

root

of R

apha

nus s

ativ

us L

. var

. nig

er (M

iller

) Ker

ner

Ph.fr

.Ph

.Eur

. 1.1

.11

(eth

anol

55

%)

Rata

nhia

see K

ram

eria

tria

ndra

Rui

z. et

Pav

.

Rauv

olfia

serp

entin

a (L.

) Be

ntha

m ex

Kur

zW

hole

or cu

t, dr

ied

root

s of R

auvo

lfia s

erpe

ntin

a (L.

) Ben

tham

ex

Kurz

DAB

; HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%),

1.2.

12 (e

than

ol

70%

)

Rauw

olfia

serp

entin

a

Resin

a Lar

icis

see L

arix

dec

idua

Mill

.

Fran

gula

alnu

s Mill

.Fr

esh

bark

of t

he st

ems a

nd b

ranc

hes o

f Fra

ngul

a aln

us M

ill.

HAB

Ph.E

ur. 1

.1.5

, HAB

33c

, 33

eTr

opae

olum

com

p.

Rheu

m o

fficin

ale B

aillo

n, R

heum

pa

lmat

um L

.Rh

ubar

b co

nsist

s of t

he w

hole

or cu

t, dr

ied

unde

rgro

und

part

s of

Rheu

m p

alm

atum

L. o

r of R

heum

offi

cinal

e Bai

llon

or o

f hyb

rids

of th

ese t

wo sp

ecie

s or o

f a m

ixtu

re. Th

e und

ergr

ound

par

ts ar

e oft

en d

ivid

ed; t

he st

em an

d m

ost o

f the

bar

k wi

th th

e roo

tlets

are

rem

oved

.

Ph.E

ur.

Ph. E

ur. 1

.1.8

(eth

anol

70

%)

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


122

Rheu

m rh

apon

ticum

L.

Who

le or

cut,

drie

d un

derg

roun

d pa

rts o

f Rhe

um rh

apon

ticum

L.

Ph.E

ur. 1

.1.8

(eth

anol

90

%)

Vade

mec

um: R

heum

rh

apon

ticum

(ext

.)

Rhod

oden

dron

chry

sant

hum

Pa

ll., R

hodo

dend

ron

aure

um

Geo

rgi

Drie

d lea

fy tw

igs o

f Rho

dode

ndro

n ca

mpy

loca

rpum

Hoo

k. f.

and

Rhod

oden

dron

aure

um G

eorg

i or t

heir

hybr

ids,

allo

ne o

r m

ixtu

res t

here

of

HAB

Ph.E

ur. 1

.1.8

(eth

anol

90

%)

Rhod

oden

dron

ferr

ugin

eum

L.

Fres

h, fl

ower

ing,

leaf

y, tw

igs o

f Rho

dode

ndro

n fe

rrug

ineu

m L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Ré

perto

ire d

e méd

. an

thr

Rhus

toxi

code

ndro

n L.

Fres

h, yo

ung

leafy

twig

s of R

hus t

oxic

oden

dron

L., h

arve

sted

in

sum

mer

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r.

Rhus

toxi

code

ndro

n L.

(T

oxic

oden

dron

que

rcifo

lium

(M

ichx.

) Gre

ene

Fres

h, yo

ung,

not

yet l

igni

fied

shoo

ts of

Rhu

s tox

icod

endr

on L

. wi

th le

aves

BP; H

ABPh

.Eur

. 1.1

.3, 1

.1.1

0 (e

than

ol 6

5%),

HAB

33d

Rhus

toxi

code

ndro

n L.

(T

oxic

oden

dron

que

rcifo

lium

(M

ichx.

) Gre

ene

Fres

h lea

ves o

f Tox

icod

endr

on q

uerc

ifoliu

m (M

ichx.

) Gre

ene

Ph.E

ur. 1

.1.3

, 1.1

.10

(eth

anol

65%

), H

AB 3

3dAc

onitu

m co

mp.

; Api

s/Rh

us

toxi

code

ndro

n co

mp.

; Bry

onia

/For

mic

a co

mp.

; Disc

i/Rhu

s tox

icod

endr

on

com

p.; R

hus t

oxic

oden

dron

; Rhu

s to

xico

dend

ron

com

p.; R

hus/

Salix

com

p.

Ribe

s nig

rum

L.

Fres

h lea

ves o

f Rib

es n

igru

m L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

55%

)

Rici

nus c

omm

unis

L.Fa

tty o

il ob

tain

ed b

y col

d ex

pres

sion

from

the s

eeds

of R

icin

us

com

mun

is L.

Ph.E

ur.

API

Berb

eris/

Cheli

doni

um co

mp.

; Ber

beris

/Ju

nipe

rus c

omp.

Rici

nus c

omm

unis

L.D

ried

seed

s of R

icin

us co

mm

unis

L.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

90%

)

Robi

nia p

seud

oaca

cia L

.Fr

esh

bark

from

youn

g br

anch

es o

f Rob

inia

pse

udoa

caci

a L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 6

5%),

1.2.

9,

HAB

33e

Robi

nia c

omp.

Rosa

gal

lica L

., Ros

a dam

asce

na

Mill

. and

Ros

a cen

tifol

ia L

.Es

sent

ial o

il ob

tain

ed b

y ste

am d

estil

latio

n fro

m fr

esh

flowe

rs o

f su

itabl

e spe

cies

of t

he ge

nus R

osa,

part

icul

arly

Ros

a gal

lica L

., Ro

sa d

amas

cena

Mill

. and

Ros

a cen

tifol

ia L

.

Ph.E

ur. 3

.1.1

(eth

anol

96

%),

API (

HAB

16.

2)An

timon

it/Ro

sae a

ethe

roleu

m co

mp.

; Be

llado

nna /

Rosa

e aet

hero

leum

; Ci

nera

ria/R

osae

aeth

erol

eum

; Cor

nea/

Levi

sticu

m co

mp.

; Cor

pus v

itreu

m/

Hor

nerz

com

p.; E

chin

acea

/Qua

rz

com

p.; E

chin

acea

/Ros

ae ae

ther

oleu

m;

Euph

rasia

/Ros

ae ae

ther

oleu

m; I

ris

bovi

s com

p.; M

ercu

rialis

/ Ro

sae

aeth

erol

eum

; Ner

vus o

ptic

us co

mp.

; Ro

sa, F

los;

Rosa

e aet

hero

leum

/Sili

cea

collo

idal

is co

mp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


123

Rosa

dam

asce

na L

. and

Ros

a ce

ntifo

lia L

.Su

bsta

nce o

btai

ned

by st

epwi

se ex

tract

ion

with

pet

rolet

her a

nd

alco

hol f

rom

fres

h flo

wers

of R

osa d

amas

cena

L. a

nd R

osa

cent

ifolia

L. (

DER

ca. 5

00:1

)

API

Auru

m/L

avan

dula

e aet

hero

leum

/Ros

a

Rosa

L.

Fres

h flo

wers

of s

uita

ble s

pecie

s of t

he ge

nus R

osa L

., par

ticul

arly

da

rk re

d te

a hyb

rids

HAB

37a

Ferr

um ro

satu

m/G

raph

ites;

Rosa

, Flo

s

Rosa

gal

lica L

., Ros

a cen

tifol

ia L

., Ro

sa d

amas

cena

Mill

.D

ried

buds

and

peta

ls of

suita

ble s

pecie

s of t

he ge

nus R

osa L

., pa

rtic

ular

ly R

osa g

allic

a L., R

osa c

entif

olia

L., R

osa d

amas

cena

M

ill. a

s well

as d

ark

red

tea h

ybrid

s

HAB

12f

Rosa

, Flo

s

Rosa

cent

ifolia

L.

Fres

h pe

tals

of R

osa c

entif

olia

L.

see A

pp.2

.6: F

erru

m

rosa

tum

Cheli

doni

um/T

ereb

inth

ina l

arici

na

com

p.; R

osa,

Flos

Rosm

arin

us o

fficin

alis

L.Es

sent

ial o

il ob

tain

ed b

y ste

am d

istill

atio

n fro

m th

e flow

erin

g ae

rial p

arts

of R

osm

arin

us o

fficin

alis

L.Ph

.Eur

.AP

IAc

onitu

m/A

rnic

a com

p./A

pis;

Acon

itum

/Arn

ica c

omp.

/For

mic

a; Ac

onitu

m/N

icotia

na co

mp.

; Aes

culu

s, Co

rtex/

Rosm

arin

i aet

hero

leum

; Api

s/Ar

nica

com

p.; A

rcha

ngeli

ca co

mp.

; Ar

nica

com

p./C

upru

m; A

rnic

a com

p./

Form

ica;

Arni

ca/S

ymph

ytum

com

p.;

Cera

tum

ben

zoin

atum

; Cup

rum

/Qua

rz

com

p.; E

chin

acea

/Visc

um co

mp.

; M

ajora

na/Th

uja c

omp.

; Oleu

m

lact

agog

um; P

rimul

a com

p.; P

runu

s/Ro

smar

inus

com

p.; R

esin

a Lar

icis/

Solu

tio M

yrrh

ae b

alsa

mic

a; Ro

smar

ini

aeth

erol

eum

/Tab

acum

; Ros

mar

inus

co

mp.

; Ros

mar

inöl

; Sal

Mar

is co

mp.

; Sa

lvia

e aet

hero

leum

com

p.; S

olut

io

Myr

rhae

bal

sam

ica;

Vesp

a cra

bro

com

p.

Rosm

arin

us o

fficin

alis

L.Fr

esh

leave

s of R

osm

arin

us o

fficin

alis

L.H

ABPh

.Eur

. 1.1

.5Be

toni

ca/R

osm

arin

us; R

osm

arin

us

Rosm

arin

us o

fficin

alis

L.Fr

esh

flowe

ring

twig

s of R

osm

arin

us o

fficin

alis

L.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

)Ro

smar

inus

; Ros

mar

inus

com

p.

Rosm

arin

us o

fficin

alis

L.W

hole

drie

d lea

f of R

osm

arin

us o

fficin

alis

L.(H

AB);

Ph.E

ur.

Ph.E

ur. 1

.1.8

(eth

anol

90

%),

1.4.

4Be

toni

ca/R

osm

arin

us; R

osm

arin

us

Rum

ex cr

ispus

L.

Fres

h un

derg

roun

d pa

rts o

f Rum

ex cr

ispus

L., h

arve

sted

at th

e en

d of

the v

eget

atio

n pe

riod

HAB

Ph.E

ur. 1

.1.3

, 1.1

.10

(eth

anol

45%

)Ru

mex

crisp

us

Ruta

gra

veol

ens L

.Fr

esh

aeria

l par

ts of

Rut

a gra

veol

ens L

., col

lecte

d at

the s

tart

of

flowe

ring

HAB

Ph.E

ur. 1

.1.5

, HAB

33c

Cheli

doni

um/T

ereb

inth

ina l

arici

na

com

p.; R

uta g

rave

olen

s; Sy

mph

ytum

co

mp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


124

Ruta

gra

veol

ens L

.Fr

esh,

aeria

l, un

ligni

fied

part

s of R

uta g

rave

olen

s L. h

arve

sted

befo

re fl

ower

ing

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Répe

rtoire

de m

éd.

anth

r.

Saba

dilla

see S

choe

noca

ulon

offi

cina

le (C

ham

. et S

chlec

hten

d.) A

. Gra

y

Saba

l ser

rulat

umse

e Ser

enoa

repe

ns (W

. Bar

tram

) Sm

all.

Sabi

nase

e Jun

iper

us sa

bina

L.

Sacc

haru

m o

ffici

naru

m L

.Ca

ram

el ob

tain

ed th

roug

h th

e roa

sting

of s

ucro

se fr

om

Sacc

haru

m o

ffici

naru

m L

.Ph

.Eur

. 3.1

.1 (D

1 wi

th

purifi

ed w

ater

), 3.

1.2,

3.

1.3,

4.1

.1 (t

oget

her

with

Ani

si fr

uctu

s)

Anis-

Pyrit

; Bas

ilicu

m co

mp.

; Cr

atae

gus/

Ferr

um si

dere

um/

Sacc

haru

m to

stum

Sacc

haru

m to

stum

see S

acch

arum

offi

cina

rum

L.

Salix

alba

ssp.

vite

llina

(L.)

Arch

ang.

Fres

h ba

rk an

d lea

ves o

f Sal

ix al

ba ss

p. vi

telli

na (L

.) Ar

chan

g.H

AB 3

3dH

yper

icum

/Pas

siflor

a com

p.; P

assifl

ora

com

p.; R

hus/

Salix

com

p.

Salix

pur

pure

a L.

Fres

h ba

rk an

d lea

ves o

f Sal

ix p

urpu

rea L

.H

AB 3

3dH

yper

icum

/Pas

siflor

a com

p.; R

hus/

Salix

com

p.

Salix

spec

ies

Fres

h lea

ves o

f Sal

ix al

ba, s

sp. a

lba L

. and

/or s

sp. v

itelli

na (L

.) Ar

chan

g. an

d/or

Sal

ix p

urpu

rea L

. and

/or S

alix

vim

inal

is L.

Ph.E

ur. 1

.2.5

, APC

3.8

.2,

etha

nolic

mac

erat

ion

(eth

anol

25%

)

Aspi

dium

/Sal

ix co

mp.

; Che

lidon

ium

co

mp.

Salix

spec

ies

Who

le or

frag

men

ted

drie

d ba

rk o

f you

ng b

ranc

hes o

r who

le dr

ied

piec

es o

f cur

rent

-yea

r twi

gs o

f var

ious

spec

ies o

f gen

us S

alix

in

cludi

ng S

. pur

pure

a L., S

. dap

hnoi

des V

ill. a

nd S

. fra

gilis

L.

Ph.E

ur.

Ph.E

ur. 1

.2.1

2 (e

than

ol

36%

)

Salix

vim

inal

is L.

Fres

h ba

rk an

d lea

ves o

f Sal

ix vi

min

alis

L.H

AB 3

3dH

yper

icum

/Pas

siflor

a com

p.; R

hus/

Salix

com

p.

Salv

ia o

ffici

nalis

L.

Thuj

one-

rich

esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

from

the

aeria

l par

ts of

Sal

via o

ffici

nalis

L.

DAC

API

Cera

tum

Rat

anhi

ae co

mp.

; Majo

rana

/Th

uja c

omp.

; Pru

nus/

Rosm

arin

us

com

p.; R

atan

hia c

omp.

; Sal

viae

ae

ther

oleu

m co

mp.

; Thym

us se

rpyl

lum

co

mp.

Salv

ia o

ffici

nalis

L.

Fres

h lea

ves o

f Sal

via o

ffici

nalis

L.

HAB

Ph.E

ur. 1

.1.5

, HAB

33d

, 12

cAr

chan

gelic

a/Py

rit co

mp.

; Cal

endu

la/

Echi

nace

a com

p.

Salv

ia o

ffici

nalis

L.

Who

le or

cut,

drie

d lea

ves o

f Sal

via o

ffici

nalis

L.

Ph.E

ur.

Ph.E

ur. 1

.2.1

3 (e

than

ol

70%

), AP

ICi

chor

ium

/Tar

axac

um co

mp.

; Fra

garia

/Ur

tica c

omp.

; Lev

istic

um co

mp.

; Sal

via

com

p.

Sam

bucu

s nig

ra L

.Fr

esh

pith

from

bra

nche

s of S

ambu

cus n

igra

L.

HAB

35a

Flor

es S

ambu

ci co

mp.

/Qua

rz;

Sam

bucu

s com

p.

Sam

bucu

s nig

ra L

.D

ried

pith

from

bra

nche

s of S

ambu

cus n

igra

L.

Ph.E

ur. 1

.2.1

2 (e

than

ol

36%

)Fl

ores

Sam

buci

com

p./Q

uarz

; Sa

mbu

cus c

omp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


125

Sam

bucu

s nig

ra L

.Fr

esh,

blo

omin

g flo

wer h

eads

of S

ambu

cus n

igra

L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

45

%)

Répe

rtoire

de m

éd.

anth

r.: S

ambu

cus

nigr

a, flo

s

Sam

bucu

s nig

ra L

.Fr

esh

inflo

resc

ence

s of S

ambu

cus n

igra

L.

HAB

33c

Phyt

olac

ca co

mp.

; Sam

bucu

s com

p.

Sam

bucu

s nig

ra L

.D

ried

flowe

rs o

f Sam

bucu

s nig

ra L

.Ph

.Eur

.H

AB 1

2gFl

ores

Sam

buci

com

p./Q

uarz

; Mal

va

com

p.; S

ambu

cus c

omp.

Sam

bucu

s nig

ra L

.Eq

ual p

arts

of fr

esh

leave

s and

inflo

resc

ence

s of S

ambu

cus n

igra

L.

HAB

Ph.E

ur. 1

.1.5

Sam

bucu

s/Te

ucriu

m co

mp.

Sang

uina

ria ca

nade

nsis

L.D

ried

unde

rgro

und

part

s of S

angu

inar

ia ca

nade

nsis

L., c

ollec

ted

in au

tum

nH

ABPh

.Eur

. 1.1

.8 (e

than

ol

70%

), 1.

2.12

(eth

anol

70

%)

Calen

dula

com

p.; O

xalis

com

p.;

Sang

uina

ria; S

angu

inar

ia co

mp.

Sani

cula

euro

paea

L.

Fres

h wh

ole fl

ower

ing

plan

t of S

anic

ula e

urop

aea L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

45%

)Ci

chor

ium

com

p.

Saro

tham

nus s

copa

rius

see C

ytisu

s sco

pariu

s (L.

) Lin

k.

Sars

apar

illa

see S

mila

x sp

ecie

s

Scho

enoc

aulo

n offi

cinal

e (Ch

am.

et S

chlec

hten

d.) A

. Gra

y (Sy

n.:

Saba

dilla

offi

cinar

um B

rand

t &

Ratz

eb.)

Drie

d rip

e see

ds o

f Sch

oeno

caul

on o

fficin

ale (

Cham

. et

Schl

echt

end.

) A. G

ray.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

), 1.

1.10

(eth

anol

65

%)

Bryo

nia/

Eupa

toriu

m co

mp.

; Fer

rum

ph

osph

oric

um co

mp.

Scill

ase

e Urg

inea

mar

itim

a (L.

) Bak

.

Scol

open

driu

mse

e Phy

llitis

scol

open

driu

m (L

.) N

ewm

.

Seca

le co

rnut

umse

e Clav

iceps

pur

pure

a (Fr

.) Tu

l.

Sedu

m ac

re L

.Fr

esh

aeria

l par

ts of

Sed

um ac

re L

., col

lecte

d at

flow

erin

g tim

eH

ABPh

.Eur

. 1.1

.3

Selen

icere

us g

rand

iflor

us (L

.) Br

itt. e

t Ros

eFr

esh

youn

g ste

m an

d flo

wers

of S

eleni

cere

us g

rand

iflor

us (L

.) Br

itt. e

t Ros

e.H

ABPh

.Eur

. 1.1

.5, 1

.2.3

, HAB

33

dAr

nica

/Cac

tus c

omp.

; Aur

um/V

aler

iana

co

mp.

; Cac

tus g

rand

iflor

us; C

actu

s/Cr

atae

gus;

Cact

us/C

rata

egus

com

p.;

Cact

us/M

agne

sium

pho

spho

ricum

; Ca

ctus

/Meli

ssa c

omp.

; Cac

tus/

Stro

phan

tus k

ombe

; Cra

taeg

us co

mp.

; Sa

roth

amnu

s com

p.

Sem

ecar

pus a

naca

rdiu

m L

.D

ried

frui

t of S

emec

arpu

s ana

rcar

dium

L. (

Anac

ardi

um o

rient

ale

L.)

(HAB

); Ph

.Eur

.ac

c. to

mon

ogra

ph

Ph.E

ur. (

1.1.

10, e

than

ol

90%

) or H

AB

mon

ogra

ph (a

nd P

h.Eu

r. 1.

1.8)

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


126

Sene

cio

bico

lor (

Will

d.) T

od.

Fres

h ae

rial p

arts

of S

enec

io b

icol

or (W

illd.

) Tod

., col

lecte

d be

fore

flo

werin

gPh

.Eur

. 1.1

.7Ci

nera

ria m

ariti

ma;

Cine

raria

/Ros

ae

aeth

erol

eum

Sene

cio

jaco

baea

L.

Fres

h ae

rial p

arts

of S

enec

io ja

coba

ea L

., col

lecte

d at

flow

erin

g tim

eH

AB 3

3dSe

neci

o co

mp.

Sene

gase

e Pol

ygal

a sen

ega L

.

Senn

ase

e Cas

sia an

gusti

folia

Vah

l.

Sere

noa r

epen

s (W

. Bar

tram

) Sm

all (

Syn.

Sab

al se

rrul

ata

(Mich

aux)

T. N

utta

l ex

Schu

ltes &

Sc

hulte

s

Drie

d rip

e fru

it of

Ser

enoa

repe

ns (W

. Bar

tram

) Sm

all (

Syn.

Sab

al

serr

ulat

a (M

ichau

x) T

. Nut

tal e

x Sc

hulte

s & S

chul

tes

Ph.E

ur.;

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Berb

eris/

Saba

l com

p.; S

abal

/Sol

idag

o co

mp.

Sily

bum

mar

ianu

m (L

.) G

aert

n.M

atur

e fru

it, d

evoi

d of

the p

appu

s, of

Sily

bum

mar

ianu

m (L

.) G

aert

ner

HAB

; Ph

.Eur

.; Ph

.fr.

Acco

rdin

g to

the

relev

ant m

onog

raph

(H

AB o

r Ph.

fr.)

Aesc

ulus

/Que

rcus

com

p.; A

naga

llis

com

p.; C

ardu

us m

aria

nus;

Card

uus

mar

ianu

s/ V

iscum

Mal

i com

p.; C

ardu

us

mar

ianu

s/O

xalis

; Che

lidon

ium

com

p.;

Lyco

podi

um co

mp.

Smila

x ar

istol

ochi

ifolia

Mill

. (S

yn.: S

. med

ica S

chlec

hten

d. et

Ch

am)

Drie

d un

derg

roun

d pa

rts o

f Sm

ilax

arist

oloc

hiifo

lia M

ill. (

S.

med

ica S

chlec

hten

d. et

Cha

m) a

nd re

lated

spec

ies

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.10

(eth

anol

55

%),

1.2.

12 (e

than

ol

70%

)

Répe

rtoire

de m

éd.

anth

r.: S

arsa

paril

la

Sola

num

dul

cam

ara L

.Fr

esh

flowe

rs o

f Sol

anum

dul

cam

ara L

.Ph

.Eur

. 1.2

.11;

dec

octio

n wi

th w

ater

and

etha

nol

96%

(12:

9.5)

(DER

1:

2.15

)

Dul

cam

ara/

Lysim

achi

a

Sola

num

dul

cam

ara L

.D

ried,

lign

ified

stem

s of S

olan

um d

ulca

mar

a L.

DAB

6

Erg.

B.Aq

ueou

s dec

octio

n to

geth

er w

ith o

ther

dr

ugs

Siru

pus Th

ymi c

omp.

Sola

num

dul

cam

ara L

.Fr

esh,

youn

g, b

loom

ing,

leaf

y-ste

m o

f Sol

anum

dul

cam

ara L

.Ph

.fr.

Ph.E

ur. 1

.1.1

0 (e

than

ol

45%

)

Sola

num

lyco

pers

icum

see L

ycop

ersic

on ly

cope

rsic

um (L

.) Ka

rst.

ex F

arw.

Solid

ago

virg

aure

a L.

Fres

h in

flore

scen

ce o

f Sol

idag

o vi

rgau

rea L

.H

AB; P

h.fr.

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

55%

)Aq

uilin

um co

mp.

; Sab

al/S

olid

ago

com

p.

Solid

ago

virg

aure

a L.

Fres

h ae

rial p

arts

of S

olid

ago

virg

aure

a L., c

ollec

ted

at fl

ower

ing

time

HAB

12c

, 33c

Aesc

ulus

/Pru

nus c

omp.

; Ber

beris

/Ju

nipe

rus c

omp.

; Sci

lla co

mp.

; Sol

idag

o vi

rgau

rea

Solu

m u

ligin

osum

Fres

h m

oist

peat

from

moo

rland

[e.g

. upl

and

moo

r]se

e App

. 2.6

: Pea

t mos

s ex

tract

com

posit

ion

I an

d Pe

at m

oss e

xtra

ct

com

posit

ion

II

Solu

m u

ligin

osum

com

p.Va

dem

ecum

: Sol

um

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


127

Spar

tium

scop

ariu

mse

e Cyt

isus s

copa

rius (

L.) L

ink.

Spig

elia a

nthe

lmia

L.

Drie

d ae

rial p

arts

of Sp

igeli

a ant

helm

ia L

.H

ABPh

.Eur

. 1.1

.8 (e

than

ol

90%

)

Spin

acia

oler

acea

L.

Fres

h un

derg

roun

d pa

rts o

f Spi

naci

a oler

acea

L.

HAB

34f

Frag

aria

/Urt

ica c

omp.

; Sen

ecio

com

p.

Spira

ease

e Fili

pend

ula u

lmar

ia (L

.) M

axim

.

Spiri

tus e

vino

see V

itis v

inife

ra L

.

Stac

hys o

fficin

alis

(L.)

Trev

.Fr

esh

aeria

l par

ts of

Stac

hys o

fficin

alis

(L.)

Trev

., col

lecte

d at

flo

werin

g tim

eH

ABPh

.Eur

. 1.1

.5, 1

.1.1

0 (e

than

ol 6

5%)

Beto

nica

/Ros

mar

inus

Stap

hysa

gria

see D

elphi

nium

stap

hisa

gria

L.

Stic

tase

e Lob

aria

pul

mon

aria

(L.)

Hoff

m.

Stra

mon

ium

see D

atur

a stra

mon

ium

L.

Stro

phan

thus

kom

be O

liv.

Fatty

oil

from

the s

eeds

of S

troph

anth

us k

ombe

Oliv

.AP

ICi

nis A

rnic

ae co

mp.

; Oleu

m

Stro

phan

thi;

Ono

pord

on co

mp.

/Ado

nis

Stro

phan

thus

kom

be O

liv.

Drie

d rip

e see

ds o

f Stro

phan

thus

kom

bé O

liv.

Ph.E

ur. 1

.2.6

(eth

anol

70

%),

HAB

35b

Auru

m/S

troph

anth

us k

ombe

; Aur

um/

Valer

iana

com

p.; C

actu

s/St

roph

antu

s ko

mbe

; Nico

tiana

/Stro

phan

tus c

omp.

; O

leum

Stro

phan

thi;

Stro

phan

thus

co

mp.

; Stro

phan

thus

kom

be

Stry

chno

s ign

atii

P.J. B

ergi

usD

ried,

ripe

seed

s of S

tryc

hnos

igna

tii J.

P. Be

rgiu

s.Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

), 1.

1.10

(eth

anol

65

%, 3

-5 w

eeks

), H

AB

35b

Apis

regi

na/A

urum

com

p.; I

gnat

ia;

Igna

tia co

mp.

; Sep

ia co

mp.

Stry

chno

s nux

-vom

ica L

.D

ried,

ripe

seed

s of S

tryc

hnos

nux

-vom

ica L

.Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

), 1.

1.10

(eth

anol

65

%);

HAB

35b

Cocc

ulus

/Oleu

m P

etra

e com

p.;

Gen

tiana

com

p.; N

icotia

na/N

ux vo

mic

a co

mp.

; Nux

vom

ica;

Nux

vom

ica c

omp.

; Rh

us/S

alix

com

p.; R

obin

ia co

mp.

Styr

ax to

nkin

ensis

see B

enzo

e

Sym

phyt

um o

fficin

ale L

.Fr

esh

unde

rgro

und

part

s of S

ymph

ytum

offi

cinal

e L.

HAB

Ph.E

ur. 1

.1.5

, 1.2

.11,

H

AB 3

4cAl

lium

cepa

/Ten

do co

mp.

; Ant

imon

it co

mp.

; Arn

ica c

omp.

; Arn

ica/

Sym

phyt

um co

mp.

; Art

icul

atio

ta

locr

ural

is co

mp.

; Sal

via c

omp.

; St

annu

m/S

ymph

ytum

com

p.;

Sym

phyt

um; S

ymph

ytum

com

p.

Sym

phyt

um o

fficin

ale L

.Fr

esh

aeria

l par

ts of

Sym

phyt

um o

fficin

ale L

., col

lecte

d at

flo

werin

g tim

eH

AB 1

2cAr

gent

um/U

rtic

a com

p.; C

alen

dula

/Ur

tica c

omp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


128

Syzy

gium

arom

atic

um (L

.) M

err.

et L

. M. P

erry

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

from

the d

ried

flowe

r bu

ds o

f Syz

ygiu

m ar

omat

icum

(L.)

Mer

r. et

L. M

. Per

ry (s

yn.

Euge

nia c

aryo

phyl

lus [

Spre

ng.]

Bullo

ck et

S.G

. Har

rison

)

Ph.E

ur.

API

Cera

tum

Rat

anhi

ae co

mp.

; Rat

anhi

a co

mp.

; Res

ina L

aric

is/So

lutio

Myr

rhae

ba

lsam

ica;

Solu

tio M

yrrh

ae b

alsa

mic

a; Sp

iritu

s con

tra tu

ssim

; Spi

ritus

Meli

ssae

co

mp.

Syzy

gium

arom

atic

um (L

.) M

err.

et L

. M. P

erry

Who

le flo

wer b

uds o

f Syz

ygiu

m ar

omat

icum

(L.)

Mer

r. et

L.M

. Pe

rry (

syn.

Eug

enia

cary

ophy

llus [

Spre

ng.]

Bullo

ck et

S.G

. H

arris

on) d

ried

until

they

bec

ome r

eddi

sh-b

rown

Ph.E

ur.

Ph.E

ur. 1

.2.1

3; et

hano

lic

disti

llate

(tog

ethe

r with

ot

her d

rugs

)

Absin

thiu

m/C

aryo

phyl

li co

mp.

; Ce

ntau

rium

com

p.

Taba

cum

see N

icot

iana

taba

cum

L.

Tara

xacu

m o

ffici

nale

F.H. W

igg.

(fr

.: Tar

axac

um o

ffici

nale

Web

er)

Who

le fre

sh fl

ower

ing

plan

ts of

Tar

axac

um o

ffici

nale

F.H. W

igg.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.3, 1

.1.1

0 (e

than

ol 4

5%),

HAB

21,

34

c

Agro

pyro

n co

mp.

; Ana

galli

s com

p.;

Aqui

linum

com

p.; C

helid

oniu

m co

mp.

; Ch

ryso

splen

ium

com

p.; C

ichor

ium

/Ta

raxa

cum

com

p.; G

entia

na co

mp.

; Ta

raxa

cum

; Tar

axac

um St

anno

cultu

m;

Tara

xacu

m St

anno

cultu

m/H

epar

Bov

is

Tara

xacu

m o

ffici

nale

F.H. W

igg.

Fres

h un

derg

roun

d pa

rts o

f Tar

axac

um o

ffici

nale

F.H. W

igg.

co

llect

ed in

autu

mn

(aut

umna

le) o

r spr

ing

(ver

nale)

HAB

34c

; Ph.

Eur.

1.1.

2 (th

e lat

ex o

nly i

s pr

oces

sed)

Tara

xacu

m

Tart

arus

crud

usse

e Viti

s vin

ifera

L.

Teuc

rium

mar

um L

.Fr

esh

flowe

ring,

aeria

l par

ts of

Teu

criu

m m

arum

L.

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

65%

)Ré

perto

ire d

e méd

. an

thr.

Teuc

rium

scor

odon

ia L

.Fr

esh

aeria

l par

ts of

flow

erin

g pl

ants

of T

eucr

ium

scor

odon

ia L

.H

AB; P

h.fr.

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

65%

)Ka

lium

/Teu

criu

m co

mp.

; Sam

bucu

s/Te

ucriu

m co

mp.

; Teu

criu

m sc

orod

onia

Teuc

rium

scor

odon

ia L

.D

ried

aeria

l par

ts of

flow

erin

g pl

ants

of T

eucr

ium

scor

odon

ia L

.AP

I, AP

C 4.

3Sp

ecie

s pul

mon

ales

; Teu

criu

m

scor

odon

ia

Thuj

a occ

iden

talis

L.

Fres

h lea

fy b

ranc

hes o

f Thuj

a occ

iden

talis

L., c

ollec

ted

pref

erab

ly

in sp

ring

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

65

%)

Thuj

a occ

iden

talis

L.

Fres

h, le

afy,

one-

year

-old

twig

s of Th

uja o

ccid

enta

lis L

.H

ABPh

.Eur

. 1.1

.5, H

AB 1

2c,

22, 3

3eAr

gent

um n

itric

um co

mp.

; Arg

entu

m/

Urtic

a com

p.; C

alen

dula

/Urt

ica c

omp.

; M

ajora

na/Th

uja c

omp.

; Prim

ula A

uro

culta

com

p.; S

abal

/Sol

idag

o co

mp.

; Th

uja c

omp.

; Thuj

a occ

iden

talis

; Thuj

a oc

cide

ntal

is Ar

gent

o cu

lta; V

espa

cr

abro

com

p.

Thym

us se

rpyl

lum

L. e

men

d.

Mill

.W

hole

or cu

t, dr

ied,

flow

erin

g ae

rial p

arts

of Th

ymus

serp

yllu

m L

.Ph

.Eur

.D

ecoc

tion

with

wat

er,

toge

ther

with

oth

er

herb

al d

rugs

Siru

pus Th

ymi c

omp.

; Thym

us

serp

yllu

m co

mp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


129

Thym

us vu

lgar

is L.

, Th

ymus

zygi

s L.

Esse

ntia

l oil

obta

ined

by s

team

dist

illat

ion

from

the f

resh

flo

werin

g ae

rial p

arts

of Th

ymus

vulg

aris

L., T

. zyg

is L.

or a

m

ixtu

re o

f bot

h sp

ecie

s

Ph.E

ur.

HAB

12i

, API

Echi

nace

a/Pr

unus

com

p.; M

ajora

na/

Thuj

a com

p.; O

leum

rhin

ale;

Plan

tago

co

mp.

; Thym

i aet

hero

leum

; Thym

us

serp

yllu

m co

mp.

Thym

us vu

lgar

is L.

Fres

h ae

rial p

arts

of Th

ymus

vulg

aris

L., c

ollec

ted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.1.5

Thym

us vu

lgar

is L.

, Th

ymus

zygi

s L.

Who

le lea

ves a

nd fl

ower

s sep

arat

ed fr

om th

e pre

viou

sly d

ried

stem

s of Th

ymus

vulg

aris

L. o

r Thym

us zy

gis L

. or a

mix

ture

of

both

spec

ies.

Ph.E

ur.

Dec

octio

n wi

th w

ater

, to

geth

er w

ith o

ther

he

rbal

dru

gs

Siru

pus Th

ymi c

omp.

Tilia

cord

ata M

iller

, Ti

lia p

latyp

hyllo

s Sco

poli

Fres

h in

flore

scen

ce o

f Tili

a cor

data

Mill

er an

d Ti

lia p

latyp

hyllo

s Sc

opol

iH

AB 3

4Ph

.Eur

. 1.1

.5Fl

ores

Sam

buci

com

p./Q

uarz

Tilia

cord

ata M

iller

, Tili

a pl

atyp

hyllo

s Sco

poli,

Tili

a x

vulg

aris

Hey

ne

Who

le, d

ried

inflo

resc

ence

of T

ilia c

orda

ta M

iller

, of T

ilia

plat

yphy

llos S

cop.

, of T

ilia x

vulg

aris

Hey

ne o

r a m

ixtu

re o

f the

sePh

.Eur

.H

AB 1

2gM

alva

com

p.

Torm

entil

lase

e Pot

entil

la er

ecta

(L.)

Raeu

sch.

Toxi

code

ndro

nse

e Rhu

s tox

icode

ndro

n L.

Toxi

code

ndro

n qu

ercif

oliu

mse

e Rhu

s tox

icode

ndro

n L.

Triti

cum

aesti

vum

L.

Fatty

oil

obta

ined

from

the g

erm

of t

he g

rain

of T

ritic

um ae

stivu

m

L. b

y col

d ex

pres

sion

or o

ther

suita

ble m

echa

nica

l mea

ns an

d/or

by

extra

ctio

n. It

is th

en re

fined

.

Ph.E

ur.

API

Berb

eris/

Cheli

doni

um co

mp.

Triti

cum

aesti

vum

L. e

men

d.

Fior

i et P

aol.

Fres

h ge

rmin

ated

frui

t of T

ritic

um ae

stivu

m L

. em

end.

Fio

ri et

Pa

ol.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

), H

AB 3

3dH

irnsta

mm

/Trit

icum

Triti

cum

aesti

vum

L. e

men

d.

Fior

i et P

aol.

Fres

h pa

rts p

roje

ctin

g ou

t of t

he in

flore

senc

e spi

kelet

of T

ritic

um

aesti

vum

L. e

men

d. F

iori

et P

aol.

HAB

33d

Triti

cum

aesti

vum

L. e

men

d.

Fior

i et P

aol.

Drie

d ge

rm o

f the

gra

in o

f Trit

icum

aesti

vum

L. e

men

d Fi

ori e

t Pa

ol.

API

Hirn

stam

m/T

ritic

um; L

evist

icum

co

mp.

Triti

cum

aesti

vum

L. e

men

d.

Fior

i et P

aol.

Whe

at g

lute

nSt

artin

g m

ater

ial f

or th

e pr

epar

atio

n of

Cal

icum

sil

icicu

m co

mp.

(app

. 2.

6)

Triti

cum

repe

nsse

e Ely

mus

repe

ns (L

.) G

ould

Triti

cum

aesti

vum

L. e

men

d.

Fior

i et P

aol.

Drie

d in

flore

scen

ces o

f Trit

icum

aesti

vum

L. e

men

d. F

iori

et P

aol.

Ph.E

ur. 1

.1.1

0 (e

than

ol

65%

), 4.

1.1

(and

then

3.

2.1)

Flor

es T

ritici

com

p.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


130

Trop

aeol

um m

ajus L

.Fr

esh

aeria

l par

ts of

Tro

paeo

lum

maju

s L., c

ollec

ted

at fl

ower

ing

time

HAB

12c

, 33b

, 33c

Belli

s/Tr

opae

olum

; Cal

endu

la/

Trop

aeol

um co

mp.

; Pla

cent

a/Tr

opae

olum

; Tro

paeo

lum

com

p.

Tulip

a silv

estr

is L.

Fres

h wh

ole fl

ower

ing

plan

t of T

ulip

a silv

estr

is L.

HAB

33a

Vade

mec

um: T

ulip

a

Urgi

nea m

ariti

ma (

L.) B

aker

se

nsu

latio

re (e

.g. U

rgin

ea

num

idic

a [Jo

rd. e

t Fou

rr.] G

rey)

Fres

h, fl

eshy

scal

e lea

ves o

f the

red-

scal

ed su

bspe

cies

of U

rgin

ea

mar

itim

a (L.

) Bak

er se

nsu

latio

re (e

.g. U

rgin

ea n

umid

ica [

Jord

. et

Four

r.] G

rey)

with

a cle

arly

det

ecta

ble s

cilli

rosid

e con

tent

HAB

Ph.E

ur. 1

.1.5

, 1.2

.3, H

AB

33b

Adon

is/Sc

illa c

omp.

; Con

valla

ria/

Prim

ula c

omp.

; Sci

lla al

ba; S

cilla

com

p.

Urtic

a dio

ica L

.W

hole,

fres

h, fl

ower

ing

plan

ts of

Urt

ica d

ioic

a L.

HAB

; Ph

.Eur

.Ph

.Eur

. 1.1

.3, 1

.1.4

, 1.

1.10

(eth

anol

45%

), H

AB 3

3c; e

xtra

ctio

n wi

th et

hano

l 73%

and

sucr

ose (

3:2)

(D

rug:

excip

ient

1:0

.9)

Aqua

Mar

is co

mp.

; Ber

beris

e fr

uctib

us

com

p.; C

helid

oniu

m co

mp.

; Fer

rum

sil

icic

um co

mp.

; Fra

garia

/Urt

ica;

Frag

aria

/Urt

ica/

Gen

tiana

; Tro

paeo

lum

co

mp.

; Urt

ica d

ioic

a

Urtic

a dio

ica L

.Fr

esh

aeria

l par

ts of

Urt

ica d

ioic

a L.

Ph.E

ur. 1

.1.4

, 1.1

.7 an

d 4.

2.1,

HAB

21

Conc

hae/

Ferr

um u

stum

com

p.; F

erru

m

ustu

m co

mp.

; Urt

ica d

ioic

a; Ur

tica

dioi

ca F

erro

culta

Urtic

a dio

ica L

.D

ried

flowe

rs o

f Urt

ica d

ioic

a L.

Ph.E

ur. 1

.2.1

3, in

fusio

n wi

th et

hano

l 33%

(DER

1:

6) o

r with

wat

er

toge

ther

with

oth

er

herb

al d

rugs

Caps

ella/

Majo

rana

com

p.

Urtic

a dio

ica L

.D

ried,

aeria

l par

ts wi

th m

axim

um 3

mm

thick

stem

s of U

rtic

a di

oica

L., c

ollec

ted

shor

tly b

efor

e flow

erin

gH

AB 1

2gAr

nica

/Lap

pa co

mp.

; Bet

ula/

Lapp

a co

mp.

; Lev

istic

um co

mp.

; Urt

ica d

ioic

a

Urtic

a dio

ica L

.Fr

esh

unde

rgro

und

part

s of U

rtic

a dio

ica L

.H

AB 2

1 (s

ee A

pp.2

.5

Urtic

a dio

ica F

erro

culta

, Ra

dix)

Urtic

a dio

ica;

Urtic

a dio

ica F

erro

culta

Urtic

a ure

ns L

.Fr

esh,

who

le flo

werin

g pl

ant o

f Urt

ica u

rens

L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

45

%)

Berb

eris,

Pla

nta t

ota/

Urtic

a ure

ns;

Prim

ula A

uro

culta

com

p.

Urtic

a ure

ns L

.Fr

esh,

flow

erin

g ae

rial p

arts

of U

rtic

a ure

ns L

.BP

; HAB

Ph.E

ur. 1

.1.3

, 1.1

.4, H

AB

12c,

33c

Arge

ntum

/Urt

ica c

omp.

; Arn

ica/

Urtic

a ur

ens;

Berb

eris/

Pros

tata

com

p.;

Berb

eris/

Saba

l com

p.; B

erbe

ris/S

epia

co

mp.

; Ber

beris

/Urt

ica u

rens

, Her

ba;

Berb

eris/

Ute

rus c

omp.

; Cal

endu

la/

Urtic

a com

p.; P

runu

s/Ro

smar

inus

co

mp.

; Urt

ica c

omp.

Urtic

a ure

ns L

.D

ried,

aeria

l par

ts of

Urt

ica u

rens

L.

Ph.E

ur. 1

.2.1

3 (e

than

ol

36%

), 1.

4.4

Berb

eris/

Urtic

a ure

ns, H

erba

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


131

Usne

a bar

bata

(L.)

Wig

g.D

ried

thal

lus f

rom

Usn

ea P.

Br.

ex A

dans

. spe

cies,

espe

cial

ly

Usne

a bar

bata

(L.)

Wig

g.Ph

.Eur

. 1.1

.10

(eth

anol

65

%);

extra

ctio

n wi

th

wate

r tog

ethe

r with

ot

her l

ichen

s (D

ER 1

:6)

Lich

enes

com

p.

Uva

urs

ise

e Arc

tosta

phyl

os u

va-u

rsi

Valer

iana

offi

cinal

is L.

Fres

h, u

nder

grou

nd p

arts

of V

aler

iana

offi

cinal

is L.

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

55

%)

Répe

rtoire

de m

éd.

anth

r.: V

aler

iana

offi

cinal

is, ra

dix

Valer

iana

offi

cinal

is L.

sens

u lat

iore

Fres

h un

derg

roun

d pa

rts o

f Val

eria

na o

fficin

alis

L. se

nsu

latio

reH

ABPh

.Eur

. 1.2

.9, H

AB 3

3c,

extra

ct w

ith w

ater

and

sucr

ose (

2:4:

4)

Auru

m/V

aler

iana

com

p.; A

vena

com

p.;

Aven

a sat

iva c

omp.

; Ave

na/P

assifl

ora

com

p.; C

inis

Arni

cae c

omp.

; H

yosc

yam

us/V

aler

iana

; Hyp

eric

um/

Pass

iflor

a com

p.; V

aler

iana

com

p.

Valer

iana

offi

cinal

is L.

Drie

d, w

hole

or fr

agm

ente

d un

derg

roun

d pa

rts o

f Val

eria

na

officin

alis

L. s.

l., in

cludi

ng th

e rhi

zom

e sur

roun

ded

by th

e roo

ts an

d sto

lons

(HAB

); Ph

.Eur

.Ph

.Eur

. 1.1

.8 (e

than

ol

70%

)

Vauc

heria

DC

spec

ies

Fres

h, w

hole

orga

nism

of V

auch

eria

DC

spec

ies

Ph.E

ur. 1

.1.5

, 1.1

.10

(eth

anol

65%

)Va

uche

ria

Vera

trum

albu

m L

.Ca

refu

lly d

ried

rhiz

ome w

ith at

tach

ed ro

ots o

f Ver

atru

m al

bum

L.

HAB

Ph.E

ur. 1

.1.8

(eth

anol

70

%),

1.2.

12 (e

than

ol

70%

)

Dro

sera

/Ipec

acua

nha c

omp.

; Ver

atru

m

albu

m

Vera

trum

albu

m L

.Fr

esh,

und

ergr

ound

par

ts of

Ver

atru

m al

bum

L.

HAB

33c

Equi

setu

m/R

enes

com

p.; S

koro

dit

com

p.; V

erat

rum

albu

m; V

erat

rum

co

mp.

Verb

ascu

m d

ensifl

orum

Ber

tol.

Fres

h, u

nrip

e fru

its o

f Ver

basc

um d

ensifl

orum

Ber

tol.

Ph.E

ur. 1

.1.7

Verb

ascu

m co

mp.

Vero

nica

offi

cinal

is L.

Drie

d ae

rial p

arts

of V

eron

ica o

fficin

alis

L., c

ollec

ted

at fl

ower

ing

time

HAB

Ph.E

ur. 1

.2.1

2 (e

than

ol

50%

), AP

C 4.

3Lo

belia

com

p.; V

eron

ica o

fficin

alis

Vero

nica

offi

cinal

is L.

Fres

h ae

rial p

arts

of V

eron

ica o

fficin

alis

L., c

ollec

ted

at fl

ower

ing

time

Ph. E

ur. 1

.1.3

, HAB

33c

Vero

nica

offi

cinal

is

Vinu

mse

e Viti

s vin

ifera

L.

Viol

a tric

olor

L.

Fres

h ae

rial p

arts

of V

iola

trico

lor L

., col

lecte

d at

flow

erin

g tim

eH

ABPh

.Eur

. 1.1

.3, H

AB 3

3eTr

opae

olum

com

p.

Viro

la se

bife

ra A

ubl.

Fres

h ju

ice o

f Viro

la se

bife

ra A

ubl.

obta

ined

by i

ncisi

ng th

e bar

k,

and

pres

erve

d wi

th an

appr

oxim

ately

equa

l vol

ume o

f eth

anol

(9

6%) (

Ph.E

ur.)

HAB

Ph.E

ur. 3

.1.1

(see

mon

. H

AB (s

ol. w

ith et

hano

l 70

%))

Myr

istic

a seb

ifera

; Myr

istic

a seb

ifera

co

mp.

Visc

um al

bum

ssp.

abie

tis

(Wie

sb.)

Abro

m.

Fres

h pl

ant i

nclu

ding

frui

t and

hau

storiu

m o

f Visc

um al

bum

ssp.

ab

ietis

(Wie

sb.)

Abro

m. (

Hos

t tre

e: Ab

ies s

pecie

s)H

AB 3

4gBe

rber

is/Pr

osta

ta co

mp.

; Visc

um al

bum

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


132

Visc

um al

bum

ssp.

abie

tis (B

eck)

(W

iesb

.) Ab

rom

. (Ab

ies p

ectin

ata

(Lam

.) D

C)

Fres

h pl

ant e

xclu

ding

hau

storiu

m o

f Visc

um al

bum

ssp.

abie

tis

(Bec

k) (W

iesb

.) Ab

rom

. (H

ost t

ree:

Abie

s alb

a Mill

. (Ab

ies

pect

inat

a (La

m.)

DC)

; fir)

APC

7.2.

2Vi

scum

albu

m

Visc

um al

bum

ssp.

albu

m L

.Fr

esh

plan

t inc

ludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m ss

p.

albu

m L

. (H

ost t

rees

: Pop

ulus

spec

ies)

HAB

33f

Visc

um al

bum

Visc

um al

bum

L. s

sp. a

ustr

iacu

m

(Wie

sb.)

Vollm

.Fr

esh

plan

t inc

ludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m L

. ss

p. au

stria

cum

(Wie

sb.)

Vollm

. (H

ost t

ree:

Pinu

s spe

cies

)H

AB 3

4gVi

scum

albu

m

Visc

um al

bum

ssp.

albu

m L

.Fr

esh

plan

t exc

ludi

ng h

austo

rium

of V

iscum

albu

m ss

p. al

bum

L.

(Hos

t tre

e: M

alus

dom

estic

a Bor

kh.; A

pple

tree)

APC

7.2.

2Vi

scum

albu

m

Visc

um al

bum

ssp.

austr

iacu

m

(Wie

sb.)

Vollm

.Fr

esh

plan

t exc

ludi

ng h

austo

rium

of V

iscum

albu

m ss

p.

austr

iacu

m (W

iesb

.) Vo

llm. (

Hos

t tre

e: Pi

nus s

ylve

stris

L.; P

ine)

APC

7.2.

2Vi

scum

albu

m

Visc

um al

bum

ssp.

albu

m L

.Fr

esh

haus

toriu

m o

f Visc

um al

bum

L ss

p. al

bum

(Hos

t tre

e: M

alus

spec

ies)

HAB

33e

Visc

um al

bum

Visc

um al

bum

L. s

sp. a

lbum

Drie

d pl

ant i

nclu

ding

frui

t, ex

cludi

ng h

austo

rium

of V

iscum

al

bum

L. s

sp. a

lbum

(Hos

t tre

es: O

ak sp

ecie

s)H

AB 3

8Vi

scum

albu

m

Visc

um al

bum

ssp.

albu

m L

.D

ried

plan

t inc

ludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m ss

p.

albu

m L

. (H

ost t

rees

: Cra

taeg

us sp

ecie

s)H

AB 3

8Vi

scum

albu

m

Visc

um al

bum

ssp.

albu

m L

.D

ried

plan

t inc

ludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m ss

p.

albu

m L

. (H

ost t

rees

: Sal

ix sp

ecie

s)H

AB 3

8Vi

scum

albu

m

Visc

um al

bum

ssp.

albu

m L

.D

ried

bran

ches

with

leav

es, fl

ower

s, fr

uit o

f Visc

um al

bum

ssp.

al

bum

L. (

Hos

t tre

es: M

alus

spec

ies)

HAB

12g

Visc

um al

bum

Visc

um al

bum

L. s

sp. a

lbum

Fres

h pl

ant i

nclu

ding

frui

t and

hau

storiu

m o

f Visc

um al

bum

ssp.

al

bum

L. (

Hos

t tre

e: M

alus

dom

estic

a Bor

kh.; A

pple

tree)

HAB

34i

Berb

eris/

Ute

rus c

omp.

; Bry

onia

/Vi

scum

com

p.; C

ardu

us m

aria

nus/

Vi

scum

Mal

i com

p.; C

artil

ago/

Hor

nerz

co

mp.

; Cor

pus v

itreu

m/H

orne

rz co

mp.

; D

isci c

omp.

cum

Pul

satil

la; D

isci/

Pulsa

tilla

com

p. cu

m St

anno

; Disc

i/Vi

scum

com

p. cu

m A

rgen

to; D

isci/

Visc

um co

mp.

cum

Stan

no; E

chin

acea

/Vi

scum

; Ech

inac

ea/V

iscum

com

p.;

Equi

setu

m/R

enes

com

p.; E

quise

tum

/Vi

scum

; Len

s cris

talli

na/V

iscum

com

p.

cum

Stan

no; L

ilium

tigr

inum

com

p.;

Mag

nesit

/Mam

ma c

omp.

; Mag

nesiu

m

sulfu

ricum

/Ova

ria co

mp.

; Visc

um

albu

m

Visc

um al

bum

ssp.

albu

m L

.Fr

esh

plan

t inc

ludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m ss

p.

albu

m L

. (H

ost t

ree:

Tilia

e spe

cies

; lim

e tre

e)H

AB 3

3fCr

atae

gus/

Visc

um; V

iscum

albu

m

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


133

Visc

um al

bum

L. s

sp. a

biet

is (W

iesb

.) Ja

nch.

Drie

d pl

ants

inclu

ding

frui

t and

hau

storiu

m o

f Visc

um al

bum

L.

ssp.

abie

tis (W

iesb

.) Ja

nch.

(Hos

t tre

e: Ab

ies s

pecie

s)H

AB 3

8Vi

scum

albu

m

Visc

um al

bum

ssp.

albu

m L

.D

ried

plan

ts in

cludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m ss

p.

albu

m L

. (H

ost t

ree:

Malu

s dom

estic

a Bor

kh.)

HAB

38

Visc

um al

bum

Visc

um al

bum

L. s

sp. a

ustri

acum

(W

iesb

.)Vol

lm.

Drie

d pl

ant i

nclu

ding

frui

t and

hau

storiu

m o

f Visc

um al

bum

L.

ssp.

austr

iacu

m (W

iesb

.)Vol

lm. (

host

tree:

Pinu

s spe

cies)

HAB

38

Visc

um al

bum

Visc

um al

bum

L. s

sp. a

lbum

Drie

d pl

ant i

nclu

ding

frui

t and

hau

storiu

m o

f Visc

um al

bum

L.

ssp.

albu

m (h

ost t

ree:

Popu

lus s

pecie

s)H

AB 3

8Vi

scum

albu

m

Visc

um al

bum

L. s

sp. a

lbum

Drie

d pl

ant i

nclu

ding

frui

t and

hau

storiu

m o

f Visc

um al

bum

L.

ssp.

albu

m (h

ost t

ree:

Tilia

spec

ies)

HAB

38

Visc

um al

bum

Visc

um al

bum

ssp.

abie

tis (B

eck)

(W

iesb

.) Ab

rom

.Fr

esh

one-

year

shoo

ts fro

m m

ale a

nd fe

mal

e pla

nts i

ncl.

ripe

berr

ies o

f the

win

ter h

arve

st (H

ost t

ree:

Abie

s alb

a)H

AB 3

2Vi

scum

albu

m

Vite

x ag

nus-

castu

s L.

whol

e, rip

e, dr

ied

frui

ts of

Vite

x ag

nus-

castu

s L.

(HAB

); Ph

.Eur

.; Ph

.fr.

Ph.E

ur. 1

.1.8

(eth

anol

70

%),

1.1.

10 (e

than

ol

65%

)

Meli

ssa/

Phos

phor

us co

mp.

Vitis

vini

fera

L.

Dist

illed

red

wine

vine

gar (

acet

um vi

ni d

estil

latum

)se

e App

. 2.6

(Kal

ium

ac

etic

um co

mp.

)An

agal

lis/M

alac

hit c

omp.

; Ch

amom

illa/

Mal

achi

t com

p.; K

aliu

m

acet

icum

com

p.

Vitis

vini

fera

L.

Red

wine

vine

gar (

acet

um vi

ni)

Dist

illat

ion

(to ge

t di

stille

d re

d wi

ne

vine

gar)

Vitis

vini

fera

L.

Drie

d lea

ves o

f Viti

s vin

ifera

L.

Ph.E

ur. 1

.2.1

2 (e

than

ol

36%

), AP

ICo

ncha

e/Fe

rrum

ustu

m co

mp.

; Fr

agar

ia/V

itis;

Vitis

com

p.

Vitis

vini

fera

L.

Dist

illat

e of w

ine

Vehi

cle fo

r pre

parin

g a

tinct

ure o

f Cro

cus

sativ

us (s

ee A

pp. 2

.6,

Kaliu

m ac

etic

um co

mp.

)

Vitis

vini

fera

L.

Crea

m o

f tar

tar (

Tart

arus

crud

us)

raw

mat

eria

l for

the

prod

uctio

n of

Tar

taru

s sti

biat

us an

d So

lutio

al

kalin

a

Vitis

vini

fera

L.

Whi

te w

ine

Dist

illat

ion

(for

prep

arin

g di

stilla

te o

f wi

ne),

raw

mat

eria

l for

th

e pro

duct

ion

of

Ferr

um-Q

uarz

(see

app.

2.

6)

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.2


134

Zing

iber

offi

cina

le Ro

scoe

Drie

d, w

hole

or cu

t rhi

zom

e of Z

ingi

ber o

ffici

nale

Rosc

oe, w

ith

the c

ork

rem

oved

, eith

er co

mpl

etely

or f

rom

the w

ide,

flat s

urfa

ces

only

Ph.E

ur.

Aque

ous e

xtra

ct to

geth

er

with

oth

er h

erba

l dru

gsG

entia

na/Z

ingi

ber c

omp.

Nam

e of t

he o

rigi

nal p

lant

Abbr

evia

ted

defin

ition

of t

he p

art u

sed

Refe

renc

e to

Sta

ndar

dPr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Appendix 2.2


135

•

Ap

pend

ix 2

.3

APPENDIX 2.3

List of starting materials of zoological originAdditional Information, see p. 17-18 and pp. 65-71 Abbreviation *: p. 65


136

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

Acid

um F

orm

icae

(A

cidu

m fo

rmic

icum

e fo

rmic

a; Ac

idum

Fo

rmic

ae ve

nenu

m)

Seve

ral s

peci

es o

f woo

d an

ts of

th

e Sub

genu

s For

mic

a s. s

tr. (e

.g.

Form

ica l

ugub

ris Z

ett.,

F.

poly

cten

a För

ster,

F. pa

ralu

gubr

is Se

ifert

or F

. ruf

a L.)

Aque

ous s

olut

ion

of th

e sec

retio

n of

wo

od an

ts of

the s

ubge

nus F

orm

ica s

. str.

, co

ntai

ning

not

less

than

1.2

% m

/m o

f fo

rmic

acid

Ph.E

ur. 3

.1.1

, 3.1

.2; D

2 is

stand

ardi

zed

to

1.0%

form

ic ac

id

Liste

HAS

(10.

2012

)

Ambr

a gris

eaPh

yset

er ca

todo

n L.

(Phy

sete

r m

acro

ceph

alus

L.)

Subs

tanc

e pro

duce

d in

the d

iges

tive

syste

m o

f the

sper

m w

hale

HAB

; Ph.

fr.H

AB A

mbr

a gris

ea,

Ph.E

ur. 1

.1.1

1 (P

h.fr.

Et

hano

l 90%

)

Zinc

um va

leria

nicu

m co

mp.

Amni

onBo

s tau

rus L

.Am

nion

from

the b

ovin

e foe

tus

Ph.E

ur. 2

.2.2

Vade

mec

um: A

mni

on

Anus

Bos t

auru

s L.

Anus

from

the c

alf

Ph.E

ur. 2

.2.3

Prun

us/R

osm

arin

us co

mp.

Aort

aBo

s tau

rus L

.D

iffer

ent s

ectio

ns o

f the

aort

a fro

m th

e ca

lfPh

.Eur

. 2.2

.3Va

dem

ecum

[m

entio

ned

unde

r: At

ropa

bell

adon

na e

radi

ce]

Aort

aO

ryct

olag

us cu

nicu

lus L

.Ao

rta f

rom

the r

abbi

tPh

.Eur

. 2.1

.1IV

AA st

atem

ent 2

013

Apis

mell

ifica

Apis

mell

ifera

L.

Live

wor

ker h

oney

bee

(HAB

); Ph

.Eur

.ac

c.to

mon

ogra

ph

(60-

70%

etha

nol);

H

AB m

onog

raph

; Ph

.Eur

. 2.1

.1, 2

.1.2

, 2.

2.3

Acon

itum

/Arn

ica c

omp.

/Api

s; Ap

is co

mp.

; Api

s cum

Lev

istic

o; A

pis

mell

ifica

; Api

s/Ar

nica

; Api

s/Ar

nica

co

mp.

; Api

s/Be

llado

nna;

Apis/

Bella

donn

a/M

ercu

rius;

Apis/

Berb

eris

com

p.; A

pis/

Bryo

nia;

Apis/

Lary

nx

com

p.; A

pis/

Levi

sticu

m; A

pis/

Rhus

to

xico

dend

ron

com

p.; A

rnic

a/Le

visti

cum

com

p.; B

erbe

ris/P

yrit

com

p.; B

olus

Euc

alyp

ti co

mp.

; Br

yoni

a/Pu

lsatil

la co

mp.

; Bry

onia

/Sp

ongi

a com

p.; E

chin

acea

/Mer

curiu

s co

mp.

; Equ

isetu

m/R

enes

com

p.;

Euca

lypt

us co

mp.

; Mag

nesit

/Mam

ma

com

p.; M

agne

sium

sulfu

ricum

/Ova

ria

com

p.

Apis

regi

naAp

is m

ellife

ra L

.W

hole

quee

n ce

ll wi

th la

rvae

and

nour

ishin

g sa

pPh

.Eur

. 2.2

.3Ap

is re

gina

com

p.; A

pis r

egin

a/Au

rum

co

mp.

; Fra

garia

/Urt

ica c

omp.

; Ova

ria

com

p.; T

este

s com

p.

Apisi

num

Apis

mell

ifera

L.

Drie

d po

ison

from

the h

oney

bee

HAB

Mon

ogra

phBo

lus E

ucal

ypti

com

p.; Z

inno

ber

com

p.

Appe

ndix

verm

iform

isO

ryct

olag

us cu

nicu

lus L

.Ve

rmifo

rm p

roce

ss o

f the

blin

d gu

t fro

m

the r

abbi

tPh

.Eur

. 2.2

.2D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

•

Appendix 2.3


137

Aran

ea av

icul

aris

Avic

ular

ia av

icul

aria

L.

Who

le bi

rd sp

ider

Ph.E

ur. 1

.1.9

(eth

anol

90

%),

1.1.

11 (e

than

ol

65%

)

Myg

ale c

omp.

IVAA

stat

emen

t 201

3

Aran

ea d

iade

ma

Aran

eus d

iade

mat

us C

lerk

Who

le di

adem

spid

er(H

AB 1

924)

Ph.E

ur. 1

.1.9

(HAB

19

24: 9

0% E

than

ol),

2.1.

1, 2

.2.3

Vade

mec

um: A

rane

a

Arte

ria b

asila

ris*

Bos t

auru

s L.

Arte

ria b

asila

ris fr

om th

e cal

fPh

.Eur

. 2.2

.3IV

AA st

atem

ent 2

013

Arte

ria b

rach

ialis

Bos t

auru

s L.

Arte

ria b

rach

ialis

from

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Arte

ria ca

rotis

co

mm

unis

et si

nus

caro

ticus

Bos t

auru

s L.

Part

s fro

m th

e Arte

ria ca

rotis

com

mun

is de

xtra

and

sinist

ra fr

om th

e cal

fPh

.Eur

. 2.2

.3Va

dem

ecum

: Arte

ria

caro

tis co

mm

unis

et

sinus

caro

ticus

Arte

ria ce

rebr

i med

ia*

Bos t

auru

s L.

Arte

ria ca

rotis

cere

bral

is an

d its

ra

mifi

catio

ns fr

om th

e cal

fPh

.Eur

. 2.2

.3Va

dem

ecum

: Arte

ria

cere

bri m

edia

Arte

ria co

eliac

ase

e Tru

ncus

coeli

acus

IVAA

stat

emen

t 201

3

Arte

ria co

rona

riaBo

s tau

rus L

.Ar

teria

coro

naria

from

the c

alf

Ph.E

ur. 2

.2.3

Vade

mec

um: A

rteria

co

rona

ria

Arte

ria fe

mor

alis

Bos t

auru

s L.

Arte

ria fe

mor

alis

from

the c

alf

Ph.E

ur. 2

.2.3

Vade

mec

um

[men

tione

d un

der:

Seca

le/Bl

eigl

anz c

omp.

]

Arte

ria o

phth

alm

ica*

Bos t

auru

s L.

Arte

ria o

phth

alm

ica e

xter

na fr

om th

e cal

fPh

.Eur

. 2.2

.3Va

dem

ecum

: Arte

ria

opht

halm

ica

Arte

ria p

oplit

eaBo

s tau

rus L

.Ar

teria

pop

litea

from

the c

alf

Ph.E

ur. 2

.2.3

Blei

glan

z/Se

cale

com

p.

Arte

ria p

ulm

onal

isBo

s tau

rus L

.Ar

teria

pul

mon

alis

from

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Arte

ria re

nalis

Bos t

auru

s L.

Arte

ria re

nalis

from

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Arte

ria ve

rtebr

alis

Bos t

auru

s L.

Part

s fro

m th

e Arte

ria ve

rtebr

alis

dext

ra

and

sinist

ra fr

om th

e cal

fPh

.Eur

. 2.2

.3

Arte

riae*

Bos t

auru

s L.

Part

s of A

rteria

bas

ilaris

, Arte

ria

brac

hial

is, A

rteria

coro

naria

, Arte

ria

fem

oral

is, A

rteria

mes

ente

rica,

Arte

ria

pulm

onal

is an

d Ar

teria

rena

lis fr

om th

e ca

lf

Ph.E

ur. 2

.2.3

Vade

mec

um: A

rteria

e

Artic

ulat

ioBo

s tau

rus L

.Th

e fol

lowi

ng ar

ticul

atio

ns: c

ubits

, gen

us,

hum

eri,

radi

ocar

pa, s

acro

iliac

a, su

btal

aris,

talo

crur

alis,

te

mpo

rom

andi

bula

ris

Ph.E

ur. 2

.2.2

, APC

3.

3.1

Liste

HAS

(10.

2012

) AB

MA-

Vade

mec

um:

Artic

ulat

io-A

rgen

tum

p.

49

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


138

Artic

ulat

io co

xae

Bos t

auru

s L.

Hip

join

t with

equa

l par

ts fro

m th

e ac

etab

ulum

, Cap

ut fe

mor

is, jo

int c

artil

age

and

Liga

men

tum

capi

tis fe

mor

is fro

m th

e ca

lf

Ph.E

ur. 2

.2.2

Artic

ulat

io co

xae

Artic

ulat

io cu

biti

Bos t

auru

s L.

Elbo

w jo

int w

ith p

arts

from

the b

ones

th

at fo

rm th

e joi

nt, j

oint

cart

ilage

, par

ts of

jo

int c

apsu

le, sy

novi

a and

par

ts of

the

ligam

ents

from

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Artic

ulat

io ge

nus

Bos t

auru

s L.

Knee

join

t with

par

ts fro

m th

e bon

es th

at

form

the j

oint

, men

iscus

, joi

nt ca

psul

e, lig

amen

ts, ca

rtila

ge an

d sy

novi

a fro

m th

e ca

lf

Ph.E

ur. 2

.2.2

Artic

ulat

io ge

nus

Artic

ulat

io h

umer

iBo

s tau

rus L

.Sh

ould

er jo

int w

ith p

arts

of th

e bon

es th

at

form

the j

oint

, car

tilag

e, pa

rts o

f the

join

t ca

psul

e and

the B

ursa

inte

rtube

rcul

aris

from

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um

[men

tione

d un

der:

Acon

it Sc

hmer

zöl]

Artic

ulat

io

inte

rpha

lang

eaBo

s tau

rus L

.Pa

rts o

f the

toe j

oint

from

the f

ore

extre

miti

es fr

om th

e cal

fPh

.Eur

. 2.2

.2Ca

rtila

go/E

chin

acea

com

p.

Artic

ulat

io

radi

ocar

pea

Bos t

auru

s L.

Radi

ocar

pal j

oint

with

par

ts of

the b

ones

, ca

rtila

ge, l

igam

ents

and

join

t cap

sule

that

fo

rm th

e pro

xim

al ca

rpal

join

t fro

m th

e ca

lf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Artic

ulat

io sa

croi

liaca

Bos t

auru

s L.

Part

s of I

lium

and

sacr

um fr

om th

e joi

nt

area

, joi

nt ca

psul

e and

liga

men

ts fro

m th

e ca

lf

Ph.E

ur. 2

.2.2

Der

Mer

kurs

tab:

So

nder

heft

1999

Artic

ulat

io su

btal

aris

Bos t

auru

s L.

Part

s of t

he ca

rtila

ge, j

oint

caps

ule a

nd

syno

via o

f the

par

t dist

al to

the O

s ce

ntro

quar

tale

of th

e joi

nt li

ke u

nion

be

twee

n Ta

lus a

nd C

alca

neus

from

the

calf

Ph.E

ur. 2

.2.2

Artic

ulat

io ta

locr

ural

is co

mp.

Artic

ulat

io ta

locr

ural

isBo

s tau

rus L

.Pa

rts o

f the

bon

es fo

rmin

g th

e joi

nt, T

ibia

an

d Ta

lus,

of th

e joi

nt ca

psul

e, lig

amen

ts as

well

as sy

novi

a of t

he an

kle j

oint

from

th

e cal

f

Ph.E

ur. 2

.2.2

Artic

ulat

io ta

locr

ural

is co

mp.

Artic

ulat

io

tem

poro

man

dibu

laris

Bos t

auru

s L.

Part

s of t

he O

s man

dibu

lare

and

of th

e Os

tem

pora

le in

the j

oint

area

, of t

he jo

int

caps

ule,

of th

e lig

amen

ts, o

f car

tilag

e, as

we

ll as

syno

via f

rom

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


139

Artic

ulat

ione

s in

terc

arpe

aeBo

s tau

rus L

.Pa

rts o

f the

bon

es fo

rmin

g th

e joi

nt, o

f th

e car

tilag

e lik

e sur

face

of t

he

artic

ulat

ion,

as w

ell as

syno

via f

rom

the

calf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Artic

ulat

ione

s in

terv

erte

bral

es

cerv

ical

es

Bos t

auru

s L.

Regi

on o

f the

cerv

ix: P

arts

of th

e bon

e pr

oces

sus t

hat p

artic

ipat

e to

the

inte

rver

tebr

al jo

ints,

cart

ilage

and

join

t ca

psul

es, a

s well

as sy

novi

a fro

m th

e cal

f

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Artic

ulat

ione

s in

terv

erte

bral

es

lum

bales

Bos t

auru

s L.

Regi

on o

f the

loin

: Par

ts of

the b

one

proc

essu

s tha

t par

ticip

ate t

o th

e in

terv

erte

bral

join

ts, ca

rtila

ge an

d jo

int

caps

ules

, as w

ell as

syno

via f

rom

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Ascid

iaSe

vera

l spe

cies o

f pro

to-

Chor

date

s of A

scid

ia g

roup

The w

hole

anim

alAP

C 3.

3.1

ABM

A-Va

dem

ecum

Ar

teria

e-Ba

rium

p. 4

8

Atla

s*Bo

s tau

rus L

.Pa

rts o

f the

Atla

s (1.

cerv

ical

) fro

m th

e ca

lfPh

.Eur

. 2.2

.2IV

AA st

atem

ent 2

013

Audi

tum

Bos t

auru

s L.

The w

hole

hear

ing

orga

n (p

arts

of co

chlea

fro

m th

e ske

letou

s as w

ell as

der

mal

par

ts of

the i

nner

ear f

rom

the c

alf

APC

3.3.

1AB

MA-

Vade

mec

um

Audi

tum

-Arg

entu

m p

. 51

Audi

tum

inte

rnum

Bos t

auru

s L.

Inte

rnal

hea

ring

orga

n (p

arts

of co

chlea

fro

m th

e ske

letou

s as w

ell as

der

mal

par

ts of

the i

nner

ear a

nd la

byrin

thus

from

the

calf

).

APC

3.3.

1AB

MA-

Vade

mec

um

Laby

rinth

us-M

ercu

rius

p. 1

61

Axis*

Bos t

auru

s L.

Part

s of t

he A

xis (

2. ce

rivic

al) f

rom

the

calf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Bron

chi

Bos t

auru

s L.

Bron

chi f

rom

the c

alf

Ph.E

ur. 2

.2.2

Bron

chi/P

lant

ago

com

p.

Bron

chi

Ory

ctol

agus

cuni

culu

s L.

Bron

chi f

rom

the r

abbi

tPh

.Eur

. 2.1

.1Br

onch

i/Pla

ntag

o co

mp.

Bulb

us o

lfact

oriu

s*Bo

s tau

rus L

.Bu

lbus

olfa

ctor

ius o

f bot

h he

misp

here

s of

the c

ereb

rum

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: B

ulbu

s ol

fact

oriu

s

Burs

ae ar

ticul

atio

nis

hum

eri-K

ompl

exBo

s tau

rus L

.Pa

rts o

f Bur

sa m

uscu

li in

frasp

inam

and

Burs

a int

ertu

berc

ular

is hu

mer

i fro

m th

e ca

lf

Ph.E

ur. 2

.2.2

Vade

mec

um: B

ursa

e ar

ticul

atio

nis h

umer

i-Ko

mpl

ex

Calca

rea c

arbo

nica

os

trear

umse

e Con

chae

Ph.fr

.

Calci

um ca

rbon

icum

H

ahne

man

nise

e Con

chae

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


140

Cant

haris

Lytta

vesic

ator

ia L

.As

far a

s pos

sible

inta

ct sp

ecim

ens,

kille

d an

d dr

ied

at a

tem

pera

ture

not

exce

edin

g 40

°C

HAB

Ph.E

ur. 1

.1.9

(HAB

: Et

hano

l 90%

), 2.

2.3

Arge

ntum

/Urt

ica c

omp.

; Cal

endu

la/

Urtic

a com

p.; C

anth

aris;

Can

thar

is co

mp.

; Hyp

eric

um co

mp.

; Uva

urs

i co

mp.

Vade

mec

um: C

anth

aris

Card

iaSu

s scr

ofa d

omes

tica L

.Ca

rdia

, par

ts of

the w

all o

f the

stom

ach

in

the r

egio

n of

the e

ntra

nce i

nto

the

stom

ach

from

the p

ig

Ph.E

ur. 2

.2.3

Vade

mec

um: C

ardi

a

Cart

ilago

Ory

ctol

agus

cuni

culu

s L.

Cart

ilage

of j

oint

from

the r

abbi

tPh

.Eur

. 2.1

.1

Cart

ilago

artic

ular

isBo

s tau

rus L

.Ca

rtila

ge o

f the

hip

, kne

e and

shou

lder

jo

ints

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.2Ca

rtila

go co

mp.

; Car

tilag

o/H

orne

rz

com

p.; C

artil

ago/

Man

drag

ora c

omp.

Cart

ilago

artic

ular

is co

xae

Bos t

auru

s L.

Cart

ilage

of t

he h

ip jo

int f

rom

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Cart

ilago

artic

ular

is ge

nus

Bos t

auru

s L.

Cart

ilage

of t

he k

nee j

oint

from

the c

alf

Ph.E

ur. 2

.2.2

Der

Mer

kurs

tab:

So

nder

heft

1999

Cavu

m ty

mpa

ni*

Bos t

auru

s L.

Part

s of t

he w

all o

f the

Cav

um ty

mpa

ni,

as w

ell as

audi

tory

bon

es fr

om th

e cal

fPh

.Eur

. 2.2

.2Va

dem

ecum

: Cav

um

tym

pani

Cera

flav

aW

ax o

btai

ned

by m

eltin

g th

e wal

ls of

the

hone

ycom

b m

ade b

y the

hon

ey-b

ee, A

pis

mell

ifera

L., w

ith h

ot w

ater

and

rem

ovin

g fo

reig

n m

atte

r

Ph.E

ur.

API

Aesc

ulus

/Cer

a com

p.; O

leum

Pet

rae

com

p.; P

lant

ago

com

p.

Cere

bellu

mO

ryct

olag

us cu

nicu

lus L

.Ce

rebe

llum

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

nica

/Epi

phys

is/Pl

umbu

m m

ellitu

m

com

p.; A

rnic

a/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Epi

phys

is co

mp.

; Aur

um/H

ypop

hysis

com

p.;

Cere

bellu

m co

mp.

; Epi

phys

is co

mp.

; G

naph

aliu

m co

mp.

; Hyp

ophy

sis co

mp.

Cere

bellu

m*

Bos t

auru

s L.

Cere

bellu

m fr

om th

e cal

fPh

.Eur

. 2.2

.1Ar

nica

/Epi

phys

is/Pl

umbu

m m

ellitu

m

com

p.; A

rnic

a/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Epi

phys

is co

mp.

; Aur

um/H

ypop

hysis

com

p.;

Cere

bellu

m co

mp.

; Epi

phys

is co

mp.

; G

naph

aliu

m co

mp.

; Hyp

ophy

sis co

mp.

Cere

brum

Bos t

auru

s L.

Cere

brum

from

the c

alf

see a

pp. 2

.6: A

rnic

a-Ce

rebr

umAr

nica

-Cer

ebru

m

Cere

brum

, reg

io

mot

oric

a*Bo

s tau

rus L

.G

rey m

atte

r of t

he G

yrus

pra

ecen

tralis

be

long

ing

to th

e Lob

us fr

onta

lis o

f bot

h he

misp

here

s fro

m th

e cal

f

Ph.E

ur. 2

.2.1

Vade

mec

um:

Cere

brum

, reg

io

mot

oric

a

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


141

Cerv

ix u

teri

Bos t

auru

s L.

Part

s of t

he n

eck

of th

e ute

rus f

rom

the

cow

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Circ

ulus

arte

riosu

s ce

rebr

i*Bo

s tau

rus L

.Ci

rcul

us ar

terio

sus c

ereb

ri of

the p

ituita

ry

shaft

from

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Cocc

us ca

cti

Dac

tylo

pius

cocc

us C

osta

The d

ried,

fert

ilize

d, fe

mal

e of

Dac

tylo

pius

cocc

us C

osta

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.9 (H

AB

etha

nol 9

0%),

1.1.

11

(eth

anol

65%

)

Dro

sera

/Ipec

acua

nha c

omp.

IVAA

stat

emen

t 201

3

Coch

lea*

Bos t

auru

s L.

Part

s of t

he C

ochl

ea fr

om th

e ske

letou

s as

well

as d

erm

al p

arts

of th

e inn

er ea

r fro

m

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um: C

ochl

ea

Cod

liver

oil

see I

ecor

is as

elli o

leum

Colo

nSu

s scr

ofa d

omes

tica L

.Co

lon

from

the p

igPh

.Eur

. 2.1

.1, 2

.2.3

Colo

n

Colo

nO

ryct

olag

us cu

nicu

lus L

.Co

lon

from

the r

abbi

tPh

.Eur

. 2.1

.1

Colo

n sig

moi

deum

Sus s

crof

a dom

estic

a L.

Colo

n sig

moi

deum

, par

ts of

the fi

nal t

ract

of

the C

olon

des

cend

ens f

rom

the p

igPh

.Eur

. 2.2

.3Co

lon

Vade

mec

um

[men

tione

d un

der:

Erys

idor

on® 1

; M

ercu

rius v

ivus

na

tura

lis]

Colu

mna

Bos t

auru

s L.

Part

s of s

pina

l cor

d fro

m th

e cal

fAP

C 3.

3.1

ABM

A-Va

dem

ecum

: Co

lum

na-A

rgen

tum

p.

97

Colu

mna

ante

rior*

Bos t

auru

s L.

Part

s of t

he co

lum

na an

terio

r of t

he sp

inal

ch

ord

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Colu

mna

pos

terio

r*Bo

s tau

rus L

.Pa

rts o

f the

colu

mna

pos

terio

r of d

iffer

ent

part

s of t

he sp

inal

chor

d fro

m th

e cal

fPh

.Eur

. 2.2

.1IV

AA st

atem

ent 2

013

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


142

Conc

hae

Ostr

ea ed

ulis

L. P

h.fr.

also

: Cr

asos

trea a

ngul

ata L

amk.

, Cr

asos

trea g

igas

Lam

k.

The i

nner

par

ts of

the s

hells

of t

he o

yste

rH

AB; P

h.fr.

HAB

-Mon

ogra

ph an

d Ph

.Eur

. 4.1

.1., A

PI

(Apa

tit/C

onch

ae)

Agar

icus

com

p./P

hosp

horu

s; Ap

atit/

Conc

hae;

Aven

a com

p.; A

vena

/Co

ncha

e com

p.; B

ariu

m co

mp.

; Br

yoph

yllu

m/C

onch

ae; C

ereb

ellum

co

mp.

; Con

chae

; Con

chae

com

p.;

Conc

hae/

Ferr

um u

stum

com

p.;

Conc

hae/

Que

rcus

com

p.; C

onva

llaria

/Pr

imul

a com

p.; F

raga

ria/U

rtic

a com

p.;

Hep

ar su

lfuris

; Hep

ar su

lfuris

com

p.;

Levi

sticu

m co

mp.

; Ono

pord

um/

Prim

ula c

omp.

; Pan

krea

s com

p.;

Prun

us/R

osm

arin

us co

mp.

; Sep

ia

com

p.; Th

yreo

idea

com

p.; U

rtic

a co

mp.

; Val

eria

na co

mp.

Vade

mec

um: C

onch

ae

Conj

unct

iva

Bos t

auru

s L.

Conj

unct

iva f

rom

the c

alf

Ph.E

ur. 2

.2.2

Conj

unct

iva c

omp.

Conn

ectiv

e tiss

uese

e Tex

tus c

onne

ctiv

us

Cor

Bos t

auru

s L.

Cor f

rom

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.3Ar

nica

, Pla

nta t

ota/

Cor;

Auru

m/C

or;

Calci

um ca

rbon

icum

/Mes

ench

ym

com

p.; C

onva

llaria

/Prim

ula c

omp.

; Co

r; Co

r/Cr

atae

gus c

omp.

; Cra

taeg

us

com

p.; O

rgan

um q

uadr

uplex

Cor

Bos t

auru

s L.

Part

s of t

he ep

icar

dium

, myo

card

ium

, en

doca

rdiu

m an

d th

e arte

rial

mus

culat

ure o

f the

hea

rt fr

om th

e cal

f

Ph.E

ur. 2

.1.1

, 2.2

.3Ca

lcium

carb

onic

um/M

esen

chym

co

mp.

; Con

valla

ria/P

rimul

a com

p.;

Cor;

Cor/

Crat

aegu

s com

p.; C

rata

egus

co

mp.

; Org

anum

qua

drup

lex

Cor

Ory

ctol

agus

cuni

culu

s L.

Cor f

rom

the r

abbi

tPh

.Eur

. 2.1

.1

Cora

llium

Seve

ral s

peci

es o

f Cor

al o

f the

ge

nus M

ussid

ae o

r Cor

allii

deae

or

Tra

chyp

hylii

deae

Frag

men

ted

part

s obt

aine

d by

co

mm

unitu

ng th

e fre

sh an

imal

APC

3.3.

1AB

MA-

Vade

mec

um:

Cora

llium

-Mill

efol

ium

-St

ibiu

m S

irim

im

Cora

llium

rubr

umCo

ralli

um ru

brum

L.

Frag

men

ted

part

s of t

he ch

alk

skele

ton

from

Cor

alliu

m ru

brum

, con

tain

ing

at

least

82%

CaC

O3

(Mr 1

00,1

)

HAB

Ph.E

ur. 4

.1.1

; see

also

ap

p. 2

.6 (K

aliu

m

acet

icum

com

p.)

Anag

allis

/Mal

achi

t com

p.; C

oral

lium

co

mp.

; Kal

ium

acet

icum

com

p.

Corn

eaBo

s tau

rus L

.Co

rnea

from

the c

alf

Ph.E

ur. 2

.2.3

Corn

ea/L

evist

icum

com

p.

Corn

u Ca

prae

ibec

isCa

pra i

bex

L.H

orn

from

the i

bex

Ph.E

ur. 4

.1.1

IVAA

stat

emen

t 201

3

Corn

u Ce

rvi

Cerv

us el

aphu

s L.

Antle

rs fr

om th

e dee

rPh

.Eur

. 4.1

.1M

edul

la sp

inal

is co

mp.

Liste

HAS

(10.

2012

)

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


143

Corp

ora

quad

rigem

ina*

Bos t

auru

s L.

Part

s of t

he L

amin

a tec

ti wi

th th

e Co

rpor

a qua

drig

emin

a fro

m th

e cal

fPh

.Eur

. 2.2

.1Ar

nica

/Epi

phys

is/Pl

umbu

m m

ellitu

m

com

p.; A

rnic

a/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Epi

phys

is co

mp.

; Aur

um/H

ypop

hysis

com

p.;

Epip

hysis

com

p.; G

naph

aliu

m co

mp.

; H

ypop

hysis

com

p.; N

ervu

s opt

icus

co

mp.

Corp

us

amyg

dalo

ideu

m*

Bos t

auru

s L.

Brai

n m

atte

r of t

he re

gion

of t

he C

orpu

s am

ygda

loid

eum

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: C

orpu

s am

ygda

loid

eum

Corp

us ci

liare

Ory

ctol

agus

cuni

culu

s L.

Corp

us ci

liare

from

the r

abbi

tPh

.Eur

. 2.1

.1

Corp

us lu

teum

Bos t

auru

s L.

Corp

us lu

teum

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.2M

eliss

a/Ph

osph

orus

com

p.

Corp

us lu

teum

Sus s

crof

a dom

estic

a L.

Corp

us lu

teum

from

the s

owPh

.Eur

. 2.1

.1M

eliss

a/Ph

osph

orus

com

p.

Corp

us vi

treum

Ory

ctol

agus

cuni

culu

s L.

Corp

us vi

treum

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

gent

um-C

orpu

s vitr

eum

; Cor

nea/

Levi

sticu

m co

mp.

; Cor

pus v

itreu

m-

Stan

num

; Cor

pus v

itreu

m/H

orne

rz

com

p.; C

orpu

s vitr

eum

/Suc

cinum

Corp

us vi

treum

*Bo

s tau

rus L

.Co

rpus

vitre

um fr

om th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.1

, 2.

2.2;

star

ting

mat

eria

l fo

r the

pro

duct

ion

of

Arge

ntum

-Cor

pus

vitre

um an

d Co

rpus

vi

treum

-Sta

nnum

(see

ap

p. 2

.6)

Arge

ntum

-Cor

pus v

itreu

m; C

orne

a/Le

visti

cum

com

p.; C

orpu

s vitr

eum

-St

annu

m; C

orpu

s vitr

eum

/Hor

nerz

co

mp.

; Cor

pus v

itreu

m/S

uccin

um

Corte

x ce

rebr

iO

ryct

olag

us cu

nicu

lus L

.Co

rtex

of th

e cer

ebru

m fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Crot

alus h

orrid

usCr

otalu

s hor

ridus

L.

Free

ze d

ried

poiso

n fro

m C

rota

lus

horr

idus

L.

HAB

HAB

Mon

ogra

phD

er M

erku

rsta

b 19

93;

46(3

): 28

8-29

7

Crot

alus t

errifi

cus

Crot

alus d

uriss

us te

rrifi

cus

Laur

enti

Free

ze d

ried

poiso

n fro

m C

rota

lus

duris

sus t

errifi

cus L

aure

nti

acc.

to m

onog

raph

La

ches

is H

ABN

aja co

mp.

Der

Mer

kurs

tab

1993

; 46

(3):

288-

297

Der

M

erku

rsta

b 20

05;

58(1

)32-

39

Cutis

(fet

i fem

ini)

Bos t

auru

s L.

The e

xter

nal s

kin

of a

ca. 5

mon

ths o

ld

fem

ale b

ovin

e foe

tus

Ph.E

ur. 2

.2.2

Prun

us/R

osm

arin

us co

mp.

Cutis

(fet

i)Bo

s tau

rus L

.Th

e ext

erna

l ski

n of

a 3

to 9

mon

ths o

ld

bovi

ne fo

etus

Ph.E

ur. 2

.2.2

Calen

dula

/Tro

paeo

lum

com

p.;

Echi

nace

a/Vi

scum

com

p.; V

espa

cr

abro

com

p.

Cutis

(fet

i)Su

s scr

ofa d

omes

tica L

.Th

e ext

erna

l ski

n fro

m th

e foe

tus o

f the

pi

gPh

.Eur

. 2.1

.1

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


144

Dac

tylo

pius

cocc

usse

e Coc

cus c

acti

Den

sBo

s tau

rus L

.Te

eth

from

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Dia

phra

gma

Bos t

auru

s L.

Mus

cula

r and

tend

inou

s par

ts of

the

diap

hrag

m fr

om th

e cal

fPh

.Eur

. 2.2

.2Va

dem

ecum

[m

entio

ned

unde

r: Re

gio

subs

tant

iae

nigr

ae]

Dia

phra

gma p

elvis

Bos t

auru

s L.

Part

s of t

he m

uscle

and

fasc

ies c

losin

g th

e pe

lvis,

inclu

ding

conn

ectiv

e tiss

ue fr

om

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um:

Dia

phra

gma p

elvis

Die

ncep

halo

n*Bo

s tau

rus L

.D

ienc

epha

lon

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Disc

i int

erve

rtebr

ales

Sus s

crof

a dom

estic

a L.

Inte

rver

tebr

al d

iscs o

f cer

vica

l spi

ne fr

om

the p

igPh

.Eur

. 2.1

.1

Disc

i int

erve

rtebr

ales

(c

ervi

cales

)Bo

s tau

rus L

.Fi

broc

artil

age o

f int

erve

rtebr

al d

iscs o

f ce

rvic

al sp

ine f

rom

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um

[men

tione

d un

der:

Disc

i int

erve

rtebr

ales

(fe

ti)]

Disc

i int

erve

rtebr

ales

(c

ervi

cales

, tho

raci

ci et

lu

mba

les)

Bos t

auru

s L.

Part

s of i

nter

verte

bral

disc

s of c

ervi

cal,

thor

acic

and

lum

bar s

pine

from

the c

alf

Ph.E

ur. 2

.2.2

Disc

i com

p. cu

m A

escu

lo; D

isci c

omp.

cu

m A

rgen

to; D

isci c

omp.

cum

Aur

o;

Disc

i com

p. cu

m N

icot

iana

; Disc

i co

mp.

cum

Pul

satil

la; D

isci c

omp.

cum

St

anno

; Disc

i com

p. cu

m St

ibio

; Disc

i/Pu

lsatil

la co

mp.

cum

Stan

no; D

isci/

Rhus

toxi

code

ndro

n co

mp.

; Disc

i/Vi

scum

com

p. cu

m A

rgen

to; D

isci/

Visc

um co

mp.

cum

Stan

no

Disc

i int

erve

rtebr

ales

(fe

ti)Bo

s tau

rus L

.In

terv

erte

bral

disc

s of d

iffer

ent r

egio

ns o

f th

e spi

ne fr

om a

3 to

9 m

onth

s old

bov

ine

foet

us

Ph.E

ur. 2

.1.1

, 2.2

.2D

iscus

inte

rver

tebr

alis

embr

yona

lis/

Solu

tio S

ilice

ae co

mp.

Vade

mec

um: D

isci

inte

rver

tebr

ales

(fet

i)

Disc

i int

erve

rtebr

ales

(lu

mba

les)

Bos t

auru

s L.

Inte

rver

tebr

al d

iscs o

f lum

bar s

pine

from

th

e cal

fPh

.Eur

. 2.2

.2Va

dem

ecum

[m

entio

ned

unde

r: D

isci i

nter

verte

bral

es

(feti)

]

Duc

tus c

holed

ochu

sSu

s scr

ofa d

omes

tica L

.D

uctu

s cho

ledoc

hus f

rom

the p

igPh

.Eur

. 2.2

.3D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Duc

tus t

hora

cicu

sBo

s tau

rus L

.D

uctu

s tho

raci

cus f

rom

the c

alf

Ph.E

ur. 2

.2.3

Bora

go/R

enes

com

p.

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


145

Duo

denu

mSu

s scr

ofa d

omes

tica L

.Pa

rts o

f duo

denu

m fr

om th

e pig

Ph.E

ur. 2

.2.3

Vade

mec

um

[men

tione

d un

der:

Plex

us g

astri

cus]

Dur

a mat

er en

ceph

ali*

Bos t

auru

s L.

Dur

a mat

er en

ceph

ali f

rom

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Endo

card

ium

Bos t

auru

s L.

Endo

card

ium

from

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Endo

met

rium

Bos t

auru

s L.

Endo

met

rium

from

the c

owPh

.Eur

. 2.2

.3En

dom

etriu

m co

mp.

Epid

idym

isBo

s tau

rus L

.Le

ft ep

idid

ymis

from

the b

ull

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Epip

hysis

Ory

ctol

agus

cuni

culu

s L.

Part

s of t

he ep

iphy

sis fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Arni

ca/E

piph

ysis/

Plum

bum

mell

itum

co

mp.

; Aur

um/E

piph

ysis

com

p.;

Epip

hysis

; Epi

phys

is co

mp.

; Epi

phys

is/Pl

umbu

m; G

naph

aliu

m co

mp.

Epip

hysis

*Bo

s tau

rus L

.Pa

rts o

f the

epip

hysis

from

the c

alf

Ph.E

ur. 2

.2.1

Arni

ca/E

piph

ysis/

Plum

bum

mell

itum

co

mp.

; Aur

um/E

piph

ysis

com

p.;

Epip

hysis

; Epi

phys

is co

mp.

; Epi

phys

is/Pl

umbu

m; G

naph

aliu

m co

mp.

Eryt

rocy

tes

Equu

s prz

ewal

skii

f. ca

ballu

s PO

LIAK

OV

Eryt

hroc

ytes

from

the b

lood

of t

he h

orse

Ph.E

ur. 2

.2.4

IVAA

stat

emen

t 201

3

Fasc

icul

us

atrio

vent

ricul

aris

Bos t

auru

s L.

Part

s of t

he co

nduc

tion

syste

m o

f the

he

art,

His´

s bun

dle a

nd P

urki

nje´

s fibe

r fro

m th

e cal

f

Ph.E

ur. 2

.2.3

Vade

mec

um: F

ascic

ulus

at

riove

ntric

ular

is

Fasc

icul

us o

ptic

us*

Bos t

auru

s L.

Fasc

icul

us o

ptic

us fr

om th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.1

Lam

ina/

Retin

a com

p.Li

ste H

AS (1

0.20

12)

Fel p

iscis

Salm

o tr

utta

L.

Bile

from

pre

dato

ry fi

sh, e

.g. t

rout

Ph.E

ur. 2

.1.1

Der

Mer

kurs

tab

2004

; 57

(3):

224

Fel t

auri

Bos t

auru

s L.

Fres

h bi

le fro

m g

all b

ladd

er fr

om th

e cal

fPh

.Eur

. 2.2

.1G

land

ulae

supr

aren

ales

com

p.

Fem

urBo

s tau

rus L

.Pa

rts o

f the

dia

phys

is of

os f

emor

is fro

m

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um: F

emur

Folli

culi

lym

phat

ici

aggr

egat

iSu

s scr

ofa d

omes

tica L

.Pa

rts o

f Pey

er’s

patc

h of

the s

mal

l in

testi

ne fr

om th

e pig

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


146

Form

ica

Form

ica r

ufa L

., For

mic

a po

lyct

ena F

ÖRS

TER

Live

wor

ker a

nts

HAB

; Ph.

fr.Ph

.Eur

. 2.1

.1, 2

.2.3

H

AB m

onog

raph

; di

lutio

ns P

h.Eu

r. 1.

1.9;

Ph

.fr. m

onog

raph

(e

than

ol 6

5%)

Extra

ctio

n wi

th

glyc

erol

85%

to ge

t an

API w

ith 2

.4%

form

ic

acid

. see

also

Aci

dum

Fo

rmic

ae

Acon

itum

/Arn

ica c

omp.

/For

mic

a; Ae

scul

us/C

era c

omp.

; Api

s com

p.;

Arni

ca co

mp.

; Arn

ica c

omp.

/For

mic

a; Ar

nica

, Pla

nta t

ota/

Form

ica;

Arni

ca/

Form

ica c

omp.

; Arn

ica/

Lapp

a com

p.;

Auru

m/O

nopo

rdon

com

p.;

Bella

donn

a/Be

tula

/For

mic

a; Be

tula

/Ar

nica

com

p.; B

etul

a/La

ppa c

omp.

; Br

yoni

a/Fo

rmic

a com

p.; C

artil

ago

com

p.; D

isci c

omp.

cum

Aes

culo

; Disc

i co

mp.

cum

Arg

ento

; Disc

i com

p. cu

m

Auro

; Disc

i com

p. cu

m N

icot

iana

; D

isci c

omp.

cum

Pul

satil

la; D

isci

com

p. cu

m St

anno

; Disc

i com

p. cu

m

Stib

io; D

isci/P

ulsa

tilla

com

p. cu

m

Stan

no; D

isci/R

hus t

oxic

oden

dron

co

mp.

; Disc

i/Visc

um co

mp.

cum

Ar

gent

o; D

isci/V

iscum

com

p. cu

m

Stan

no; E

quise

tum

arve

nse/

Form

ica;

Form

ica;

Form

ica D

3/Fo

rmic

a D15

; Fo

rmic

a/O

xalis

; For

mic

a/Pr

unus

sp

inos

a; Le

ns cr

istal

lina/

Visc

um co

mp.

cu

m St

anno

; Mag

nesiu

m

phos

phor

icum

com

p.; M

andr

agor

a co

mp.

Vade

mec

um: F

orm

ica

Form

ica p

arva

Lasiu

s nig

erLi

ve w

orke

r ant

sPh

.Eur

. 2.1

.1Fl

ores

Trit

ici c

omp.

Liste

HAS

(10.

2012

)

Funi

culu

s um

bilic

alis

Bos t

auru

s L.

Funi

culu

s um

bilic

alis

from

a bo

vine

fo

etus

bet

ween

the t

hird

and

nint

h m

onth

of

pre

gnan

cy

Ph.E

ur. 2

.2.2

Bora

go/R

enes

com

p.; C

alen

dula

/Tr

opae

olum

com

p.; E

chin

acea

/Visc

um

com

p.; M

agne

sit/M

amm

a com

p.;

Mag

nesiu

m su

lfuric

um/O

varia

com

p.;

Prun

us/R

osm

arin

us co

mp.

Gal

ea ap

oneu

rotic

aBo

s tau

rus L

.Pa

rts o

f the

supe

rfici

al fa

scia

of t

he

fore

head

from

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Gin

giva

Bos t

auru

s L.

Gin

giva

from

the c

alf

Ph.E

ur. 2

.2.2

Calen

dula

/Ech

inac

ea co

mp.

; Pe

riodo

ntiu

m/S

ilice

a com

p.;

Perio

dont

ium

/Sta

nnum

com

p.

Gin

giva

Sus s

crof

a dom

estic

a L.

Gin

giva

from

the f

oetu

s of t

he p

igPh

.Eur

. 2.1

.1

Gla

ndul

a lac

rimal

isBo

s tau

rus L

.G

land

ula l

acrim

alis

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: G

land

ula

lacr

imal

is

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


147

Gla

ndul

a par

otis

Bos t

auru

s L.

Gla

ndul

ar ti

ssue

of t

he b

ody o

f the

pa

rotid

gla

nd fr

om th

e cal

fPh

.Eur

. 2.2

.1IV

AA st

atem

ent 2

013

Gla

ndul

a sup

rare

nales

Ory

ctol

agus

cuni

culu

s L.

Supr

aren

al g

land

from

the r

abbi

tPh

.Eur

. 2.1

.1

Gla

ndul

a sup

rare

nalis

Bos t

auru

s L.

Gla

ndul

a sup

rare

nalis

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1Ca

lendu

la/T

ropa

eolu

m co

mp.

; Cu

prum

-Ren

-Gla

ndul

a sup

rare

nalis

; G

land

ula s

upra

rena

lis; G

land

ula

supr

aren

alis/

Solu

tio F

erri

com

p.;

Gla

ndul

ae su

prar

enal

es co

mp.

Gla

ndul

a sup

rare

nalis

(C

orte

x)Bo

s tau

rus L

.G

land

ula s

upra

rena

lis (C

orte

x) fr

om th

e ca

lfPh

.Eur

. 2.2

.1IV

AA st

atem

ent 2

013

Gla

ndul

a sup

rare

nalis

(M

edul

la)

Bos t

auru

s L.

Med

ulla

gla

ndul

ae su

prar

enal

is of

bot

h ad

rena

l gla

nds f

rom

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Gla

ndul

a sup

rare

nalis

de

xtra

Bos t

auru

s L.

Gla

ndul

a sup

rare

nalis

dex

tra fr

om th

e ca

lfPh

.Eur

. 2.2

.1Cu

prum

/Gla

ndul

a sup

rare

nalis

dex

tra

Gla

ndul

a sup

rare

nalis

sin

istra

Bos t

auru

s L.

Gla

ndul

a sup

rare

nalis

sini

stra f

rom

the

calf

Ph.E

ur. 2

.2.1

Cupr

um/G

land

ula s

upra

rena

lis

sinist

ra; G

land

ula s

upra

rena

lis/

Mer

curiu

s

Gla

ndul

a Thym

usse

e Thym

us (G

land

ula)

Gla

ndul

a thy

reoi

dea

Bos t

auru

s L.

Gla

ndul

a thy

reoi

dea f

rom

the c

alf

Ph.E

ur. 2

.2.1

, 2.1

.1Co

lchic

um co

mp.

; Fer

rum

/Thyr

eoid

ea;

Gla

ndul

a thy

reoi

dea;

Thyr

eoid

ea

com

p.

Gla

ndul

a thy

reoi

dea

Ory

ctol

agus

cuni

culu

s L.

Gla

ndul

a thy

reoi

dea f

rom

the r

abbi

tPh

.Eur

. 2.1

.1Co

lchic

um co

mp.

; Fer

rum

/Thyr

eoid

ea;

Gla

ndul

a thy

reoi

dea;

Thyr

eoid

ea

com

p.

Gla

ndul

ae

para

thyr

eoid

eae

Bos t

auru

s L.

Gla

ndul

ae p

arat

hyre

oide

ae fr

om th

e cal

fPh

.Eur

. 2.2

.1Au

rum

/Par

athy

reoi

dea;

Para

thyr

eoid

ea co

mp.

; Pha

rmak

olith

co

mp.

Gla

ndul

ae

para

thyr

eoid

eae

Sus s

crof

a dom

estic

a L.

Gla

ndul

ae p

arat

hyre

oide

ae fr

om th

e pig

APC

3.3.

3 G

lyce

rol

mac

erat

e 1:1

000

(as

Ph.E

ur. 2

.1.1

)

Auru

m/P

arat

hyre

oide

a; Pa

rath

yreo

idea

com

p.; P

harm

akol

ith

com

p.

Gla

ndul

ae

supr

aren

ales

see G

land

ula s

upra

rena

lis

Glo

bus o

culi

Ory

ctol

agus

cuni

culu

s L.

Eyeb

all o

f the

rabb

itPh

.Eur

. 2.1

.1Ré

perto

ire d

e méd

. an

thr.:

Glo

be o

cula

ire

Gyr

us ci

ngul

i*Bo

s tau

rus L

.G

yrus

cing

uli f

rom

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


148

Hep

arBo

s tau

rus L

.Pa

rs in

term

edia

of t

he li

ver f

rom

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1Ca

lcium

carb

onic

um/M

esen

chym

co

mp.

; Car

duus

mar

ianu

s/ V

iscum

M

ali c

omp.

; Hep

ar; H

epar

-M

agne

sium

; Hep

ar/S

tann

um

met

allic

um A

; Hep

ar/S

tann

um

met

allic

um B

; Org

anum

qua

drup

lex;

Tara

xacu

m St

anno

cultu

m/H

epar

Bo

vis

Hep

arO

ryct

olag

us cu

nicu

lus L

.Li

ver f

rom

the r

abbi

tPh

.Eur

. 2.1

.1Ca

lcium

carb

onic

um/M

esen

chym

co

mp.

; Car

duus

mar

ianu

s/ V

iscum

M

ali c

omp.

; Hep

ar/S

tann

um

met

allic

um A

; Hep

ar/S

tann

um

met

allic

um B

; Org

anum

qua

drup

lex

IVAA

stat

emen

t 201

3

Hip

poca

mpu

s*Bo

s tau

rus L

.H

ippo

cam

pus f

rom

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um:

Hip

poca

mpu

s

Hiru

do ex

anim

ale

Hiru

do m

edic

inal

is L.

Leec

h im

med

iate

ly aft

er sa

crifi

cePh

.Eur

. 1.1

.11,

2.2

.3H

irudo

com

p.; V

espa

crab

ro co

mp.

Hyp

ophy

sisO

ryct

olag

us cu

nicu

lus L

.H

ypop

hysis

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

nica

/Hyp

ophy

sis/P

lum

bum

m

ellitu

m co

mp.

; Aur

um/H

ypop

hysis

co

mp.

; Disc

i com

p. cu

m N

icot

iana

; H

ypop

hysis

; Hyp

ophy

sis co

mp.

; H

ypop

hysis

/Sta

nnum

; Mag

nesit

/M

amm

a com

p.; M

agne

sium

su

lfuric

um/O

varia

com

p.;

Perio

dont

ium

/Sta

nnum

com

p.;

Skor

odit

com

p.

Hyp

ophy

sis*

Bos t

auru

s L.

Hyp

ophy

sis fr

om th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.1

Arni

ca/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Hyp

ophy

sis

com

p.; D

isci c

omp.

cum

Nic

otia

na;

Hyp

ophy

sis; H

ypop

hysis

com

p.;

Hyp

ophy

sis/S

tann

um; M

agne

sit/

Mam

ma c

omp.

; Mag

nesiu

m

sulfu

ricum

/Ova

ria co

mp.

; Pe

riodo

ntiu

m/S

tann

um co

mp.

; Sk

orod

it co

mp.

Hyp

otha

lam

usO

ryct

olag

us cu

nicu

lus L

.H

ypot

hala

mus

from

the r

abbi

tPh

.Eur

. 2.1

.1

Hyp

otha

lam

us*

Bos t

auru

s L.

Hyp

otha

lam

us fr

om th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.1

Vade

mec

um:

Hyp

otha

lam

us

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


149

Ieco

ris as

elli o

leum

Gad

us m

orhu

a L.

Purifi

ed fa

tty o

il ob

tain

ed fr

om th

e fre

sh

liver

s of w

ild co

d, G

adus

mor

hua L

. and

ot

her s

pecie

s of G

adid

ae, s

olid

subs

tanc

es

bein

g re

mov

ed b

y coo

ling

and

filte

ring

Ph.E

ur.

API

Berb

eris/

Cheli

doni

um co

mp.

; Be

rber

is/Ju

nipe

rus c

omp.

Ileum

Sus s

crof

a dom

estic

a L.

Ileum

from

the p

igPh

.Eur

. 2.2

.3Va

dem

ecum

[m

entio

ned

unde

r: N

ux

vom

ica/

Nico

tiana

co

mp.

]

Iris

Bos t

auru

s L.

Iris

from

the c

alf

Ph.E

ur. 2

.2.2

Arni

ca/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Hyp

ophy

sis

com

p.; H

ypop

hysis

com

p.; I

ris b

ovis

com

p.

Jeco

ris o

leum

see I

ecor

is as

elli o

leum

Laby

rinth

us*

Bos t

auru

s L.

Coch

lea an

d la

byrin

th fr

om th

e cal

fPh

.Eur

. 2.2

.1Ar

nica

/Epi

phys

is/Pl

umbu

m m

ellitu

m

com

p.; A

urum

/Epi

phys

is co

mp.

; Ep

iphy

sis co

mp.

; Gna

phal

ium

com

p.

Lac c

anin

umCa

nis l

upus

fam

iliar

is L.

Fres

h m

ilk fr

om fe

mal

e dog

Ph.E

ur. 3

.1.1

ABM

A-Va

dem

ecum

O

varia

-Mer

curiu

s p.

195

Lac v

acca

eBo

s tau

rus L

.Fr

esh

cow’

s milk

Ph.E

ur. 3

.1.1

(eth

anol

18

%)

Vade

mec

um IV

AA

state

men

t 201

3

Lach

esis

Lach

esis

mela

noce

phal

a So

lòrz

ano

& C

erda

s, La

ches

is ste

noph

rys C

ope,

Lach

esis

mut

a L.

Care

fully

drie

d po

ison

from

Lac

hesis

m

elano

ceph

ala S

olòr

zano

& C

erda

s, La

ches

is ste

noph

rys C

ope o

r Lac

hesis

m

uta L

.

HAB

Mon

ogra

ph H

ABIg

natia

com

p.; L

ache

sis; L

ache

sis

com

p.; M

eliss

a/Se

pia c

omp.

; Naja

co

mp.

Vade

mec

um: L

ache

sis

Répe

rtoire

de m

éd.

anth

r.

Lam

ina q

uadr

igem

ina

Ory

ctol

agus

cuni

culu

s L.

Lam

ina q

uadr

igem

ina f

rom

the r

abbi

tPh

.Eur

. 2.1

.1La

min

a/Re

tina c

omp.

Lam

ina

quad

rigem

ina*

Bos t

auru

s L.

Lam

ina q

uadr

igem

ina f

rom

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1La

min

a/Re

tina c

omp.

Lapi

s can

cri

Asta

cus a

stacu

s L.

The g

astro

lithe

s fro

m th

e bod

y cav

ity

from

Asta

cus a

stacu

s L. o

r oth

er cr

ayfis

hPh

.Eur

. 4.1

.1; A

PI, r

aw

mat

eria

l for

the

prod

uctio

n of

co

mpo

sitio

ns: S

ilex

- La

pis C

ancr

i sol

utus

(a

pp. 2

.6)

Lapi

s Can

cri/F

lintst

ein

Vade

mec

um: S

ilex

- La

pis C

ancr

i sol

utus

Li

ste H

AS (1

0.20

12)

Lary

nxBo

s tau

rus L

.Pa

rts o

f the

lary

nx fr

om th

e cal

fPh

.Eur

. 2.2

.2Ap

is/La

rynx

com

p.; B

ronc

hi/P

lant

ago

com

p.; L

aryn

x co

mp.

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


150

Lary

nxO

ryct

olag

us cu

nicu

lus L

.Pa

rts o

f the

lary

nx fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Apis/

Lary

nx co

mp.

; Bro

nchi

/Pla

ntag

o co

mp.

; Lar

ynx

com

p.

Lath

rode

ctus

Lath

rode

ctus

mac

tans

Koc

hLi

ve sp

ider

of L

athr

odec

tus m

acta

ns K

och

APC

3.3.

1AB

MA-

Vade

mec

um

Cor-

Arse

nicu

m al

bum

p.

105

Lens

crist

allin

aBo

s tau

rus L

.Le

ns cr

istal

lina f

rom

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.2Co

rnea

/Lev

istic

um co

mp.

; Cor

pus

vitre

um/H

orne

rz co

mp.

; Iris

bov

is co

mp.

; Len

s cris

talli

na/V

iscum

com

p.

cum

Stan

no

Lens

crist

allin

aO

ryct

olag

us cu

nicu

lus L

.Le

ns cr

istal

lina f

rom

the r

abbi

tPh

.Eur

. 2.1

.1Co

rnea

/Lev

istic

um co

mp.

; Iris

bov

is co

mp.

; Len

s cris

talli

na/V

iscum

com

p.

cum

Stan

no

Lien

Bos t

auru

s L.

Splee

n fro

m th

e cal

fP.E

ur. 2

.1.1

, 2.2

.1G

land

ulae

supr

aren

ales

com

p.; L

ien

com

p.; L

ien/

Plum

bum

Lien

Ory

ctol

agus

cuni

culu

s L.

Splee

n fro

m th

e rab

bbit

Ph.E

ur. 2

.1.1

Gla

ndul

ae su

prar

enal

es co

mp.

; Lie

n co

mp.

; Lie

n/Pl

umbu

m

Liga

men

tum

lo

ngitu

dina

le an

teriu

sBo

s tau

rus L

.Pa

rts o

f the

Lig

amen

tum

long

itudi

nale

ante

rius o

f tho

raci

c and

lum

bar r

egio

ns o

f th

e spi

ne fr

om th

e cal

f

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Liga

men

tum

lo

ngitu

dina

le po

steriu

s*

Bos t

auru

s L.

Liga

men

tum

long

itudi

nale

dors

ale f

rom

th

e cal

fPh

.Eur

. 2.2

.2Va

dem

ecum

: Li

gam

entu

m

long

itudi

nale

poste

rius

Liga

men

tum

voca

leBo

s tau

rus L

.Pa

rts o

f the

voca

l cor

ds in

clude

d th

e m

ucou

s mem

bran

e of t

he la

rynx

from

the

calf

Ph.E

ur. 2

.2.2

Vade

mec

um

[men

tione

d un

der:

Lary

nx co

mp.

]

Ling

uaBo

s tau

rus L

.Pa

rts o

f the

tong

ue m

uscle

s, m

ucou

s m

embr

ane a

nd p

apill

ae fr

om th

e cal

fPh

.Eur

. 2.2

.3IV

AA st

atem

ent 2

013

Liqu

or ce

rebr

ospi

nalis

Bos t

auru

s L.

Cere

bros

pina

lal fl

uid

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


151

Lobu

s fro

ntal

is*Bo

s tau

rus L

.Fr

onta

l lob

e of c

ereb

rum

from

the c

alf

Ph.E

ur. 2

.2.1

Glö

ckler

, M.:

"Ant

hrop

osop

hisc

he

Arzn

eithe

rapi

e" (A

nthr

opos

ophi

c Ther

apy w

ith

Med

icina

l Pro

duct

s)

with

Med

icina

l Pr

oduc

ts), P

ublis

her

Wiss

ensc

haftl

iche

Verla

gsge

sells

chaft

, St

uttg

art 2

010

Lobu

s occ

ipita

lis*

Bos t

auru

s L.

Occ

ipita

l lob

e of c

ereb

rum

from

the c

alf

Ph.E

ur. 2

.2.1

Glö

ckler

, M.:

"Ant

hrop

osop

hisc

he

Arzn

eithe

rapi

e" (A

nthr

opos

ophi

c Ther

apy w

ith

Med

icina

l Pro

duct

s)

with

Med

icina

l Pr

oduc

ts), P

ublis

her

Wiss

ensc

haftl

iche

Verla

gsge

sells

chaft

, St

uttg

art 2

010

Lobu

s par

ieta

lis*

Bos t

auru

s L.

Parie

tal l

obe o

f the

cere

brum

from

the

calf

Ph.E

ur. 2

.2.1

Glö

ckler

, M.:

"Ant

hrop

osop

hisc

he

Arzn

eithe

rapi

e" (A

nthr

opos

ophi

c Ther

apy w

ith

Med

icina

l Pro

duct

s)

with

Med

icina

l Pr

oduc

ts), P

ublis

her

Wiss

ensc

haftl

iche

Verla

gsge

sells

chaft

, St

uttg

art 2

010

Lobu

s tem

pora

lis*

Bos t

auru

s L.

Tem

pora

l lob

e fro

m th

e cal

fPh

.Eur

. 2.2

.1G

löck

ler, M

.: "A

nthr

opos

ophi

sche

Ar

zneit

hera

pie"

(Ant

hrop

osop

hic Th

erap

y with

M

edici

nal P

rodu

cts)

wi

th M

edici

nal

Prod

ucts)

, Pub

lishe

r W

issen

scha

ftlich

e Ve

rlags

gese

llsch

aft,

Stut

tgar

t 201

0

Mam

ma

Bos t

auru

s L.

Gla

ndul

ar ti

ssue

from

bov

ine u

dder

Ph.E

ur. 2

.1.1

, 2.2

.3M

agne

sit/M

amm

a com

p.

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


152

Mam

ma

Ory

ctol

agus

cuni

culu

s L.

Mam

mae

from

the r

abbi

tPh

.Eur

. 2.1

.1M

agne

sit/M

amm

a com

p.

Mam

ma (

dext

ra)

Bos t

auru

s L.

Gla

ndul

ar ti

ssue

from

righ

t par

t of b

ovin

e ud

der

Ph.E

ur. 2

.2.3

, APC

3.

3.1

Vade

mec

um: M

amm

a AB

MA-

Vade

mec

um:

Mam

ma-

Arge

ntum

Si

rimim

p. 1

69

Mam

ma (

sinist

ra)

Bos t

auru

s L.

Gla

ndul

ar ti

ssue

from

left

part

of b

ovin

e ud

der

Ph.E

ur. 2

.2.3

, APC

3.

3.1

Vade

mec

um: M

amm

a AB

MA-

Vade

mec

um:

Mam

ma-

Arge

ntum

p.

169

Man

dibu

la (f

eti)

Bos t

auru

s L.

Man

dibl

e fro

m a

bovi

ne fo

etus

bet

ween

3

and

9 m

onth

sPh

.Eur

. 2.1

.1, 2

.2.2

Perio

dont

ium

/Sili

cea c

omp.

; Pe

riodo

ntiu

m/S

tann

um co

mp.

Man

dibu

la (f

eti)

Sus s

crof

a dom

estic

a L.

Man

dibl

e of t

he fo

etus

from

the p

igPh

.Eur

. 2.1

.1Pe

riodo

ntiu

m/S

ilice

a com

p.;

Perio

dont

ium

/Sta

nnum

com

p.

Mar

mot

fat

see M

arm

otta

e oleu

m

Max

illa (

feti)

Bos t

auru

s L.

Max

illa f

rom

a bo

vine

foet

us b

etwe

en 3

an

d 9

mon

ths

Ph.E

ur. 2

.1.1

, 2.2

.2Pe

riodo

ntiu

m/S

ilice

a com

p.;

Perio

dont

ium

/Sta

nnum

com

p.

Max

illa (

feti)

Sus s

crof

a dom

estic

a L.

Max

illa f

rom

a fo

etus

of t

he p

igPh

.Eur

. 2.1

.1Pe

riodo

ntiu

m/S

ilice

a com

p.;

Perio

dont

ium

/Sta

nnum

com

p.

Med

ulla

obl

onga

taO

ryct

olag

us cu

nicu

lus L

.M

edul

la o

blon

gata

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

nica

/Epi

phys

is/Pl

umbu

m m

ellitu

m

com

p.; A

rnic

a/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Epi

phys

is co

mp.

; Aur

um/H

ypop

hysis

com

p.;

Epip

hysis

com

p.; G

naph

aliu

m co

mp.

; H

ypop

hysis

com

p.

Med

ulla

obl

onga

ta*

Bos t

auru

s L.

Med

ulla

obl

onga

ta fr

om th

e cal

fPh

.Eur

. 2.2

.1Ar

nica

/Epi

phys

is/Pl

umbu

m m

ellitu

m

com

p.; A

rnic

a/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Epi

phys

is co

mp.

; Aur

um/H

ypop

hysis

com

p.;

Epip

hysis

com

p.; G

naph

aliu

m co

mp.

; H

ypop

hysis

com

p.

Med

ulla

oss

ium

(r

ubra

)Bo

s tau

rus L

.Re

d bo

ne m

arro

w fro

m th

e epi

phys

is of

tu

bula

r bon

es fr

om th

e cal

fPh

.Eur

. 2.2

.1M

edul

la o

ssiu

m

Med

ulla

oss

ium

(r

ubra

)O

ryct

olag

us cu

nicu

lus L

.Re

d bo

ne m

arro

w fro

m th

e epi

phys

is of

tu

bula

r bon

es fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Med

ulla

oss

ium

Med

ulla

spin

alis

Ory

ctol

agus

cuni

culu

s L.

spin

al co

rd fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Med

ulla

spin

alis

com

p.

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


153

Med

ulla

spin

alis

tota

*Bo

s tau

rus L

.M

edul

la sp

inal

is of

diff

eren

t sec

tions

from

th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.1

Med

ulla

spin

alis

com

p.Va

dem

ecum

: Med

ulla

sp

inal

is (to

ta)

Mel

Hon

ey is

pro

duce

d by

bee

s (Ap

is m

ellife

ra

L.) f

rom

the n

ecta

r of p

lant

s or f

rom

se

cret

ions

of l

ivin

g pa

rts o

f pla

nts w

hich

th

e bee

s col

lect,

trans

form

by c

ombi

ning

wi

th sp

ecifi

c sub

stanc

es o

f the

ir ow

n,

depo

sit, d

ehyd

rate

, sto

re an

d lea

ve in

the

hone

y com

b to

ripe

n an

d m

atur

e.

Ph.E

ur.

API,

raw

mat

eria

l for

th

e pro

duct

ion

of

seve

ral c

ompo

sitio

ns

(see

app.

2.6

).

Aesc

ulus

/Cer

a com

p.; A

qua M

aris

com

p.; A

rcha

ngeli

ca co

mp.

; Ave

na/

Conc

hae c

omp.

; Bro

nchi

alpas

tillen

; Fe

rrum

/Acid

um ch

olal

icum

; Fra

garia

/Ur

tica;

Frag

aria

/Urt

ica/

Gen

tiana

; Le

visti

cum

com

p.; L

ichen

es co

mp.

; M

el; M

ercu

rialis

/Mel;

Sol

utio

Sac

char

i co

mp.

Mem

bran

a sin

us

front

alis

Bos t

auru

s L.

Muc

osa o

f Sin

us fr

onta

lis fr

om th

e cal

fPh

.Eur

. 2.2

.1Ci

na co

mp.

Liste

HAS

(10.

2012

)

Mem

bran

a sin

us

max

illar

isBo

s tau

rus L

.M

ucos

a of S

inus

max

illar

is fro

m th

e cal

fPh

.Eur

. 2.2

.1G

löck

ler, M

.: "A

nthr

opos

ophi

sche

Ar

zneit

hera

pie"

(Ant

hrop

osop

hic Th

erap

y with

M

edici

nal P

rodu

cts)

Pu

blish

er

Wiss

ensc

haftl

iche

Verla

gsge

sells

chaft

, St

uttg

art

Mem

bran

a sin

us

para

nasa

lisBo

s tau

rus L

.M

ucos

a of s

inus

par

anas

ales

from

the c

alf

Ph.E

ur. 2

.2.1

Hep

ar su

lfuris

com

p.

Mem

bran

a syn

ovia

lisBo

s tau

rus L

.In

ner l

ayer

of t

he jo

int c

apsu

le of

diff

eren

t jo

ints

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um

[men

tione

d un

der:

Salix

/Rhu

s com

p.]

Men

iscus

artic

ular

isBo

s tau

rus L

.M

enisc

us ar

ticul

aris

of th

e kne

e fro

m ca

lfPh

.Eur

. 2.2

.2D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Men

iscus

genu

sBo

s tau

rus L

.M

enisc

us o

f the

kne

e fro

m th

e cal

fPh

.Eur

. 2.1

.1M

andr

agor

a com

p.; M

andr

agor

a/M

enisc

us G

enus

Mep

hitis

put

oriu

sM

ephi

tis m

ephi

tis S

chre

b.Li

quid

secr

etio

n of

anal

gla

nds f

rom

M

ephi

tis m

ephi

tis S

chre

b.H

AB 3

4Ph

.Eur

. 3.1

.1 (D

2 wi

th

etha

nol 9

0% ac

c. to

H

AB 3

4)

Dro

sera

/Ipec

acua

nha c

omp.

Mes

ence

phal

on*

Bos t

auru

s L.

Mes

ence

phal

on fr

om th

e cal

fPh

.Eur

. 2.2

.1Va

dem

ecum

[m

entio

ned

unde

r: Re

gio

subs

tant

iae

nigr

ae]

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


154

Mes

ench

ymBo

s tau

rus L

.Em

bryo

nal c

onne

ctiv

e tiss

ue an

d tis

sue

part

s of t

he ad

ult a

nim

al. F

oeta

l tiss

ues

deve

lope

d fro

m m

esen

chym

a with

a hi

gh

mes

ench

ymal

func

tion:

ute

rus o

f the

ad

ult a

nim

al; f

oeta

l sla

ck co

nnec

tive

tissu

e (e.g

. fro

m ax

illa)

, thy

mus

, hea

rt

tissu

e (wi

thou

t val

ves)

, red

bon

e mar

row

with

retic

ular

conn

ectiv

e tiss

ue an

d sp

ongi

ous b

ones

, nuc

leus p

ulpo

sus

inte

rver

tebr

alis,

mes

ente

rium

Ph.E

ur. 2

.2.2

Bora

go/R

enes

com

p.; C

alciu

m

carb

onic

um/M

esen

chym

com

p.; L

ien

com

p.; M

esen

chym

; Ves

pa cr

abro

co

mp.

Mes

ench

ymSu

s scr

ofa d

omes

tica L

.Em

bryo

nal c

onne

ctiv

e tiss

ue an

d tis

sue

part

s of t

he ad

ult a

nim

al. F

oeta

l tiss

ues

deve

lope

d fro

m m

esen

chym

a with

a hi

gh

mes

ench

ymal

func

tion:

ute

rus o

f the

ad

ult a

nim

al; f

oeta

l sla

ck co

nnec

tive

tissu

e (e.g

. fro

m ax

illa)

, thy

mus

, hea

rt

tissu

e (wi

thou

t val

ves)

, red

bon

e mar

row

with

retic

ular

conn

ectiv

e tiss

ue an

d sp

ongi

ous b

ones

, nuc

leus p

ulpo

sus

inte

rver

tebr

alis,

mes

ente

rium

Ph.E

ur. 2

.1.1

Liste

HAS

(10.

2012

) Ré

perto

ire d

e méd

. an

thr.:

T.R

.E.

Muc

osa b

ucca

lisBo

s tau

rus L

.M

ucou

s mem

bran

es o

f the

follo

wing

in

tern

al p

arts

of th

e cal

fs m

outh

: Arc

us

glos

sopa

latin

us, A

. pha

ryng

opal

atin

us,

ging

iva,

lingi

na, p

alat

um, u

vula

and

tons

illa p

alat

inae

APC

3.3.

1AB

MA-

Vade

mec

um

Cydo

nia-

Silic

ea p

. 117

Muc

osa s

inus

alis

Ory

ctol

agus

cuni

culu

s L.

Sinu

sal m

ucos

a fro

m th

e rab

bit

Ph.E

ur. 2

.1.1

Répe

rtoire

de m

éd.

anth

r.: M

uque

use

sinus

ale

Mus

culi

Bos t

auru

s L.

The f

ollo

wing

mus

cles o

f the

ox

(age

1,5

-4

year

s): M

uscu

lus d

eltoi

deus

, M.

supr

aspi

natu

s, M

. inf

rasp

inat

us, M

. bic

eps

brac

hii,

M. t

ricep

s bra

chii,

M. s

oleu

s and

M

. glu

tei

APC

3.3.

1AB

MA-

Vade

mec

um:

Mus

culi-

Auru

m p

. 178

Mus

culi

glut

aei

Bos t

auru

s L.

Glu

teal

mus

cles f

rom

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Mus

culu

s delt

oide

us-

Kom

plex

Bos t

auru

s L.

Part

s of t

he M

uscu

lus d

eltoi

deus

-co

mpl

ex, M

uscu

lus s

upra

spin

am,

Mus

culu

s inf

ra sp

inam

, Mus

culu

s de

ltoid

eus,

Mus

culu

s bic

eps b

rach

ii an

d M

uscu

lus t

ricep

s bra

chii

from

the c

alf

Ph.E

ur. 2

.2.3

Der

Mer

kurs

tab:

So

nder

heft

1999

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


155

Mus

culu

s rec

tus

abdo

min

isBo

s tau

rus L

.M

uscu

lus r

ectu

s abd

omin

is fro

m th

e cal

fPh

.Eur

. 2.2

.3Va

dem

ecum

: Mus

culu

s re

ctus

abdo

min

is

Mus

culu

s sol

eus-

Kom

plex

Bos t

auru

s L.

Part

s of t

he M

uscu

lus s

oleu

s-Ko

mpl

ex,

Mus

culu

s sol

eus,

Mus

culu

s fibu

laris

(p

eron

aeus

) lon

gus,

Mus

culu

s ga

stroc

nem

ius f

rom

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Myg

ale

Seve

ral s

pecie

s of t

he

Ther

aphr

osid

ae fa

mily

Live

spid

erAP

C 3.

3.1

ABM

A-Va

dem

ecum

H

epar

-Plu

mbu

m p

. 148

Myg

ale a

vicu

laris

see A

rane

a avi

cula

ris

Myo

card

ium

Bos t

auru

s L.

Myo

card

ium

from

the c

alf

Ph.E

ur. 2

.2.3

Prim

ula c

omp.

Naja

trip

udia

nsN

aja n

aja L

.Ca

refu

lly d

ried

poiso

n fro

m N

aja n

aja L

.H

ABM

onog

raph

HAB

Naja

com

p.Va

dem

ecum

: Naja

co

mp.

Ner

vi in

terc

osta

lesBo

s tau

rus L

.In

terc

osta

l ner

ves f

rom

the c

alf

Ph.E

ur. 2

.2.1

Der

Mer

kurs

tab:

So

nder

heft

1999

Ner

vus a

bduc

ens*

Bos t

auru

s L.

Ner

vus a

bduc

ens f

rom

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Ner

vus a

cces

soriu

sBo

s tau

rus L

.N

ervu

s acc

esso

rius f

rom

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Ner

vus f

acia

lis*

Bos t

auru

s L.

Ner

vus f

acia

lis fr

om th

e cal

fPh

.Eur

. 2.2

.1D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Ner

vus f

emor

alis

Bos t

auru

s L.

Ner

vus f

emor

alis

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Ner

vus

glos

soph

aryn

geus

Bos t

auru

s L.

Ner

vus g

loss

opha

ryng

eus f

rom

the c

alf

Ph.E

ur. 2

.2.1

Glö

ckler

, M.:

"Ant

hrop

osop

hisc

he

Arzn

eithe

rapi

e" (A

nthr

opos

ophi

c Ther

apy w

ith

Med

icina

l Pro

duct

s)

Publ

isher

W

issen

scha

ftlich

e Ve

rlags

gese

llsch

aft,

Stut

tgar

t

Ner

vus h

ypog

loss

usBo

s tau

rus L

.N

ervu

s hyp

oglo

ssus

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Ner

vus i

schi

adic

usBo

s tau

rus L

.N

ervu

s isc

hiad

icus

from

the c

alf

Ph.E

ur. 2

.2.1

Artic

ulat

io ta

locr

ural

is co

mp.

; Ner

vus

ischi

adic

us

Ner

vus i

schi

adic

usO

ryct

olag

us cu

nicu

lus L

.N

ervu

s isc

hiad

icus

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

ticul

atio

talo

crur

alis

com

p.; N

ervu

s isc

hiad

icus

Ner

vus l

aryn

geus

re

curr

ens

Bos t

auru

s L.

Ner

vus l

aryn

geus

recu

rren

s fro

m th

e cal

fPh

.Eur

. 2.2

.1Ap

is/La

rynx

com

p.; L

aryn

x co

mp.

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


156

Ner

vus l

aryn

geus

su

perio

rBo

s tau

rus L

.N

ervu

s lar

ynge

us su

perio

r fro

m th

e cal

fPh

.Eur

. 2.2

.1Ap

is/La

rynx

com

p.; L

aryn

x co

mp.

Ner

vus m

edia

nus

Bos t

auru

s L.

Ner

vus m

edia

nus f

rom

the c

alf

Ph.E

ur. 2

.2.1

Der

Mer

kurs

tab:

So

nder

heft

1999

Ner

vus o

culo

mot

oriu

sSu

s scr

ofa d

omes

tica L

.Pa

rts o

f the

Ner

vus o

culo

mot

oriu

s fro

m

the p

igPh

.Eur

. 2.2

.1Ir

is bo

vis c

omp.

; Ner

vus o

ptic

us co

mp.

Ner

vus

ocul

omot

oriu

s*Bo

s tau

rus L

.N

ervu

s ocu

lom

otor

ius f

rom

the c

alf

Ph.E

ur. 2

.2.1

Iris

bovi

s com

p.; N

ervu

s opt

icus

com

p.

Ner

vus o

phta

lmic

usBo

s tau

rus L

.N

ervu

s oph

talm

icus

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1Ir

is bo

vis c

omp.

Ner

vus o

phta

lmic

usSu

s scr

ofa d

omes

tica L

.Pa

rts o

f the

Ner

vus o

phta

lmic

us fr

om th

e pi

gPh

.Eur

. 2.2

.1Ir

is bo

vis c

omp.

Ner

vus o

ptic

usO

ryct

olag

us cu

nicu

lus L

.N

ervu

s opt

icus

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

nica

/Hyp

ophy

sis/P

lum

bum

m

ellitu

m co

mp.

; Aur

um/H

ypop

hysis

co

mp.

; Cor

nea/

Levi

sticu

m co

mp.

; H

ypop

hysis

com

p.; N

ervu

s opt

icus

co

mp.

Ner

vus o

ptic

usSu

s scr

ofa d

omes

tica L

.Pa

rts o

f Ner

vus o

ptic

us fr

om th

e pig

Ph.E

ur. (

2371

) 2.2

.1Ar

nica

/Hyp

ophy

sis/P

lum

bum

m

ellitu

m co

mp.

; Aur

um/H

ypop

hysis

co

mp.

; Cor

nea/

Levi

sticu

m co

mp.

; H

ypop

hysis

com

p.; N

ervu

s opt

icus

co

mp.

Ner

vus o

ptic

us*

Bos t

auru

s L.

Ner

vus o

ptic

us fr

om th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.1

Arni

ca/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Hyp

ophy

sis

com

p.; C

orne

a/Le

visti

cum

com

p.;

Hyp

ophy

sis co

mp.

; Ner

vus o

ptic

us

com

p.

Ner

vus

para

sym

path

icus

Ory

ctol

agus

cuni

culu

s L.

Ner

vus p

aras

ympa

thic

us fr

om th

e rab

bit

APC

3.3.

3 (g

lyce

rol

mac

erat

e 1:1

000

(as

Ph.E

ur. 2

.1.1

))

Ner

vus p

eron

aeus

Bos t

auru

s L.

Ner

vus p

eron

aeus

(fibu

laris

) fro

m th

e cal

fPh

.Eur

. 2.2

.1D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Ner

vus p

hren

icus

Bos t

auru

s L.

Ner

vus p

hren

icus

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: N

ervu

s ph

reni

cus

Ner

vus p

uden

dus

Bos t

auru

s L.

Ner

vus p

uden

dus f

rom

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Ner

vus r

adia

lisBo

s tau

rus L

.N

ervu

s rad

ialis

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


157

Ner

vus s

tato

acus

ticus

Ory

ctol

agus

cuni

culu

s L.

Ner

vus s

tato

acus

ticus

from

the r

abbi

tAP

C 3.

3.3

(gly

cero

l m

acer

ate 1

:100

0 (a

s Ph

.Eur

. 2.1

.1))

Arni

ca/E

piph

ysis/

Plum

bum

mell

itum

co

mp.

; Aur

um/E

piph

ysis

com

p.;

Epip

hysis

com

p.; G

naph

aliu

m co

mp.

Ner

vus s

tato

acus

ticus

*Bo

s tau

rus L

.N

ervu

s sta

toac

ustic

us fr

om th

e cal

fPh

.Eur

. 2.2

.1Ar

nica

/Epi

phys

is/Pl

umbu

m m

ellitu

m

com

p.; A

urum

/Epi

phys

is co

mp.

; Ep

iphy

sis co

mp.

; Gna

phal

ium

com

p.

Ner

vus t

ibia

lisBo

s tau

rus L

.N

ervu

s tib

ialis

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Ner

vus t

rigem

inus

*Bo

s tau

rus L

.N

ervu

s trig

emin

us fr

om th

e cal

fPh

.Eur

. 2.2

.1N

ervu

s trig

emin

usVa

dem

ecum

Ner

vus t

roch

learis

*Bo

s tau

rus L

.N

ervu

s tro

chlea

ris fr

om th

e cal

fPh

.Eur

. 2.2

.1D

er M

erku

rsta

b 20

05;

58(4

): 31

0-31

5

Ner

vus u

lnar

isBo

s tau

rus L

.N

ervu

s uln

aris

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Ner

vus v

agus

Bos t

auru

s L.

Ner

vus v

agus

from

the c

alf

Ph.E

ur. 2

.2.1

Apis/

Lary

nx co

mp.

; Lar

ynx

com

p.

Ner

vus v

agus

Ory

ctol

agus

cuni

culu

s L.

Ner

vus v

agus

from

the r

abbi

tPh

.Eur

. 2.1

.1Ap

is/La

rynx

com

p.; L

aryn

x co

mp.

Nod

i lym

phat

iciBo

s tau

rus L

.Pa

rts o

f lym

ph n

ode t

issue

from

diff

eren

t pa

rts o

f the

bod

y fro

m th

e cal

fPh

.Eur

. 2.2

.1D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Nuc

leus r

uber

*Bo

s tau

rus L

.Br

ain

subs

tanc

e fro

m th

e nuc

leus r

uber

fro

m th

e cal

fPh

.Eur

. 2.2

.1D

er M

erku

rsta

b 20

05;

58(4

): 31

0-31

5

Oes

opha

gus

Sus s

crof

a dom

estic

a L.

Oes

opha

gus f

rom

the p

igPh

.Eur

. 2.2

.3IV

AA st

atem

ent 2

013

Oss

aAv

es va

riae,

e.g. P

hasia

nus

colch

icus

L.

Clea

ned

and

mill

ed b

ones

from

bird

s, e.g

. Ph

asia

nus c

olch

icus

L.

Raw

mat

eria

l for

the

prod

uctio

n of

Ciss

us-

Oss

a (se

e app

. 2.6

)

Ciss

us-O

ssa

Liste

HAS

(10.

2012

)

Oss

icul

a aud

itus*

Bos t

auru

s L.

Audi

tory

bon

es fr

om th

e cal

fPh

.Eur

. 2.2

.2IV

AA st

atem

ent 2

013

Ova

riase

e Ova

rium

Ova

rium

Bos t

auru

s L.

Ova

ry fr

om th

e cow

Ph.E

ur. 2

.1.1

, 2.2

.1Ar

gent

um/O

varia

; Ber

beris

/Ute

rus

com

p.; E

chin

acea

/Par

amet

rium

com

p.;

Mag

nesiu

m su

lfuric

um/O

varia

com

p.;

Ova

ria co

mp.

; Ova

rium

; Ova

rium

co

mp.

Ova

rium

Ory

ctol

agus

cuni

culu

s L.

Ova

ry fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Ova

rium

; Ova

rium

com

p.

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


158

Panc

reas

Bos t

auru

s L.

Panc

reas

from

the c

alf

Ph.E

ur. 2

.1.1

Arge

ntum

/Pan

crea

s; Ba

rium

/Pan

crea

s co

mp.

; Bas

ilicu

m co

mp.

; Cal

cium

ca

rbon

icum

/Mes

ench

ym co

mp.

; Ci

chor

ium

/Pan

crea

s com

p.;

Equi

setu

m/P

ancr

eas;

Ferr

um

sider

eum

/Pan

krea

s; Pa

ncre

as/P

latin

um

chlo

ratu

m co

mp.

; Pan

krea

s; Pa

nkre

as

com

p.

Panc

reas

Ory

ctol

agus

cuni

culu

s L.

Panc

reas

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

gent

um/P

ancr

eas;

Bariu

m/P

ancr

eas

com

p.; C

alciu

m ca

rbon

icum

/M

esen

chym

com

p.; C

ichor

ium

/Pa

ncre

as co

mp.

; Equ

isetu

m/P

ancr

eas;

Ferr

um si

dere

um/P

ankr

eas;

Panc

reas

/Pl

atin

um ch

lora

tum

com

p.; P

ankr

eas;

Pank

reas

com

p.

Panc

reas

Sus s

crof

a dom

estic

a L.

Panc

reas

from

the p

igPh

.Eur

. 2.2

.1Ar

gent

um/P

ancr

eas;

Bariu

m/P

ancr

eas

com

p.; B

asili

cum

com

p.; C

alciu

m

carb

onic

um/M

esen

chym

com

p.;

Cich

oriu

m/P

ancr

eas c

omp.

; Eq

uise

tum

/Pan

crea

s; Fe

rrum

sid

ereu

m/P

ankr

eas;

Panc

reas

/Plat

inum

ch

lora

tum

com

p.; P

ankr

eas;

Pank

reas

co

mp.

Papi

llae d

uode

niSu

s scr

ofa d

omes

tica L

.Pa

pilla

duo

deni

regi

on o

f the

smal

l in

testi

ne fr

om th

e pig

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Para

met

rium

Bos t

auru

s L.

Tiss

ue fr

om th

e bro

ad li

gam

ent o

f the

ut

erus

from

the c

owPh

.Eur

. 2.2

.2Ec

hina

cea/

Para

met

rium

com

p.

Para

met

rium

dex

trum

Bos t

auru

s L.

Tiss

ue fr

om th

e rig

ht b

road

liga

men

t of

the u

teru

s fro

m th

e cow

Ph.E

ur. 2

.2.2

Der

Mer

kurs

tab:

So

nder

heft

1999

Pars

feta

lis (p

lace

nta)

Bos t

auru

s L.

Alla

ntoc

horio

n fro

m th

e bov

ine f

oetu

sPh

.Eur

. 2.2

.2Pr

unus

/Ros

mar

inus

com

p.

Pars

pal

lida*

Bos t

auru

s L.

Part

s of t

he b

ase o

f the

bra

in fr

om th

e cal

fPh

.Eur

. 2.2

.1IV

AA st

atem

ent 2

013

Pate

llaBo

s tau

rus L

.Pa

tella

from

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Peni

sBo

s tau

rus L

.Pe

nis f

rom

the b

ull

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Peric

ardi

umBo

s tau

rus L

.Pe

ricar

dium

from

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um

Perio

dont

ium

Bos t

auru

s L.

Part

s of t

he al

veol

ar an

d de

ntal

s reg

ions

fro

m th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.2

Perio

dont

ium

/Sili

cea c

omp.

; Pe

riodo

ntiu

m/S

tann

um co

mp.

Vade

mec

um

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


159

Perio

dont

ium

Sus s

crof

a dom

estic

a L.

Part

s of t

he al

veol

ar an

d de

ntal

regi

ons

from

the p

igPh

.Eur

. 2.1

.1Pe

riodo

ntiu

m/S

ilice

a com

p.;

Perio

dont

ium

/Sta

nnum

com

p.

Perio

steum

Bos t

auru

s L.

Perio

steum

from

the c

alf

Ph.E

ur. 2

.2.2

Alliu

m ce

pa/T

endo

com

p.; A

rtic

ulat

io

talo

crur

alis

com

p.

Perio

steum

Ory

ctol

agus

cuni

culu

s L.

Perio

steum

from

the r

abbi

tPh

.Eur

. 2.1

.1Al

lium

cepa

/Ten

do co

mp.

; Art

icul

atio

ta

locr

ural

is co

mp.

Perit

onae

umBo

s tau

rus L

.Pe

riton

aeum

from

the c

alf

Ph.E

ur. 2

.2.2

Bryo

nia/

Visc

um co

mp.

Perit

onae

umO

ryct

olag

us cu

nicu

lus L

.Pe

riton

aeum

from

the r

abbi

tPh

.Eur

. 2.1

.1Br

yoni

a/Vi

scum

com

p.

Phar

ynx

Bos t

auru

s L.

Part

s fro

m th

e Pha

rynx

dig

esto

rium

and

Phar

ynx

resp

irato

rius f

rom

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um: P

hary

nx

Phys

eter

cato

don

see A

mbr

a gris

ea

Phys

eter

m

acro

ceph

alus

see A

mbr

a gris

ea

Pia m

ater

ence

phal

i*Bo

s tau

rus L

.Pi

a mat

er en

ceph

ali f

rom

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Plac

enta

Bos t

auru

s L.

Plac

ento

mas

from

the p

regn

ant c

owPh

.Eur

. 2.2

.2Be

rber

is/Se

pia c

omp.

; Cal

endu

la/

Trop

aeol

um co

mp.

; Ech

inac

ea/V

iscum

co

mp.

; Pla

cent

a/Tr

opae

olum

Glö

ckler

, M.:

"Ant

hrop

osop

hisc

he

Arzn

eithe

rapi

e" (A

nthr

opos

ophi

c Ther

apy w

ith

Med

icina

l Pro

duct

s)

Publ

isher

W

issen

scha

ftlich

e Ve

rlags

gese

llsch

aft,

Stut

tgar

t

Pleu

raBo

s tau

rus L

.Pl

eura

par

ieta

lis fr

om th

e cal

fPh

.Eur

. 2.2

.1D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Plex

us b

rach

ialis

Bos t

auru

s L.

Plex

us b

rach

ialis

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um

[men

tione

d un

der:

Disc

i/Rhu

s to

xico

dend

ron

com

p.]

Plex

us ca

rdia

cus

Bos t

auru

s L.

Plex

us ca

rdia

cus f

rom

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: P

lexus

ca

rdia

cus

Plex

us co

eliac

usBo

s tau

rus L

.Pl

exus

coeli

acus

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: P

lexus

co

eliac

us

Plex

us g

astri

cus

Bos t

auru

s L.

Plex

us g

astri

cus f

rom

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: P

lexus

ga

stric

us

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


160

Plex

us

haem

orrh

oida

lisBo

s tau

rus L

.Ve

nous

net

work

in th

e reg

ion

of th

e re

ctum

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: P

lexus

ha

emor

rhoi

dalis

Plex

us lu

mba

lisBo

s tau

rus L

.Pl

exus

lum

balis

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Plex

us p

elvin

usBo

s tau

rus L

.Pl

exus

pelv

inus

from

the c

alf

Ph.E

ur. 2

.2.1

Der

Mer

kurs

tab:

So

nder

heft

1999

Plex

us p

ulm

onal

is (N

ervu

s vag

us)

Bos t

auru

s L.

Plex

us p

ulm

onal

is fro

m th

e cal

fPh

.Eur

. 2.2

.1Va

dem

ecum

: Plex

us

pulm

onal

is (N

ervu

s va

gus)

Plex

us re

ctal

isse

e Plex

us h

aem

orrh

oida

lisIV

AA st

atem

ent 2

013

Plex

us sa

cral

isBo

s tau

rus L

.Pl

exus

sacr

alis

from

the c

alf

Ph.E

ur. 2

.2.1

Der

Mer

kurs

tab:

So

nder

heft

1999

Pons

*Bo

s tau

rus L

.Po

ns fr

om th

e cal

fPh

.Eur

. 2.2

.1D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Prop

olis

Apis

mell

ifera

L.

Prop

olis

Ph.fr

.Ph

.Eur

. 1.1

.10

(eth

anol

90

%)

Der

Mer

kurs

tab

2011

; 64

(4):

338

Pros

tata

Bos t

auru

s L.

Pros

tata

from

the b

ull

Ph.E

ur. 2

.2.1

Berb

eris/

Pros

tata

com

p.

Pude

ndum

fem

iniu

mBo

s tau

rus L

.La

bia v

ulva

e, cli

toris

and

glan

dula

ve

stibu

laris

majo

r fro

m th

e cow

Ph.E

ur. 2

.2.2

Prun

us/R

osm

arin

us co

mp.

Pulm

oBo

s tau

rus L

.Lu

ng ti

ssue

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1Ca

lcium

carb

onic

um/M

esen

chym

co

mp.

; Fer

rum

/Pul

mo;

Mer

curiu

s/Pu

lmo;

Org

anum

qua

drup

lex; P

ulm

o/Ta

rtar

us st

ibia

tus A

; Pul

mo/

Tart

arus

sti

biat

us B

; Pul

mo/

Vivi

anit

com

p.

Pulm

oO

ryct

olag

us cu

nicu

lus L

.Lu

ng fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Calci

um ca

rbon

icum

/Mes

ench

ym

com

p.; F

erru

m/P

ulm

o; M

ercu

rius/

Pulm

o; O

rgan

um q

uadr

uplex

; Pul

mo/

Tart

arus

stib

iatu

s A; P

ulm

o/Ta

rtar

us

stibi

atus

B; P

ulm

o/Vi

vian

it co

mp.

Pulp

a den

tisBo

s tau

rus L

.Pu

lpa d

entis

from

the c

alf

Ph.E

ur. 2

.2.1

Vade

mec

um: P

ulpa

de

ntis

Pylo

rus

Sus s

crof

a dom

estic

a L.

Pylo

rus f

rom

the p

igPh

.Eur

. 2.2

.3D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Rect

umSu

s scr

ofa d

omes

tica L

.Re

ctum

from

the p

igPh

.Eur

. 2.2

.3D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


161

Regi

o su

bsta

ntia

e ni

grae

*Bo

s tau

rus L

.Ti

ssue

from

the s

ubsta

ntia

nig

ra fr

om th

e ca

lfPh

.Eur

. 2.2

.1Va

dem

ecum

: Reg

io

subs

tant

iae n

igra

e

Rene

sBo

s tau

rus L

.Ki

dney

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1Ar

gent

um n

itric

um/R

enes

; Bor

ago/

Rene

s com

p.; C

alciu

m ca

rbon

icum

/M

esen

chym

com

p.; C

upru

m ac

etic

um

com

p.; C

upru

m-R

en-G

land

ula

supr

aren

alis;

Cup

rum

/Ren

es;

Equi

setu

m/R

enes

com

p.; L

ien

com

p.;

Nico

tiana

/Nux

vom

ica c

omp.

; O

rgan

um q

uadr

uplex

; Ren

Rene

sO

ryct

olag

us cu

nicu

lus L

.Ki

dney

from

the r

abbi

tPh

.Eur

. 2.1

.1Ar

gent

um n

itric

um/R

enes

; Bor

ago/

Rene

s com

p.; C

alciu

m ca

rbon

icum

/M

esen

chym

com

p.; C

upru

m ac

etic

um

com

p.; C

upru

m-R

en-G

land

ula

supr

aren

alis;

Cup

rum

/Ren

es;

Equi

setu

m/R

enes

com

p.; L

ien

com

p.;

Nico

tiana

/Nux

vom

ica c

omp.

; O

rgan

um q

uadr

uplex

; Ren

Rene

s, re

gio

pyelo

rena

lisBo

s tau

rus L

.Pa

rts o

f tiss

ue fr

om th

e pelv

is re

nalis

and

med

ulla

rena

lis fr

om th

e cal

fPh

.Eur

. 2.2

.1IV

AA st

atem

ent 2

013

Retic

uloe

ndot

helia

l Sy

stem

Bos t

auru

s L.

Part

s fro

m th

e thy

mus

gla

nd, l

ymh

node

s, bo

ne m

arro

w, li

ver a

nd sp

leen

from

the

calf

Ph.E

ur. 2

.2.1

Vade

mec

um

[men

tione

d un

der:

Levi

co co

mp.

]

Retin

a (et

Cho

rioid

ea)

Ory

ctol

agus

cuni

culu

s L.

Part

s of t

he re

tina a

nd th

e cho

rioid

ea

from

the r

abbi

tPh

.Eur

. 2.1

.1Re

tina;

Retin

a com

p.; R

etin

a/Se

cale

com

p.

Retin

a et C

horio

idea

*Bo

s tau

rus L

.Pa

rts o

f the

retin

a and

the c

horio

idea

fro

m th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.3

Arni

ca/H

ypop

hysis

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Hyp

ophy

sis

com

p.; C

hrys

olith

com

p.; G

alen

it/Re

tina c

omp.

; Hyp

ophy

sis co

mp.

; La

min

a/Re

tina c

omp.

; Ner

vus o

ptic

us

com

p.; R

esin

a Lar

icis/

Retin

a; Re

tina;

Retin

a com

p.; R

etin

a/Se

cale

com

p.

Scler

a*Bo

s tau

rus L

.Sc

lera f

rom

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Scol

open

dra

Seve

ral s

pecie

s of S

colo

pend

ra

fam

ilyLi

ving

cent

iped

e of S

colo

pend

ridea

e fa

mily

APC

3.3.

1AB

MA-

Vade

mec

um

Sinu

s fac

ialis

-Mer

curiu

s p.

238

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


162

Sepi

a offi

cina

lisSe

pia o

ffici

nalis

L.

Drie

d in

k ba

g fro

m S

epia

offi

cina

lis L

.Ph

.fr.

Ph.E

ur. 1

.1.1

1 (E

than

ol 6

5% V

/V);

see a

lso A

pp. 2

.7:

Sepi

a Gru

neris

Der

Mer

kurs

tab

1997

; 52

(1):

51

Sepi

a offi

cina

lis e

volu

min

e bur

sae r

ec.

Sepi

a offi

cina

lis L

.Fr

esh

secr

etio

n fro

m in

k gl

and

from

Sep

ia

offici

nalis

L.

Ph.E

ur. 2

.2.3

Auru

m/P

ulsa

tilla

/Spo

ngia

com

p.;

Berb

eris/

Sepi

a com

p.; M

eliss

a/Se

pia

com

p.

Vade

mec

um: S

epia

Der

M

erku

rsta

b 19

97; 5

2(1)

: 51

Sinu

s cav

erno

sus-

Kom

plex

*Bo

s tau

rus L

.Pa

rts o

f the

sinu

s cav

erno

sus-

Kom

plex

; sin

us ca

vern

osus

, ner

vus o

ptic

us, n

ervu

s oc

ulom

otor

ius,

nerv

us tr

ochl

earis

, ner

vus

trig

emin

us an

d ne

rvus

abdu

cens

from

the

calf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Spon

gia t

osta

Eusp

ongi

a offi

cina

lis L

.To

aste

d Eu

spon

gia o

ffici

nalis

L.

HAB

; Ph.

fr.Ph

.Eur

. 1.1

.9, (

etha

nol

70%

), 1.

1.11

(eth

anol

65

%),

4.1.

1 (a

nd th

en

3.2.

2), A

PI

Auru

m/P

ulsa

tilla

/Spo

ngia

com

p.;

Bryo

nia/

Spon

gia c

omp.

; Col

chic

um

com

p.; C

olch

icum

/Spo

ngia

com

p.;

Spon

gia;

Spon

gia c

omp.

Vade

mec

um: S

pong

ia

Stom

achu

sO

ryct

olag

us cu

nicu

lus L

.St

omac

h fro

m th

e rab

bit

Ph.E

ur. 2

.1.1

Cich

oriu

m co

mp.

Stom

achu

sse

e Ven

tric

ulus

from

the p

ig

Sym

path

icus

see T

runc

us sy

mpa

thic

us

Tend

oBo

s tau

rus L

.Te

ndo

from

the c

alf

Ph.E

ur. 2

.2.2

Alliu

m ce

pa/T

endo

com

p.; A

rtic

ulat

io

talo

crur

alis

com

p.

Tend

oO

ryct

olag

us cu

nicu

lus L

.Te

ndo

from

the r

abbi

tPh

.Eur

. 2.1

.1

Testa

ovi

Gal

lus g

allu

s dom

estic

us L

.Sh

ell o

f hen

's eg

gsPh

.Eur

. 4.1

.1Au

rum

/Pul

satil

la/S

pong

ia co

mp.

; Sp

ongi

a com

p.

Teste

sBo

s tau

rus L

.Te

stes f

rom

the b

ull

Ph.E

ur. 2

.2.1

Arge

ntum

/Tes

tes;

Teste

s com

p.

Text

us co

nnec

tivus

Bos t

auru

s L.

Subc

utan

eous

and

inte

rmus

cula

r co

nnec

tive t

issue

, fas

cia,

ligam

ents,

te

ndon

s, as

well

as m

esen

teriu

m fr

om th

e ca

lf

Ph.E

ur. 2

.2.2

Bora

go/R

enes

com

p.

Thal

amus

*Bo

s tau

rus L

.Th

alam

us fr

om th

e cal

fPh

.Eur

. 2.2

.1Ar

nica

/Hyp

ophy

sis/P

lum

bum

m

ellitu

m co

mp.

; Aur

um/H

ypop

hysis

co

mp.

; Hyp

ophy

sis co

mp.

Thro

mbo

cyte

sEq

uus p

rzew

alsk

ii f.

caba

llus

POLI

AKO

VTh

rom

bocy

tes f

rom

the b

lood

of t

he

hors

ePh

.Eur

. 2.2

.4Va

dem

ecum

: Th

rom

bocy

ten

Thym

us (G

land

ula)

Bos t

auru

s L.

Thym

us fr

om th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.1

Gla

ndul

a Thym

us

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


163

Thym

us (G

land

ula)

Ory

ctol

agus

cuni

culu

s L.

Thym

us fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Gla

ndul

a Thym

us

Tons

illa p

hary

ngea

Bos t

auru

s L.

Tons

illa p

hary

ngea

from

the c

alf

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Tons

illae

pal

atin

aeBo

s tau

rus L

.To

nsill

a pal

atin

ae fr

om th

e cal

fPh

.Eur

. 2.2

.1Ca

lendu

la/E

chin

acea

com

p.

Trab

ecul

um*

Bos t

auru

s L.

Trab

ecul

um fr

om th

e cal

fRa

w m

ater

ial f

or th

e pr

oduc

tion

of

Trab

ecul

um co

mp.

(s

ee ap

p. 2

.6)

Trab

ecul

um co

mp.

Liste

HAS

(10.

2012

)

Trac

hea

Bos t

auru

s L.

Trac

hea f

rom

the c

alf

Ph.E

ur. 2

.2.2

IVAA

stat

emen

t 201

3

Trac

tus d

iges

tivus

Bos t

auru

s L.

Equa

l par

ts of

the c

ompl

ete d

iges

tive

syste

m fr

om th

e cal

fAP

C 3.

3.1

ABM

A-Va

dem

ecum

: Tr

actu

s dig

estiv

us-

Cupr

um p

. 257

Trig

onum

vesic

ae et

M

uscu

lus s

phin

cter

Bos t

auru

s L.

Tiss

ue o

f the

vesic

a fro

m th

e reg

ion

of th

e tri

gonu

m ve

sicae

and

mus

cula

r tiss

ue

from

the s

phin

cter

of t

he ve

sica f

rom

the

calf

Ph.E

ur. 2

.2.3

Der

Mer

kurs

tab:

So

nder

heft

1999

Trun

cus c

ereb

riO

ryct

olag

us cu

nicu

lus L

.Br

ain

stem

from

the r

abbi

tPh

.Eur

. 2.1

.1Ap

is re

gina

com

p.; H

irnsta

mm

/Tr

iticu

m

Trun

cus c

ereb

ri*Bo

s tau

rus L

.Pa

rts f

rom

Hyp

otha

lam

us, Th

alam

us,

Corp

ora q

uadr

igem

ina,

Pons

, Med

ulla

ob

long

ata a

nd C

ereb

ellum

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1Ap

is re

gina

com

p.; H

irnsta

mm

/Tr

iticu

m

Trun

cus c

oelia

cus

Bos t

auru

s L.

Arte

ria co

eliac

a (tr

uncu

s coe

liacu

s) fr

om

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Trun

cus s

ympa

thic

usBo

s tau

rus L

.Tr

uncu

s sym

path

icus

from

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.1Va

dem

ecum

: Sy

mpa

thic

us

Trun

cus s

ympa

thic

usO

ryct

olag

us cu

nicu

lus L

.Tr

uncu

s sym

path

icus

from

the r

abbi

tAP

C 3.

3.3

(gly

cero

l m

acer

ate 1

:100

0 (a

s Ph

.Eur

. 2.1

.1))

Vade

mec

um:

Sym

path

icus

Tuba

audi

tiva*

Bos t

auru

s L.

Tuba

audi

tiva f

rom

the c

alf

Ph.E

ur. 2

.2.2

Vade

mec

um: T

uba

audi

tiva

Tuba

ute

rina

Bos t

auru

s L.

Tuba

ute

rina f

rom

the c

owPh

.Eur

. 2.1

.1, 2

.2.2

Echi

nace

a/Pa

ram

etriu

m co

mp.

Tuba

ute

rina

Ory

ctol

agus

cuni

culu

s L.

Tuba

ute

rina f

rom

the (

fem

ale)

rabb

itPh

.Eur

. 2.1

.1Ec

hina

cea/

Para

met

rium

com

p.

Tuni

ca m

ucos

a in

testi

ni te

nuis

Sus s

crof

a dom

estic

a L.

Muc

osa f

rom

the d

iffer

ent r

egio

ns o

f the

sm

all i

ntes

tine f

rom

the p

igPh

.Eur

. 2.2

.1IV

AA st

atem

ent 2

013

Tuni

ca m

ucos

a nas

iBo

s tau

rus L

.Tu

nica

muc

osa n

asi f

rom

the c

alf

Ph.E

ur. 2

.2.1

Bron

chi/P

lant

ago

com

p.Va

dem

ecum

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


164

Tuni

ca m

ucos

a rec

tiSu

s scr

ofa d

omes

tica L

.Tu

nica

muc

osa r

ecti

from

the p

igPh

.Eur

. 2.2

.1IV

AA st

atem

ent 2

013

Tuni

ca m

ucos

a ve

ntric

uli

Sus s

crof

a dom

estic

a L.

Muc

osa f

rom

the d

iffer

ent r

egio

ns o

f the

sto

mac

h fro

m th

e pig

Ph.E

ur. 2

.2.1

IVAA

stat

emen

t 201

3

Uret

erBo

s tau

rus L

.Ur

eter

from

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Uret

hra f

emin

ina

Bos t

auru

s L.

Uret

hra f

rom

the f

emal

e cal

fPh

.Eur

. 2.2

.3D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Uret

hra m

ascu

lina

Bos t

auru

s L.

Uret

hra f

rom

the m

ale c

alf

Ph.E

ur. 2

.2.3

Der

Mer

kurs

tab:

So

nder

heft

1999

Ute

rus

Bos t

auru

s L.

Ute

rus f

rom

the c

owPh

.Eur

. 2.2

.3Be

rber

is/U

teru

s com

p.; B

ryop

hyllu

m

com

p.

Ute

rus

Ory

ctol

agus

cuni

culu

s L.

Ute

rus f

rom

the (

fem

ale)

rabb

itPh

.Eur

. 2.1

.1Be

rber

is/U

teru

s com

p.; B

ryop

hyllu

m

com

p.

Uve

a*Bo

s tau

rus L

.U

vea f

rom

the c

alf

Raw

mat

eria

l for

the

prod

uctio

n of

Uve

a co

mp.

(see

app.

2.6

)

Liste

HAS

(10.

2010

: U

vea c

omp.

)

Vagi

naBo

s tau

rus L

.Va

gina

from

the c

owPh

.Eur

. 2.2

.3IV

AA st

atem

ent 2

013

Vagi

nae s

ynov

iales

te

ndin

umBo

s tau

rus L

.Te

ndon

shea

ths f

rom

the c

alf

Ph.E

ur. 2

.1.1

, 2.2

.3Al

lium

cepa

/Ten

do co

mp.

Vade

mec

um

Vagi

nae s

ynov

ialis

te

ndin

umSu

s scr

ofa d

omes

tica L

.Te

ndon

shea

ths f

rom

the p

igPh

.Eur

. 2.1

.1Al

lium

cepa

/Ten

do co

mp.

Valv

a tru

nci

pulm

onal

isBo

s tau

rus L

.Va

lva t

runc

i pul

mon

alis

from

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Valv

ula a

orta

eBo

s tau

rus L

.Va

lva a

orta

e fro

m th

e cal

fPh

.Eur

. 2.2

.3Va

dem

ecum

Valv

ula m

itral

isBo

s tau

rus L

.Va

lva m

itral

is fro

m th

e cal

fPh

.Eur

. 2.2

.3IV

AA st

atem

ent 2

013

Valv

ula t

ricus

pida

lisBo

s tau

rus L

.Va

lva t

ricus

pida

lis fr

om th

e cal

fPh

.Eur

. 2.2

.3D

er M

erku

rsta

b:

Sond

erhe

ft 19

99

Vena

cava

Bos t

auru

s L.

Part

s of t

he V

ena c

ava c

rani

alis

and

Vena

ca

va ca

udal

is fro

m th

e cal

fPh

.Eur

. 2.1

.1, 2

.2.3

IVAA

stat

emen

t 201

3

Vena

cava

Ory

ctol

agus

cuni

culu

s L.

Part

s of t

he ve

na ca

va fr

om th

e rab

bit

Ph.E

ur. 2

.1.1

Vena

fem

oral

isBo

s tau

rus L

.Ve

na fe

mor

alis

from

the c

alf

Ph.E

ur. 2

.2.3

Der

Mer

kurs

tab:

So

nder

heft

1999

Vena

por

tae

Bos t

auru

s L.

Vena

por

tae f

rom

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.3


165

Vena

saph

ena m

agna

Bos t

auru

s L.

Vena

saph

ena m

agna

from

the c

alf

Ph.E

ur. 2

.2.3

Vade

mec

um: V

ena

saph

ena m

agna

Vent

ricul

usSu

s scr

ofa d

omes

tica L

.Ve

ntric

ulus

from

the p

igPh

.Eur

. 2.1

.1, 2

.2.3

Vade

mec

um:

Vent

ricul

us

Verte

bra c

ervi

calis

*Bo

s tau

rus L

.Ve

rtebr

a cer

vica

lis fr

om th

e cal

fPh

.Eur

. 2.2

.3IV

AA st

atem

ent 2

013

Verte

bra c

occy

gea

Bos t

auru

s L.

Verte

bra c

occy

gea f

rom

the c

alf

Ph.E

ur. 2

.2.3

IVAA

stat

emen

t 201

3

Verte

bra l

umba

lis*

Bos t

auru

s L.

Verte

bra l

umba

lis fr

om th

e cal

fPh

.Eur

. 2.2

.3IV

AA st

atem

ent 2

013

Vesic

a fell

eaBo

s tau

rus L

.Ve

sica f

ellea

from

the c

alf

Ph.E

ur. 2

.2.3

Ferr

um/V

esic

a fell

ea

Vesic

a urin

aria

Bos t

auru

s L.

Vesic

a urin

aria

from

the c

alf

Ph.E

ur. 2

.2.3

Cant

haris

com

p.Va

dem

ecum

Vesic

a urin

aria

Ory

ctol

agus

cuni

culu

s L.

Vesic

a urin

aria

from

the r

abbi

tPh

.Eur

. 2.1

.1Ca

ntha

ris co

mp.

Vesp

a cra

bro

Vesp

a cra

bro

L.Li

ve h

orne

tsH

ABM

onog

raph

, Dilu

tions

ac

c. to

Ph.

Eur.

1.1.

9;

Ph.E

ur. 1

.1.1

1 (e

than

ol

65%

), 2.

1.1,

2.2

.3

Arge

ntum

com

p.; A

rnic

a, Pl

anta

tota

/Ve

spa C

rabr

o; C

olch

icum

com

p.;

Mag

nesiu

m su

lfuric

um/O

varia

com

p.;

Vesp

a cra

bro;

Ves

pa cr

abro

com

p.

Vade

mec

um: V

espa

cr

abro

Vesp

a vul

garis

Vesp

ula g

erm

anic

a Fab

riciu

s, Ve

spul

a vul

garis

L. a

nd/o

r D

olich

oves

pula

saxo

nia

Fabr

icius

Live

wor

ker w

asps

Ph.E

ur. 1

.1.1

1 (e

than

ol

65%

), 2.

1.1

Flor

es T

ritici

com

p.Li

ste H

AS (1

0.20

12)

Vipe

ra b

erus

Vipe

ra b

erus

L.

Free

ze d

ried

veno

m o

f Vip

era b

erus

L.

acc.

to H

AB

mon

ogra

ph L

ache

sisN

aja co

mp.

Scie

ntifi

c nam

eSc

ient

ific n

ame o

f the

anim

alAb

brev

iate

d de

finiti

on o

f the

par

t use

dRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.3


166

•

Appendix 2.3


167

•

Ap

pend

ix 2

.4

APPENDIX 2.4

Starting materials that can be described chemically Additional Information, see p. 18


168

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

Acid

um ar

seni

cosu

mse

e Ars

enii

trio

xidu

m

Acid

um ci

tric

umAc

idum

citr

icum

Citr

ic ac

idPh

.Eur

.ex

cipie

nt

Acid

um ci

tric

um

mon

ohyd

ricum

Acid

um ci

tric

um

mon

ohyd

ricum

Citr

ic ac

id m

onoh

ydra

tePh

.Eur

.as

raw

mat

eria

l for

the

prep

arat

ion

for c

itrat

es

of F

e and

Ba

Berb

eris/

Silic

ea co

mp.

Acid

um F

orm

icae

see a

pp. 2

.3

Acid

um

hexa

chlo

ropl

atin

icum

Hex

achl

orop

latin

ic ac

idH

ABPh

.Eur

. 3.1

.2, 4

.1.1

, 4.

1.2

Panc

reas

/Plat

inum

chlo

ratu

m co

mp.

Acid

um h

ydro

chlo

ridum

di

lutu

mAc

idum

hyd

roch

loric

umH

ydro

chlo

ric ac

id, d

ilute

(10%

)Ph

.Eur

.se

e mon

ogra

ph H

AB

(D2

with

wat

er, D

3 wi

th

etha

nol 5

0%);

excip

ient

Acid

um h

ydro

chlo

ricum

com

p.

Acid

um la

ctic

umAc

idum

lact

icum

Lact

ic ac

idPh

.Eur

.AP

IM

ajora

na/Th

uja c

omp.

Acid

um n

itric

umAc

idum

nitr

icum

, N

itric

um ac

idum

pph

Nitr

ic ac

id(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(see

m

onog

raph

HAB

), 3.

1.2,

API

& ex

cipie

nt

Mix

tura

Stan

ni co

mp.

Acid

um p

hosp

horic

um

dilu

tum

Acid

um p

hosp

horic

umPh

osph

oric

acid

, dilu

te (1

0%)

Ph.E

ur.

Ph.E

ur. 3

.1.1

(eth

anol

50

%),

3.1.

2Ac

idum

pho

spho

ricum

; Api

s reg

ina/

Auru

m co

mp.

Acid

um p

hosp

horic

um

conc

entra

tum

Acid

um p

hosp

horic

um

conc

entra

tum

, Ph

osph

oric

um ac

idum

pp

h

Phos

phor

ic ac

id, c

once

ntra

ted

Ph.E

ur.

Ph.E

ur. 3

.1.1

, 3.1

.2Ap

is re

gina

/Aur

um co

mp.

Acid

um si

licic

umAc

idum

silic

icum

Prec

ipita

ted

silic

on d

ioxi

deD

ABPh

.Eur

. 4.1

.1, 4

.1.2

, AP

I, ra

w m

ater

ial f

or

prod

uctio

n

Acid

um su

lfuric

umAc

idum

sulfu

ricum

, Su

lfuric

um ac

idum

pph

Sulfu

ric ac

id (9

5-10

0.5%

H2S

O4)

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (s

ee

mon

ogra

ph H

AB),

raw

mat

eria

l for

the

prod

uctio

n of

star

ting

mat

eria

ls

Acid

um ta

rtar

icum

Acid

um ta

rtar

icum

Tart

aric

acid

Ph.E

ur.

raw

mat

eria

l for

the

prep

arat

ion

of S

olut

io

Ferr

i com

p. (a

pp. 2

.6)

Gla

ndul

a sup

rare

nalis

/Sol

utio

Fer

ri co

mp.

Aesc

ulin

umAe

scul

inD

AB; H

ABLi

quid

dilu

tion

see

Aesc

ulin

um H

AB

(Ph.

Eur.

3.1.

1 (e

than

ol

90%

), Ph

.Eur

. 4.1

.1,

4.1.

2, A

PI

Echi

nace

a/Pr

unus

com

p.

•

Appendix 2.4


169

Aeth

iops

antim

onia

lisse

e Hyd

rarg

yrum

stib

iato

-sul

fura

tum

Aeth

iops

antim

onia

lis

Alum

enAl

umen

Alum

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (s

ee

mon

ogra

ph H

AB),

3.1.

1 (D

1 wi

th w

ater

, fro

m

D2

with

etha

nol 3

0%),

4.1.

1, A

PI

Alum

en/H

elleb

orus

com

p.; M

ixtu

ra

Stan

ni co

mp.

Alum

en ch

rom

icum

Pota

ssiu

m ch

rom

ium

(III)

sulfa

te

dode

cahy

drat

ePh

.Eur

. 4.1

.1, 4

.1.2

Vade

mec

um: A

lum

en

chro

mic

um

Alum

iniu

m-k

aliu

m-

sulfu

ricum

see A

lum

enPh

.Eur

.

Amm

onia

e sol

utio

co

ncen

trata

Amm

onia

solu

tion,

conc

entra

ted

(25-

30%

N

H3)

Ph.E

ur.

raw

mat

eria

l for

the

prod

uctio

n of

star

ting

mat

eria

ls

Amm

oniu

m ca

rbon

icum

Mix

ture

of a

mm

oniu

m h

ydro

gen

carb

onat

e and

amm

oniu

m ca

rbam

ate o

f va

ryin

g pr

opor

tions

HAB

Ph.E

ur. 3

.1.1

(eth

anol

18

%)

Echi

nace

a com

p.

Antim

oniu

m ta

rtar

icum

see K

aliu

m st

ibyl

tart

aric

um

Arge

nti c

arbo

nas

Arge

ntum

carb

onic

umSi

lver

carb

onat

e, 99

-100

.5%

Ag2

CO3

see A

ppen

dix

2.6,

e.g.

Vi

scum

Mal

i cum

Ar

gent

o

Visc

um al

bum

c. A

rg

Arge

nti n

itras

Arge

ntum

nitr

icum

, Ar

gent

um n

itric

um p

phSi

lver

nitr

ate

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (w

ater

) se

e Arg

entu

m n

itric

um

HAB

; raw

mat

eria

l for

pr

epar

atio

n of

Ar

gent

um-C

orpu

s vi

treum

(see

app,

2.6

) an

d an

excip

ient

(p

rese

rvat

ive)

Antim

onit/

Rosa

e aet

hero

leum

com

p.;

Arch

ange

lica/

Pyrit

com

p.; A

rgen

tum

ni

tricu

m; A

rgen

tum

nitr

icum

com

p.;

Arge

ntum

nitr

icum

/Ren

es; C

alen

dula

/Ec

hina

cea c

omp.

; Cer

atum

Rat

anhi

ae

com

p.; M

yrist

ica s

ebife

ra co

mp.

; Pe

riodo

ntiu

m/S

ilice

a com

p.;

Phyt

olac

ca co

mp.

; Rat

anhi

a com

p.;

Robi

nia c

omp.

; Sal

via c

omp.

; Sili

cea

com

p.

Arge

ntum

collo

idal

eAr

gent

um co

lloid

ale

Collo

idal

silv

er, a

silv

er p

repa

ratio

n wi

th a

prot

ectiv

e col

loid

coat

ing

of so

lubl

e pr

otei

n

HAB

see m

onog

raph

HAB

Arge

ntum

/Urt

ica c

omp.

; Majo

rana

/Th

uja c

omp.

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


170

Arge

ntum

met

allic

um,

Arge

ntum

met

allic

um

pph

Met

allic

silv

erH

AB; P

h.fr.

Ph.E

ur. 4

.1.1

, 4.1

.2,

Ph.fr

. (se

e mon

ogra

ph)

Agar

icus

com

p./P

hosp

horu

s; Ar

gent

um co

mp.

; Arg

entu

m

met

allic

um; A

rgen

tum

-Cor

pus

vitre

um; A

rgen

tum

/Ber

beris

com

p.;

Arge

ntum

/Ech

inac

ea; A

rgen

tum

/H

yosc

yam

us; A

rgen

tum

/Ova

ria;

Arge

ntum

/Pan

crea

s; Ar

gent

um/Q

uarz

; Ar

gent

um/Q

uerc

us co

mp.

; Arg

entu

m/

Rohr

zuck

er; A

rgen

tum

/Sec

ale;

Arge

ntum

/Stib

ium

; Arg

entu

m/T

este

s; Be

tula

/Arn

ica c

omp.

; Bry

ophy

llum

co

mp.

; Car

tilag

o/M

andr

agor

a com

p.;

Cham

omill

a com

p.; C

onch

ae co

mp.

; Co

njun

ctiv

a com

p.; D

isci c

omp.

cum

Ar

gent

o; D

isci/R

hus t

oxic

oden

dron

co

mp.

; Disc

i/Visc

um co

mp.

cum

Ar

gent

o; E

chin

acea

/Mer

curiu

s com

p.;

Echi

nace

a/Pr

unus

com

p.; E

chin

acea

/Vi

scum

com

p.; E

ndom

etriu

m co

mp.

; O

varia

com

p.; R

osm

arin

us co

mp.

; Te

stes c

omp.

; Thuj

a com

p.

Arse

nii t

rioxi

dum

Arse

nicu

m al

bum

aph

Arse

nicu

m al

bum

(HAB

); Ph

.Eur

.Ph

.Eur

. 4.1

.1, 4

.1.2

, so

lutio

n ac

c. to

m

onog

raph

HAB

Arse

nicu

m al

bum

; Bol

us al

ba co

mp.

; Br

yoni

a/G

elsem

ium

com

p.; C

olch

icum

co

mp.

Auru

m ch

lora

tum

Hyd

roge

n te

trach

loro

aura

te(II

I) tr

ihyd

rate

HAB

Ph.E

ur. 3

.1.1

, 3.1

.2Ap

is re

gina

/Aur

um co

mp.

Auru

m ch

lora

tum

na

trona

tum

see N

atriu

m te

trach

loro

aura

tum

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.4


171

Auru

m m

etal

licum

, Au

rum

met

allic

um p

phM

etal

lic go

ldH

AB; P

h.fr.

Ph.E

ur. 4

.1.1

, 4.1

.2Ar

nica

, Pla

nta t

ota/

Auru

m; A

urum

co

mp.

; Aur

um m

etal

licum

; Aur

um/

Bella

donn

a com

p.; A

urum

/Cor

; Au

rum

/Cra

taeg

us; A

urum

/Epi

phys

is co

mp.

; Aur

um/E

quise

tum

; Aur

um/

Ferr

um si

dere

um; A

urum

/H

yosc

yam

us co

mp.

; Aur

um/

Hyp

ophy

sis co

mp.

; Aur

um/L

avan

dula

e ae

ther

oleu

m/R

osa;

Auru

m/

Ono

pord

on co

mp.

; Aur

um/

Para

thyr

eoid

ea; A

urum

/Plu

mbu

m

mell

itum

com

p.; A

urum

/Pru

nus;

Auru

m/P

ulsa

tilla

/Spo

ngia

com

p.;

Auru

m/S

tibiu

m; A

urum

/Stro

phan

thus

ko

mbe

; Aur

um/V

aler

iana

com

p.;

Berb

eris/

Sepi

a com

p.; C

artil

ago

com

p.;

Crat

aegu

s com

p.; D

isci c

omp.

cum

Au

ro; K

aliu

m p

hosp

horic

um co

mp.

; M

edul

la sp

inal

is co

mp.

; Pan

krea

s co

mp.

; Sar

otha

mnu

s com

p.; S

tann

um

com

p.; S

troph

anth

us co

mp.

Auru

m m

etal

licum

fo

liatu

mG

old

leaf

Raw

mat

eria

l for

the

prep

arat

ion

of M

yrrh

a co

mp.

(see

app.

2.6

)

Auru

m m

uria

ticum

na

trona

tum

see N

atriu

m te

trach

loro

aura

tum

Auru

m n

atur

ale

see A

ppen

dix

2.1

Auru

m su

lfura

tum

Mix

ture

of g

old(

I)- an

d go

ld(II

I) su

lfide

Ph.E

ur. 4

.1.1

(the

n 3.

1.1

or 3

.1.2

), 4.

1.2

Bariu

m ci

tricu

mBa

rium

citra

te h

exah

ydra

t with

diff

eren

t am

ount

s of c

rysta

l wat

er:

Ba3(

C6H

5O7)

2*n

H2O

(n =

5-7

)

Ph.E

ur. 4

.1.1

(the

n pe

rhap

s 3.2

.2),

4.1.

2Ba

rium

citri

cum

; Bar

ium

com

p.;

Bariu

m/P

ancr

eas c

omp.

; Ves

pa cr

abro

co

mp.

Barii

iodi

dum

Bariu

m io

datu

mBa

rium

iodi

de m

onoh

ydra

teH

ABPh

.Eur

. 3.1

.1 (e

than

ol

50%

), 4.

1.1,

4.1

.2Ba

rium

joda

tum

; Ech

inac

ea co

mp.

Bism

uthu

m p

phse

e Bism

utum

subn

itras

pon

dero

sus

Bism

utum

met

allic

umM

etal

lic b

ismut

hH

ABPh

.Eur

. 4.1

.1, 4

.1.2

Bism

utum

/Stib

ium

; Pul

vis

stom

achi

cus c

um B

ismut

o pr

aepa

rato

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


172

Bism

utum

subn

itras

po

nder

osus

Bism

utum

subn

itric

um,

Bism

uthu

m p

phBi

smut

h su

bnitr

ate,

heav

yPh

.Eur

.Ph

.Eur

. 4.1

.1, 4

.1.2

, API

Arge

ntum

/Que

rcus

com

p.; C

arbo

Sa

ngui

nis c

omp.

; Pul

vis S

tom

achi

cus

cum

Bell

adon

na

Bora

xN

atriu

m te

trabo

raciu

m,

Bora

x pp

hD

isodi

um te

trabo

rate

dec

ahyd

rate

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (e

than

ol

18%

, see

mon

ogra

ph

HAB

), 4.

1.1,

4.1

.2,

excip

ient

Calca

rea f

orm

icic

aCa

lcium

form

ate,

obta

ined

from

Con

chae

an

d Ac

idum

For

mic

ae (s

ee A

ppen

dix

2.3)

Ph.E

ur. 4

.1.1

, 4.1

.2Vi

tis co

mp.

Calca

rea p

hosp

horic

ase

e Cal

cii h

ydro

geno

phos

phas

dih

ydric

usPh

.Eur

.Ph

.Eur

. 4.1

.1, 4

.1.2

Répe

rtoire

de m

éd.

anth

r.: C

alca

rea

phos

phor

ica

Calci

i hyd

roge

noph

osph

as

dihy

dric

usCa

lcium

pho

spho

ricum

, Ca

lcium

pho

spho

rica

pph

Calci

um h

ydro

gen

phos

phat

e dih

ydra

te(H

AB);

Ph.E

ur.

Ph.E

ur. 4

.1.1

, 4.1

.2

Calci

i hyd

roxi

dum

Calci

i hyd

roxi

dum

Calci

um h

ydro

xide

Ph.E

ur.

Ph.E

ur. 4

.1.1

, 4.1

.2; r

aw

mat

eria

l for

the

prep

arat

ion

of

Caus

ticum

H

ahne

man

ni

Calci

i lac

tas

Calci

i lac

tas

Calci

um la

ctat

e pen

tahy

drat

ePh

.Eur

.AP

IAr

gent

um/Q

uerc

us co

mp.

Calci

i oxi

dum

Calci

i oxi

dum

Fres

hly b

urnt

lim

e or m

arbl

era

w m

ater

ial f

or th

e pr

epar

atio

n of

Cal

cium

sil

icic

um co

mp.

(see

ap

p. 2

.6)

Calci

um st

ibia

to-

sulfu

ratu

mA

mix

ture

, pre

pare

d by

melt

ing

stibi

um

sulfu

ratu

m n

igru

m, s

ulfu

r and

conc

hae

toge

ther

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2

d-Ca

mph

ora

Cam

phor

a, Ca

mph

ora

pph

D-C

amph

orPh

.Eur

.Ph

.Eur

. 3.1

.1 (e

than

ol

70%

), 3.

1.2,

HAB

12i

, AP

I

Acon

itum

/Cam

phor

a com

p.; A

escu

lus/

Cera

com

p.; A

urum

/Val

eria

na co

mp.

; Be

rber

is/Ju

nipe

rus c

omp.

; Cam

phor

a; Ca

mph

ora/

Hyp

eric

um; O

leum

ca

mph

orat

um co

mp.

; Oleu

m P

etra

e co

mp.

; Oleu

m rh

inal

e; Pl

anta

go co

mp.

; Sa

l Mar

is co

mp.

; Sar

otha

mnu

s com

p.;

Skor

odit

com

p.

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.4


173

Caus

ticum

Hah

nem

anni

Caus

ticum

Hah

nem

anni

A su

bsta

nce,

prep

ared

acco

rdin

g to

the

mon

ogra

ph C

austi

cum

Hah

nem

anni

H

AB

HAB

Ph.E

ur. 3

.1.1

(see

mon

. H

AB)

Ceru

ssa

see P

lum

bum

carb

onic

um

Chlo

roph

yllu

mCh

loro

phyl

lum

The g

reen

pla

nt p

igm

ent (

gree

n of

leav

es)

API

Arge

ntum

/Que

rcus

com

p.

Cinn

abar

isse

e Hyd

rarg

yrum

sulfu

ratu

m ru

brum

or

Cinn

abar

in A

ppen

dix

2.1

Coba

ltum

met

allic

umM

etal

lic co

balt

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Co

baltu

m m

etal

licum

Copp

er te

tram

min

e su

lfate

mon

ohyd

rate

Prep

ared

from

copp

er(II

) sul

fate

pe

ntah

ydra

te an

d co

ncen

trate

d am

mon

ia

solu

tion

Raw

mat

eria

l for

the

prep

arat

ion

of

Cupr

um-R

en-G

land

ula

supr

aren

aes (

see a

pp.

2.6)

Cupr

um-R

en-G

land

ula s

upra

rena

lis

Creo

sotu

mse

e Kre

osot

um

Cupr

i ace

tas m

onoh

ydric

us

aph

Cupr

um ac

etic

umCo

pper

(II) a

ceta

te m

onoh

ydra

te fh

pPh

.Eur

.Ph

.Eur

. 3.1

.1 (s

olut

ion

acco

rdin

g to

m

onog

raph

HAB

, et

hano

l 50%

), 3.

1.2,

4.

1.1

Bora

go/R

enes

com

p.; C

upru

m

acet

icum

; Cup

rum

acet

icum

com

p.;

Cupr

um ac

etic

um/Z

incu

m

valer

iani

cum

; Ech

inac

ea/V

iscum

co

mp.

Cupr

i sul

fas p

enta

hydr

icus

Cu

prum

sulfu

ricum

Copp

er(II

) sul

fate

pen

tahy

drat

ePh

.Eur

.Ph

.Eur

. 3.1

.1 (D

1 wi

th

wate

r, se

e mon

ogra

ph

HAB

), 4.

1.1,

4.1

.2

Cina

com

p.; C

inis

Caps

ellae

com

p.;

Cupr

um su

lfuric

um; C

upru

m

sulfu

ricum

com

p.; C

upru

m

sulfu

ricum

/Euc

alyp

tus;

Trab

ecul

um

com

p.; V

erat

rum

com

p.

Cupr

o-St

ibiu

mAl

loy o

f 1 p

art o

f cop

per a

nd 1

par

t of

antim

ony

Ph.E

ur. 4

.1.1

, 4.1

.2

Cupr

um ci

tricu

mCo

pper

(II) c

itrat

e 2.5

hyd

rate

Ph.E

ur. 4

.1.1

, 4.1

.2Cu

prum

citri

cum

Cupr

um ap

hCu

prum

met

allic

um ap

hCu

prum

met

allic

um fh

p(H

AB);

Ph.E

ur.

Ph.E

ur. 4

.1.1

, 4.1

.2Ar

nica

com

p./C

upru

m; C

upru

m

met

allic

um; C

upru

m/G

land

ula

supr

aren

alis

dext

ra; C

upru

m/G

land

ula

supr

aren

alis

sinist

ra; C

upru

m/

Nico

tiana

; Cup

rum

/Qua

rz co

mp.

; Cu

prum

/Ren

es; C

upru

m/S

tibiu

m;

Euca

lypt

i aet

hero

leum

com

p.; M

ixtu

ra

Stan

ni co

mp.

Cupr

um o

xydu

latum

ru

brum

Copp

er(I)

oxi

deAP

ICu

prum

oxy

dulat

um ru

brum

; Cu

prum

/Nico

tiana

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


174

Din

atrii

pho

spha

s do

deca

hydr

icus

Nat

rium

pho

spho

ricum

D

isodi

um p

hosp

hate

dod

ecah

ydra

te(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(eth

anol

18

%),

3.1.

2, 4

.1.1

, 4.1

.2Ro

bini

a com

p.

Ferr

osi s

ulfa

s des

icca

tus

Ferr

um su

lfuric

umD

ried

ferr

ous s

ulfa

te w

ith li

mit

valu

es fo

r M

n (0

.5%

) and

Zn

(150

ppm

) diff

eren

t fro

m th

ose f

or F

erro

us su

lfate

, drie

d Ph

.Eur

.

Ph.E

ur. 4

.1.1

, 4.1

.2,

start

ing

mat

eria

l for

the

prep

arat

ion

of F

erru

m/

Qua

rz (s

ee ap

p. 2

.6),

API

Ferr

um/Q

uarz

; Kal

ium

pho

spho

ricum

co

mp.

; Ova

rium

com

p.

Ferr

osi s

ulfa

s hep

tahy

dric

usFe

rrou

s sul

fate

hep

tahy

drat

e with

lim

it va

lues

for M

n (0

.5%

) and

Zn

(150

ppm

) di

ffere

nt fr

om th

ose f

or F

erro

us su

lfate

he

ptah

ydra

te P

h.Eu

r.

API f

or th

e pre

para

tion

of F

erru

m-Q

uarz

(app

. 2.

6)

Cini

s Cap

sella

e com

p.; F

erru

m/Q

uarz

Ferr

um ap

hFe

rrum

met

allic

umIr

on fh

p (o

btai

ned

by re

duct

ion

or

subl

imat

ion)

(HAB

); Ph

.Eur

.Ph

.Eur

. 4.1

.1; 4

.1.2

, sta

rtin

g m

ater

ial f

or

prep

arat

ion

of F

erru

m

pom

atum

(see

app.

2.6

)

Cheli

doni

um/O

xalis

com

p.; F

erru

m

met

allic

um; F

erru

m p

raep

arat

um

com

p.; F

erru

m/A

nisu

m; F

erru

m/

Pulm

o; F

erru

m/S

ulfu

r com

p.; F

erru

m/

Thyr

eoid

ea; F

erru

m/V

esic

a fell

ea

Der

Mer

kurs

tab

2014

; 67

(4)2

70-2

82

Ferr

um ci

tric

umIr

on(II

I) cit

rate

, con

tain

ing

not l

ess t

han

18.0

and

not m

ore t

han

20.0

% o

f Fe (

Ar

55.8

5)

Ph.E

ur. 3

.1.1

(eth

anol

18

%)

Ferr

um h

ydro

xyda

tum

see A

ppen

dix

2.6

(Fer

rum

hyd

roxy

datu

m)

Ferr

umFe

rrum

met

allic

um

redu

ctum

Iron

obt

aine

d by

redu

ctio

n of

the m

iner

al

sider

ite(H

AB)

Ph.E

ur. 4

.1.1

, 4.1

.2; r

aw

mat

eria

l for

the

prep

arat

ion

of F

erru

m

hydr

oxyd

atum

(app

. 2.

6)

Ferr

um p

hosp

horic

um,

Ferr

um p

hosp

horic

um

pph

Ferr

i pho

spha

s aph

Hyd

rate

d iro

n(III

) pho

spha

teH

AB; P

h.fr.

Ph.E

ur. 4

.1.1

, 4.1

.2Fe

rrum

pho

spho

ricum

; Fer

rum

ph

osph

oric

um co

mp.

Ferr

um se

squi

chlo

ratu

m

solu

tum

, Fer

rum

se

squi

chlo

ratu

m

Aque

ous s

olut

ion

of ir

on(II

I) ch

lorid

e he

xahy

drat

e with

9.8

-10.

3% F

eH

ABPh

.Eur

. 3.1

.1 (D

1 an

d D

2 ac

c. to

mon

HAB

!)Fe

rrum

pra

epar

atum

com

p.

Ferr

um u

stum

Com

plex

Iron

(II, I

II) o

xide

- ob

tain

ed b

y gl

owin

g an

d fo

rgin

g m

etal

lic ir

on -

cont

aini

ng n

ot le

ss th

an 7

1.0

and

not

mor

e tha

n 75

.0%

of F

e (Ar

55.

85)

Ph.E

ur. 4

.1.1

, 4.1

.2Co

ncha

e/Fe

rrum

ustu

m co

mp.

; Fe

rrum

silic

icum

com

p.; F

erru

m

ustu

m co

mp.

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.4


175

Ferr

um(II

I)-ka

lium

-ta

rtar

icum

Iron(

III) p

otas

sium

tart

rate

deh

ydra

te

(Fer

ric p

otas

sium

tart

rate

)sta

rtin

g m

ater

ial f

or

prep

arat

ion

of S

olut

io

Ferr

i com

p. an

d So

lutio

Sa

ccha

ri co

mp.

(see

ap

p. 2

.6)

Gla

ndul

a sup

rare

nalis

/Sol

utio

Fer

ri co

mp.

; Sol

utio

Fer

ri co

mp.

; Sol

utio

Sa

ccha

ri co

mp.

Glo

noin

umse

e Nitr

ogly

cerin

um

Hep

ar su

lfuris

Hep

ar su

lfuris

A su

bsta

nce,

obta

ined

thro

ugh

heat

ing

toge

ther

to g

lowi

ng a

mix

ture

of c

alciu

m

carb

onic

um H

ahne

man

ni an

d su

lfur.

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2H

epar

sulfu

ris; H

epar

sulfu

ris co

mp.

; La

ches

is co

mp.

Hyd

rarg

yri s

ulfa

sM

ercu

ry(II

) sul

fate

, 99-

100.

5% H

gSO

4ra

w m

ater

ial f

or

prep

arat

ion

of e.

g.

Visc

um M

ali c

um

Hyd

rarg

yro

(see

app.

2.

6)

Hyd

rarg

yri d

ichlo

ridum

Hyd

rarg

yrum

bi

chlo

ratu

mM

ercu

ric ch

lorid

e(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(eth

anol

90

%),

4.1.

1, 4

.1.2

Hyd

rarg

yrum

bi

cyan

atum

Mer

cury

(II) c

yani

deH

ABPh

.Eur

. 3.1

.1 (e

than

ol

50%

), 4.

1.1,

4.1

.2M

ercu

rius c

yana

tus

Hyd

rarg

yrum

biio

datu

mM

ercu

ry(II

) iod

ide

HAB

Ph.E

ur. 3

.1.1

(D3

with

et

hano

l 90%

), 4.

1.1;

4.

1.2,

star

ting

mat

eria

l fo

r pre

para

tion

of

Trab

ecul

um co

mp.

(a

pp. 2

.6)

Trab

ecul

um co

mp.

Hyd

rarg

yrum

chlo

ratu

m

Mer

curiu

s dul

cis p

phM

ercu

ry(I)

chlo

ride

HAB

; Ph.

fr.Ph

.Eur

. 4.1

.1, 4

.1.2

Lyco

podi

um co

mp.

; Mer

curiu

s dul

cis

Hyd

rarg

yrum

m

etal

licum

, M

ercu

rius v

ivus

pph

Met

allic

mer

cury

HAB

; Ph.

fr.Ph

.Eur

. 4.1

.1, 4

.1.2

Hiru

do co

mp.

; Mer

curiu

s viv

us;

Mer

curiu

s/Pu

lmo

Hyd

rarg

yrum

nitr

icum

ox

ydul

atum

Mer

cury

(I) n

itrat

e dih

ydra

teH

ABPh

.Eur

. 4.1

.1, 4

.1.2

; for

th

e pre

para

tion

of

Mer

curiu

s sol

ubili

s H

ahne

man

ni

Hyd

rarg

yri s

ulfid

um ap

hH

ydra

rgyr

um su

lfura

tum

ru

brum

, Hyd

rarg

yri

disu

lfura

tum

rubr

um ap

h Ci

nnab

aris,

Cin

naba

ris

pph

Red

Mer

cury

(II) s

ulfid

eH

AB; P

h.fr.

Ph.E

ur. 4

.1.1

; API

Echi

nace

a/Pr

unus

com

p.; O

leum

rh

inal

e

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


176

Iodu

mJo

dum

, Iod

um p

phIo

dine

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (D

2 wi

th

etha

nol 9

0% ac

c. to

m

on. H

AB);

raw

mat

eria

l for

pre

para

tion

of Su

lfur i

odat

um

Jodu

m

Kalii

bich

rom

as ap

hKa

lium

bich

rom

icum

Pota

ssiu

m d

ichro

mat

e fhp

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (D

2 wi

th

wate

r acc

. to

mon

. H

AB),

3.1.

2

Kaliu

m b

ichro

mic

um; M

yrist

ica

sebi

fera

com

p.

Kaliu

m ca

rbon

icum

Kaliu

m ca

rbon

icum

, Ka

lium

carb

onic

um p

phPo

tass

ium

carb

onat

e(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(eth

anol

18

%),

4.1.

1, 4

.1.2

; sta

rtin

g m

ater

ial f

or

prep

arat

ion

of K

aliu

m

acet

icum

com

p. an

d So

lutio

Fer

ri co

mp.

(see

ap

p. 2

.6)

Anag

allis

/Mal

achi

t com

p.;

Cham

omill

a/M

alac

hit c

omp.

; Kal

ium

ac

etic

um co

mp.

; Kal

ium

carb

onic

um;

Kaliu

m/T

eucr

ium

com

p.; S

olut

io F

erri

com

p.; S

olut

io S

acch

ari c

omp.

; Sol

utio

Si

licea

com

p.

Kalii

chlo

ridum

Kaliu

m ch

lora

tum

, Ka

lium

mur

iatic

um p

phPo

tass

ium

chlo

ride

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (E

than

ol

18%

acc.

to m

on. H

AB),

3.1.

2, 4

.1.1

, 4.1

.2

Répe

rtoire

de m

éd.

anth

r.: K

aliu

m

mur

iatic

um

Kalii

dih

ydro

geno

phos

phas

Kaliu

m p

hosp

horic

um,

Kaliu

m p

hosp

horic

um

pph

Pota

ssiu

m d

ihyd

roge

n ph

osph

ate

Ph.E

ur.

Ph.E

ur. 3

.1.1

, 4.1

.1,

4.1.

2Be

rber

is/H

yper

icum

com

p.; J

ugla

ns

regi

a com

p.; K

aliu

m p

hosp

horic

um

com

p.; L

ilium

tigr

inum

com

p.

Kalii

hyd

roge

nota

rtra

sPo

tass

ium

hyd

roge

n ta

rtra

tePh

.Eur

.Ra

w m

ater

ial f

or th

e pr

epar

atio

n of

Tar

taru

s sti

biat

us an

d So

lutio

fe

rri c

omp.

(app

. 2.6

)

Kalii

iodi

dum

Kaliu

m io

datu

m,

Kaliu

m io

datu

m p

phPo

tass

ium

iodi

de(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(eth

anol

50

%),

4.1.

1, 4

.1.2

Kalii

nitr

asKa

lium

nitr

icum

, Ka

lium

nitr

icum

pph

Pota

ssiu

m n

itrat

e(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(D2

with

et

hano

l 18%

acc.

to

mon

. HAB

), 4.

1.1;

sta

rtin

g m

ater

ial f

or

prep

arat

ion

of S

ilex

- La

pis c

ancr

i sol

utus

(a

pp. 2

.6),

excip

ient

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.4


177

Kalii

sulfa

sKa

lium

sulfu

ricum

, Ka

lium

sulfu

ricum

pph

Pota

ssiu

m su

lfate

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (D

1 wi

th

wate

r acc

. to

mon

. H

AB),

start

ing

mat

eria

l fo

r pre

para

tion

of

Kaliu

m su

lfuric

um

com

p. (s

ee ap

p. 2

.6)

Kaliu

m/T

eucr

ium

com

p.

Kaliu

m ca

rbon

icum

e cin

ere F

agi

Pota

ssiu

m ca

rbon

ate,

prep

ared

from

the

ash

of b

eech

wood

(Fag

us si

lvat

ica)

Ph.E

ur. 3

.1.2

Agro

pyro

n co

mp.

; Ana

galli

s com

p.;

Frag

aria

/Urt

ica c

omp.

Kaliu

m st

ibyl

tart

aric

uKa

lium

stib

ylta

rtar

icum

Pota

ssiu

m d

i-µ-

tart

rato

bis[

antim

onat

e(III

)] tri

hydr

ate,

98.0

-103

.0%

C8H

4K2O

12Sb

2, 3

H20

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2;

liqui

d so

lutio

ns ac

c. to

m

on. H

AB o

r Ph.

Eur.

3.1.

2

Phos

phor

us/T

arta

rus s

tibia

tus;

Pulm

o/Ta

rtar

us st

ibia

tus A

; Pul

mo/

Tart

arus

sti

biat

us B

; Pul

mo/

Vivi

anit

com

p.;

Tart

arus

stib

iatu

s; Ta

rtar

us st

ibia

tus

com

p.

Hep

ar su

lfuris

kal

inum

Kaliu

m su

lfura

tum

Crud

e pot

ash,

cont

aini

ng a

mix

ture

of

mai

nly p

otas

sium

trisu

lfide

and

pota

ssiu

m m

etab

isulfi

te (d

ipot

assiu

m

pyro

sulfi

te)

DAB

6AP

IKa

lium

sulfu

ratu

mVa

dem

ecum

: Kal

ium

su

lfura

tum

(ext

.)

Kaliu

m-E

isen-

Tart

rat

see F

erru

m(II

I)-ka

lium

-tart

aric

um

Kreo

sotu

mM

ixtu

re o

f gua

jaco

le, cr

eoso

le an

d cr

esol

ene o

btai

ned

thro

ugh

disti

llatio

n of

ta

r fro

m b

eech

woo

d

HAB

Ph.E

ur. 3

.1.1

(with

et

hano

l 90%

, see

m

onog

raph

)

Kreo

sotu

m; M

ajora

na/Th

uja c

omp.

Liqu

or n

atrii

silic

icise

e Nat

rii si

licici

, Liq

uor

Lith

ii ca

rbon

asLi

thiu

m ca

rbon

icum

, Li

thiu

m ca

rbon

icum

pph

Lith

ium

carb

onat

e(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(D2

with

wa

ter a

cc. t

o m

on.

HAB

), 4.

1.1,

4.1

.2

Mag

nesii

chlo

ridum

he

xahy

dric

usM

agne

sium

chlo

ratu

m,

Mag

nesia

mur

iatic

a pph

Mag

nesiu

m ch

lorid

e hex

ahyd

rate

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (e

than

ol

50%

), 4.

1.1;

raw

mat

eria

l for

the

prep

arat

ion

of H

epar

-M

agne

sium

(app

. 2.6

)

Mag

nesii

hyd

roge

noph

osph

as

trihy

dric

usM

agne

sium

ph

osph

oric

um,

Mag

nesia

pho

spho

rica

pph

Mag

nesiu

m h

ydro

gen

phos

phat

e tri

hydr

ate

(HAB

); Ph

.Eur

.Ph

.Eur

. 4.1

.1, 4

.1.2

; sta

rtin

g m

ater

ial f

or

prep

arat

ion

of C

inis

e fr

uctib

us A

vena

e cum

M

agne

sio

phos

phor

icum

(1:1

)(see

ap

p. 2

.6)

Cor/

Crat

aegu

s com

p.; F

raga

ria/U

rtic

a co

mp.

; Mag

nesiu

m p

hosp

horic

um;

Mag

nesiu

m p

hosp

horic

um co

mp.

; M

agne

sium

pho

spho

ricum

cum

cine

re

Aven

ae; V

erat

rum

com

p.

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


178

Mag

nesiu

m

hydr

oxyd

atum

Mag

nesiu

m h

ydro

xide

Ph.E

ur.

Raw

mat

eria

l for

pr

epar

atio

n of

e.g.

H

epar

-Mag

nesiu

m(s

ee

app.

2.6

)

Hep

ar-M

agne

sium

Mag

nesii

sulfa

s hep

tahy

dric

usM

agne

sium

sulfu

ricum

, M

agne

sia su

lfuric

a pph

Mag

nesiu

m su

lfate

hep

tahy

drat

ePh

.Eur

.Ph

.Eur

. 3.1

.2Be

rber

is/Pr

osta

ta co

mp.

; Ber

beris

/U

teru

s com

p.; M

agne

sium

sulfu

ricum

/O

varia

com

p.

Mag

nesiu

m m

etal

licum

Met

allic

mag

nesiu

mH

ABAP

I

Mag

nesiu

m

phos

phor

icum

acid

um

20%

Aque

ous s

olut

ion

of m

agne

sium

di

hydr

ogen

pho

spha

te (2

0%)

Ph.E

ur. 3

.1.1

, 3.1

.2Ca

ctus

/Mag

nesiu

m p

hosp

horic

um;

Mag

nesiu

m p

hosp

horic

um ac

idum

; M

agne

sium

pho

spho

ricum

acid

um/

Taba

cum

; Ono

pord

on co

mp.

/M

agne

sium

pho

spho

ricum

acid

um

Mer

curiu

s aur

atus

Gol

d-m

ercu

ry al

loy,

cont

aini

ng at

leas

t 32

.0 an

d no

t mor

e tha

n 35

.0%

Au

(Ar

196.

97) a

nd at

leas

t 65.

0 an

d no

t mor

e th

an 6

8.0%

Hg

(Ar 2

00.5

9)

Ph.E

ur. 4

.1.1

, 4.1

.2

Mer

curiu

s bijo

datu

sse

e Hyd

rarg

yrum

biio

datu

m

Mer

curiu

s cya

natu

sse

e Hyd

rarg

yrum

bic

yana

tum

Mer

curiu

s dul

cisse

e Hyd

rarg

yrum

chlo

ratu

m

Mer

curiu

s sol

ubili

s H

ahne

man

niA

mix

ture

with

86.

0-90

.0%

Hg

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2Ap

is/Be

llado

nna/

Mer

curiu

s; Ec

hina

cea/

Mer

curiu

s com

p.;

Mer

curiu

s sol

ubili

s Hah

nem

anni

Mer

curiu

s sub

limat

us

corr

osiv

usse

e Hyd

rarg

yrum

bich

lora

tum

(H

ydra

rgyr

um d

ichlo

ridum

)

Mer

curiu

s viv

usse

e Hyd

rarg

yrum

met

allic

um

Min

ium

Min

ium

[Lea

d(II,

IV) o

xide

]H

ABPh

.Eur

. 4.1

.1, 4

.1.2

Min

ium

Nat

rii ca

rbon

as d

ecah

ydric

usSo

dium

carb

onat

e dec

ahyd

rate

Ph.E

ur.

Ph.E

ur. 3

.1.1

(wat

er),

4.1.

1, 4

.1.2

; raw

m

ater

ial f

or th

e pr

epar

atio

n of

zinc

um

isova

leria

nicu

m

Levi

sticu

m co

mp.

Nat

rii ca

rbon

as m

onoh

ydric

usN

atriu

m ca

rbon

icum

, N

atru

m ca

rbon

icum

pph

Sodi

um ca

rbon

ate m

onoh

ydra

te(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(wat

er),

3.1.

2, 4

.1.1

, 4.1

.2Ce

rebe

llum

com

p.; F

raga

ria/U

rtic

a co

mp.

Nat

rii ch

lorid

umN

atriu

m ch

lora

tum

, N

atru

m m

uria

ticum

pph

Sodi

um ch

lorid

e(H

AB);

Ph.E

ur.

Ph.E

ur. 3

.1.1

(eth

anol

18

%),

4.1.

1, 4

.1.2

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.4


179

Nat

rii si

licici

, Liq

uor

Liqu

or n

atrii

silic

iciAq

ueou

s sol

utio

n of

sodi

um p

olys

ilica

te

with

7.5

- 8.

5% so

dium

oxi

de (N

a2O

) and

25

.5 -

28.5

% si

lcicu

m d

ioxi

de (S

iO2)

DAB

6Ra

w m

ater

iel fo

r pr

epar

atio

n of

e.g.

Uve

a co

mp.

(see

app.

2.6

)

Nat

rii su

lfas a

nhyd

ricus

Nat

rium

sulfu

ricum

, N

atru

m su

lfuric

um p

phAn

hydr

ous s

odiu

m su

lfate

Ph.E

ur.

Ph.E

ur. 3

.1.1

(D2

with

et

hano

l 18%

acc.

to

mon

ogra

ph H

AB),

3.1.

2, 4

.1.1

, 4.1

.2; r

aw

mat

eria

l for

pre

parin

g Ka

lium

sulfu

ricum

co

mp.

(see

app.

2.6

)

Lyco

podi

um co

mp.

Nat

rii te

trach

loro

aura

s di

hydr

icus

aph

Nat

rium

te

trach

loro

aura

tum

Sodi

um te

trach

loro

aura

te d

ihyd

rate

fhp

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (w

ater

, see

m

onog

raph

HAB

), 4.

1.1

Répe

rtoire

de m

éd.

anth

r.: A

urum

m

uria

ticum

na

trona

tum

Nat

rium

pho

spho

ricum

see D

inat

rii p

hosp

has d

odec

ahyd

ricus

HAB

Nat

rium

tetra

bora

cicum

see B

orax

Ph.E

ur.

Nitr

icum

acid

um p

phse

e Acid

um n

itric

um

Nitr

ogly

cerin

umG

lono

inum

, Glo

noin

um

pph

Solu

tion

of g

lyce

rol t

rinitr

ate (

1%) i

n et

hano

l 96%

HAB

HAB

: The s

ubsta

nce i

s id

entic

al w

ith D

2;

furt

her p

oten

cies w

ith

etha

nol 5

0%

Glo

noin

um

Petro

leum

rect

ifica

tum

, Pe

troleu

m p

phPe

troleu

m sp

irit d

istill

ing

betw

een

180

and

220

°C o

btai

ned

by re

ctifi

catio

n of

cr

ude o

il

(HAB

); Ph

.Eur

.Ph

.Eur

. 3.1

.1 (e

than

ol

90%

acco

rdin

g to

m

onog

raph

HAB

), AP

I

Cocc

ulus

/Oleu

m P

etra

e com

p.; O

leum

Pe

trae c

omp.

; Pet

roleu

m

Phos

phor

icum

acid

um

pph

see A

cidum

pho

spho

ricum

conc

entra

tum

Phos

phor

usYe

llow

phos

phor

usH

ABse

e Pho

spho

rus H

AB

(D3

with

anhy

drou

s et

hano

l), A

PI (e

.g. 0

.1%

in

oil)

Agar

icus

com

p./P

hosp

horu

s; Ap

atit/

Phos

phor

us co

mp.

; Ave

na co

mp.

; Br

yoni

a/Eu

pato

rium

com

p.; B

ryon

ia/

Gels

emiu

m co

mp.

; Equ

isetu

m co

mp.

; M

eliss

a/Ph

osph

orus

com

p.;

Met

eore

isen/

Phos

phor

/Qua

rz; O

leum

Pe

trae c

omp.

; Pho

spho

rus;

Phos

phor

us/M

alva

; Pho

spho

rus/

Sulfu

r; Ph

osph

orus

/Tar

taru

s stib

iatu

s; Sa

mbu

cus/

Teuc

rium

com

p.; V

aler

iana

co

mp.

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


180

Phos

phor

us m

etal

licus

(n

iger

)Bl

ack

met

allic

pho

spho

rus

Ph.E

ur. 4

.1.1

, 4.1

.2

Plat

inum

chlo

ratu

mse

e Aci

dum

hex

achl

orop

latin

icum

Plat

inum

met

allic

umM

etal

lic p

latin

HAB

Ph.E

ur. 4

.1.1

(D2)

, 4.1

.2Ré

perto

ire d

e méd

. an

thr.:

Plat

ina

Plum

bi ca

rbon

asPl

umbu

m ca

rbon

icum

Basic

lead

(II) c

arbo

nate

Raw

mat

eria

l for

pr

epar

atio

n of

Cin

is Ca

psell

ae co

mp.

APC

(s

ee ap

p. 2

.6)

Cini

s Cap

sella

e com

p.

Plum

bum

acet

icum

Lead

(II) a

ceta

te tr

ihyd

rate

HAB

Liqu

id so

lutio

n ac

c. to

m

onog

raph

HAB

and

Ph.E

ur. 3

.1.1

; 4.1

.1,

4.1.

2

Vade

mec

um: P

lum

bum

ac

etic

um/M

el co

mp.

Plum

bum

joda

tum

Lead

(II) i

odid

ePh

.Eur

. 4.1

.1, 4

.1.2

; API

Plum

bum

met

allic

umM

etal

lic le

adH

ABPh

.Eur

. 4.1

.1, 4

.1.2

; raw

m

ater

ial f

or th

e pr

epar

atio

n of

Pl

umbu

m m

ellitu

m

(see

app.

2.6

)

Cupr

um su

lfuric

um co

mp.

; Epi

phys

is/Pl

umbu

m; L

ien

com

p.; L

obeli

a com

p.;

Ono

pord

on co

mp.

/Plu

mbu

m;

Plum

bum

mell

itum

; Plu

mbu

m

met

allic

um; P

lum

bum

/Sta

nnum

Plum

bum

silic

icum

Lead

(II) m

eta s

ilica

te, o

btai

ned

by

smelt

ing

ceru

ssite

and

quar

tzPh

.Eur

. 4.1

.1, 4

.1.2

Plum

bum

silic

icum

Vade

mec

um

Sacc

haru

mSa

ccha

rum

Sac

char

iSu

cros

e obt

aine

d fro

m th

e ste

ms o

f Sa

ccha

rum

offi

cina

rum

L.

Ph.E

ur.

Ph.E

ur. 3

.1.2

, raw

m

ater

ial f

or p

repa

ratio

n of

e.g.

Plu

mbu

m

mell

itum

(see

app.

2.6

)

Anis-

Pyrit

; Arg

entu

m/Q

uerc

us co

mp.

; Ar

gent

um/R

ohrz

ucke

r; Pa

rath

yreo

idea

co

mp.

; Plu

mbu

m m

ellitu

m

Sacc

haru

m ca

ndid

umCr

ysta

ls, w

hich

dev

elop

by so

lvin

g an

d cr

ysta

llizi

ng su

cros

ePh

.Eur

. 4.1

.1, 4

.1.2

Auru

m/P

ulsa

tilla

/Spo

ngia

com

p.;

Spon

gia c

omp.

Silic

ease

e Aci

dum

silic

icum

Silic

ea co

lloid

alis

Collo

idal

silic

a, di

rect

ly o

btai

ned

in th

e m

anuf

actu

re o

f the

fini

shed

pro

duct

by

reac

tion

of ad

juste

d am

ount

s of a

queo

us

solu

tions

of s

odiu

m si

licat

e and

citr

ic ac

id

mon

ohyd

rate

.

API

Berb

eris/

Euca

lypt

us/ S

ilice

a com

p.;

Berb

eris/

Silic

ea co

mp.

; Ros

ae

aeth

erol

eum

/Sili

cea c

ollo

idal

is co

mp.

; Si

licea

collo

idal

is co

mp.

Stan

nosi

chlo

ridum

di

hydr

icum

Stan

nous

chlo

ride d

ihyd

rate

, tin

(II)c

hlor

ide

Ph.E

ur.

Star

ting

mat

eria

l for

pr

epar

atio

n of

stan

num

hy

drox

ydat

um (s

ee ap

p.

2.6,

Hep

ar-S

tann

um)

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.4


181

Stan

num

hyd

roxy

datu

mTi

n(II)

hyd

roxi

deRa

w m

ater

ial f

or

prep

arat

ion

of e.

g.

Hep

ar-S

tann

um (s

ee

app.

2.6

)

Corp

us vi

treum

-Sta

nnum

; Hep

ar-

Stan

num

Stan

num

met

allic

umM

etal

lic ti

nH

ABPh

.Eur

. 4.1

.1, 4

.1.2

; raw

m

ater

ial f

or p

repa

ratio

n of

Stan

num

mell

itum

(s

ee ap

p. 2

.6)

Alliu

m ce

pa/T

endo

com

p.; A

patit

/St

annu

m; A

rtic

ulat

io ta

locr

ural

is co

mp.

; Bry

onia

/Sta

nnum

; Bry

onia

/Vi

scum

com

p.; C

artil

ago

com

p.; C

ina

com

p.; C

onch

ae/Q

uerc

us co

mp.

; Disc

i co

mp.

cum

Nico

tiana

; Disc

i com

p.

cum

Pul

satil

la; D

isci c

omp.

cum

St

anno

; Disc

i/Pul

satil

la co

mp.

cum

St

anno

; Disc

i/Visc

um co

mp.

cum

St

anno

; Equ

isetu

m/S

tann

um;

Gna

phal

ium

com

p.; H

epar

/Sta

nnum

m

etal

licum

A; H

epar

/Sta

nnum

m

etal

licum

B; H

yper

icum

com

p.;

Hyp

ophy

sis/S

tann

um; J

ugla

ns re

gia

com

p.; L

ens c

rista

llina

/Visc

um co

mp.

cu

m St

anno

; Lili

um ti

grin

um co

mp.

; M

agne

sium

sulfu

ricum

/Ova

ria co

mp.

; M

enisc

us G

enus

/Sta

nnum

; Mer

curiu

s vi

vus c

omp.

; Mix

tura

Stan

ni co

mp.

; Pe

riodo

ntiu

m/S

tann

um co

mp.

; Pl

umbu

m/S

tann

um; P

runu

s/Ro

smar

inus

com

p.; S

cilla

com

p.;

Sene

cio co

mp.

; Sta

nnum

com

p.;

Stan

num

met

allic

um; S

tann

um/

Succ

inum

; Sta

nnum

/Sym

phyt

um

com

p.; U

rtic

a com

p.

Stib

ium

arse

nico

sum

Mix

ture

of e

qual

par

ts of

an

timon

y(V

)oxi

de an

d ar

seni

c(III

)oxi

deH

ABPh

.Eur

. 4.1

.1, 4

.1.2

Stib

ium

arse

nico

sum

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


182

Stib

ium

met

allic

umM

etal

lic an

timon

yH

ABPh

.Eur

. 4.1

.1, 4

.1.2

Arge

ntum

/Stib

ium

; Arn

ica/

Echi

nace

a co

mp.

; Aur

um/H

yosc

yam

us co

mp.

; Au

rum

/Stib

ium

; Bism

utum

/Stib

ium

; Ca

lendu

la/M

ercu

rialis

com

p.;

Calen

dula

/Stib

ium

; Cich

oriu

m co

mp.

; Ci

chor

ium

/Pan

crea

s com

p.; C

upru

m/

Stib

ium

; Disc

i com

p. cu

m St

ibio

; H

amam

elis c

omp.

; Mar

mor

/Stib

ium

; M

edul

la sp

inal

is co

mp.

; Mer

curia

lis

com

p.; M

ercu

rialis

/Stib

ium

com

p.;

Ova

rium

com

p.; R

hus/

Salix

com

p.;

Stib

ium

com

p.; S

tibiu

m m

etal

licum

; St

roph

anth

us co

mp.

; Tor

men

tilla

co

mp.

; Ver

atru

m co

mp.

Stib

ium

sulfu

ratu

m

aura

ntia

cum

Mix

ture

of a

ntim

ony(

V) s

ulfid

e and

su

lfur

HAB

Ph.E

ur. 4

.1.1

, 4.1

.2St

ibiu

m su

lfura

tum

aura

ntia

cum

Sulfu

r ad

usum

exte

rnal

Sulfu

r for

exte

rnal

use

(99.

0-10

1.0%

S)

Ph.E

ur.

Ph.E

ur. 4

.1.1

, 4.1

.2; A

PI

(for o

intm

ents)

Sulfu

r aph

Sulfu

rSu

lfur o

btai

ned

by su

blim

atio

nPh

.Eur

.Li

quid

solu

tions

acc.

to

mon

ogra

ph H

AB (D

4);

Ph.E

ur. 4

.1.1

, 4.1

.2;

API;

raw

mat

eria

l for

pr

epar

atio

n of

Eq

uise

tum

cum

Sulfu

re

tostu

m (s

ee ap

p. 2

.6)

Aven

a com

p.; B

etul

a/Ar

nica

com

p.;

Carb

o Be

tula

e/Su

lfur;

Disc

us

inte

rver

tebr

alis

embr

yona

lis/S

olut

io

Silic

eae c

omp.

; Equ

isetu

m cu

m Su

lfure

to

stum

; Fer

rum

side

reum

com

p.;

Ferr

um/S

ulfu

r com

p.; G

land

ula

supr

aren

alis/

Solu

tio F

erri

com

p.;

Hep

ar su

lfuris

; Pho

spho

rus/

Sulfu

r; Pu

lvis

stom

achi

cus c

um B

ismut

o pr

aepa

rato

; Sol

utio

Fer

ri co

mp.

; So

lutio

Sili

cea c

omp.

; Sul

fur;

Valer

iana

co

mp.

Sulfu

r iod

idum

Sulfu

r iod

atum

Mix

ture

of 4

par

ts of

iodi

ne an

d 1

part

of

sulfu

r car

eful

ly m

elted

toge

ther

(con

tain

s 70

-80%

I)

HAB

Liqu

id so

lutio

ns ac

c. m

onog

raph

HAB

(D3)

; Ph

.Eur

. 4.1

.1, 4

.1.2

Sulfu

r iod

idum

aph

Iode

et so

ufre

(méla

nge

d’) p

phM

ixtu

re o

f 4 p

arts

of io

dine

and

1 pa

rt o

f su

lfur c

aref

ully

melt

ed to

geth

er (c

onta

ins

75-8

2% I)

Ph.fr

.Ph

.Eur

. 4.1

.1, 4

.1.2

Sulfu

r sele

nosu

mM

ixtu

re o

btai

ned

by m

eltin

g 1

part

of

selen

with

99

part

s of s

ulfu

r.Ph

.Eur

. 4.1

.1, 4

.1.2

Vade

mec

um: S

ulfu

r se

lenos

um

Sulfu

ricum

acid

um p

phse

e Aci

dum

sulfu

ricum

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.4


183

Tart

arus

dep

urat

usPu

rified

tart

ar, m

ainl

y con

sistin

g of

po

tass

ium

hyd

roge

n ta

rtra

teO

nly u

sed

as a

raw

mat

eria

l for

pro

duct

ion

of T

arta

rus s

tibia

tus

Tart

arus

stib

iatu

sse

e Kal

ium

stib

ylta

rtar

icum

Tetra

mm

ine c

oppe

r(II)

su

lfate

see C

oppe

r tet

ram

min

e sul

fate

m

onoh

ydra

te

Zinc

um is

oval

eria

nicu

mZi

ncum

isov

aler

iani

cum

, Zi

ncum

valer

iani

cum

Zinc

isov

aler

ate d

ihyd

rate

with

98-

103%

Zn

(C5H

9O2)

, 2H

2OH

ABPh

.Eur

. 3.1

.1 (D

2 wi

th

etha

nol a

cc. t

o m

onog

raph

HAB

), 4.

1.1,

4.1

.2

Cupr

um ac

etic

um/Z

incu

m

valer

iani

cum

; Zin

cum

valer

iani

cum

; Zi

ncum

valer

iani

cum

com

p.

Vade

mec

um

Zinc

umZi

ncum

met

allic

um,

Zinc

um m

etal

licum

pph

Met

allic

zinc

with

97.

0-10

0.5

(HAB

) or

99.5

-101

.5%

(Ph.

fr.) Z

nH

AB; P

h.fr.

Ph.E

ur. 4

.1.1

, 4.1

.2

Zinc

um va

leria

nicu

mse

e Zin

cum

isov

aler

iani

cum

Latin

nam

e: Ph

.Eur

., H

AB

or P

h.fr.

Trad

ition

al n

ame:

H

AB

and/

or P

h.fr.

Abbr

evia

ted

defin

ition

En

glish

Nam

e in

Ph.E

ur. i

f app

licab

leRe

fere

nce

to S

tand

ard

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.4


184

•

Appendix 2.4


185

•

Ap

pend

ix 2

.5

APPENDIX 2.5

Starting materials that have undergone special treatment Additional Information, see p. 18


186

Nam

e of t

he su

bsta

nce

Abbr

evia

ted

defin

ition

Re

fere

nce t

o St

anda

rd

(for t

he p

lant

)Pr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

Acon

itum

nap

ellus

Pl

umbo

cultu

mW

hole

fresh

pla

nts o

f Aco

nitu

m n

apell

us L

., col

lecte

d at

the s

tart

of fl

ower

ing,

cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

lead

cont

aini

ng

subs

tanc

e for

the t

reat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

(HAB

)Ph

.Eur

. 1.1

.3,

HAB

21

Acon

itum

nap

ellus

Plu

mbo

cultu

m

Atro

pa b

ellad

onna

Cu

pro

culta

Who

le fre

sh p

lant

s of A

tropa

bell

a-do

nna L

., with

out w

oody

lowe

r ste

m se

ctio

ns,

colle

cted

at th

e end

of fl

ower

ing,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a

dilu

ted

copp

er co

ntai

ning

subs

tanc

e for

the t

reat

men

t of t

he so

il fo

r the

1st

life

cycle

).

Ph.E

ur. 1

.1.3

Bryo

phyl

lum

pin

natu

m

Arge

nto

cultu

mFr

esh

leave

s of B

ryop

hyllu

m p

inna

tum

(Lam

.) O

ken

[Syn

. Kal

anch

oe p

inna

ta

(Lam

.) Pe

rs.],

har

veste

d in

the fi

rst y

ear o

f gro

wth,

culti

vate

d ac

cord

ing

to A

PC

Met

hod

1.1.

1 (u

sing

a dilu

ted

silve

r con

tain

ing

subs

tanc

e for

the t

reat

men

t of t

he

soil

for t

he 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.7,

HAB

21

Bryo

phyl

lum

Arg

ento

cultu

m

Bryo

phyl

lum

pin

natu

m

Mer

curio

cultu

mFr

esh

leave

s of B

ryop

hyllu

m p

inna

tum

(Lam

.) O

ken

[Syn

. Kal

anch

oe p

inna

ta

(Lam

.) Pe

rs.],

har

veste

d in

the fi

rst y

ear o

f gro

wth,

culti

vate

d ac

cord

ing

to A

PC

Met

hod

1.1.

1 (u

sing

a dilu

ted

mer

cury

cont

aini

ng su

bsta

nce f

or th

e tre

atm

ent o

f th

e soi

l for

the 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.7,

HAB

21

Bryo

phyl

lum

Mer

curio

cultu

mVa

dem

ecum

Cham

omill

a rec

utita

Cu

pro

culta

Fres

h un

derg

roun

d pa

rts o

f Cha

mom

illa r

ecut

ita (L

.) Ra

usch

ert,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a d

ilute

d co

pper

cont

aini

ng su

bsta

nce f

or

the t

reat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

Ph.E

ur. 1

.2.9

, H

AB 2

1Ch

amom

illa C

upro

culta

, Rad

ix

Cheli

doni

um m

ajus

Ferr

o cu

ltum

Fres

h rh

izom

e and

adhe

rent

root

s of C

helid

oniu

m m

ajus L

., col

lecte

d du

ring

late

autu

mn

or o

n th

e app

eara

nce o

f the

firs

t sho

ots,

culti

vate

d ac

cord

ing

to A

PC

Met

hod

1.1.

1 (u

sing

a dilu

ted

iron

cont

aini

ng su

bsta

nce f

or th

e tre

atm

ent o

f the

soil

for t

he 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.5,

HAB

21

Cheli

doni

um F

erro

cultu

mVa

dem

ecum

: Ch

elido

nium

Fer

ro

cultu

m

Cich

oriu

m in

tybu

s Pl

umbo

cultu

mW

hole

fresh

flow

erin

g pl

ants

of C

ichor

ium

inty

bus L

. (va

r. in

tybu

s and

/or v

ar.

sativ

um D

C), c

ultiv

ated

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

lead

cont

aini

ng su

bsta

nce f

or th

e tre

atm

ent o

f the

soil

for t

he 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.7,

HAB

21

Cich

oriu

m P

lum

bo cu

ltum

Cich

oriu

m in

tybu

s St

anno

cultu

mW

hole

fresh

flow

erin

g pl

ants

of C

ichor

ium

inty

bus L

. (va

r. in

tybu

s and

/or v

ar.

sativ

um D

C), c

ultiv

ated

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

tin

cont

aini

ng su

bsta

nce f

or th

e tre

atm

ent o

f the

soil

for t

he 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.7,

HAB

21

Cich

oriu

m St

anno

cultu

m

Cich

oriu

m in

tybu

s St

anno

cultu

m, R

adix

Fres

h ro

ot o

f Cich

oriu

m in

tybu

s L. (

var,

inty

bus a

nd/o

r var

. sat

ivum

DC)

, col

lecte

d at

flow

erin

g tim

e, cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

tin

cont

aini

ng su

bsta

nce f

or th

e tre

atm

ent o

f the

soil

for t

he 1

st lif

e cyc

le).

Ph.E

ur. 1

.1.7

Cich

oriu

m St

anno

cultu

m

Equi

setu

m ar

vens

e Si

licea

cultu

mFr

esh

gree

n ste

rile a

eria

l par

ts of

Equ

isetu

m ar

vens

e L., c

ultiv

ated

acco

rdin

g to

APC

M

etho

d 1.

1.2

(usin

g a d

ilute

d sil

icat

e con

tain

ing

subs

tanc

e for

the t

reat

men

t of t

he

soil

for t

he 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.7,

HAB

21

(see

m

onog

raph

!)

Equi

setu

m ar

vens

e Sili

cea c

ultu

mVa

dem

ecum

Hyp

eric

um p

erfo

ratu

m

Auro

cultu

mFr

esh

aeria

l par

ts of

Hyp

eric

um p

erfo

ratu

m L

., col

lecte

d at

flow

erin

g tim

e, cu

ltiva

ted

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

gold

cont

aini

ng

subs

tanc

e for

the t

reat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

(HAB

)Ph

.Eur

. 1.1

.5,

HAB

21

Aqua

Mar

is co

mp.

; Hyp

eric

um

Auro

cultu

m

Kala

ncho

e pin

natu

m

Arge

nto

culta

see B

ryop

hyllu

m p

inna

tum

Arg

ento

culta

•

Appendix 2.5


187

Kala

ncho

e pin

natu

m

Mer

curio

culta

see B

ryop

hyllu

m p

inna

tum

Mer

curio

culta

Meli

ssa o

fficin

alis

Cupr

o cu

ltaFr

esh

aeria

l par

ts of

Meli

ssa o

fficin

alis

L., c

ultiv

ated

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

copp

er co

ntai

ning

subs

tanc

e for

the t

reat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

(HAB

)Ph

.Eur

. 1.1

.5,

HAB

21

Meli

ssa C

upro

culta

Vade

mec

um

Nas

turt

ium

offi

cinal

e M

ercu

rio cu

ltum

Fres

h ae

rial p

arts

of N

astu

rtiu

m o

fficin

ale R

. Br.,

colle

cted

at fl

ower

ing

time,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a d

ilute

d m

ercu

ry co

ntai

ning

su

bsta

nce f

or th

e tre

atm

ent o

f the

soil

for t

he 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.5,

HAB

21

Nas

turt

ium

Mer

curio

cultu

mVa

dem

ecum

: N

astu

rtiu

m M

ercu

rio

cultu

m

Nico

tiana

taba

cum

Cu

pro

culta

Fres

h lea

ves o

f Nico

tiana

taba

cum

L., c

ultiv

ated

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

copp

er co

ntai

ning

subs

tanc

e for

the t

reat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

(HAB

)H

AB 2

1Ta

bacu

m C

upro

cultu

mVa

dem

ecum

: Ta

bacu

m C

upro

cu

ltum

Oen

othe

ra A

rgen

to

culta

Fres

h ae

rial p

arts

of O

enot

hera

bie

nnis

L., c

ollec

ted

at fl

ower

ing

time,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a d

ilute

d sil

ver c

onta

inin

g su

bsta

nce f

or th

e tre

atm

ent o

f the

soil

for t

he 1

st lif

e cyc

le).

(HAB

192

4)Ph

.Eur

. 1.1

.3Va

dem

ecum

: O

enot

hera

Arg

ento

cu

lta Ja

chen

s: D

erm

atol

ogie.

Sa

lum

ed V

erla

g 20

12,

pp 3

86-3

91.

Prim

ula v

eris

Auro

cu

ltaFr

esh

flowe

rs o

f Prim

ula v

eris

L., c

ultiv

ated

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a di

lute

d go

ld co

ntai

ning

subs

tanc

e for

the t

reat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.Ph

.Eur

. 1.1

.5,

HAB

21

Prim

ula A

uro

culta

; Prim

ula A

uro

culta

com

p.Va

dem

ecum

: Prim

ula

Auro

culta

Tara

xacu

m o

fficin

ale

Stan

no cu

ltum

Who

le fre

sh fl

ower

ing

plan

ts of

Tar

axac

um o

fficin

ale a

gg. F

.H. W

igg.

, cul

tivat

ed

acco

rdin

g to

APC

Met

hod

1.1.

1 (u

sing

a dilu

ted

tin co

ntai

ning

subs

tanc

e for

the

treat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

(HAB

)Ph

.Eur

. 1.1

.3,

HAB

21

Tara

xacu

m St

anno

cultu

mVa

dem

ecum

: Ta

raxa

cum

Stan

no

cultu

m

Thuj

a occ

iden

talis

Ar

gent

o cu

ltaFr

esh,

leaf

y, on

e-ye

ar-o

ld tw

igs o

f Thuj

a occ

iden

talis

L., c

ultiv

ated

acco

rdin

g to

AP

C M

etho

d 1.

1.1

(usin

g a d

ilute

d sil

ver c

onta

inin

g su

bsta

nce f

or th

e tre

atm

ent o

f th

e soi

l for

the 1

st lif

e cyc

le).

(HAB

)Ph

.Eur

. 1.1

.5,

HAB

21

Thuj

a occ

iden

talis

Arg

ento

culta

Urtic

a dio

ica F

erro

cu

ltaFr

esh

aeria

l par

ts of

Urt

ica d

ioic

a L., c

ollec

ted

at fl

ower

ing

time,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a d

ilute

d iro

n co

ntai

ning

subs

tanc

e for

the

treat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

(HAB

)Ph

.Eur

. 1.1

.3,

HAB

21

Urtic

a dio

ica F

erro

culta

Vade

mec

um: U

rtic

a di

oica

Fer

ro cu

lta

Urtic

a dio

ica F

erro

cu

lta, C

inis

see C

inis

Urtic

ae F

erro

culta

e app

. 2.7

Urtic

a dio

ica F

erro

cu

lta, R

adix

Fres

h un

derg

roun

d pa

rts o

f Urt

ica d

ioic

a L., c

ollec

ted

at fl

ower

ing

time,

culti

vate

d ac

cord

ing

to A

PC M

etho

d 1.

1.1

(usin

g a d

ilute

d iro

n co

ntai

ning

subs

tanc

e for

the

treat

men

t of t

he so

il fo

r the

1st

life c

ycle)

.

HAB

21;

for t

he

prep

arat

ion

of

Cini

s Urt

icae

Fe

rro

culta

e (a

pp. 2

.5)

Urtic

a dio

ica F

erro

culta

Nam

e of t

he su

bsta

nce

Abbr

evia

ted

defin

ition

Re

fere

nce t

o St

anda

rd

(for t

he p

lant

)Pr

epar

atio

n m

etho

dRe

fere

nce f

or u

se in

anth

ropo

soph

ic m

edic

ine

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.5


188

•


189

•

Ap

pend

ix 2

.6

APPENDIX 2.6

List of compositions Additional Information, see p. 18


190

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

Alka

li co

mp.

Com

mip

hora

Jacq

. spe

cies

(M

yrrh

) / K

aliu

m

carb

onic

um /

Qua

rz /

Tron

a

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Cich

oriu

m in

tybu

s, Pl

anta

tota

, Al

kali

com

p. is

mad

e fro

m: P

otas

sium

carb

onat

e / T

rona

/ Q

uart

z and

Myr

rh. P

otas

sium

ca

rbon

ate,

Tron

a and

qua

rtz a

re in

tens

ively

tritu

rate

d an

d m

ixed

with

an o

rgan

ic b

inde

r (M

yrrh

). Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Vade

mec

um: A

lkal

i co

mp.

Anis-

Pyrit

Pim

pine

lla an

isum

L. /

Py

rite /

Sac

char

um

(Sac

char

um o

ffici

naru

m L

.)

1 g

Anis-

Pyrit

is p

repa

red

from

: Pim

pine

lla an

isum

, Fru

ctus

0.3

3 g

/ pyr

ite 0

.33

g /

sacc

haru

m 0

.33

g. W

arm

ed p

yrite

pow

der a

nd m

elted

sucr

ose (

cane

suga

r) ar

e th

orou

ghly

mix

ed, t

he p

owde

red

anise

ed ad

ded,

with

fina

l tho

roug

h m

ixin

g. Th

is fo

rmul

atio

n is

dilu

ted

with

an eq

ual a

mou

nt o

f lac

tose

mon

ohyd

rate

, grin

ded

and

sieve

d. Th

e res

ultin

g pr

epar

atio

n is

nam

ed A

nis-

Pyrit

50%

. The p

oten

cy A

nis-

Pyrit

D1

is pr

epar

ed fr

om 2

Par

ts An

is-Py

rit 5

0% an

d 8

part

s lac

tose

mon

ohyd

rate

, D2

acc.

to

Ph.E

ur. 4

.1.1

.

Anis-

Pyrit

Apis

cum

Lev

istic

oAp

is m

ellifi

ca L

. /

Levi

sticu

m o

ffici

nale

W. D

. J.

Koch

1 g

Apis

cum

Lev

istic

o Ø

(= D

1) is

pre

pare

d fro

m 0

.1 g

Api

s mell

ifica

/ 0.

1 g

aque

ous

extra

ct o

f Lev

istic

um, R

adix

(dru

g to

extra

ct =

4:1

). Th

e bee

s are

kill

ed, c

omm

inut

ed an

d m

ixed

with

a fre

shly

pre

pare

d aq

ueou

s ext

ract

of L

evist

icum

, Rad

ix (d

rug

to ex

tract

=

4:1)

and

glyc

erol

85%

. The l

iqui

d is

furt

her p

roce

ssed

imm

edia

tely.

Pot

entis

atio

n ac

c. to

Ph

.Eur

. 3.1

.2 (a

nd th

en H

AB 1

1).

Apis

cum

Lev

istic

o

Arge

ntum

-Cor

pus

vitre

umAr

gent

um m

etal

licum

/ Co

rpus

vitre

um (B

os ta

urus

L.

or O

ryct

olag

us cu

nicu

lus

L.)

Fres

h ey

e bal

l (Co

rpus

vitre

um) i

s clea

ned

and

mix

ed w

ith a

solu

tion

prep

ared

of s

ilver

ni

trate

, con

cent

rate

d am

mon

ia so

lutio

n an

d pu

rified

wat

er an

d m

ixed

. Afte

r add

ition

of

a sol

utio

n of

glu

cose

mon

ohyd

rate

in p

urifi

ed w

ater

the m

ixtu

re is

gent

ly w

arm

ed so

that

th

e silv

er n

itrat

e is r

educ

ed to

the m

etal

. Afte

r filte

ring,

the r

esid

ue is

drie

d wi

th la

ctos

e m

onoh

ydra

te, b

eing

adju

sted

to g

ive a

fina

l silv

er co

nten

t of 1

%. P

oten

tisat

ion

acc.

to

Ph.E

ur. 3

.2.2

.

Arge

ntum

-Cor

pus v

itreu

m

Arni

ca-C

ereb

rum

Arni

ca m

onta

na L

. /

Cere

brum

, Cer

ebell

um,

Trun

cus c

ereb

ri

1 g

Arni

ca-C

ereb

rum

D1

cont

ains

: Arn

ica,

Plan

ta to

ta, p

ress

ed ju

ice 0

.05

g/ C

ereb

rum

0.

05 g

(Cer

ebru

m =

Cer

ebru

m, C

ereb

ellum

, bra

in st

em =

2+1

+1).

The c

leane

d in

gred

ient

s of C

ereb

rum

are m

ixed

with

the f

resh

pre

ssed

pla

nt ju

ice o

f Arn

ica m

onta

na

and

inte

nsiv

ely tr

itura

ted.

Wat

er fo

r inj

ectio

ns is

adde

d an

d th

e mix

ture

pot

entis

ed to

m

ake t

he D

1 po

tenc

y. Th

e D1

pote

ncy i

s fur

ther

pro

cess

ed im

med

iate

ly ac

c. to

Ph.

Eur.

3.1.

2.

Arni

ca-C

ereb

rum

Calci

um Q

uerc

usse

e Que

rcus

e co

rtic

e cum

Cal

cio

carb

onic

o

Calci

um si

licic

um co

mp.

Arni

ca m

onta

na L

. / C

alci

i ox

idum

/ Ca

mph

ora /

Kal

ii ca

rbon

as /

Qua

rz /

Que

rcus

ro

bur L

., Que

rcus

pet

raea

(M

att.)

Lie

bl. a

nd Q

uerc

us

pube

scen

s Will

d./ T

ritic

um

aesti

vum

L. e

men

d Fi

ori e

t Pa

ol.

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Arn

ica m

onta

na, R

adix

, Cal

cium

sil

icic

um co

mp.

is p

repa

red

from

: Sili

cate

melt

(obt

aine

d fro

m q

uart

z / p

otas

sium

ca

rbon

ate /

calci

um o

xide

) / ar

nica

late

x / d

ried

wate

r-ex

tract

of Q

uerc

us, C

orte

x /

cam

phor

/ es

sent

ial o

il fro

m A

rnic

a mon

tana

, Rad

ix /

fresh

whe

at g

lute

n. Th

e sili

cate

m

elt is

adde

d to

a m

ixtu

re o

f the

Arn

ica l

atex

and

drie

d ex

tract

of Q

uerc

us, C

orte

x an

d tr

itura

ted.

Fin

ally

the c

amph

or an

d th

erea

fter t

he es

sent

ial o

il of

Arn

ica a

re ad

ded.

The

mix

ture

is tr

itura

ted

well,

fres

h wh

eat g

lute

n ad

ded

and

the w

hole

knea

ded

to m

ake a

pa

ste. Th

is is

then

drie

d, p

owde

red

and

dilu

ted

with

lact

ose m

onoh

ydra

te. P

oten

tisat

ion

acco

rdin

g to

Ph.

Eur.

4.1.

1.

Vade

mec

um: C

alciu

m

silic

icum

com

p.

•

Appendix 2.6


191

Carb

o Be

tula

e cum

M

etha

noBe

tula

pen

dula

Rot

h /

Met

han

Carb

o Be

tula

e (ch

arco

al fr

om th

e birc

h) sa

tura

ted

with

met

hane

R1

(Ph.

Eur.)

is u

sed:

Po

wder

ed C

arbo

Bet

ulae

is h

eate

d un

der v

acuu

m. A

fter h

eatin

g an

d du

ring

cool

ing

Carb

o Be

tula

e is s

atur

ated

with

met

hane

. Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Carb

o Be

tula

e cum

Met

hano

Cheli

doni

um/ C

urcu

ma

prae

p.Ch

elido

nium

maju

s L. /

Cu

rcum

a xan

thor

rhiz

a Ro

xb.

Cheli

doni

um Ø

(Ph.

Eur.

1.1.

5) C

urcu

ma x

anth

orrh

iza,

Rhiz

oma Ø

(Ph.

Eur.

1.2.

12) w

ith

70%

etha

nol V

/V) a

re m

ixed

by d

ropp

ing

1 pa

rt o

f the

firs

t int

o 1

part

of t

he ro

tatin

g se

cond

mot

her t

inct

ure.

Cheli

doni

um/C

urcu

ma

Cini

s Cap

sella

e com

p.

APC

Arte

misi

a abs

inth

ium

L. /

Ca

psell

a bur

sa-p

asto

ris (L

.) M

ed. /

Cup

ri su

lfas

pent

ahyd

ricus

/ Fe

rros

i su

lfas d

esicc

ates

/ H

alite

/ Ka

lii ca

rbon

as/ P

lant

ago

lanc

eolat

a L. /

Plu

mbu

m

subc

arbo

nicu

m (C

reus

sa) /

Ro

sa ce

ntifo

lia L

. / C

rem

or

Tart

ari (

Crea

m o

f Tar

tar)

The d

ried

plan

t mat

eria

l is i

ncin

erat

ed. Th

e wat

er so

lubl

e ash

salts

obt

aine

d th

eref

rom

, po

tass

ium

carb

onat

e (ob

tain

ed fr

om cr

eam

of t

arta

r) an

d ha

lite a

re m

ixed

and

adde

d to

th

e pow

der-

mix

ture

of c

oppe

r sul

fate

and

ferr

ous s

ulfa

te. Th

is co

mbi

ned

powd

er is

gr

ound

unt

il th

e col

our c

hang

es to

redd

ish b

rown

. In

the n

ext s

tep

wine

vine

gar,

in

which

fres

h ro

se p

etal

s hav

e bee

n so

aked

, is a

dded

and

the m

ixtu

re is

hea

ted

and

mix

ed

while

the c

olou

r tur

ns to

pist

achi

o gr

een.

Whe

n th

e pas

ty m

ass g

ets m

ore s

olid

, cer

ussa

is

adde

d an

d he

atin

g is

cont

inue

d un

til th

e mix

ture

is so

lid an

d dr

y. Aft

er co

olin

g th

e su

bsta

nce o

btai

ned

is po

wder

ed. F

or ex

tern

al u

se (e

.g. o

intm

ent,

gel)

an aq

ueou

s so

lutio

n of

the w

ater

solu

ble s

alts i

s use

d as

activ

e sub

stanc

e: 9

part

s of p

urifi

ed w

ater

are

adde

d to

1 p

art o

f Cin

is Ca

psell

ae co

mp.

APC

, the

mix

ture

is ag

itate

d in

a clo

sed

cont

aine

r and

allo

wed

to st

and

at ro

om te

mpe

ratu

re fo

r at l

east

20 h

ours

. The

supe

rnat

ant i

s filte

red.

The r

esul

ting

Cini

s Cap

sella

e com

p. aq

ueou

s sol

utio

n 10

% is

clea

r an

d vi

ridia

n gr

een

(turq

uoise

blu

e to

emer

ald

gree

n) in

colo

ur an

d ha

s to

be p

roce

ssed

im

med

iate

ly. 1

par

t Cin

is Ca

psell

ae co

mp.

aque

ous s

olut

ion

10%

corr

espo

nds t

o 0.

1 pa

rts o

f Cin

is Ca

psell

ae co

mp.

APC

.

Vade

mec

um: C

inis

Caps

ellae

com

p.

Cini

s e fr

uctib

us A

vena

e sa

tivae

cum

Mag

nesio

ph

osph

orico

(1:1

)

Aven

a sat

iva L

. / M

agne

sium

ph

osph

oric

um fh

p1.

Cin

is e f

ruct

ibus

Ave

nae s

ativ

ae (a

sh o

f the

frui

t of A

vena

sativ

a, oa

ts): O

ats a

re

moi

stene

d wi

th w

ater

to st

art g

erm

inat

ion,

drie

d an

d as

hed.

2. A

sh o

f oat

s with

m

agne

sium

pho

spho

ricum

: Equ

al p

arts

of as

h of

oat

s and

mag

nesiu

m p

hosp

horic

um ar

e m

ixed

toge

ther

. 3. P

oten

tisat

ion

acco

rdin

g to

Ph.

Eur.

4.1.

1.

Arni

ca/C

actu

s com

p.; C

or/

Crat

aegu

s com

p.; F

raga

ria/U

rtic

a co

mp.

; Mag

nesiu

m p

hosp

horic

um

com

p.; M

agne

sium

pho

spho

ricum

cu

m ci

nere

Ave

nae;

Vera

trum

co

mp.

Mey

er, U

. & P

eder

sen,

P.A

. (ed

): An

thro

poso

phisc

he

Phar

maz

ie 2

016

p.

587-

590.

Ciss

us-O

ssa

Aves

varia

e, e.g

. Pha

sianu

s co

lchic

us L

. (O

ssae

) / C

issus

go

ngyl

odes

(Bak

.) Bu

rch.

1 g

Ciss

us-O

ssa i

s pre

pare

d fro

m: E

than

olic

extra

ct fr

om: C

issus

gong

ylod

es, a

eria

l roo

t 1.

5 g/

Oss

a 0.5

g. Th

e bon

es o

f par

tridg

e or p

heas

ant a

re cl

eane

d, b

oiled

, drie

d,

powd

ered

and

mix

ed w

ith eq

ual p

arts

of la

ctos

e mon

ohyd

rate

. To

this

mix

ture

add

the

mot

her t

inct

ure o

f Ciss

us go

ngyl

odes

, aer

ial r

oots

drie

d (P

h.Eu

r. M

etho

d 1.

1.7)

. Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Ciss

us-O

ssa

Vade

mec

um

Com

posit

io C

ichor

iiSe

e Com

posit

io M

iner

alis

cum

Myr

rha

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.6


192

Com

posit

io M

iner

alis

cum

Myr

rha A

PCQ

uarz

/ Ka

lii ca

rbon

as /

Com

mip

hora

Jaco

b sp

ecie

s (m

yrrh

) / A

cidu

m

phos

phor

icum

/ H

alite

/ Fr

ucto

sum

/ La

ctos

um

mon

ohyd

ricum

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Cich

oriu

m in

tybu

s, Pl

anta

tota

, Co

mpo

sitio

Cich

orii,

is p

repa

red

by m

eltin

g qu

artz

with

pot

assiu

m ca

rbon

ate.

After

co

olin

g, th

e pro

duct

is d

issol

ved

in w

ater

and

adde

d to

pow

dere

d m

yrrh

, swo

llen

by

addi

ng Sp

iritu

s vin

i and

wat

er. Th

en p

hosp

horic

acid

is ad

ded,

lead

ing

to p

recip

itatio

n of

sil

icic

acid

. The m

ixtu

re is

drie

d, si

eved

and

mix

ed w

ith h

alite

. A co

ncen

trate

d aq

ueou

s so

lutio

n of

cara

mel

of fr

ucto

se an

d th

en la

ctos

e mon

ohyd

rate

is ad

ded.

Afte

r dry

ing,

the

whol

e mix

ture

is g

rinde

d to

a un

iform

pow

der.

Pote

ntisa

tion

acc.

to P

h.Eu

r. 4.

1.1

Com

posit

io M

iner

alis

cum

Sac

char

o AP

CKa

lii ca

rbon

as /

Qua

rz /

Tron

a / S

acch

arum

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Cha

mom

illa (

Mat

ricar

ia re

cutit

a L.)

Radi

x, C

ompo

sitio

Min

eral

is cu

m S

acch

aro

is pr

epar

ed fr

om: P

otas

sium

carb

onat

e/qu

artz

/tron

a. Po

tass

ium

carb

onat

e and

qua

rtz a

re m

elted

toge

ther

. The m

elt is

diss

olve

d in

wat

er to

pro

duce

a cle

ar so

lutio

n, an

d sim

ulta

neou

sly w

ith a

solu

tion

of su

cros

e add

ed

to a

solu

tion

of p

otas

sium

carb

onat

e and

tron

a. Th

is m

ixtu

re is

imm

edia

tely

pot

entis

ed

with

etha

nol 1

5% to

D1.

Pot

entis

atio

n ac

c. to

Ph.

Eur.

3.1.

1

Der

Mer

kurs

tab

2012

; 65

(1):

46-5

3

Corp

us vi

treum

-St

annu

mCo

rpus

vitre

um /

Stan

num

hy

drox

atum

1 g

Corp

us vi

treum

-Sta

nnum

D1

cont

ains

: Cor

pus v

itreu

m 0

.08

g / s

tann

um

hydr

oxyd

atum

0.0

2 g.

A so

lutio

n of

tin

(II) c

hlor

ide i

n pu

rified

wat

er is

mix

ed w

ith a

solu

tion

of so

dium

carb

onat

e in

purifi

ed w

ater

. The r

esul

ting

prec

ipita

te (s

tann

um

hydr

oxat

um) i

s add

ed to

fres

h, m

ince

d co

rpus

vitre

um an

d th

orou

ghly

mix

ed. Th

e m

ixtu

re is

dilu

ted

in th

e pro

port

ion

1:10

with

wat

er fo

r inj

ectio

ns to

pre

pare

the D

1 po

tenc

y. Th

e D1

pote

ncy i

s fur

ther

pro

cess

ed im

med

iate

ly ac

c. to

Ph.

Eur.

2.1.

1 an

d 3.

1.2

Corp

us vi

treum

-Sta

nnum

Cupr

um-R

en-G

land

ula

supr

aren

alis

Gla

ndul

a sup

rare

nalis

/ Re

nes (

Bos t

auru

s L. o

r O

ryct

olag

us cu

nicu

lus L

.) /

Tetra

mm

ine c

oppe

r(II)

su

lfate

1 g

Cupr

um-R

en (=

D1)

cont

ains

: Gla

ndul

a sup

rare

nalis

0.0

23 g

/ re

n 0.

060

g /

tetra

mm

ine c

oppe

r(II)

sulfa

te 0

.017

g. Th

e fre

sh, c

leane

d an

imal

ingr

edie

nt is

mix

ed w

ith

a sm

all a

mou

nt o

f wat

er fo

r inj

ectio

ns an

d te

tram

min

e cop

per (

II) su

lfate

, and

tritu

rate

d to

geth

er. A

fterw

ards

the r

est o

f the

wat

er fo

r inj

ectio

ns is

adde

d to

mak

e the

D1

pote

ncy,

and

the s

olut

ion

is po

tent

ised.

The D

1 po

tenc

y is f

urth

er p

roce

ssed

imm

edia

tely

acc.

to

Ph.E

ur. 3

.1.2

Cupr

um-R

en-G

land

ula

supr

aren

alis

Equi

setu

m cu

m Su

lfure

to

stum

Equi

setu

m ar

vens

e L. /

Su

lfur

Equi

setu

m cu

m Su

lfure

tostu

m is

pre

pare

d fro

m E

quise

tum

arve

nse,

Her

ba an

d su

lfur.

99 p

arts

Equi

setu

m ar

vens

e, H

erba

(drie

d, h

erba

l dru

g, co

mm

inut

ed to

a

part

icle s

ize <

4 m

m) a

re m

ixed

with

1 p

art s

ulfu

r (pa

rticl

e siz

e < 0

,063

mm

) and

then

to

aste

d ac

cord

ing

to A

PC 4

.1. H

eatin

g tim

e: ab

out 5

- 15

min

utes

. Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Equi

setu

m cu

m Su

lfure

tostu

m

Equi

setu

m h

yem

ale-

Rube

llit

Equi

setu

m h

yem

ale,

Rube

llit

Fres

h ha

rves

ted

shoo

ts of

Equ

isetu

m h

yem

ale L

. are

put

into

a aq

ueou

s dilu

tion

of

Rube

llit D

6 du

ring

the d

ay an

d un

der p

rese

nce o

f day

ligh

t. In

the e

veni

ng th

e sho

ots a

re

take

n ou

t, co

mm

inut

ed an

d ex

pres

sed.

The e

xpre

ssed

juic

e is m

ixed

with

an eq

ual m

ass

of et

hano

l 96%

. Filt

er aft

er 5

to 1

0 da

ys. Th

e filtr

ate i

s Equ

isetu

m h

yem

ale-

Rube

llit Ø

. Po

tent

isatio

n ac

c. to

Ph.

Eur.

1.1.

1

Der

Mer

kurs

tab

2013

; 66

(5):

415-

438.

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.6


193

•

Ap

pend

ix 2

.6

Equi

setu

m li

mos

um-

Rube

llit

Equi

setu

m li

mos

um L

. (E

quise

tum

fluv

iatil

e L.)

/ Ru

belli

t

Fres

h ha

rves

ted

shoo

ts of

Equ

isetu

m li

mos

um L

. (Eq

uise

tum

fluv

iatil

e L.)

are p

ut in

to a

aque

ous d

ilutio

n of

Rub

ellit

D6

durin

g th

e day

and

unde

r pre

senc

e of d

ay li

ght.

In th

e ev

enin

g th

e sho

ots a

re ta

ken

out,

com

min

uted

and

expr

esse

d. Th

e exp

ress

ed ju

ice is

m

ixed

with

an eq

ual m

ass o

f eth

anol

96%

. Filt

er aft

er 5

to 1

0 da

ys. Th

e filtr

ate i

s Eq

uise

tum

lim

osum

-Rub

ellit

Ø. P

oten

tisat

ion

acc.

to P

h.Eu

r. 1.

1.1

Sold

ner G

, Ste

llman

n H

M. I

ndiv

idue

lle

Pädi

atrie

, 4. A

uflag

e, W

issen

scha

ftl. V

erl.

Ges

., Stu

ttgar

t, 20

11, p

. 74

3

Ferr

um h

ydro

xyda

tum

Ferr

um ap

h / V

itis v

inife

ra

L.Fe

rrum

hyd

roxy

datu

m is

pre

pare

d fro

m F

erru

m m

etal

licum

redu

ctum

and

red

wine

vi

nega

r. Iro

n th

at p

revi

ously

has

bee

n ob

tain

ed fr

om si

derit

e by r

educ

tion

is co

vere

d wi

th re

d wi

ne vi

nega

r and

ligh

tly w

arm

ed fo

r abo

ut 1

4 da

ys. Th

en th

e sol

utio

n is

filte

red,

an

d th

e res

idue

was

hed

with

wat

er an

d left

to re

act w

ith ai

r. Th

is ox

idat

ion

relea

ses h

eat,

wher

efor

e the

pre

para

tion

has t

o be

kep

t moi

st. Th

e oxi

dise

d iro

n is

redu

ced

to p

owde

r. Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Ferr

um h

ydro

xyda

tum

Ferr

um p

omat

umFe

rrum

aph

/ Malu

s do

mes

tica B

orkh

.1

g of

the D

1 co

ntai

ns: F

e 5 m

g. S

our a

pples

are p

ress

ed; 1

00 p

arts

juice

is m

ixed

with

4

part

s Fer

rum

met

allic

um. Th

e mix

ture

is le

ft fo

r sev

eral

day

s and

then

war

med

to ab

out

50 °C

. Afte

rwar

ds th

e sol

utio

n is

filte

red,

evap

orat

ed to

55-

65%

of t

he w

eigh

ed m

ass a

nd

mix

ed w

ith et

hano

l 96%

(sta

ndar

disa

tion

on 1

0% et

hano

l and

0.5

% F

e). P

oten

tisat

ion

acc.

to P

h.Eu

r. 3.

1.1

(eth

anol

18%

).

Ferr

um ro

satu

mFe

rrum

side

reum

/ Ro

sa

cent

ifolia

L.

Ferr

um ro

satu

m is

pre

pare

d fro

m R

osa c

entif

olia

and

Ferr

um si

dere

um D

1. F

resh

rose

pe

tals

are t

ritur

ated

with

1%

Fer

rum

side

reum

D1

and

the a

mou

nt o

f wat

er, c

alcu

lated

ac

cord

ing

to P

h.Eu

r. 1.

1.6,

and

then

allo

wed

to st

and

for 2

-4 d

ays a

t 15-

20 °C

. Then

the

calcu

lated

amou

nt o

f eth

anol

94%

is ad

ded

and

the p

repa

ratio

n co

ntin

ued

acco

rdin

g to

Ph

.Eur

. 1.1

.6. Th

e com

posit

ion

can

be p

oten

tised

acc.

to P

h.Eu

r. 1.

1.6.

Ferr

um ro

satu

m/G

raph

ites;

Trop

aeol

um co

mp.

Ferr

um-Q

uarz

Ferr

osi s

ulfa

s hep

tahy

dric

us

APC/

Mel,

Qua

rz /

Vinu

m

(Viti

s vin

ifera

L.)

A m

ixtu

re o

f fer

rous

sulfa

te h

epta

hydr

ate,

hone

y, wh

ite w

ine,

and

calci

nate

d qu

artz

is

prep

ared

. This

mix

ture

is h

eate

d an

d dr

ied

unde

r vac

uum

. Pot

entis

atio

n ac

c. to

Ph.

Eur.

4.1.

1 or

4.1

.2

Ferr

um/Q

uarz

Hell

ebor

us fo

etid

usH

elleb

orus

foet

idus

L.

Aque

ous e

xtra

cts p

repa

red

from

the f

resh

pla

nt p

arts

of H

elleb

orus

foet

idus

L. (

Flos

rec.

and

Foliu

m et

Rad

ix re

c., se

e app

. 2.2

) are

mix

ed 1

:1 ac

cord

ing

to A

PC 7

.5.

Der

Mer

kurs

tab

6/20

10

p. 5

65

Hell

ebor

us n

iger

Hell

ebor

us n

iger

L.

Aque

ous e

xtra

cts p

repa

red

from

the f

resh

pla

nt p

arts

of H

elleb

orus

nig

er L

. (Fl

os re

c. an

d Pl

anta

tota

rec.,

see a

pp. 2

.2) a

re m

ixed

1:1

, acc

ordi

ng to

APC

7.5

.D

er M

erku

rsta

b 6/

2010

p.

500

-566

Hep

ar su

lfuris

see a

pp. 2

.4

Hep

ar-M

agne

sium

Hep

ar /

Mag

nesiu

m

hydr

oxyd

atum

1 g

Hep

ar-M

agne

sium

D1

cont

ains

: Hep

ar 0

.06

g / m

agne

sium

hyd

roxy

datu

m 0

.04

g. A

so

lutio

n of

mag

nesiu

m ch

lorid

e in

wate

r is m

ixed

with

a so

lutio

n of

sodi

um h

ydro

xide

in

wat

er. Th

e res

ultin

g pr

ecip

itate

(Mag

nesiu

m h

ydro

xyda

tum

) is w

ashe

d se

vera

l tim

es

with

wat

er an

d th

an m

ixed

with

chop

ped

piec

es o

f liv

er an

d th

en to

geth

er w

ith h

oney

, it

is fin

ely tr

itura

ted.

The m

ixtu

re is

mix

ed w

ith w

ater

for i

njec

tions

(Ph.

Eur.

3.1.

2) o

r gl

ycer

ol 8

5% (P

h.Eu

r. 2.

1.1)

, and

pot

entis

ed to

mak

e the

D1

pote

ncy.

This

D1

pote

ncy i

s pr

oces

sed

imm

edia

tely

acc.

to P

h.Eu

r. 3.

1.2

Hep

ar-M

agne

sium

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er


194

Hep

ar-S

tann

umH

epar

/ St

annu

m

hydr

oxyd

atum

1 g

Hep

ar-S

tann

um co

ntai

ns: H

epar

0.0

8 g

/ Sta

nnum

hyd

roxy

datu

m 0

.02

g. A

solu

tion

of ti

n (II

) chl

orid

e in

wate

r is m

ixed

with

a so

lutio

n of

sodi

um ca

rbon

ate i

n wa

ter.

The

resu

lting

pre

cipita

te (S

tann

um h

ydro

xyda

tum

) is w

ashe

d wi

th w

ater

. The r

esul

ting

Stan

num

hyd

roxy

datu

m is

mix

ed w

ith ch

oppe

d pi

eces

of l

iver

and

then

thor

ough

ly

tritu

rate

d wi

th h

oney

. The m

ixtu

re is

mix

ed w

ith w

ater

for i

njec

tions

(Ph.

Eur

. 3.1

.2) o

r gl

ycer

ol 8

5% (P

h. E

ur. 2

.1.1

), an

d po

tent

ised

to m

ake t

he D

1 po

tenc

y. Th

is D

1 po

tenc

y is

proc

esse

d im

med

iate

ly ac

c. to

Ph.

Eur.

3.1.

2

Hep

ar-S

tann

um

Kaliu

m ac

etic

um co

mp.

Antim

onite

/ Co

ralli

um

rubr

um L

. / C

rocu

s sat

ivus

L.

/ Ka

lii ca

rbon

as /

Acet

um

Vini

des

tillat

um (V

itis

vini

fera

L.)

/ Spi

ritus

e Vi

no

(Viti

s vin

ifera

L.)

Kaliu

m ac

etic

um co

mp.

is p

repa

red

from

: Pot

assiu

m ca

rbon

ate /

dist

illed

red

wine

vi

nega

r / an

timon

ite /

Croc

us sa

tivus

tinc

ture

1:2

0 (v

ehicl

e: sp

iritu

s e vi

no) /

spiri

tus e

vi

no /

Cora

llium

rubr

um. P

otas

sium

carb

onat

e/di

stille

d re

d wi

ne vi

nega

r / an

timon

ite /

Croc

us sa

tivus

tinc

ture

/ Cor

alliu

m ru

brum

and

spiri

tus e

vino

are s

tepw

ise co

mbi

ned

and

repe

ated

ly d

istill

ed. Th

e res

ulta

nt d

ried

resid

ue is

use

d. P

oten

tisat

ion

acc.

to P

h.Eu

r. 4.

1.1

Anag

allis

/Mal

achi

t com

p.;

Cham

omill

a/M

alac

hit c

omp.

; Ka

lium

acet

icum

com

p.

Kaliu

m su

lfuric

um

com

p.Ka

lii su

lfas /

Nat

rii su

lfas /

Li

num

usit

atiss

imum

L.

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Ana

galli

s arv

ensis

, Her

ba, K

aliu

m

sulfu

ricum

com

p. is

pre

pare

d by

mix

ing

Kalii

sulfa

s and

Nat

rii su

lfas a

nd m

akin

g a p

aste

by

grin

ding

with

muc

ilage

of l

inse

ed. Th

e mix

ture

is d

ried,

grin

ded,

siev

ed; a

nd fi

nally

di

lute

d wi

th la

ctos

e mon

ohyd

rate

. Pot

entis

atio

n ac

c. to

Ph.

Eur.

4.1.

1

Vade

mec

um: K

aliu

m

sulfu

ricum

com

p.

Lapi

s Can

cri-F

lintst

ein

Lapi

s Can

cri/

Flin

t / Sp

iritu

s e v

ino

(Viti

s vin

ifera

L.)

1 g

Lapi

s Can

cri-F

lintst

ein

cont

ains

: Lap

is Ca

ncri

0.5

g/fli

nt 0

.5 g

: Fin

ely p

owde

red

Lapi

s Ca

ncri

and

flint

are t

horo

ughl

y mix

ed w

ith sp

irito

e vi

no an

d th

e slu

rry t

reat

ed w

ith

wate

r. Th

e res

ulta

nt d

ry re

sidue

is th

e sub

stanc

e. Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Lapi

s Can

cri/F

lintst

ein

Mix

tura

Stan

ni co

mp.

Alum

en /

Cupr

um

met

allic

um /

Stan

num

m

etal

licum

/ Ac

idum

ni

tric

um (6

5 pe

r cen

tum

);

1 g

susp

ensio

n is

prep

ared

from

: 1 m

g Al

umen

/ 0.

002

mg

Cupr

um m

etal

licum

/ 2

mg

Stan

num

met

allic

um 1

0.4

mg

Acid

um n

itric

um (6

5 pe

r cen

tum

).M

ixtu

ra St

anni

com

p.D

er M

erku

rsta

b 20

11;

64(4

): 33

2-33

7

Myr

rha c

omp.

Auru

m m

etal

licum

/ Bo

swell

ia sp

ecie

s /

Com

mip

hora

Jacq

. Spe

cies

/ Sa

ccha

rum

(Sac

char

um

offici

naru

m L

.)

1 g

Myr

rha c

omp.

D1

is pr

epar

ed fr

om: M

yrrh

a 0.1

g /

Auru

m m

etal

licum

folia

tum

(gol

d lea

f) 0

.001

g an

d O

liban

um 0

.1g.

Myr

rha a

nd go

ld le

af ar

e bou

nd to

geth

er w

ith th

e aid

of

mod

erat

e hea

t; in

cens

e sm

oke (

from

Olib

anum

) is p

asse

d th

roug

h th

e mix

ture

. This

com

posit

ion

is sti

rred

into

mol

ten

sucr

ose (

cane

suga

r). A

fter c

oolin

g it

is tr

itura

ted

for

one h

our b

y han

d, re

sulti

ng th

e pot

ency

D1.

Pot

entis

atio

n ac

c. to

Ph.

Eur.

4.1.

1

Vade

mec

um: M

yrrh

a co

mp.

Ono

pord

on co

mp.

Hyo

scya

mus

nig

er L

. /

Ono

pord

um ac

anth

ium

L. /

Pr

imul

a ver

is L.

A co

mbi

natio

n of

Ono

pord

um ac

anth

ium

, Flo

s rec

., eth

anol

. Dig

estio

(1:3

.1) w

ith

0.1-

1% H

yosc

yam

us n

iger

, Her

ba re

c. Ø

and

Prim

ula v

eris,

Flo

s rec

., eth

anol

. Dig

estio

(1

:3.1

) with

0.1

-1%

Hyo

scya

mus

nig

er, H

erba

rec.

Ø

Ono

pord

on co

mp.

Ono

pord

on co

mp.

pr

aepa

ratu

m C

HO

nopo

rdum

acan

thiu

m L

. /

Hyo

scya

mus

nig

er L

. /

Prim

ula v

eris

L.

0.1

part

of P

rimul

a ver

is, F

los r

ec., e

than

ol. D

iges

tio (1

:3.1

) pre

pare

d wi

th 2

%

Hyo

scya

mus

nig

er, H

erba

rec.

Ø is

dilu

ted

with

0.3

15 p

arts

of p

urifi

ed w

ater

("m

ixtu

re

a").

0.1

part

of O

nopo

rdum

acan

thiu

m, F

los r

ec., e

than

ol. D

iges

tio (1

:3.1

) is d

ilute

d wi

th

0.31

5 pa

rts o

f pur

ified

wat

er (m

ixtu

re b

). In

a sp

ecia

l equ

ipm

ent "

mix

ture

b" i

s dro

pped

in

to th

e rot

atin

g "m

ixtu

re a"

. 0.1

7 pa

rts o

f Eth

anol

96%

are a

dded

to o

btai

n 1

part

of t

he

final

pro

duct

Ono

pord

on co

mp.

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.6


195

Ono

pord

um ac

anth

ium

, Fl

os re

c., et

hano

l. D

iges

tio (1

:3.1

) with

0.

1-1%

Hyo

scya

mus

ni

ger,

Her

ba re

c. Ø

Ono

pord

um ac

anth

ium

L. /

H

yosc

yam

us n

iger

L.

Dig

estio

pre

pare

d fro

m 1

par

t of t

he fr

esh

flowe

rhea

ds o

f Ono

pord

um ac

anth

ium

L. a

nd

3.1

part

s of e

than

ol o

f sui

tabl

e con

cent

ratio

n or

wat

er fo

r inj

ectio

ns an

d th

e add

ition

of

0.00

4 to

0.0

4 pa

rts (

corr

espo

ndin

g to

0.1

to 1

%) o

f Hyo

scya

mus

nig

er L

., Her

ba, m

othe

r tin

ctur

e ( P

h.Eu

r. 1.

1.3)

.

Ono

pord

on co

mp.

Peat

mos

s ext

ract

co

mpo

sitio

n I (

light

)So

lum

ulig

inos

um /

Aesc

ulus

hip

poca

stanu

m

L. /

Equi

setu

m ar

vens

e L.

98 p

arts

of p

eat m

oss e

xtra

ct in

anal

ogy t

o to

HAB

Met

hod

12c (

usin

g pu

rified

wat

er

only

), ar

e mix

ed w

ith ea

ch 1

par

t of A

escu

lus h

ippo

casta

num

e se

min

e acc

ordi

ng to

H

AB M

etho

d 12

m an

d Eq

uise

tum

arve

nse e

x he

rba a

ccor

ding

to H

AB M

etho

d 12

c. Th

e su

pern

atan

t liq

uid

is de

cant

ed an

d fil

tere

d aft

er 1

0 - 1

2 we

eks y

ieldi

ng at

leas

t 75%

Pea

t m

oss e

xtra

ct co

mpo

sitio

n I.

API o

r Pot

entis

atio

n ac

c. to

Ph.

Eur.

3.1.

2

Solu

m u

ligin

osum

com

p.

Peat

mos

s ext

ract

co

mpo

sitio

n II

(dar

k)So

lum

ulig

inos

um /

Aesc

ulus

hip

poca

stanu

m

L. /

Equi

setu

m ar

vens

e L.

The r

est l

eft fr

om th

e dec

antin

g fo

r pre

parin

g Pe

at m

oss e

xtra

ct co

mpo

sitio

n I,

(max

. 25

%) i

s Pea

t mos

s ext

ract

com

posit

ion

IISo

lum

ulig

inos

um co

mp.

Plan

tago

lanc

eolat

a, Fo

lium

rec.,

etha

nol.

Dig

estio

(1:3

.1) w

ith

1-2%

Hyo

scya

mus

nig

er,

Her

ba re

c. Ø

Plan

tago

lanc

eolat

a L. /

H

yosc

yam

us n

iger

L.

Dig

estio

pre

pare

d fro

m 1

par

t of t

he fr

esh

leave

s of P

lant

ago

lanc

eolat

a L. a

nd 3

.1 p

arts

of et

hano

l of s

uita

ble c

once

ntra

tion

or w

ater

for i

njec

tions

and

the a

dditi

on o

f 0.0

4 to

0.

08 p

arts

(cor

resp

ondi

ng to

1 to

2%

) of H

yosc

yam

us n

iger

L., H

erba

, mot

her t

inct

ure

(Ph.

Eur

. 1.1

.3).

Plan

tago

-Prim

ula c

um

Hyo

scya

mo

Plum

bum

mell

itum

Plum

bum

met

allic

um /

Mel

/ Sac

char

um

(Sac

char

um o

fficin

arum

L.)

Plum

bum

mell

itum

is p

repa

red

from

lead

, hon

ey an

d ca

ne su

gar.

Dep

ress

ions

are

intro

duce

d in

to a

shee

t of l

ead,

this

is fil

led w

ith h

oney

, and

the w

hole

cove

red

with

m

olte

n lea

d. A

fter c

oolin

g it

is gr

ated

, melt

ed ag

ain

and

then

laid

out

as a

shee

t. N

ew

depr

essio

ns ar

e int

rodu

ced

once

mor

e. Th

ese a

re fi

lled

this

time w

ith m

olte

n su

cros

e (c

ane s

ugar

) and

cove

red

with

mol

ten

lead

from

the fi

rst l

ead-

hone

y-sh

eet.

After

cool

ing

it is

finely

gra

ted

and

the D

1 po

tenc

y is p

repa

red

by tr

itura

tion

with

lact

ose

mon

ohyd

rate

. Dur

ing

the g

rindi

ng an

d tri

tura

tion

proc

ess t

he p

owde

r mus

t be

sieve

d.Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Arni

ca/B

etul

a com

p.; A

rnic

a/Ep

iphy

sis/P

lum

bum

mell

itum

co

mp.

; Arn

ica/

Hyp

ophy

sis/

Plum

bum

mell

itum

com

p.;

Arni

ca/P

lum

bum

mell

itum

; Au

rum

/Plu

mbu

m m

ellitu

m

com

p.; N

icotia

na/S

troph

antu

s co

mp.

; Plu

mbu

m m

ellitu

m

Prim

ula v

eris,

Flo

s rec

., et

hano

l. D

iges

tio (1

: 12

.35)

with

0.6

%

Hyo

scya

mus

nig

er,

Her

ba re

c. Ø

Prim

ula v

eris

L. /

Hyo

scya

mus

nig

er L

.Pr

epar

ed b

y dig

estio

n ac

cord

ing

to A

PC 3

.8.1

from

1 p

art o

f the

fres

h flo

wers

of P

rimul

a ve

ris L

. and

12.

35 p

arts

of et

hano

l of s

uita

ble c

once

ntra

tion

and

the a

dditi

on o

f 0.0

8 pa

rts (

corr

espo

ndin

g to

0.6

%) o

f Hyo

scya

mus

nig

er L

., Her

ba, m

othe

r tin

ctur

e (Ph

. Eur

. 1.

1.3)

.

Prim

ula v

eris,

Flo

s rec

., et

hano

l. D

iges

tio (1

:3.1

) wi

th 0

.1-1

% H

yosc

yam

us

nige

r, H

erba

rec.

Ø

Prim

ula v

eris

L. /

Hyo

scya

mus

nig

er L

.A

dige

stio

prep

ared

from

1 p

art o

f the

fres

h flo

wers

of P

rimul

a ver

is L.

and

3.1

part

s of

etha

nol o

f sui

tabl

e con

cent

ratio

n or

wat

er fo

r inj

ectio

ns an

d th

e add

ition

of 0

.004

to 0

.04

part

s (co

rres

pond

ing

to 0

.1 to

1%

) of H

yosc

yam

us n

iger

L., H

erba

, mot

her t

inct

ure (

Ph.

Eur.

1.1.

3).

Ono

pord

on co

mp.

Prun

usei

sen

Prun

us sp

inos

a L. /

Fer

rum

m

etal

licum

Prep

ared

acco

rdin

g to

HAB

met

hod

37a

Levi

co co

mp.

; Pru

nus s

pino

sa

cum

Fer

ro

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.6


196

Que

rcus

e co

rtic

e cum

Ca

lcio

carb

onic

oQ

uerc

us ro

bur L

., Que

rcus

pe

traea

(Mat

t.) L

iebl

., Q

uerc

us p

ubes

cens

Will

d.

1. C

alciu

m ca

rbon

icum

e ci

nere

Que

rcus

: oak

bar

k is

inci

nera

ted.

The a

sh is

susp

ende

d 1

part

in 1

0 pa

rts o

f pur

ified

wat

er. C

arbo

n di

oxid

e is i

nduc

ed fo

r 5 to

10

min

utes

and

then

wa

rmed

unt

il bu

bblin

g sta

rts (

75-8

5 °C

). Th

is te

mpe

ratu

re is

kep

t unt

il bu

bblin

g en

ds.

The c

ooled

susp

ensio

n is

filte

red

and

the r

esid

ue d

ried

= Ca

lcium

carb

onic

um e

cine

re

Que

rcus

. 2. C

alciu

m ca

rbon

icum

e ci

nere

Que

rcus

solu

tum

: 0.1

par

t of C

alciu

m

carb

onic

um e

cine

re Q

uerc

us is

mix

ed w

ith 6

100

part

s of p

urifi

ed w

ater

or w

ater

for

Inje

ctio

ns an

d bo

iled

for 5

min

utes

. The c

ooled

solu

tion

is fil

tere

d (fo

r sol

utio

ns fo

r in

ject

ion

it is

deca

nted

and

filte

red)

. The r

esul

t is a

satu

rate

d aq

ueou

s sol

utio

n of

Ca

lcium

carb

onic

um e

cine

re Q

uerc

us =

Cal

cium

carb

onic

um e

cine

re Q

uerc

us

solu

tum

. 2.1

. Cal

cium

carb

onic

um e

cine

re Q

uerc

us so

lutu

m sa

ccha

ratu

m: s

yrup

pr

epar

ed w

ith su

cros

e and

Cal

cium

carb

onic

um e

cine

re Q

uerc

us so

lutu

m (6

4:36

). 3.

Q

uerc

us ro

bur/

petra

ea e

cort

ice c

um C

alci

o ca

rbon

ico

solu

tion

= D

5: A

dec

octio

n of

oa

k ba

rk ac

cord

ing

to H

AB 2

3a (Ø

=D1)

is p

oten

tised

to D

5 wi

th C

alciu

m ca

rbon

icum

e ci

nere

Que

rcus

solu

tum

as a

vehi

cle. A

ppen

dix:

acco

rdin

g to

the d

osag

e for

m to

be

prod

uced

eith

er p

oten

tise f

urth

er w

ith C

alciu

m ca

rbon

icum

e ci

nere

Que

rcus

solu

tum

(e

.g. s

olut

ion

for i

njec

tion)

or w

ith C

alciu

m ca

rbon

icum

e ci

nere

Que

rcus

solu

tum

sa

ccha

ratu

m (G

lobu

li ve

lati).

Calci

um ca

rbon

icum

cum

Q

uerc

u; C

alciu

m ca

rbon

icum

/M

esen

chym

com

p.

Rose

neise

nRo

sa L

., sui

tabl

e spe

cies

of

the g

enus

/ Fer

rum

m

etal

licum

Prep

ared

acco

rdin

g H

AB m

etho

d 37

aFe

rrum

rosa

tum

/Gra

phite

s

Rube

llit c

omp.

Equi

setu

m li

mos

um

(Equ

isetu

m fl

uvia

tile L

.),

Rube

llit,

Mel

Fres

h ha

rves

ted

shoo

ts of

Equ

isetu

m li

mos

um L

. (Eq

uise

tum

fluv

iatil

e L.)

are p

ut in

to an

aq

ueou

s dilu

tion

of R

ubell

it D

6 du

ring

the d

ay an

d in

the p

rese

nce o

f day

ligh

t. In

the

even

ing

the s

hoot

s are

take

n ou

t, co

mm

inut

ed an

d ex

pres

sed.

4 p

arts

of ex

pres

sed

juic

e ar

e mix

ed w

ith 1

par

t of m

el. A

fter s

tand

ing

at 3

7 °C

for 1

2 h

durin

g th

e nig

ht, 5

par

ts of

et

hano

l 96%

are a

dded

. Filt

er aft

er 5

to 1

0 da

ys. Th

e filtr

ate i

s Rub

ellit

com

p. Ø

. Po

tent

isatio

n ac

c. to

Ph.

Eur.

1.1.

1

Der

Mer

kurs

tab

2013

; 66

(5):

415-

436,

43

9-44

2.

Silex

Lap

is ca

ncri

solu

tus

Silex

(Flin

t) / K

alii

nitra

s /

Lapi

s can

cri /

Ace

tum

Vin

i de

st. (V

itis v

inife

ra L

.)

Calci

um si

licat

e is p

recip

itate

d by

addi

ng an

aque

ous s

olut

ion

of p

otas

sium

silic

ate

(pre

pare

d fro

m fl

int a

nd p

otas

sium

nitr

ate)

to an

aque

ous s

olut

ion

of ca

lcium

acet

ate

(pre

pare

d fro

m L

apis

Canc

ri an

d di

stille

d re

d wi

ne vi

nega

r in

seve

ral s

teps

) and

di

ssol

ved

in d

istill

ed re

d wi

ne vi

nega

r to

give

a cle

ar so

lutio

n. Th

e sol

utio

n is

dilu

ted

with

wat

er to

1.0

% an

d th

en su

ccus

sed

to re

sult

the p

oten

cy D

2. P

oten

tisat

ion

acc.

to

Ph.E

ur. 3

.1.1

Vade

mec

um 2

013:

Si

lex-L

apis

Canc

ri so

lutu

s

Solu

tio al

kalin

aTa

rtar

us cr

udus

An aq

ueou

s sol

utio

n (1

0% d

ry re

sidue

) pre

pare

d fro

m as

h of

gre

en p

lant

s and

crud

e cr

eam

of t

arta

r. Po

tent

ising

acc.

to P

h.Eu

r. 3.

1.1

(eth

anol

18%

)So

lutio

alka

lina

Vade

mec

um

Solu

tio F

erri

com

p.Ka

lii ca

rbon

as /

Ferr

um(II

I)-Ka

lium

-ta

rtar

icum

/ Su

lfur /

Tro

na /

Acid

um ta

rtar

icum

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Urt

ica d

ioic

a, Pl

anta

tota

, Sol

utio

Fe

rri c

omp.

is p

repa

red

from

: Pot

assiu

m ca

rbon

ate /

ferr

ic p

otas

sium

tart

rate

/ su

lfur /

tro

na /

acid

um ta

rtar

icum

. Pot

assiu

m ca

rbon

ate,

trona

and

sulfu

r are

melt

ed to

geth

er.

The r

esul

ting

melt

is d

issol

ved

in w

ater

and

alte

rnat

ely h

eate

d an

d su

bjec

ted

to an

in

tens

ive a

ir-str

eam

. Afte

r thi

s pro

cedu

re fe

rric

pot

assiu

m ta

rtra

te an

d ac

idum

ta

rtar

icum

are a

dded

. The r

esul

ting

solu

tion

is ex

pose

d to

the l

ight

. Pot

entis

atio

n ac

c. to

Ph

.Eur

. 3.1

.1

Aqua

Mar

is co

mp.

; Gla

ndul

a su

prar

enal

is/So

lutio

Fer

ri co

mp.

; So

lutio

Fer

ri co

mp.

Vade

mec

um

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.6


197

Solu

tio S

acch

ari c

omp.

Acid

um su

lfuric

um /

Betu

la

pend

ula R

oth

/ Kal

ii ca

rbon

as /

Ferr

um(II

I)-Ka

lium

-tart

aric

um /

Mel

/ Q

uart

z / T

rona

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Cha

mom

illa (

Mat

ricar

ia re

cutit

a L),

Radi

x, S

olut

io S

acch

ari c

omp.

is p

repa

red

from

: Car

bo B

etul

ae /

pota

ssiu

m ca

rbon

ate /

fe

rric

pota

ssiu

m ta

rtra

te /

hone

y / q

uart

z / tr

ona.

Pota

ssiu

m ca

rbon

ate,

quar

tz an

d Ca

rbo

Betu

lae a

re m

elted

toge

ther

. The m

elt is

diss

olve

d in

wat

er to

pro

duce

a cle

ar so

lutio

n, to

wh

ich a

solu

tion

of p

otas

sium

carb

onat

e, tro

na an

d di

lute

d su

lfuric

acid

is ad

ded.

Afte

r ad

ditio

n of

furt

her d

ilute

d su

lfuric

acid

, hon

ey an

d th

en fe

rric

pota

ssiu

m ta

rtra

te ar

e ad

ded.

The r

esul

ting

solu

tion

is ex

pose

d to

the l

ight

. Pot

entis

atio

n ac

c. to

Ph.

Eur.

3.1.

1

Cini

s Arn

icae

com

p.; S

olut

io

Sacc

hari

com

p.Va

dem

ecum

Solu

tio S

ilice

ae co

mp.

Kalii

carb

onas

/ M

arm

or /

Qua

rz /

Sulfu

r / T

rona

The m

iner

al co

mpo

sitio

n ac

cord

ing

to th

e mod

el of

Equ

isetu

m ar

vens

e, H

erba

, Sol

utio

Si

licea

e com

p. is

pre

pare

d fro

m: P

otas

sium

carb

onat

e / m

arbl

e / q

uart

z / tr

ona a

nd

sulfu

r. Q

uart

z and

pot

assiu

m ca

rbon

ate a

re m

elted

toge

ther

and

diss

olve

d in

wat

er. I

n a

furt

her s

tep

mar

ble,

pota

ssiu

m ca

rbon

ate a

nd tr

ona a

re d

issol

ved

in w

ater

by a

ddin

g va

pour

from

bur

ning

sulfu

r to

a sec

ond

solu

tion.

Bot

h so

lutio

ns ar

e com

bine

d un

der

cont

inuo

s vap

our f

rom

bur

ning

sulfu

r. Ai

r is p

asse

d th

roug

h th

e res

ultin

g so

lutio

n fo

r se

vera

l hou

rs. P

oten

tisat

ion

acc.

to P

h.Eu

r. 3.

1.1

Disc

us in

terv

erte

bral

is em

bryo

nalis

/Sol

utio

Sili

ceae

co

mp.

; Sol

utio

Sili

cea c

omp.

Vade

mec

um

Stan

num

mell

itum

Stan

num

met

allic

um /

Mel

/ Sa

ccha

rum

(Sac

char

um

officin

arum

L.)

Stan

num

mell

itum

is p

repa

red

from

tin

with

hon

ey an

d ca

ne su

gar.

Dep

ress

ions

are

intro

duce

d in

to a

shee

t of t

in, t

his i

s fille

d wi

th h

oney

, and

the w

hole

cove

red

with

m

olte

n tin

. Afte

r coo

ling

it is

grat

ed, m

elted

agai

n an

d th

en la

id o

ut as

a sh

eet.

New

de

pres

sions

are i

ntro

duce

d on

ce m

ore.

Thes

e are

fille

d th

is tim

e with

mol

ten

sucr

ose

(can

e sug

ar) a

nd co

vere

d wi

th m

olte

n tin

. Afte

r coo

ling

it is

finely

gra

ted

and

the D

1 po

tenc

y is p

repa

red

by tr

itura

tion

with

lact

ose m

onoh

ydra

te. D

urin

g th

e grin

ding

and

tritu

ratio

n pr

oces

s the

pow

der m

ust b

e sie

ved.

Pot

entis

atio

n ac

c. to

Ph.

Eur.

4.1.

1

Der

Mer

kurs

tab

1992

; 45

(2):

108-

12

Trab

ecul

um co

mp.

Acid

um fo

rmici

cum

e fo

rmic

a / A

mm

onia

e sol

utio

co

ncen

trata

25%

/ Cu

pri

sulfa

s pen

tahy

dric

us /

Hyd

rarg

yrum

biio

datu

m /

Kalii

iodi

dum

/ Tr

abec

ulum

(B

os ta

urus

L.)

1 g

of T

rabe

culu

m co

mp.

(=D

1) is

pre

pare

d fro

m: 0

.1 g

Tra

becu

lum

/ 0.

1 g

acid

um

form

icicu

m e

form

ica (

5%) /

0.0

05 g

Cup

ri su

lfas /

0.0

07 g

Am

mon

iae s

olut

io

conc

entra

ta /

0.03

g H

ydra

rgyr

um b

iioda

tum

/ 0.

0225

g K

alii

iodi

dum

. Tra

becu

lum

is

treat

ed w

ith an

aque

ous s

olut

ion

of ac

idum

form

icicu

m e

form

ica t

o m

ake a

pul

p wi

th a

smoo

th co

nsist

ency

and

then

mix

ed w

ith an

amm

onia

cal s

olut

ion

of co

pper

sulfa

te.

Then

a so

lutio

n of

mer

cury

(II)

iodi

de an

d po

tass

ium

iodi

de an

d fin

ally

lact

ose

mon

ohyd

rate

is ad

ded.

Afte

r dry

ing,

the w

hole

mix

ture

is ru

bbed

to a

unifo

rm p

owde

r. Po

tent

isatio

n ac

c. to

Ph.

Eur.

4.1.

1

Trab

ecul

um co

mp.

Uve

a com

p.Ac

idum

form

icicu

m e

form

ica /

Acid

um

asco

rbic

um /

Liqu

or n

atrii

sil

icici

DAB

6/ F

erro

si su

lfas /

Hyo

scya

mus

nig

er L

. / M

agne

sium

pho

spho

ricum

ac

idum

/ U

vea (

Bos t

auru

s L.

)

1 g

Uve

a com

p. co

ntai

ns: U

vea b

ovis

1.00

g /

Mag

nesiu

m p

hosp

horic

um ac

idum

0.1

0 g

/ Ac

idum

asco

rbic

um 0

.10

g / F

erru

m su

lfuric

um 0

.33

g / S

olut

io n

atrii

silic

ici 1

.00

g /

Hyo

scya

mus

nig

er, P

lant

a tot

a Rh

Ø (H

AB, M

etho

d 21

) 1.0

0 g.

Uve

a is t

reat

ed w

ith an

aq

ueou

s sol

utio

n of

Acid

um fo

rmici

cum

e fo

rmic

a to

mak

e a p

ulp

with

a sm

ooth

co

nsist

ency

and

then

mix

ed w

ith a

solu

tion

of m

agne

sium

pho

spha

te d

ihyd

rate

and

sodi

um si

licat

e. Th

en an

aque

ous s

olut

ion

of fe

rrou

s sul

fate

and

asco

rbic

acid

are a

dded

, an

d fin

ally

Hyo

scya

mus

, Pla

nta t

ota R

h Ø

is ad

ded.

Afte

r dry

ing,

the s

ubsta

nce i

s po

wder

ed. P

oten

tisat

ion

acc.

to P

h.Eu

r. 4.

1.1

Visc

um A

biet

isVi

scum

albu

m ss

p. ab

ietis

(W

iesb

.) Ja

nch.

Aque

ous e

xtra

cts f

rom

fres

h pl

ants

of V

iscum

albu

m ss

p. ab

ietis

(Wie

sb.)

Janc

h.,

prep

ared

acco

rdin

g to

APC

7.2

.2.

Visc

um al

bum

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.6


198

Visc

um al

bum

(Abi

etis)

e pl

anta

tota

KVi

scum

albu

m ss

p. ab

ietis

(B

eck)

(Wie

sb.)

Abro

m.

Aque

ous e

xtra

ct p

repa

red

from

the d

ried

plan

t inc

ludi

ng fr

uit a

nd h

austo

rium

of

Visc

um al

bum

ssp.

abie

tis (B

eck)

(Wie

sb.)

Abro

m. (

Hos

t tre

e: Ab

ies a

lba M

ill.)

prep

ared

ac

cord

ing

to H

AB 3

8

Visc

um al

bum

Visc

um al

bum

(Cra

taeg

i) e p

lant

a tot

a KVi

scum

albu

m ss

p. al

bum

L.

Aque

ous e

xtra

cts p

repa

red

from

drie

d pl

ants

inclu

ding

frui

t and

hau

storiu

m o

f Visc

um

albu

m ss

p. al

bum

L. (

Hos

t tre

e: Cr

atae

gus L

.) pr

epar

ed ac

cord

ing

to H

AB 3

8Vi

scum

albu

m

Visc

um al

bum

(Mal

i) e

plan

ta to

ta K

Visc

um al

bum

L. s

sp. a

lbum

Aque

ous e

xtra

ct p

repa

red

from

the d

ried

plan

t inc

ludi

ng fr

uit a

nd h

austo

rium

of

Visc

um al

bum

L. s

sp. a

lbum

(hos

t tre

e: M

alus

dom

estic

a Bor

ck.)

prep

ared

acco

rdin

g to

H

AB 3

8

Visc

um al

bum

Visc

um al

bum

(Pin

i) e

plan

ta to

ta K

Visc

um al

bum

ssp.

au

stria

cum

(Wie

sb.)

Vollm

.Aq

ueou

s ext

ract

pre

pare

d fro

m d

ried

plan

ts in

cludi

ng fr

uit a

nd h

austo

rium

of V

iscum

al

bum

L. s

sp. a

ustr

iacu

m (W

iesb

.) Vo

llm. (

Hos

t tre

e: Pi

nus s

peci

es) p

repa

red

acco

rdin

g to

HAB

38

Visc

um al

bum

Visc

um al

bum

(Pop

uli)

e pl

anta

tota

KVi

scum

albu

m L

. ssp

. alb

umAq

ueou

s ext

ract

pre

pare

d fro

m d

ried

plan

ts in

cludi

ng fr

uit a

nd h

austo

rium

of V

iscum

al

bum

L ss

p. al

bum

(Hos

t tre

e: Po

pulu

s L.)

prep

ared

acco

rdin

g to

HAB

38

Visc

um al

bum

Visc

um al

bum

(Que

rcus

) ex

her

ba K

Visc

um al

bum

L ss

p. al

bum

Aque

ous e

xtra

ct p

repa

red

from

drie

d pl

ant i

nclu

ding

frui

t and

exclu

ding

hau

storiu

m o

f Vi

scum

albu

m L

. ssp

. alb

um (H

ost t

ree:

Que

rcus

L.)

prep

ared

acco

rdin

g to

HAB

met

hod

38

Visc

um al

bum

Visc

um al

bum

(Sal

icis)

e pl

anta

tota

KVi

scum

albu

m L

. ssp

. alb

um

L.Aq

ueou

s ext

ract

s of d

ried

plan

ts in

cludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m ss

p.

albu

m L

. (H

ost t

ree:

Salix

L.)

prep

ared

acco

rdin

g to

HAB

38

Visc

um al

bum

Visc

um al

bum

(Tili

ae) e

pl

anta

tota

KVi

scum

albu

m L

. ssp

. alb

umAq

ueou

s ext

ract

of d

ried

plan

ts in

cludi

ng fr

uit a

nd h

austo

rium

of V

iscum

albu

m ss

p.

albu

m L

. (H

ost t

ree:

Tilia

L.)

prep

ared

acco

rdin

g to

HAB

38

Visc

um al

bum

Visc

um M

ali

Visc

um al

bum

ssp.

albu

m L

.Fe

rmen

ted

aque

ous e

xtra

ct p

repa

red

from

the f

resh

pla

nts e

xclu

ding

hau

storiu

m o

f Vi

scum

albu

m ss

p. al

bum

L. (

Hos

t tre

e: M

alus

dom

estic

a Bor

kh.; a

pple

tree)

, pre

pare

d ac

cord

ing

to A

PC 7

.2.3

.

Visc

um al

bum

Visc

um M

ali

Visc

um al

bum

ssp.

albu

m L

.pr

epar

ed ac

cord

ing

to A

PC 7

.2.2

.

Visc

um M

ali c

um

Arge

nto

Visc

um al

bum

L. s

sp.

albu

m /

Arge

nti c

arbo

nas

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d wi

th ad

ditio

n of

silv

er ca

rbon

ate (

2x10

-5 m

g pe

r 10

0 m

g fre

sh p

lant

), ac

cord

ing

to A

PC 7

.2.4

.Vi

scum

albu

m c.

Arg

Visc

um M

ali c

um C

upro

Visc

um al

bum

ssp.

albu

m

L./ M

alac

hite

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d wi

th ad

ditio

n of

copp

er ca

rbon

ate (

mal

achi

te)

(2x1

0-5

mg

per 1

00 m

g fre

sh p

lant

), ac

cord

ing

to A

PC 7

.2.4

.Vi

scum

albu

m c.

Cu

Visc

um M

ali c

um

Hyd

rarg

yro

Visc

um al

bum

ssp.

albu

m

L. /

Hyd

rarg

yri s

ulfa

sFe

rmen

ted

aque

ous e

xtra

ct w

ith ad

ditio

n of

mer

cury

sulfa

te (2

x10-

5 m

g pe

r 100

mg

fresh

pla

nt),

prep

ared

acco

rdin

g to

APC

7.2

.4.

Visc

um al

bum

c. H

g

Visc

um P

ini

Visc

um al

bum

L. s

sp.

austr

iacu

m (W

iesb

.) Vo

llm.

prep

ared

acco

rdin

g to

APC

7.2

.3.

Visc

um al

bum

Visc

um P

ini

Visc

um al

bum

ssp.

au

stria

cum

(Wie

sb.)

Vollm

.pr

epar

ed ac

cord

ing

to A

PC 7

.2.2

.Vi

scum

albu

m

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Appendix 2.6


199

Visc

um P

ini c

um

Hyd

rarg

yro

Visc

um al

bum

ssp.

au

stria

cum

(Wie

sb.)

Vollm

ann

/ Hyd

rarg

yri

sulfa

s

Ferm

ente

d aq

ueou

s ext

ract

with

addi

tion

of m

ercu

ry su

lfate

(10-

5 m

g pe

r 100

mg

fresh

pl

ant),

pre

pare

d ac

cord

ing

to A

PC 7

.2.4

.Vi

scum

albu

m c.

Hg

Visc

um Q

uerc

iVi

scum

albu

m ss

p. al

bum

L.

Ferm

ente

d aq

ueou

s ext

ract

pre

pare

d ac

cord

ing

to A

PC 7

.2.3

.Vi

scum

albu

m

Visc

um Q

uerc

i cum

Ar

gent

oVi

scum

albu

m ss

p. al

bum

L.

/ Ar

gent

i car

bona

sFe

rmen

ted

aque

ous e

xtra

ct w

ith ad

ditio

n of

silv

er ca

rbon

ate (

10-8

mg

per 1

00 m

g fre

sh

plan

t), p

repa

red

acco

rdin

g to

APC

7.2

.4.

Visc

um al

bum

c. A

rg

Visc

um Q

uerc

i cum

Cu

pro

Visc

um al

bum

ssp.

albu

m

L. /

Mal

achi

teFe

rmen

ted

aque

ous e

xtra

ct w

ith ad

ditio

n of

copp

er ca

rbon

ate (

mal

achi

te) (

10-5

mg

per

100

mg

fresh

pla

nt),

prep

ared

acco

rdin

g to

APC

7.2

.4.

Visc

um al

bum

c. C

u

Visc

um Q

uerc

i cum

H

ydra

rgyr

oVi

scum

albu

m L

. ssp

. alb

um

L. /

Hyd

rarg

yri s

ulfa

sFe

rmen

ted

aque

ous e

xtra

ct w

ith ad

ditio

n of

mer

cury

sulfa

te (1

0-5

mg

per 1

00 m

g fre

sh

plan

t), p

repa

red

acco

rdin

g to

APC

7.2

.4.

Visc

um al

bum

c. H

g

Visc

um U

lmi c

um

Hyd

rarg

yro

Visc

um al

bum

ssp.

albu

m

L./ H

ydra

rgyr

i sul

fas

Ferm

ente

d aq

ueou

s ext

ract

with

addi

tion

of m

ercu

ry su

lfate

(10-

5 m

g pe

r 100

mg

fresh

pl

ant),

pre

pare

d ac

cord

ing

to A

PC 7

.2.4

.Vi

scum

albu

m c.

Hg

Nam

e of c

ompo

sitio

nSc

ient

ific n

ames

of

ingr

edie

nts

Prep

arat

ion

met

hod

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.6


200

•


201

•

Ap

pend

ix 2

.7

APPENDIX 2.7

Stocks with special manufacturing methods


202

Nam

e of t

he su

bsta

nce

Defi

nitio

nPr

epar

atio

n m

etho

dRe

fere

nce

to S

tand

ard

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

Arni

ca m

onta

na, P

lant

a tot

a re

c. 1:

1,1

Etha

nolic

extra

ct o

f who

le pl

ants

of

Arni

ca m

onta

na L

.W

hole,

fres

h flo

werin

g pl

ants

of A

rnic

a mon

tana

L. a

re

com

min

uted

and

mac

erat

ed fo

r 10-

30 d

ays w

ith 1

.1 p

arts

of et

hano

l, gi

ving

an E

than

ol co

ncen

tratio

n of

36%

V/V

, th

en p

ress

ed an

d fil

trate

d.

HAB

Arni

ca, P

lant

a tot

a

Bryo

phyl

lum

pin

nata

1:1

,1Aq

ueou

s ext

ract

of B

ryop

hyllu

m

pinn

atum

(Lam

.) O

ken

Fres

h lea

ves o

f Bry

ophy

llum

pin

natu

m ar

e mac

erat

ed

unde

r occ

asio

nal s

tirrin

g wi

th 1

.1 p

arts

of w

ater

for

1.5-

2.5

h, p

ress

ed an

d th

e flui

d lat

er fi

ltrat

ed.

HAB

Bryo

phyl

lum

Carb

o Be

tula

eCa

rbon

obt

aine

d fro

m w

ood

of B

etul

a pe

ndul

a Rot

h or

B. p

ubes

cens

Ehr

h.Ca

rbon

pre

pare

d fro

m w

ood

of B

etul

a pen

dula

or B

. pu

besc

ens a

ccor

ding

to A

PC 4

.2 (c

f. Ph

.Helv

. 17.

7.4.

2).

Pote

ntisa

tion

acc.

to P

h.Eu

r. 4.

1.1

HAB

; Ph.

fr.Ba

rium

/Pan

crea

s com

p.; C

arbo

Be

tula

e; Ca

rbo

Betu

lae c

um M

etha

no;

Carb

o Be

tula

e/Ca

rvi a

ethe

roleu

m;

Carb

o Be

tula

e/Cr

atae

gus;

Carb

o Be

tula

e/Su

lfur

Carb

o Co

ffeae

Prod

uct w

ith m

in. 1

.0%

caffe

ine,

obta

ined

by i

nten

sive r

oasti

ng o

f rip

e, dr

ied

seed

s of C

offea

arab

ica L

.

Inte

nsiv

e roa

sting

of r

ipe,

drie

d se

eds o

f Coff

ea ar

abic

a H

AB. P

oten

tisat

ion

acc.

to P

h.Eu

r. 4.

1.1

(HAB

)

Carb

o Pt

erid

ii aq

uilin

iCa

rbon

obt

aine

d fro

m le

aves

of

Pter

idiu

m aq

uilin

um (L

.) Ku

hnLe

aves

of P

terid

ium

aqui

linum

are d

ried

and

the c

arbo

n is

prep

ared

acco

rdin

g to

APC

4.2

. Pot

entis

atio

n ac

cord

ing

to

Ph.E

ur. 4

.1.1

Carb

ones

/Pan

krea

s/W

ither

it

Care

x ar

enar

ia, e

than

ol.

Dec

octu

m 1

:4Et

hano

lic d

ecoc

tion

of th

e drie

d rh

izom

e of C

arex

aren

aria

L.

The c

omm

inut

ed d

ried

rhiz

ome i

s mix

ed w

ith 3

.14

part

s of

wat

er an

d 0.

86 p

arts

of et

hano

l 96%

. Afte

r 12-

18 h

, the

m

ixtu

re is

hea

ted

for 3

0 m

in u

nder

reflu

x to

get a

n et

hano

lic d

ecoc

tion

1:4

(DEV

) (cf

. Ph.

Eur.

1.2.

12).

The

mix

ture

is p

ress

ed an

d lat

er fi

ltere

d.

Cini

s Glec

hom

atis

Ash

from

drie

d flo

werin

g pl

ant o

f G

lecho

ma h

eder

acea

L.

Ash

obta

ined

from

drie

d flo

werin

g pl

ant o

f Glec

hom

a he

dera

cea a

cc. t

o AP

C 4.

3. P

oten

tisat

ion

acc.

to P

h.Eu

r. 4.

1.1

Cini

s Urt

icae

Fer

ro cu

ltae

Ash

obta

ined

from

drie

d, ae

rial p

arts

of

Urtic

a dio

ica F

erro

culta

Urtic

a dio

ica F

erro

culta

(app

. 2.5

) is d

ried

and

the a

sh

prep

ared

acco

rdin

g to

Ph.

Helv

. 17.

7.4.

3 (c

f. AP

C 4.

3).

Pote

ntisa

tion

acc.

to P

h.Eu

r. 4.

1.1.

Urtic

a dio

ica F

erro

culta

Vade

mec

um

Citr

us li

mon

, Fru

ct. r

ec.,

1:0.

41Et

hano

lic ex

tract

of f

resh

frui

t of C

itrus

lim

on (L

.) Bu

rman

fil.

Fres

h fr

uit o

f Citr

us li

mon

is ex

tract

ed w

ith et

hano

l 36%

(D

ER =

1:0

.41)

Hyp

eric

um p

erfo

ratu

m; F

los;

Extr.

oleo

s 1:2

Oil

extra

ct o

f fre

sh fl

ower

s of

Hyp

eric

um p

erfo

ratu

mFr

esh

flowe

rs o

f Hyp

eric

um p

erfo

ratu

m ar

e ext

ract

ed w

ith

2 pa

rts o

f refi

ned

sesa

me o

il.H

yper

icum

Lac T

arax

aci

Fres

h lat

ex o

f Tar

axac

um o

ffici

nale

(fres

h un

derg

roun

d pa

rts)

colle

cted

in

sprin

g (v

erna

le)

Ph.E

ur. 1

.1.2

Laur

ocer

asus

100

%Aq

ueou

s dist

illat

e of t

he fr

esh

leave

s of

Prun

us la

uroc

eras

us L

. with

0.0

9-0.

11%

H

CN

See m

onog

raph

; adj

ustm

ent o

f the

dist

illat

e to

0.1%

HCN

by

addi

ng et

hano

l 4.8

%H

AB; P

h.

Helv

.Sp

iritu

s con

tra tu

ssim

•

Appendix 2.7


203

Muc

ilago

Lev

istici

D1

Aque

ous e

xtra

ct o

f the

drie

d ro

ot o

f Le

visti

cum

offi

cinal

e Koc

hTh

e drie

d ro

ot is

com

min

uted

(200

0) an

d 1

part

is

mac

erat

ed fo

r 12-

18 h

with

8.4

par

ts of

wat

er an

d th

en

pres

sed

and

filte

red.

To

one p

art o

f the

flui

d 0.

1905

par

ts of

etha

nol 9

6% ar

e add

ed to

get M

ucila

go L

evist

ici D

1 wi

th 1

8% et

hano

l. La

ter,

the e

xtra

ct is

filte

red.

Ph.E

ur.

Levi

sticu

m

Sepi

a Gru

neris

Drie

d se

cret

ion

from

ink

glan

d fro

m

Sepi

a offi

cinal

is L.

Acc.

to G

rune

r: 1

part

of t

he d

ried

secr

etio

n is

extra

cted

un

der s

tirrin

g wi

th 5

.24

part

s of w

ater

for a

t lea

st 5

h, th

en

mix

ed w

ith 4

.76

part

s of e

than

ol 9

6%, p

oten

tised

and

filtra

ted.

Pot

entis

atio

n ac

c. to

Ph.

Eur.

1.1.

9

HAB

Sepi

a com

p.

Visc

um al

bum

, Ext

ract

um

resin

osum

An ex

tract

of t

he li

poph

ilic,

resin

ous

subs

tanc

es o

f the

gre

en p

arts

of V

iscum

al

bum

L.

Fres

h gr

een

part

s (ste

ms,

leave

s and

gre

en ge

nera

tive

orga

ns) o

f Visc

um al

bum

are c

omm

inut

ed an

d ex

tract

ed

with

supe

rcrit

ical

CO

2 at

700

-900

bar

.

Phyt

omed

icine

201

5;

22. S

uppl

. 1 S

. S28

. An

thro

poso

phisc

he

Phar

maz

ie S

alum

ed

Verla

g Be

rlin

2016

Nam

e of t

he su

bsta

nce

Defi

nitio

nPr

epar

atio

n m

etho

dRe

fere

nce

to S

tand

ard

Refe

renc

e for

use

in an

thro

poso

phic

med

icin

e

KC M

onog

raph

Oth

er

•

Ap

pend

ix 2

.7


204

•


205

•

Ap

pend

ix I

I

APPENDIX II

Correlation table: Ph.Eur./HAB manufacturing methods used in anthroposophic pharmacy and corresponding manufacturing methods in the HPUS


206

•

Ph. E

ur. /

HA

B m

etho

ds u

sed

in

anth

ropo

soph

ic p

harm

acy

Cor

resp

ondi

ng m

anuf

actu

ring

Met

hods

in th

e H

PUS

Ph. E

ur. M

etho

d 1.

1.1

(HA

B 1a

)Ph

. Eur

. Met

hod

1.1.

2 (H

AB

1b)

Cla

ss O

Ph. E

ur. M

etho

d 1.

1.3

(HA

B 2a

)Ph

. Eur

. Met

hod

1.1.

4 (H

AB

2b)

Cla

ss M

Ph. E

ur. M

etho

d 1.

1.5

(HA

B 3a

)Ph

. Eur

. Met

hod

1.1.

6 (H

AB

3b)

Ph. E

ur. M

etho

d 1.

1.7

(HA

B 3c

)

Cla

ss N

Ph. E

ur. M

etho

d 1.

1.8

(HA

B 4a

)C

lass

C

Ph. E

ur. M

etho

d 1.

1.9

(HA

B 4b

)C

lass

E

Ph. E

ur. M

etho

d 1.

1.10

(Ph.

fr.)

No

corr

espo

ndin

g H

PUS

met

hod

for a

ttenu

atio

ns, t

houg

h C

lass

C is

the

sam

e pr

oces

s for

the

first

step

1

Ph. E

ur. M

etho

d 1.

1.11

(Ph.

fr.)

No

corr

espo

ndin

g H

PUS

met

hod

for a

ttenu

atio

ns, t

houg

h C

lass

D is

the

sam

e pr

oces

s for

the

first

step

2

Ph. E

ur. M

etho

d 3.

1.1

(HA

B 5a

)C

lass

A o

r Cla

ss B

, dep

endi

ng o

n so

lubi

lity

Cha

ract

erist

ics o

f the

star

ting

mat

eria

l

Ph. E

ur. M

etho

d 3.

1.2

(HA

B 5b

)C

lass

A o

r Cla

ss B

, dep

endi

ng o

n so

lubi

lity

Cha

ract

erist

ics o

f the

star

ting

mat

eria

l

Ph. E

ur. M

etho

d 4.

1.1

(HA

B 6)

Cla

ss F

Ph. E

ur. M

etho

d 4.

1.2

(Ph.

fr.)

Cla

ss F

Ph. E

ur. M

etho

d 4.

2.1

(HA

B 7)

“Med

icat

ion:

Med

icat

ed P

owde

rs” a

pplie

s for

cent

esim

al, b

ut n

ot fo

r dec

imal

atte

nuat

ions

3

Ph. E

ur. M

etho

d 3.

2.1

(HA

B 8a

)Ph

. Eur

. Met

hod

3.2.

2 (H

AB

8b)

Cla

ss H

1 Th

e Ph

. Eur

. Met

hod

1.1.

10 p

rodu

ces a

1:1

0 pr

epar

atio

n fr

om w

hich

the

D1

or C

1 is

mad

e. Th

e H

PUS

Cla

ss C

also

pro

duce

s a 1

:10

prep

arat

ion.

But

this

is co

nsid

ered

the

sam

e as

a D

1. Th

us, P

h. E

ur. M

etho

d 1.

1.10

D1

= H

PUS

D2.

For

this

reas

on, t

he m

etho

ds d

o no

t cor

resp

ond.

2 Th

e Ph

. Eur

. Met

hod

1.1.

11 p

rodu

ces a

1:2

0 pr

epar

atio

n fr

om w

hich

the

D1

or C

1 is

mad

e. Th

e H

PUS

Cla

ss D

also

pro

duce

s a 1

:20

prep

arat

ion.

But

the

Cla

ss D

pr

epar

atio

n is

then

atte

nuat

ed 2

par

ts +

8 p

arts

veh

icle

to p

rodu

ce th

e D

2. Th

e pr

epar

atio

n by

Ph.

Eur

. Met

hod

1.1.

11 is

atte

nuat

ed 1

par

t + 9

par

ts v

ehic

le to

pro

duce

th

e D

1. F

or th

is re

ason

, the

met

hods

do

not c

orre

spon

d.3

HPU

S “M

edia

ted

Pow

ders

” are

spec

ified

to b

e m

ade

from

1 p

art l

iqui

d pr

epar

atio

n +

100

part

s veh

icle

.

•

Appendix II


207

•

Ap

pend

ix I

I

Ph. E

ur. /

HA

B m

etho

ds u

sed

in

anth

ropo

soph

ic p

harm

acy

Cor

resp

ondi

ng m

anuf

actu

ring

Met

hods

in th

e H

PUS

HA

B M

etho

d 9

“Med

icat

ion:

Tab

lets”

HA

B M

etho

d 10

“Med

icat

ion:

Glo

bule

s”

HA

B M

etho

d 11

“For

ms o

f veh

icle

s for

disp

ensin

g”

HA

B M

etho

d 12

a“F

orm

s of v

ehic

les f

or d

ispen

sing”

HA

B M

etho

d 12

bC

lass

M

HA

B M

etho

d 13

“For

ms o

f veh

icle

s for

disp

ensin

g”

HA

B M

etho

d 14

“For

ms o

f veh

icle

s for

disp

ensin

g”

HA

B M

etho

d 15

“For

ms o

f veh

icle

s for

disp

ensin

g: O

phth

alm

ic S

olut

ions

”

HA

B M

etho

d 16

New

Sec

tion

39, a

nd “I

ntro

duct

ion

to th

e H

omoe

opat

hic P

harm

acop

oeia

of t

he U

nite

d St

ates

: St

atem

ent r

egar

ding

com

bina

tions

of h

omoe

opat

hic d

rugs

”H

AB

Met

hod

17“A

ttenu

atio

ns: F

ifty

Mill

esim

al S

cale

of A

ttenu

atio

n”

Ph. E

ur. M

etho

ds 1

.2.1

-2 (H

AB

18a-

b)C

lass

M, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: I

ncub

atio

n”

Ph. E

ur. M

etho

ds 1

.2.3

-5 (H

AB

18c-

e)C

lass

N, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: I

ncub

atio

n”

Ph. E

ur. M

etho

d 1.

2.6

(HA

B 18

f)C

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: I

ncub

atio

n”

Ph. E

ur. M

etho

ds 1

.2.7

-8 (H

AB

19a-

b)C

lass

M, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: D

ecoc

tion”

Ph. E

ur. M

etho

ds 1

.2.9

-11

(HA

B 19

c-e)

Cla

ss N

, “Ti

nctu

res o

f bot

anic

al su

bsta

nces

: Dec

octio

n”

Ph. E

ur. M

etho

d 1.

2.12

(HA

B 19

f)C

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: D

ecoc

tion”


208

•

Ph. E

ur. /

HA

B m

etho

ds u

sed

in a

nthr

opos

ophi

c ph

arm

acy

Cor

resp

ondi

ng m

anuf

actu

ring

Met

hods

in th

e H

PUS

Ph. E

ur. M

etho

d 1.

2.13

(HA

B 20

)C

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: I

nfus

ion”

HA

B M

etho

d 21

Cla

ss O

, fer

men

ted

HA

B M

etho

d 22

Cla

ss P

Ph. E

ur. M

etho

d 1.

4.3

(HA

B 23

a)C

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: D

ecoc

tion”

Ph. E

ur. M

etho

d 1.

4.2

(HA

B 23

b)C

lass

N, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: D

ecoc

tion”

Ph. E

ur. M

etho

d 1.

4.4

(HA

B 24

a)C

lass

C, “

Tinc

ture

s of b

otan

ical

subs

tanc

es: I

nfus

ion”

HA

B M

etho

ds 3

3C

lass

P

HA

B M

etho

ds 3

4C

lass

P

HA

B M

etho

ds 3

5C

lass

P

HA

B M

etho

ds 3

6C

lass

P

Ph. E

ur. M

etho

d 5.

1.1

(HA

B 40

a)Ph

. Eur

. Met

hod

5.1.

2 (H

AB

40b)

Ph. E

ur. M

etho

d 5.

1.3

(HA

B 40

c)

No

corr

espo

ndin

g m

etho

d

Ph. E

ur. M

etho

d 2.

1.1

(HA

B 42

a)Ph

. Eur

. Met

hod

2.1.

2 (H

AB

42b)

Cla

ss L

, Met

hod

II

Ph. E

ur. M

etho

d 2.

1.3

(Ph.

fr.)

No

corr

espo

ndin

g m

etho

d

Ph. E

ur. M

etho

d 2.

2.1

(HA

B 41

a)Ph

. Eur

. Met

hod

2.2.

2 (H

AB

41b)

Ph. E

ur. M

etho

d 2.

2.3

(HA

B 41

c)Ph

. Eur

. Met

hod

2.2.

4 (H

AB

41d)

Cla

ss L

, Met

hod

II (a

ltern

ate

met

hodo

logy

)

HA

B M

etho

ds 4

5“F

orm

s of

veh

icle

s for

disp

ensin

g: N

asal

Sol

utio

ns”

HA

B M

etho

ds 5

1C

lass

P

•

Appendix II


209

•

Ap

pend

ix I

I

i a a p anthroposophic pharmaceutical codex apc second edition 11

Documents